Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AAK1	"DKFZp686K16132, KIAA1048"	ENSG00000115977	"AP2 associated kinase 1"	Q2M2I8	2	69457997-69674349	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 89.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 777.7;Rod photoreceptor cells: 640.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebral cortex: 31.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017931, HPA020289"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Vesicles, Plasma membrane"	Cytosol	"HPA017931: AB_1844406, HPA020289: AB_1844407"	"unprognostic (2.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.06e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.24e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.18e-1)"	9.1	12.6	0.3	8.1	0.6	12.0	8.1	0.9	31.0	7.1	0.0	7.0	4.6	9.9	9.9	7.4	7.5	5.4	20.4	2.9	0.0	10.5	5.1	10.3	9.0	4.7	2.9	5.5	13.1	89.7	13.7	9.9	3.5	8.6	6.3	28.2	6.7	8.2	13.0	6.3	8.5	7.6	0.0	8.6	12.6	6.7	4.8	13.2	23.4	6.7	7.7	7.8	7.1	4.8	25.1	15.3	14.6	12.3	13.7	14.3	41.0	19.4	16.8	12.0	11.3	15.6	10.0	0.9	4.6	27.6	16.5	11.4	11.7	11.4	27.1	20.6	4.4	13.3	9.0	10.0	11.7	9.5	31.3	12.9	9.6	23.7	30.9	10.2	27.4	12.3	3.2	14.1	22.5	3.7	8.8	5.6	6.4	4.9	8.3	5.8	13.8	2.2	10.0	51.0	4.2	6.6	12.0	8.8	10.2	9.9	5.3	12.9	25.6	26.4	17.5	19.7	19.4	12.9	3.9	1.5	23.0	16.0	19.1	1.4	0.5	0.2	1.4	0.2	1.4	0.1	1.3	1.0	0.3	0.3	1.7	1.5	1.5	1.1	2.2	0.2	1.0	0.5	0.3	0.6	0.9	31.0	2.9	0.0	4.7	2.9	3.5	0.0	4.8	4.8	54.6	35.3	34.2	77.7	13.4	15.9	20.8	15.9	32.5	254.4	42.2	40.9	86.7	102.9	19.3	143.5	777.7	81.6	149.1	130.6	43.0	46.0	23.9	36.6	67.4	56.0	72.1	35.3	265.8	67.4	56.3	29.5	44.9	65.7	21.0	24.4	118.2	38.2	62.4	306.2	327.7	31.6	12.2	128.8	23.5	32.7	38.2	67.1	10.6	156.4	72.7	53.2	252.4	147.8	113.9	55.9	76.3	46.6	57.4	42.1	56.0	90.0	10.7	640.8	19.7	26.7	45.5	46.9	59.3	23.3	9.9	213.3	158.1	33.6	21.7	49.0
AC026464.6		ENSG00000272617	"Novel protein, COG8-PDF readthrough"		16	69328644-69334871	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"Cardiomyocytes: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"																					8.0	9.3	8.8	8.7	9.0	6.3	7.7	9.0	13.7	6.5	8.7	9.0	8.9	5.9	9.5	5.9	5.8	3.8	5.2	9.0	9.6	21.5	23.0	7.1	7.6	8.9	8.9	5.4	6.9	17.9	4.2	6.5	9.2	6.9	8.7	4.9	8.3	6.4	12.6	5.6	7.9	7.5	8.3	6.1	5.9	21.2	9.2	9.7	7.1	12.0	9.6	8.7	3.0	9.7	24.1	31.8	23.8	28.3	27.3	17.6	18.6	24.3	23.5	35.2	35.2	35.9	34.2	33.3	17.3	26.1	20.7	31.9	38.3	32.1	27.9	8.3	19.1	20.0	27.7	65.2	25.5	38.4	17.7	18.3	35.4	35.9	26.3	17.1	21.2	37.8	34.4	15.0	27.0	51.9	34.5	45.4	34.0	37.0	10.9	48.0	10.4	56.6	52.3	21.4	30.7	25.2	41.0	17.3	25.3	23.4	62.5	34.9	12.5	24.7	22.1	19.6	26.9	24.3	26.2	63.2	21.1	25.0	29.0	0.7	5.2	4.1	3.7	4.3	4.7	4.3	6.4	7.4	6.7	7.4	7.1	5.8	1.3	6.7	4.6	3.0	5.8	4.5	8.8	9.0	9.0	13.7	9.0	9.6	8.9	8.9	9.2	8.3	9.2	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC118553.2		ENSG00000283761	"Novel protein"		1	99970011-100083321	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 4.1;Collecting duct cells: 1.8;Respiratory ciliated cells: 5.1"					"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA073681			Approved	Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA073681: AB_2686625"																		0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.2	0.2	0.5	0.2	0.2	0.2	0.1	0.6	0.2	0.1	0.1	0.2	0.3	0.3	0.2	0.7	0.0	0.3	0.2	0.3	0.0	1.0	0.0	0.2	0.4	0.2	0.3	1.0	0.2	0.5	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.4	0.2	0.7	0.1	0.3	0.2	0.6	0.1	0.3	0.5	0.7	0.9	0.2	0.0	0.6	0.8	1.3	0.5	1.3	2.7	0.5	2.0	0.1	3.3	2.0	2.7	2.1	2.6	0.9	1.7	0.9	1.3	2.2	3.7	0.1	0.2	0.5	0.5	0.0	0.8	2.5	2.2	0.7	1.6	0.3	1.8	1.2	0.7	1.2	2.3	0.1	0.1	2.1	1.1	0.5	2.0	0.9	0.7	1.1	0.6	0.7	1.1	0.6	0.5	0.8	0.6	0.1	0.5	0.8	1.3	0.7	1.4	0.7	2.9	0.3	1.0	1.0	0.3	8.4	5.1	3.5	4.4	5.2	5.0	2.8	4.5	5.2	5.8	1.9	4.2	3.6	0.8	6.7	3.2	4.6	5.9	5.0	0.0	0.3	0.1	0.2	0.2	0.3	0.3	0.2	0.4	0.1	0.2	0.3	0.3	6.4	4.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	1.3	1.8	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.2	1.3	0.4	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.0
ACSL3	"ACS3, FACL3, PRO2194"	ENSG00000123983	"Acyl-CoA synthetase long chain family member 3"	O95573	2	222860942-222944639	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 172.1"	"Cell type enhanced"	"Detected in all"		"Horizontal cells: 523.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 410.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011315, HPA071021"	Approved		Approved	"Nucleoli,Nucleoli rim,Lipid droplets"		NA	NA		37000	"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoli, Nucleoli rim"	"Lipid droplets"	"HPA011315: AB_1848344, HPA071021: AB_2686335"	"unprognostic (1.87e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.35e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (2.75e-4)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (3.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.60e-1)"	25.2	19.8	22.2	17.5	24.7	27.7	90.8	21.9	29.5	18.4	8.8	27.0	22.2	12.6	24.8	36.1	11.0	16.7	14.8	22.9	26.7	24.3	30.9	20.6	12.3	20.9	26.0	10.8	16.7	172.1	10.0	28.0	22.4	66.1	25.5	32.2	45.4	16.2	25.3	14.9	16.0	14.5	27.5	10.5	50.6	23.3	35.3	19.8	23.8	15.2	14.2	33.5	20.6	24.5	49.7	77.0	118.3	121.9	42.1	121.3	35.0	61.0	159.5	70.5	139.8	75.0	126.4	24.0	33.8	51.9	147.2	143.9	20.4	121.3	76.0	44.0	50.1	55.8	52.2	68.0	91.0	36.2	26.6	60.0	180.7	120.0	163.6	34.7	65.6	39.8	109.6	83.1	78.1	104.8	70.4	42.5	59.9	102.9	42.4	40.0	85.4	39.7	80.8	198.2	57.3	49.3	36.0	79.5	410.5	67.5	49.8	64.8	58.0	43.9	76.2	41.5	41.0	30.0	17.2	81.3	40.7	26.0	140.0	10.7	14.0	20.0	18.0	16.0	17.5	10.5	11.2	13.6	15.2	11.1	16.0	14.9	15.6	16.6	17.2	20.8	9.5	17.5	22.2	24.7	21.9	29.5	22.9	26.7	20.9	26.0	22.4	27.5	35.3	24.5	73.1	35.3	70.8	110.4	29.6	46.5	101.8	97.5	55.2	101.9	89.9	62.9	57.2	28.6	93.8	36.8	77.2	43.7	45.0	46.6	7.9	32.7	59.2	68.9	39.6	41.4	20.9	35.8	91.0	31.1	10.7	56.6	81.1	100.7	27.3	25.3	32.2	52.7	37.4	523.3	124.2	36.0	99.7	49.0	62.7	27.1	26.1	75.3	48.0	69.3	32.1	184.7	20.6	149.3	120.1	37.3	41.3	35.7	24.6	109.4	17.5	14.6	80.3	55.6	46.0	52.8	68.2	49.7	45.3	108.6	48.7	60.6	32.4	52.0	50.7	117.1
ACTR3C	ARP11	ENSG00000106526	"Actin related protein 3C"	Q9C0K3	7	150243916-150323725	"Predicted intracellular proteins"		Actin-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 64.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 87.1;Excitatory neurons: 111.7;Inhibitory neurons: 125.4;Oligodendrocyte precursor cells: 275.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 31.1;RT4: 26.7;SiHa: 17.8"															NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (3.41e-1)"	"unprognostic (4.79e-2)"	"unprognostic (9.62e-2)"	"unprognostic (8.25e-2)"	"unprognostic (6.07e-6)"	"unprognostic (2.83e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.14e-2)"	"unprognostic (5.53e-3)"	2.2	11.9	3.5	3.4	4.5	1.9	6.2	2.9	3.9	5.2	24.3	5.2	5.2	2.5	7.0	7.1	5.4	4.3	2.0	5.3	3.3	13.2	22.9	5.1	4.1	3.1	3.3	1.5	14.5	64.1	5.3	2.2	3.3	4.3	6.9	4.7	4.8	5.4	1.4	2.6	4.1	2.6	1.9	1.8	4.9	4.1	3.2	2.5	6.0	2.8	5.9	4.9	3.2	2.3	6.7	0.6	0.1	0.2	0.0	0.0	1.1	0.1	0.2	1.1	1.4	5.1	31.1	2.5	8.1	1.2	0.8	13.3	0.0	0.0	0.7	7.1	1.9	1.7	7.5	4.7	3.3	0.0	1.1	1.2	4.2	0.0	0.0	0.8	0.3	3.2	13.2	7.1	0.0	9.4	7.1	0.3	3.5	4.5	0.0	0.0	4.9	10.1	5.1	26.7	6.7	5.4	17.8	3.8	2.7	1.0	8.4	1.6	0.1	0.0	0.0	0.2	0.1	2.5	3.4	0.0	0.2	0.1	0.0	0.3	1.1	2.2	4.9	0.9	2.2	3.4	4.0	3.0	1.7	4.6	4.2	3.4	1.7	3.2	0.5	3.0	3.4	1.3	3.5	4.5	2.9	3.9	5.3	3.3	3.1	3.3	3.3	1.9	3.2	2.3	0.2	3.2	9.5	87.1	3.8	20.1	7.6	5.5	6.8	7.3	4.3	2.4	2.1	7.2	6.4	18.4	29.2	5.6	2.0	7.1	13.7	12.6	4.2	11.7	1.3	1.4	3.5	4.0	111.7	21.3	1.0	1.3	9.7	6.9	11.4	3.4	1.8	20.8	1.2	1.7	125.4	5.1	16.2	1.0	2.8	1.2	0.9	1.2	1.8	9.4	4.6	15.9	7.2	275.5	11.7	11.3	1.3	0.7	6.2	4.8	11.0	14.8	11.1	6.3	0.0	5.0	1.0	6.7	2.8	5.3	14.9	7.1	4.1	2.5	5.7	6.1
ADAM23	MDC3	ENSG00000114948	"ADAM metallopeptidase domain 23"	O75077	2	206443532-206621127	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.7;parathyroid gland: 82.9"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 410.0;Inhibitory neurons: 236.6;Oligodendrocyte precursor cells: 127.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	16	"memory CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	16	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 54.4;RH-30: 63.8;RPMI-8226: 172.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033276	Approved				"Secreted in brain"	NA	NA		890000	"Cluster 32: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB033276: AB_2305247"	"unprognostic (7.33e-2)"	"unprognostic (7.80e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.03e-3)"	1.7	7.5	14.3	2.4	20.6	2.0	1.1	3.5	45.7	3.2	0.0	3.0	1.5	2.2	3.8	4.0	0.8	4.2	30.7	20.6	9.6	0.9	0.3	1.5	2.1	13.9	10.2	2.0	1.2	82.9	6.4	0.2	12.9	1.7	2.2	17.4	1.5	2.4	11.1	1.1	3.2	4.5	1.6	0.8	1.6	8.0	17.4	4.9	1.0	8.7	2.7	3.0	4.1	24.0	0.1	0.9	22.3	0.0	11.9	17.2	0.9	2.4	2.9	3.2	0.6	26.8	0.5	3.3	0.0	3.8	39.5	33.9	14.5	0.7	0.3	13.2	12.4	0.0	2.1	0.3	11.4	0.3	1.4	6.5	0.1	0.1	0.0	54.4	39.4	1.2	0.0	0.1	8.2	0.4	0.3	0.0	43.9	0.4	4.6	0.1	63.8	172.6	0.0	16.6	17.4	7.0	0.0	0.0	12.9	10.9	0.1	0.0	34.3	11.1	10.2	6.0	5.3	45.2	0.1	0.0	21.1	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.3	20.6	3.5	45.7	20.6	9.6	13.9	10.2	12.9	1.6	17.4	24.0	1.6	0.0	0.0	41.8	0.4	0.4	0.9	0.1	0.6	39.3	0.0	0.1	62.8	0.0	0.0	1.8	2.1	0.0	0.1	0.0	0.0	0.0	17.6	0.3	7.7	2.7	1.8	0.0	410.0	0.0	0.0	4.3	0.0	0.2	0.0	15.0	0.0	0.1	0.0	3.3	236.6	0.0	0.0	0.0	0.3	57.7	0.6	0.1	3.6	10.3	0.0	4.1	0.0	127.2	22.3	0.1	1.1	3.0	0.0	0.5	0.0	0.0	0.7	6.8	0.0	14.2	2.2	5.1	4.7	1.5	0.4	0.1	2.0	45.2	0.0	0.1
AFG1L	"AFG1, LACE1"	ENSG00000135537	"AFG1 like ATPase"	Q8WV93	6	108294991-108526796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 6.4;Distal tubular cells: 9.8;Hofbauer cells: 5.7;Proximal tubular cells: 6.3;Respiratory ciliated cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030154, HPA030155, HPA030659"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415"	"unprognostic (9.76e-5)"	"unprognostic (1.72e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.40e-8)"	"unprognostic (2.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"	1.8	2.1	2.2	1.3	2.7	2.1	2.2	2.0	3.3	1.7	2.7	2.6	4.2	1.5	1.9	1.6	2.2	1.5	4.6	1.7	1.9	5.0	3.7	1.7	1.8	1.8	2.0	1.7	2.1	5.4	1.5	2.2	2.0	1.6	3.1	3.1	1.8	1.7	3.7	1.2	3.0	1.7	1.7	2.0	2.8	10.7	2.7	2.3	3.0	4.0	2.1	1.7	1.1	3.2	2.7	1.4	3.4	6.1	3.5	5.1	3.3	3.0	4.4	4.8	4.7	5.7	3.3	4.8	3.8	4.7	5.8	1.5	4.4	4.5	5.4	2.8	2.6	5.7	1.8	6.6	3.5	5.3	2.7	4.7	3.6	3.6	5.8	3.1	2.6	3.5	5.9	2.2	4.5	2.6	0.9	4.8	2.2	4.6	2.8	3.3	4.6	2.8	6.1	2.9	3.7	3.2	2.4	3.5	6.4	4.5	2.8	9.8	3.2	2.9	0.7	2.6	3.4	1.5	2.6	3.7	3.6	6.0	4.5	0.0	1.6	2.8	1.0	1.2	1.3	2.5	1.5	1.9	1.4	3.4	2.1	1.4	0.4	2.4	4.3	1.6	2.3	0.7	2.2	2.7	2.0	3.3	1.7	1.9	1.8	2.0	2.0	1.7	2.7	3.2	2.4	0.0	4.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	5.0	3.7	0.0	6.4	1.1	0.0	9.8	3.1	0.0	2.6	2.6	2.2	0.0	0.0	0.0	3.8	4.6	1.2	0.0	1.8	2.5	5.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	6.3	5.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.2	0.9	4.5	0.0	0.0
AGBL5	"CCP5, FLJ21839"	ENSG00000084693	"ATP/GTP binding protein like 5"	Q8NDL9	2	27042364-27070622	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"parathyroid gland: 49.9;testis: 192.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 302.7;Late spermatids: 338.0;Spermatocytes: 156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030981	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytokinetic bridge"	"Microtubules, Cytosol"	"HPA030981: AB_10611673"	"unprognostic (1.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.50e-2)"	8.8	16.7	8.4	8.0	7.4	13.6	12.4	7.8	8.2	14.4	9.5	16.2	8.8	14.0	26.0	18.3	20.8	14.3	12.7	7.3	11.3	22.5	7.2	11.2	10.7	8.3	7.8	14.4	15.0	49.9	12.5	11.2	8.9	15.2	11.5	16.3	21.2	16.5	7.1	20.5	9.9	14.6	6.1	8.5	11.8	192.9	9.1	15.6	28.5	6.5	8.6	14.9	7.3	7.5	55.0	34.7	55.4	37.2	11.6	23.0	62.9	10.9	23.5	30.9	31.9	30.2	40.5	30.3	34.0	18.9	43.4	24.6	44.8	49.4	33.9	25.9	66.8	44.5	42.0	65.7	23.6	21.6	14.4	24.4	36.7	27.1	22.0	46.9	32.8	43.5	38.9	23.8	30.3	21.5	63.2	32.3	39.4	39.4	23.7	64.5	62.9	48.0	31.9	13.6	37.1	53.6	21.5	16.7	35.0	53.9	24.9	16.3	16.4	28.6	39.2	13.8	23.9	47.7	27.2	62.4	31.8	24.4	26.1	8.8	1.8	4.5	3.3	1.1	2.5	4.6	4.1	4.6	4.1	2.3	3.6	2.2	1.1	8.5	0.7	2.3	2.8	3.8	8.4	7.4	7.8	8.2	7.3	11.3	8.3	7.8	8.9	6.1	9.1	7.5	3.6	0.0	10.1	5.2	6.3	3.3	8.3	7.2	13.6	5.7	8.6	6.7	6.7	10.0	6.8	9.2	0.0	14.7	1.8	5.9	19.6	8.3	302.7	13.0	3.9	4.9	2.4	11.6	7.9	6.0	7.9	6.4	5.6	5.8	1.3	14.1	6.4	4.1	5.2	0.0	9.1	8.4	6.1	3.1	3.5	338.0	10.5	8.0	7.2	6.5	4.9	6.8	0.0	10.1	10.1	5.0	7.6	11.3	17.1	6.0	6.3	25.0	10.7	10.0	0.0	4.2	7.0	156.8	41.2	16.3	2.7	8.3	5.0	9.4	8.6	10.5
AL603832.3		ENSG00000271810	"Novel protein, PPM1J-RHOC readthrough"		1	112702614-112711433	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"WM-115: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"					"unprognostic (1.42e-2)"	"unprognostic (4.26e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.03e-3)"		"unprognostic (1.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.33e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.93e-4)"	"unprognostic (1.53e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.92e-1)"	0.4	1.8	1.3	0.7	1.3	0.5	1.5	1.1	2.5	0.3	1.1	0.6	1.0	0.5	1.9	0.4	0.2	0.2	0.7	1.2	1.3	0.7	0.4	1.3	0.1	1.3	1.4	0.8	0.0	2.7	0.0	0.9	1.5	0.5	0.8	1.3	0.1	2.2	1.5	0.1	0.8	0.3	1.3	1.7	0.8	4.6	1.4	0.2	0.3	1.0	0.1	0.4	0.0	1.6	2.7	0.0	0.7	1.5	0.4	2.1	0.1	1.4	1.4	0.2	0.8	0.4	0.5	0.0	0.4	1.8	0.9	0.6	0.6	1.3	0.1	0.0	0.2	0.2	0.0	0.3	1.6	0.0	0.0	3.3	2.7	1.7	1.4	1.7	3.6	0.3	0.6	0.0	1.3	1.9	0.0	0.0	0.3	0.7	1.4	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.6	1.9	1.2	3.5	0.7	0.0	1.7	1.3	1.0	0.0	0.1	0.0	0.0	0.3	2.5	0.1	5.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.1	1.3	1.3	1.1	2.5	1.2	1.3	1.3	1.4	1.5	1.3	1.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALCAM	"CD166, MEMD"	ENSG00000170017	"Activated leukocyte cell adhesion molecule"	Q13740	3	105366909-105576900	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Cell adhesion, Immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 438.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 737.2;Oligodendrocyte precursor cells: 680.1;Oligodendrocytes: 981.1;Respiratory ciliated cells: 318.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 29.6"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 29.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 393.4;U-138 MG: 473.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002148, HPA010926"	Enhanced		Uncertain	Vesicles	"Secreted to blood"	NA	NA		1600000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"CAB002148: AB_442053, HPA010926: AB_1078449"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.15e-4)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (7.76e-2)"	7.7	32.7	31.3	12.2	48.1	10.5	81.0	42.4	47.2	28.0	14.4	16.6	17.0	15.5	35.4	8.2	49.1	23.3	9.6	32.4	70.6	22.2	47.9	74.1	9.9	50.7	54.9	57.6	32.7	438.9	19.2	12.1	51.7	32.7	14.5	3.6	33.8	39.6	0.8	11.0	17.4	16.2	44.9	6.3	33.4	4.5	45.7	14.2	62.4	5.0	14.5	25.6	6.4	85.0	248.4	93.7	65.9	33.7	97.6	42.7	0.6	197.7	115.1	124.9	173.8	0.8	50.5	17.3	80.3	280.6	68.8	186.5	10.6	157.4	366.1	16.6	16.6	2.4	65.8	4.6	109.6	101.3	0.8	76.0	114.9	159.9	393.4	346.8	139.3	17.9	0.3	28.6	165.9	16.9	14.5	37.0	13.7	79.3	104.8	9.4	5.9	1.0	188.9	27.2	47.5	131.9	20.6	19.6	12.9	25.9	37.7	66.3	291.6	473.7	162.3	20.9	237.2	0.3	0.6	1.8	108.0	21.1	207.4	0.0	4.7	3.5	0.6	2.1	1.9	4.7	1.5	0.9	29.6	3.0	0.3	0.2	5.3	0.6	1.2	10.5	2.4	3.2	31.3	48.1	42.4	47.2	32.4	70.6	50.7	54.9	51.7	44.9	45.7	85.0	4.5	737.2	143.6	238.6	17.9	12.1	22.8	65.8	12.0	3.0	112.4	47.9	10.1	62.9	255.3	16.5	2.1	0.7	19.5	9.1	1.9	18.5	66.5	108.6	20.1	11.9	16.8	6.3	143.0	43.0	0.7	37.0	23.4	158.1	11.4	29.5	3.6	44.1	57.5	1.7	287.0	16.3	46.8	51.0	162.6	60.1	3.7	86.4	24.9	40.3	93.4	1.3	1.0	680.1	981.1	55.2	8.5	6.4	21.8	117.5	9.6	24.2	318.3	0.8	0.0	7.9	21.8	8.1	5.5	30.1	20.2	0.8	8.9	22.8	10.4	105.4
ANK3		ENSG00000151150	"Ankyrin 3"	Q12955	10	60026298-60733490	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autism spectrum disorder, Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 490.2;Excitatory neurons: 859.2;Inhibitory neurons: 881.3;Oligodendrocyte precursor cells: 592.6;Oligodendrocytes: 1579.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 50.3;SK-BR-3: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013249, CAB015179, HPA038455"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: AB_2676020"	"unprognostic (1.91e-1)"	"unprognostic (5.33e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (8.88e-16)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.83e-2)"	6.3	6.7	45.5	6.5	86.5	2.1	21.5	144.9	82.3	12.0	0.0	26.0	39.3	23.0	125.2	16.9	19.1	21.5	81.1	60.8	86.1	95.4	16.6	24.6	6.1	82.7	61.3	11.6	11.2	131.8	14.5	15.6	97.0	20.0	20.9	123.2	42.6	40.5	80.5	39.9	27.2	13.2	21.2	10.8	15.5	8.0	87.3	9.1	41.6	94.1	7.4	10.8	14.1	114.4	8.7	4.9	30.3	0.4	0.0	1.8	23.3	0.6	0.4	0.1	0.6	22.2	16.6	0.5	9.8	0.6	0.9	12.1	16.4	14.9	0.5	0.5	11.0	0.2	9.7	0.1	6.2	0.1	0.4	14.6	9.3	7.8	0.4	26.1	3.6	0.0	4.3	20.6	6.9	29.0	0.2	1.0	13.8	23.3	26.6	0.1	21.7	4.3	5.4	50.3	15.6	2.8	0.6	49.4	0.0	33.6	28.7	0.1	10.0	0.9	2.9	13.3	1.5	0.9	0.2	0.2	5.5	0.2	18.9	1.6	0.2	0.5	2.7	0.2	2.4	4.1	4.6	1.5	0.1	1.1	5.0	1.2	0.7	1.5	0.3	2.5	0.8	1.0	45.5	86.5	144.9	82.3	60.8	86.1	82.7	61.3	97.0	21.2	87.3	114.4	0.9	44.8	174.3	20.2	14.5	19.1	21.9	17.8	38.7	490.2	26.8	20.6	189.3	12.8	42.5	53.3	225.2	38.8	3.4	62.9	19.6	10.6	28.3	139.8	26.2	3.9	30.6	0.0	859.2	8.6	9.9	13.2	15.8	153.3	12.6	66.9	7.9	0.5	4.7	43.7	881.3	12.1	14.2	4.8	1.4	11.5	28.0	3.3	8.8	23.4	4.4	41.4	0.0	592.6	1579.5	4.8	41.8	5.7	3.4	12.2	62.5	51.3	66.7	216.6	0.0	30.2	11.7	1.1	2.3	35.9	18.2	25.0	18.5	4.5	17.8	18.4
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 subunit beta 1"	Q10567	22	29327680-29388583	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		660000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	30.7	46.7	38.0	47.2	38.3	45.8	26.4	37.3	45.2	22.8	35.6	34.9	43.3	22.7	12.1	63.0	23.5	30.4	23.9	36.1	40.8	34.8	34.8	30.1	57.8	44.2	44.6	17.5	38.3	67.0	39.2	44.8	43.7	38.3	30.1	35.3	40.3	25.9	24.5	47.2	45.6	27.1	41.4	52.6	40.9	24.7	52.7	34.2	29.6	20.5	54.4	39.4	32.2	48.8	84.6	47.5	49.3	50.2	37.0	27.0	60.0	59.8	65.5	71.2	68.2	74.4	33.2	46.1	37.2	68.4	33.0	74.6	71.5	97.6	45.2	58.2	102.0	79.1	60.8	42.0	38.9	114.1	99.9	38.6	36.0	67.5	55.0	33.0	98.7	17.2	54.6	54.9	48.3	93.7	45.5	36.8	37.3	124.8	53.3	89.0	54.3	119.9	50.2	194.5	75.9	52.2	74.0	82.5	36.4	33.5	66.7	49.5	84.6	79.1	48.8	46.0	62.1	60.4	32.5	84.6	56.1	48.1	46.7	0.0	29.3	5.7	9.2	29.2	9.1	16.2	6.3	7.9	28.7	18.2	4.9	5.2	3.0	7.2	31.7	9.0	8.8	24.2	38.0	38.3	37.3	45.2	36.1	40.8	44.2	44.6	43.7	41.4	52.7	48.8	17.8	12.8	16.4	27.7	53.0	7.1	9.3	16.7	16.5	26.3	26.2	20.8	16.1	21.5	16.4	22.0	39.6	52.3	15.1	69.6	23.5	41.2	7.5	16.4	11.6	19.8	21.6	40.0	24.1	40.7	30.1	12.1	33.6	30.1	5.1	13.2	35.3	34.3	138.9	45.4	25.6	24.9	18.3	95.5	24.2	13.1	11.8	65.7	12.4	51.5	29.8	28.4	9.2	16.1	14.0	65.9	33.2	12.4	28.5	17.5	51.2	30.1	14.5	42.1	6.6	17.8	12.7	23.5	17.6	33.0	9.1	68.3	17.0	39.6	36.2	18.1
AP2B1	"ADTB2, CLAPB1"	ENSG00000006125	"Adaptor related protein complex 2 subunit beta 1"	P63010	17	35578046-35726413	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 503.9;Late spermatids: 739.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017631, HPA056733, HPA067983"	Approved		Supported	Vesicles		NA	NA		380000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"CAB017631: AB_2058201, HPA056733: AB_2683219, HPA067983: AB_2732777"	"unprognostic (1.49e-2)"	"unprognostic (4.04e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.57e-2)"	46.4	42.4	77.0	38.2	87.8	49.2	58.3	69.9	88.7	54.1	76.6	67.6	33.5	41.7	70.7	25.1	46.7	42.3	67.6	92.1	83.5	69.0	35.0	53.4	38.6	69.8	78.6	57.2	33.2	126.4	55.0	66.8	76.8	40.9	84.0	76.1	41.9	50.1	57.5	29.9	38.8	56.0	80.3	42.0	48.4	93.5	78.7	59.7	65.1	61.0	45.5	46.8	34.4	95.0	188.8	233.9	113.7	132.0	184.4	202.8	51.6	94.3	138.9	131.0	141.1	129.0	154.6	90.5	81.1	175.3	168.8	173.2	162.5	264.8	190.8	108.6	147.0	117.7	161.8	71.0	104.7	119.3	80.8	128.9	104.3	134.5	209.3	151.2	211.4	111.8	190.6	126.9	206.9	36.9	113.7	58.7	94.2	98.9	164.5	94.3	165.1	64.7	166.2	108.3	94.4	114.1	114.5	39.6	126.9	273.3	161.5	78.5	211.5	99.3	93.4	109.8	142.1	53.0	106.1	84.7	124.1	86.9	112.5	19.6	11.8	16.7	16.0	15.3	16.9	12.1	13.9	14.3	10.7	11.9	6.3	8.0	13.3	9.6	16.8	10.7	20.5	11.0	77.0	87.8	69.9	88.7	92.1	83.5	69.8	78.6	76.8	80.3	78.7	95.0	76.5	16.0	17.0	49.3	45.9	31.1	26.3	57.4	70.6	67.6	88.9	50.9	62.5	68.6	37.4	112.2	56.3	29.7	70.7	97.4	117.4	105.0	503.9	74.5	83.7	56.8	71.3	214.7	105.5	120.2	42.8	47.1	36.2	85.4	41.2	46.5	79.9	64.5	44.1	69.0	109.8	79.4	28.5	54.3	25.9	739.2	58.7	37.2	16.0	60.0	47.3	52.6	74.2	81.4	89.0	177.9	46.6	68.4	32.1	37.4	39.4	102.5	30.4	40.9	59.2	25.3	37.6	258.8	60.0	19.6	14.6	32.8	49.2	37.3	89.8	29.1
ARFGEF2	BIG2	ENSG00000124198	"ADP ribosylation factor guanine nucleotide exchange factor 2"	Q9Y6D5	20	48921711-49036693	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 81.5"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 102.6;Inhibitory neurons: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026078, CAB026382"	Supported		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Vesicles, Cytosol"	"CAB026382: , HPA026078: AB_1844983"	"unprognostic (1.50e-2)"	"unprognostic (9.56e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.94e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (6.15e-7)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.90e-2)"	9.1	20.2	2.8	8.7	4.1	10.4	15.8	1.9	5.8	11.5	7.9	14.2	13.7	9.0	5.9	11.0	7.5	8.5	13.4	4.5	3.9	15.3	12.4	7.8	9.8	2.6	3.2	7.7	19.2	81.5	8.7	9.2	3.5	10.6	15.7	6.8	11.0	9.7	11.8	11.1	10.9	9.5	1.9	10.4	16.2	13.6	3.5	11.3	23.8	18.2	14.2	11.1	8.2	5.0	18.3	16.5	8.9	5.1	18.0	14.8	21.8	15.5	19.5	36.6	19.0	37.1	19.8	25.5	22.1	19.7	33.8	21.0	18.6	23.6	33.8	9.0	7.6	17.5	17.9	25.4	19.7	22.6	19.7	15.0	21.6	23.9	27.6	12.7	28.4	11.7	15.0	22.3	20.8	6.3	13.0	6.8	8.3	20.5	17.4	14.0	25.5	30.3	13.6	23.4	7.1	9.0	42.6	66.0	23.4	10.3	26.6	18.6	34.5	35.6	16.5	18.2	13.1	35.9	35.0	18.7	23.4	10.7	11.6	1.1	0.6	0.2	0.5	0.4	0.6	0.5	0.5	0.4	0.7	0.9	0.8	0.7	0.3	0.3	0.3	0.9	0.1	0.3	2.8	4.1	1.9	5.8	4.5	3.9	2.6	3.2	3.5	1.9	3.5	5.0	16.6	19.2	26.0	37.2	21.2	11.3	12.2	11.0	11.4	15.3	27.7	14.7	40.7	17.2	20.0	11.0	14.6	10.5	14.7	30.4	1.9	10.9	16.6	19.5	17.1	19.5	12.5	14.3	102.6	13.3	10.0	12.6	16.3	24.7	15.2	11.0	20.7	27.8	10.8	11.8	96.7	23.3	8.2	15.7	13.9	24.6	10.2	17.8	10.6	60.9	15.6	5.4	10.3	43.2	57.0	15.5	21.6	11.3	29.0	24.1	18.6	11.5	17.2	16.1	6.6	14.2	12.5	32.6	20.4	17.5	15.5	30.0	13.2	16.6	21.0	21.2
ARG2		ENSG00000081181	"Arginase 2"	P78540	14	67619920-67651708	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 220.0;prostate: 108.5;thyroid gland: 105.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 190.1;Collecting duct cells: 165.5;Glandular and luminal cells: 145.2;Proximal tubular cells: 220.9;Syncytiotrophoblasts: 601.3;Urothelial cells: 165.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 49.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 58.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000663, CAB009435"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria		"CAB009435: AB_2059089, HPA000663: AB_1078192"	"unprognostic (8.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.43e-3)"	"unprognostic (4.62e-3)"	"unprognostic (5.37e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.39e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.26e-1)"	2.8	7.3	5.6	2.9	6.1	0.5	4.8	6.9	13.9	17.0	7.9	2.7	3.7	7.0	3.6	16.3	1.8	9.3	3.4	6.3	11.6	64.0	3.8	3.8	0.5	6.4	7.7	18.7	5.0	220.0	45.6	8.8	9.2	108.5	1.4	22.3	17.0	5.8	35.7	2.1	15.3	3.7	5.1	0.9	3.2	3.4	6.5	3.0	105.0	52.6	1.7	17.8	9.9	5.6	8.9	1.5	14.4	9.4	2.1	0.1	20.1	6.7	17.4	20.6	34.5	36.3	4.5	14.6	1.9	4.3	9.4	2.1	58.2	26.8	24.9	0.7	14.6	6.7	2.6	41.9	6.2	1.8	37.8	1.1	33.6	10.2	49.7	1.6	35.4	37.7	19.4	0.1	1.4	4.4	2.5	1.4	27.2	4.0	0.5	0.8	2.0	16.8	16.8	14.3	31.5	12.2	4.2	4.2	6.4	32.9	15.1	1.2	7.3	6.4	15.9	0.7	5.0	1.3	2.4	4.9	12.8	7.5	10.9	0.1	0.4	0.7	0.3	0.1	0.1	0.2	0.1	0.3	0.5	0.7	0.2	0.2	0.6	0.1	0.4	0.0	0.9	1.0	5.6	6.1	6.9	13.9	6.3	11.6	6.4	7.7	9.2	5.1	6.5	5.6	3.9	0.0	5.8	5.5	8.4	8.8	190.1	17.0	7.4	5.2	41.6	28.7	6.3	4.3	20.3	165.5	10.4	86.5	14.6	9.0	37.2	8.4	16.5	75.1	18.7	5.9	36.8	8.8	20.3	3.3	6.2	5.6	37.8	145.2	7.0	23.9	2.9	1.3	14.7	10.1	41.8	24.5	12.2	0.6	3.6	3.2	0.3	9.3	10.6	7.5	0.9	40.5	1.0	9.0	9.2	5.0	5.0	0.4	5.7	95.4	72.8	220.9	3.0	17.6	6.6	6.2	8.9	8.4	3.4	9.7	5.4	601.3	15.1	2.2	8.7	165.2
ARHGAP35	"GRF-1, GRLF1, KIAA1722, P190A, p190ARhoGAP, p190RhoGAP"	ENSG00000160007	"Rho GTPase activating protein 35"	Q9NRY4	19	46860997-47005077	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, GTPase activation, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 186.4;Late spermatids: 651.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037311, HPA055184, HPA056470"	Approved		Supported	"Nuclear bodies,Aggresome"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"	Aggresome	"CAB037311: AB_477435, HPA055184: AB_2682730, HPA056470: AB_2683142"	"unprognostic (5.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.78e-3)"	"unprognostic (9.82e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (5.55e-8)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-1)"	13.6	10.1	35.7	8.0	31.5	5.3	16.1	16.8	31.1	12.9	9.2	14.8	12.9	12.8	10.6	15.7	12.8	9.1	25.8	37.0	27.3	19.1	22.3	14.9	8.7	26.0	32.3	17.3	13.6	31.3	14.1	7.8	34.5	13.4	12.3	16.6	15.7	15.7	29.4	11.6	16.3	12.9	19.8	8.8	10.9	40.3	33.3	10.8	20.2	24.2	9.0	13.1	9.0	25.1	52.0	56.7	37.9	34.0	33.9	27.9	6.4	27.3	38.7	27.1	31.0	30.6	18.0	27.4	19.1	112.0	41.2	30.8	34.8	35.3	36.9	19.3	14.7	37.2	40.1	24.1	31.7	22.3	30.4	28.3	35.1	30.6	32.5	37.9	24.7	18.2	25.2	9.9	31.4	30.3	21.8	35.4	19.9	37.4	20.8	24.1	26.0	8.5	23.0	100.0	37.9	36.1	50.5	47.5	20.0	23.4	44.6	27.1	31.3	23.9	18.9	26.2	33.0	10.1	19.6	21.7	53.6	22.8	59.7	0.3	0.2	0.2	0.6	0.2	0.6	0.1	0.6	0.7	0.3	0.2	0.2	0.2	0.1	0.2	0.3	0.3	0.2	0.3	35.7	31.5	16.8	31.1	37.0	27.3	26.0	32.3	34.5	19.8	33.3	25.1	15.7	44.8	38.4	47.7	8.6	15.2	13.9	20.1	19.4	31.9	35.2	23.0	58.2	27.1	21.4	25.8	25.0	3.7	14.8	61.0	7.9	14.6	186.4	17.8	19.0	19.5	31.2	16.6	42.4	20.0	1.0	19.1	19.9	34.1	9.5	30.9	27.8	89.7	15.0	69.0	48.8	18.5	14.2	19.5	7.8	651.3	23.3	11.0	21.4	32.8	14.2	28.2	18.6	37.2	58.2	20.9	21.4	25.6	6.7	23.3	44.5	22.6	10.4	22.0	19.7	22.6	24.9	45.9	23.5	24.4	16.6	1.6	16.1	29.5	25.7	17.0
ARHGAP5	"GFI2, p190-B, p190BRhoGAP, RhoGAP5"	ENSG00000100852	"Rho GTPase activating protein 5"	Q13017	14	32076114-32159728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 381.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046993, HPA056507"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum, Cytosol"		"HPA046993: AB_2679895, HPA056507: AB_2683158"	"unprognostic (1.79e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.97e-8)"	"unprognostic (9.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.00e-2)"	23.7	27.3	54.3	19.8	55.5	10.9	27.3	66.4	53.6	26.2	12.1	29.5	35.3	28.0	24.7	66.5	23.2	32.7	62.8	47.5	52.7	43.0	31.8	28.0	14.6	42.9	52.0	47.3	29.7	48.1	10.0	37.1	43.2	30.5	26.3	57.8	59.8	29.3	14.0	30.8	38.9	23.4	45.6	42.9	29.4	46.5	50.6	18.3	68.5	24.7	18.5	32.8	15.7	80.4	61.0	48.5	47.3	69.8	60.7	42.4	27.3	37.1	45.6	22.1	32.9	62.2	58.0	17.9	32.1	47.0	37.2	63.3	46.0	39.9	42.7	18.0	26.6	26.9	30.1	91.2	41.5	16.5	15.5	47.5	78.8	20.7	77.1	54.3	27.4	33.3	24.3	51.8	36.3	31.9	36.4	0.8	23.7	67.1	57.7	38.9	58.2	3.5	48.4	159.5	73.2	28.6	99.6	52.7	74.6	52.5	54.8	1.1	44.6	40.8	60.6	33.9	27.6	19.7	41.5	2.8	20.5	17.5	113.1	2.2	1.4	0.0	3.1	0.7	3.8	6.1	5.5	3.0	5.3	5.3	5.7	3.5	0.5	5.9	1.2	7.6	5.0	2.0	54.3	55.5	66.4	53.6	47.5	52.7	42.9	52.0	43.2	45.6	50.6	80.4	50.9	192.3	71.9	381.9	40.7	94.2	144.2	52.1	130.9	97.2	52.8	53.3	301.2	58.6	70.2	58.8	114.7	27.5	27.0	85.0	54.8	50.2	42.0	92.1	77.9	42.9	61.8	28.6	81.7	46.1	14.5	65.1	59.7	136.3	5.1	30.0	37.5	51.1	19.0	65.6	140.7	56.8	46.8	19.0	45.4	66.8	104.4	44.2	67.6	65.6	18.6	103.3	14.4	139.7	205.6	75.0	93.5	100.4	35.7	104.2	89.6	60.1	78.4	92.7	59.2	103.1	65.9	128.5	75.6	94.0	70.3	13.4	29.2	77.3	51.1	180.9
ARHGEF11	"GTRAP48, KIAA0380, PDZ-RHOGEF"	ENSG00000132694	"Rho guanine nucleotide exchange factor 11"	O15085	1	156934840-157045742	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 68.6;Cone photoreceptor cells: 93.8;Excitatory neurons: 102.4;Inhibitory neurons: 122.5;Oligodendrocyte precursor cells: 78.4;Rod photoreceptor cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"WM-115: 69.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011026, HPA012037, HPA014658"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"HPA011026: AB_1850426, HPA012037: AB_1850430, HPA014658: AB_1850428"	"unprognostic (2.19e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.30e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.73e-2)"	10.9	10.9	10.3	9.5	8.6	4.3	8.1	4.1	22.6	10.0	0.8	12.3	13.1	12.0	9.6	11.5	10.3	10.2	12.1	9.4	10.2	7.2	6.3	11.4	5.3	12.7	11.1	13.2	9.9	25.0	12.2	11.1	12.0	9.2	11.2	17.6	8.6	11.6	12.3	10.0	14.9	13.3	4.0	9.3	10.7	19.2	16.9	3.6	13.0	11.2	5.7	10.4	8.1	11.1	13.5	26.6	22.0	16.9	28.5	14.6	25.0	13.4	19.4	20.0	14.6	17.9	14.0	1.8	22.6	23.0	15.3	14.4	15.0	13.5	10.8	19.6	9.3	6.7	15.9	11.5	16.4	13.7	23.0	22.7	14.4	18.3	14.2	14.9	14.5	5.7	11.1	1.2	13.3	17.4	3.5	7.2	27.6	21.0	16.0	0.5	10.9	7.4	9.5	21.9	4.2	25.1	28.3	22.6	23.3	18.8	20.3	30.3	22.4	20.6	12.9	18.3	13.7	18.7	12.2	1.3	13.1	1.8	69.7	0.0	0.4	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.9	0.0	0.4	0.0	0.0	0.2	10.3	8.6	4.1	22.6	9.4	10.2	12.7	11.1	12.0	4.0	16.9	11.1	6.2	3.2	4.2	68.6	0.5	1.1	2.8	0.4	0.0	48.0	5.0	5.8	15.3	7.2	1.6	1.8	93.8	1.8	0.0	26.0	1.9	1.1	8.6	7.7	10.9	5.0	5.4	0.4	102.4	1.6	0.6	5.5	10.2	7.8	8.9	6.6	5.3	5.2	4.0	21.9	122.5	7.3	0.0	8.8	3.9	10.5	4.7	7.1	1.8	37.5	6.8	9.7	0.0	78.4	47.2	1.2	10.8	4.5	2.9	4.0	10.6	1.3	1.4	58.7	0.0	6.7	6.9	3.1	4.8	1.8	2.0	1.5	0.9	9.2	9.8	3.3
ARSK	"DKFZp313G1735, TSULF"	ENSG00000164291	"Arylsulfatase family member K"	Q6UWY0	5	95555101-95605102	"Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 19.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042384	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA042384: AB_10795703"	"unprognostic (9.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (3.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.06e-2)"	3.0	3.7	2.1	2.2	2.3	2.3	3.3	2.8	3.0	3.8	2.1	2.7	2.2	3.6	4.2	2.9	3.2	3.1	2.6	2.4	2.1	5.4	3.7	2.9	2.7	1.9	1.9	5.8	4.9	19.1	2.6	5.5	2.3	4.9	2.5	3.6	2.8	4.9	2.3	3.3	2.2	3.0	1.7	2.4	4.2	1.6	2.6	3.7	5.0	2.7	2.0	3.2	3.3	2.2	5.1	3.2	6.6	6.6	32.4	16.8	9.5	15.9	9.2	6.1	12.4	3.9	7.8	6.9	8.1	5.5	10.9	4.6	5.8	10.1	13.3	7.4	8.5	5.5	7.7	6.7	9.4	3.1	4.4	12.4	8.9	9.2	5.9	12.8	10.0	9.3	5.6	7.4	13.7	2.5	8.5	5.9	8.6	1.6	15.3	5.2	10.6	11.0	14.1	1.2	4.7	4.8	9.7	3.1	10.0	9.1	8.9	3.2	18.1	9.6	7.8	15.0	9.9	6.2	11.2	8.4	9.6	8.0	36.5	12.9	1.1	2.1	4.0	1.2	4.7	4.9	4.7	5.4	0.6	5.0	7.0	5.2	0.9	3.3	0.7	2.2	3.9	1.8	2.1	2.3	2.8	3.0	2.4	2.1	1.9	1.9	2.3	1.7	2.6	2.2	6.8	3.2	2.2	9.1	6.6	4.5	6.8	7.4	5.7	7.3	4.4	7.2	4.6	1.5	3.7	7.3	12.5	11.8	6.6	1.9	3.9	4.1	9.2	7.1	10.3	6.2	3.0	10.1	11.0	2.5	47.4	13.6	2.0	5.7	22.9	8.1	6.8	16.5	4.6	10.1	9.7	2.0	10.2	3.2	5.4	2.9	10.8	4.9	5.4	7.5	5.1	12.7	14.4	7.1	10.0	2.6	3.2	11.7	7.1	3.9	3.2	4.8	6.8	10.4	0.0	10.2	10.9	7.4	8.6	5.1	7.0	5.1	9.8	11.8	3.4	2.1
ATG10	"APG10L, DKFZP586I0418, FLJ13954"	ENSG00000152348	"Autophagy related 10"	Q9H0Y0	5	81972023-82276857	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044163	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli	Nucleoplasm	"HPA044163: AB_2678842"	"unprognostic (1.20e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.43e-1)"	4.0	5.4	4.8	4.1	4.9	5.6	7.0	8.3	5.7	3.5	7.9	5.5	3.3	4.6	7.8	4.9	4.2	4.3	4.6	5.0	4.7	5.7	6.5	3.7	3.5	5.0	4.5	3.2	4.4	11.6	4.0	4.7	5.0	5.6	6.1	3.5	3.7	5.6	7.2	6.6	3.3	5.5	4.6	4.1	4.4	10.4	5.0	7.8	7.1	3.1	4.3	4.0	3.9	8.0	4.7	12.6	7.9	23.0	5.3	10.0	20.1	5.4	4.4	3.9	6.0	3.7	16.7	8.4	4.4	8.8	29.7	2.5	5.9	12.2	5.1	14.4	4.2	9.2	11.4	4.0	5.0	4.8	7.3	9.3	8.2	5.7	4.7	6.0	7.4	17.7	11.3	6.8	14.4	9.5	11.0	5.2	11.0	3.5	8.2	8.0	11.5	20.1	10.0	6.7	11.8	16.9	8.8	4.9	10.0	13.6	9.4	8.9	6.0	7.0	6.6	3.8	11.5	9.4	17.0	11.5	9.8	11.4	11.7	2.7	5.7	8.5	5.1	5.8	4.8	3.6	4.5	4.8	7.5	4.5	4.2	5.2	7.4	6.5	4.3	5.6	5.0	4.1	4.8	4.9	8.3	5.7	5.0	4.7	5.0	4.5	5.0	4.6	5.0	8.0	8.1	16.0	15.6	69.2	9.3	24.9	17.4	16.3	14.2	16.3	15.6	14.4	9.3	12.8	16.7	12.9	10.4	25.5	9.7	8.2	15.6	15.7	67.6	7.7	11.4	13.0	9.6	14.5	56.4	18.4	46.3	15.1	6.6	9.7	11.4	22.1	10.0	12.8	18.3	18.5	52.2	7.8	4.1	14.1	28.4	96.6	6.8	12.3	32.0	57.1	17.2	12.5	15.5	67.8	76.5	15.2	9.9	10.1	10.1	12.0	8.5	18.8	8.8	15.2	0.0	18.2	13.6	54.1	22.9	13.8	32.0	21.1	14.3	15.6	11.5	14.0
ATMIN	"ASCIZ, KIAA0431, ZNF822"	ENSG00000166454	"ATM interactor"	O43313	16	81035842-81047350	"Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 180.6;Late spermatids: 288.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054967, HPA066900"	Approved		Supported	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA054967: AB_2682654, HPA066900: AB_2685744"	"unprognostic (9.92e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.32e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.26e-2)"	"prognostic favorable (6.80e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.60e-1)"	15.9	12.7	18.9	11.4	19.6	7.9	14.4	18.2	23.5	13.5	14.6	12.9	12.8	13.8	18.0	18.9	11.4	11.5	14.2	19.6	21.6	19.7	17.9	10.7	13.9	19.6	21.7	14.3	16.1	27.0	13.1	20.4	22.8	17.6	13.7	10.3	12.8	14.8	16.0	17.6	12.9	13.7	17.6	12.9	12.7	22.6	21.5	15.6	20.6	17.0	15.0	14.2	12.0	18.4	26.7	22.0	28.6	33.7	30.6	21.3	42.8	17.1	24.8	15.9	8.8	14.9	14.9	20.8	21.8	25.6	18.3	25.3	28.1	14.7	20.3	13.8	15.6	14.3	13.3	17.4	28.3	24.7	21.6	22.7	24.7	15.4	24.7	26.7	16.6	20.0	22.8	12.4	22.9	42.9	19.9	18.0	33.6	16.6	16.3	34.5	13.8	12.2	25.0	27.5	22.8	29.5	54.3	16.8	14.3	23.7	28.5	22.0	22.0	20.3	20.6	19.9	16.2	19.7	31.6	50.4	18.7	16.1	19.3	0.5	0.8	0.5	1.9	0.6	1.4	1.5	2.0	1.7	0.8	1.6	1.7	1.9	0.2	1.9	0.6	1.0	2.2	0.6	18.9	19.6	18.2	23.5	19.6	21.6	19.6	21.7	22.8	17.6	21.5	18.4	38.6	9.6	19.2	10.7	11.7	12.0	16.3	10.0	10.2	24.9	20.7	16.9	18.6	20.0	15.5	23.9	20.9	42.3	25.8	21.4	11.7	12.6	180.6	13.3	37.2	19.3	11.5	7.4	16.1	14.0	38.4	17.9	15.8	22.4	16.5	15.2	22.9	21.6	29.7	13.5	17.7	13.7	6.1	23.9	6.0	288.9	19.9	14.3	14.2	3.7	19.2	32.5	12.3	8.0	16.9	18.5	11.2	19.5	15.0	15.1	19.9	20.8	7.5	16.6	13.1	24.2	18.0	28.6	25.4	17.2	15.3	30.1	15.5	21.6	16.0	18.4
ATP6AP2	"APT6M8-9, ATP6IP2, ATP6M8-9, M8-9, PRR, RENR"	ENSG00000182220	"ATPase H+ transporting accessory protein 2"	O75787	X	40579372-40606848	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Congenital disorder of glycosylation, Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 765.1"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 702.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003156	Approved					NA	NA		140000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA003156: AB_1078245"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.01e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.86e-2)"	81.2	71.5	85.6	60.6	86.5	124.4	95.1	76.4	116.9	106.1	72.4	82.9	32.1	86.6	91.3	70.1	75.6	79.7	55.1	90.8	90.2	165.6	96.8	87.3	67.4	80.4	79.8	68.9	53.3	765.1	30.7	106.9	83.4	86.6	89.0	99.3	39.4	97.9	18.4	71.9	47.8	124.7	84.6	69.0	49.1	40.4	87.6	72.0	177.1	40.1	72.5	97.7	41.4	98.7	83.9	117.5	78.7	106.7	472.6	312.4	47.9	182.4	274.1	127.0	152.9	68.0	142.6	48.4	88.1	257.0	141.3	86.6	114.0	136.0	168.2	92.7	97.7	57.5	100.2	66.5	172.0	104.6	111.6	259.6	175.2	154.2	121.4	200.3	168.1	46.1	63.8	130.7	201.7	109.8	45.5	93.7	73.4	140.8	112.7	43.8	132.6	161.6	182.8	96.8	55.2	51.9	185.8	111.7	118.4	284.2	147.8	97.1	172.5	175.0	91.3	207.7	62.8	38.0	70.7	46.2	139.1	93.0	138.5	269.0	511.1	404.8	156.1	364.9	164.3	106.7	157.3	161.9	341.3	110.3	174.8	159.3	255.9	141.2	378.6	124.2	167.2	692.9	85.6	86.5	76.4	116.9	90.8	90.2	80.4	79.8	83.4	84.6	87.6	98.7	102.3	57.7	65.6	36.2	65.4	97.3	135.4	254.3	46.1	155.8	74.1	61.2	30.4	94.4	175.4	138.0	54.2	173.4	109.6	70.3	62.6	146.6	3.6	97.2	115.5	94.7	57.1	62.3	44.8	59.1	106.3	156.5	34.7	124.5	87.5	63.7	96.0	64.0	702.2	188.4	56.3	54.6	349.9	279.5	263.3	9.5	117.4	222.0	149.4	28.1	185.4	193.0	72.1	40.2	40.6	64.0	58.9	151.2	74.8	97.9	61.0	106.4	127.4	93.3	105.2	116.7	138.7	106.7	43.1	60.0	99.9	174.4	100.3	188.2	63.6	121.1
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.5"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1218.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.5"	"Region enhanced"	"Detected in all"		"white matter: 84.5"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 27.5;Daudi: 46.3;HEL: 16.4;REH: 16.1;SH-SY5Y: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA052935: AB_2681992"	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	2.8	8.9	5.8	9.5	26.7	23.4	3.7	3.6	18.3	2.1	0.0	12.8	4.2	2.4	12.2	2.2	2.4	2.5	8.4	14.5	11.7	3.8	1.7	11.8	15.0	9.5	4.4	16.2	7.0	36.0	2.2	2.4	9.5	8.3	11.7	19.4	4.4	5.3	10.0	1.7	8.9	2.8	18.1	9.0	12.5	2.1	9.5	9.9	39.7	15.6	11.8	2.5	1.5	84.5	0.0	0.1	0.4	27.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	0.4	46.3	12.6	0.2	0.0	2.4	6.5	0.1	0.0	7.4	4.5	16.4	1.6	0.7	0.1	4.0	0.3	0.4	0.0	0.0	0.0	0.6	0.2	10.3	0.0	5.1	0.0	2.0	6.0	1.4	2.0	1.9	0.6	16.1	0.0	5.3	9.5	0.6	4.9	14.8	0.3	9.4	0.0	1.1	3.1	0.0	0.4	0.0	2.0	0.5	0.0	1.7	0.0	9.4	0.7	5.6	0.2	0.0	0.6	0.6	3.7	0.2	1.9	1.5	1.1	4.1	0.6	2.5	1.7	4.4	0.5	2.2	2.5	2.4	1.0	0.6	5.8	26.7	3.6	18.3	14.5	11.7	9.5	4.4	9.5	18.1	9.5	84.5	26.1	28.9	80.1	136.1	23.3	1.5	1.8	0.6	2.2	19.7	4.0	1.5	14.4	0.0	5.3	5.5	81.3	0.0	52.9	48.4	3.9	0.2	4.6	1.3	1.3	13.6	84.6	13.9	295.9	2.5	0.1	4.8	19.9	4.2	8.2	26.5	16.8	1.1	1.6	62.2	255.9	28.6	0.0	8.8	4.6	2.9	3.4	8.9	3.6	31.9	5.1	2.2	33.0	144.8	1218.1	0.6	10.2	1.9	37.6	9.6	45.6	2.0	0.3	38.1	0.0	6.3	2.7	1.5	3.6	5.0	1.4	0.0	51.6	8.6	25.0	3.0
ATPSCKMT	"FAM173B, JS-2"	ENSG00000150756	"ATP synthase c subunit lysine N-methyltransferase"	Q6P4H8	5	10225507-10249897	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 7.1;Cytotrophoblasts: 5.9;Extravillous trophoblasts: 4.1;Fibroblasts: 2.3;Hofbauer cells: 7.8;Syncytiotrophoblasts: 2.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SiHa: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074513			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"HPA074513: AB_2686698"	"prognostic unfavorable (1.32e-6)"	"unprognostic (8.87e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.20e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.03e-1)"	8.5	10.3	12.4	5.4	13.0	3.9	6.6	13.5	15.5	5.7	13.8	7.4	6.1	6.9	9.1	5.8	6.5	7.2	6.9	11.7	14.3	9.0	9.9	5.1	7.8	13.2	13.6	6.3	5.1	17.1	9.9	4.1	13.2	8.8	8.7	5.0	7.4	8.3	6.7	5.8	5.6	7.5	12.0	4.5	6.2	5.7	13.4	6.9	8.8	7.4	6.8	7.1	5.3	14.8	14.1	13.3	13.9	13.8	12.7	9.8	4.8	20.4	9.2	9.2	8.0	14.1	21.0	16.8	35.2	13.0	27.7	9.6	19.6	17.0	15.8	30.9	13.2	14.5	47.6	11.4	9.7	22.8	16.5	9.1	18.3	17.4	5.5	11.8	19.7	17.8	19.9	18.0	26.6	11.9	11.6	20.2	9.1	29.9	17.4	15.8	9.7	15.9	24.6	16.5	11.1	10.9	69.3	24.5	12.2	10.5	25.7	23.2	11.2	22.4	13.9	14.2	14.9	11.9	14.5	19.7	14.1	25.3	9.0	3.2	5.8	8.1	4.3	6.7	5.3	3.8	4.2	5.5	5.8	2.6	4.1	5.4	2.2	3.8	5.5	2.1	5.4	2.6	12.4	13.0	13.5	15.5	11.7	14.3	13.2	13.6	13.2	12.0	13.4	14.8	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	5.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.0
BMI1	"PCGF4, RNF51"	ENSG00000168283	"BMI1 proto-oncogene, polycomb ring finger"	P35226	10	22321099-22331484	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 134.0;Late spermatids: 165.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 508.3;U-937: 583.9"									"CAB011120, HPA030471, HPA030472"	Supported		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Nucleoli, Cytosol"	"CAB011120: , HPA030471: AB_2673491, HPA030472: AB_10601090"	"unprognostic (5.44e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.24e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.76e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (2.60e-8)"	"unprognostic (9.43e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.84e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.41e-2)"	29.0	31.1	26.6	25.1	35.1	21.9	36.0	29.9	42.4	27.6	28.2	26.2	19.7	30.7	29.7	21.9	22.6	23.9	20.5	25.0	27.8	26.0	35.6	23.4	27.7	29.5	30.1	21.7	25.7	56.9	25.0	28.7	31.6	33.7	21.5	40.4	19.9	26.1	44.4	14.4	20.8	36.2	29.9	36.2	22.5	35.3	28.1	24.9	23.9	35.5	27.0	23.8	14.8	45.4	74.9	36.1	41.2	12.7	68.9	54.6	40.5	49.7	22.2	37.3	43.5	37.6	93.4	38.1	32.8	45.6	42.2	26.1	59.1	35.0	45.4	508.3	72.8	104.7	28.7	42.9	41.1	39.8	55.7	35.5	58.8	41.2	45.3	47.0	26.2	62.1	105.4	63.3	48.6	30.2	106.9	11.4	9.3	36.3	83.4	79.6	57.1	37.3	35.3	25.2	33.8	66.0	32.7	42.5	57.3	17.8	38.5	153.8	56.4	41.4	122.6	99.6	67.6	76.1	110.8	83.1	59.5	583.9	27.4	15.1	1.3	2.5	5.2	3.0	7.0	4.4	5.3	5.0	0.9	2.2	4.4	4.3	0.6	5.2	2.1	1.6	4.1	2.0	26.6	35.1	29.9	42.4	25.0	27.8	29.5	30.1	31.6	29.9	28.1	45.4	18.9	25.6	24.0	0.0	23.1	15.9	20.5	12.4	22.8	20.9	24.4	20.3	19.0	22.8	19.8	12.9	8.4	12.7	14.2	5.6	13.7	16.3	134.0	12.1	25.3	24.0	13.2	19.1	0.0	18.2	22.2	19.8	7.7	9.8	12.0	12.6	28.5	30.7	9.9	30.3	0.0	9.9	14.2	19.7	25.6	165.1	36.1	13.8	37.4	0.0	17.5	13.9	15.5	0.0	0.0	22.9	7.3	36.5	33.9	29.1	4.6	13.0	16.9	15.2	19.7	26.5	28.6	19.8	22.2	11.2	14.6	6.7	22.4	17.0	10.3	20.4
BSPRY	FLJ20150	ENSG00000119411	"B-box and SPRY domain containing"	Q5W0U4	9	113349541-113371233	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 447.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 61.9;Ductal cells: 66.8;Exocrine glandular cells: 65.8;Pancreatic endocrine cells: 48.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	21	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in many"		"A-431: 41.8;CAPAN-2: 25.9;MCF7: 62.0;OE19: 70.9;RPMI-8226: 32.3;SK-BR-3: 29.9;T-47d: 30.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.8"	"HPA042889, HPA077485"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	Cytosol	"HPA042889: AB_10795515, HPA077485: "	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.56e-14)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.70e-1)"	0.3	3.1	3.7	2.6	11.3	5.9	14.6	5.9	4.2	6.5	1.2	12.0	8.8	1.1	10.9	30.1	4.4	4.4	1.5	2.5	3.0	14.4	0.8	5.6	0.8	2.1	4.8	0.0	41.7	447.2	8.3	1.7	1.7	5.0	11.0	6.9	81.6	4.5	0.0	26.3	7.0	0.7	1.7	0.5	24.7	2.8	5.9	1.8	30.3	0.1	3.1	3.0	7.6	2.5	41.8	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	8.6	25.9	0.0	0.4	0.0	0.0	3.6	0.4	0.0	0.0	4.6	3.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	20.8	0.3	0.0	0.0	62.0	0.7	0.0	1.0	70.9	0.0	0.9	0.0	32.3	4.0	8.8	13.7	0.0	0.0	29.9	0.0	1.7	30.3	4.3	0.0	0.0	0.0	0.1	0.0	9.7	13.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.4	0.0	0.0	3.7	11.3	5.9	4.2	2.5	3.0	2.1	4.8	1.7	1.7	5.9	2.5	0.3	6.4	6.9	0.0	2.5	1.0	2.0	4.4	0.0	1.8	61.9	31.2	2.8	17.2	9.5	27.6	6.2	9.2	9.9	20.8	39.2	66.8	0.5	11.3	1.6	0.9	20.4	15.6	1.0	65.8	1.1	0.7	21.4	17.3	3.8	1.5	0.0	0.8	1.4	0.0	3.2	19.1	12.2	0.3	0.3	0.6	0.0	0.5	10.6	0.0	1.0	0.8	3.1	0.5	0.2	48.6	14.5	0.0	2.5	13.8	13.5	21.2	9.7	12.1	0.0	0.0	1.7	0.6	4.3	26.4	14.2	6.7	1.3	0.1	24.9	17.7
BTBD11	"ABTB2B, FLJ33957"	ENSG00000151136	"BTB domain containing 11"	A6QL63	12	107318421-107659642	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 100.3"	"Cell type enriched"	"Detected in many"	9	"Inhibitory neurons: 266.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 25.0;Hep G2: 13.6;MOLT-4: 17.9;PC-3: 12.3;RT4: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055898, HPA061334"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA055898: AB_2682964, HPA061334: "	"unprognostic (3.40e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.85e-2)"	"unprognostic (8.78e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.92e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.07e-3)"	0.4	0.7	7.2	2.7	4.3	4.4	2.9	5.5	10.9	8.1	5.9	0.6	0.7	0.9	1.2	29.4	0.3	0.9	0.6	2.9	13.2	4.2	1.1	0.6	2.9	24.3	16.0	0.1	0.8	100.3	3.5	2.0	24.4	3.4	0.6	1.9	5.6	1.3	0.5	11.1	1.4	0.5	11.4	1.4	0.6	0.7	21.7	17.2	18.9	0.2	3.3	1.7	11.1	5.3	0.1	25.0	5.0	0.0	1.8	0.5	0.0	0.6	0.0	0.2	0.0	0.3	4.0	0.0	6.1	0.1	2.4	9.2	5.1	9.5	0.3	0.0	1.6	0.0	0.1	13.6	0.0	0.2	0.1	2.0	4.0	0.0	2.9	3.8	0.7	10.5	0.0	0.0	0.2	0.9	17.9	2.0	5.3	0.5	12.3	0.0	8.1	0.0	0.0	11.4	6.8	2.5	0.0	0.2	0.0	0.4	0.5	0.7	1.0	0.1	0.2	0.0	2.0	0.1	0.0	0.1	6.4	2.6	0.0	0.9	0.4	0.5	1.0	0.1	3.5	0.0	1.1	0.6	0.7	0.1	1.4	1.3	1.3	0.1	0.3	0.1	0.6	0.6	7.2	4.3	5.5	10.9	2.9	13.2	24.3	16.0	24.4	11.4	21.7	5.3	0.3	0.0	0.0	17.3	0.3	5.2	3.7	2.5	6.8	3.5	0.7	3.2	2.9	0.0	3.0	0.0	0.0	0.2	1.2	0.0	0.0	0.8	0.0	1.2	1.9	0.3	3.5	1.3	8.7	0.0	0.0	1.5	0.0	2.3	0.0	0.0	0.0	0.9	0.3	1.7	266.4	0.4	0.0	0.6	4.3	0.0	0.6	1.7	0.0	1.0	1.8	0.2	3.1	12.5	1.9	0.3	0.0	4.1	0.7	2.8	0.2	0.9	0.3	0.4	0.0	0.0	1.1	0.1	0.2	27.5	7.7	0.4	4.5	3.4	0.4	3.4
C1GALT1	"C1GALT, T-synthase"	ENSG00000106392	"Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1"	Q9NS00	7	7156934-7248616	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 204.3;Syncytiotrophoblasts: 204.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"LHCN-M2: 288.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011294, HPA012819"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA		43000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear bodies, Cytosol"		"HPA011294: AB_1845623, HPA012819: AB_1845624"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.38e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (2.03e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.33e-1)"	12.9	7.2	12.8	14.2	17.7	37.7	16.6	16.1	15.5	18.5	25.0	15.2	29.4	5.6	6.4	21.6	16.2	16.6	12.6	11.3	13.7	30.8	22.0	15.0	19.1	17.7	15.6	4.6	6.1	45.8	8.6	27.0	17.7	5.1	18.0	23.6	23.3	6.8	7.5	8.8	19.3	7.3	17.9	15.5	22.4	7.3	14.2	14.3	12.5	11.3	14.0	13.0	7.3	24.6	63.5	25.9	9.6	16.0	28.1	57.0	28.0	71.5	60.7	32.4	51.1	20.0	63.9	33.4	17.0	31.7	93.5	18.3	14.0	27.5	58.3	15.1	8.1	31.1	15.9	62.3	28.1	34.3	13.2	44.0	20.0	75.7	70.0	47.4	30.3	29.9	61.0	19.9	288.7	10.5	8.8	22.8	51.7	47.8	20.3	29.6	53.1	19.3	46.6	32.4	9.9	27.2	46.9	57.0	52.8	57.5	15.6	19.6	30.4	55.2	76.7	74.7	31.3	34.4	28.7	32.9	36.9	42.9	55.8	56.0	12.9	38.4	17.7	20.2	19.7	20.4	16.6	20.6	15.1	16.6	17.7	19.4	29.1	22.7	34.0	16.4	16.2	14.1	12.8	17.7	16.1	15.5	11.3	13.7	17.7	15.6	17.7	17.9	14.2	24.6	23.2	41.7	54.2	32.3	57.1	26.3	17.0	48.4	29.0	28.1	24.5	10.8	24.0	25.8	40.6	18.4	33.3	91.9	44.8	29.9	5.9	29.1	17.2	28.4	8.7	12.7	15.6	49.7	44.3	25.3	81.1	26.0	41.3	31.7	12.0	36.2	13.9	23.5	38.2	47.1	42.5	18.8	30.5	21.1	20.5	19.9	6.5	33.0	23.2	65.6	21.9	22.9	49.4	52.3	204.3	46.2	22.6	6.4	43.2	14.5	27.7	40.0	29.7	34.8	6.6	17.2	15.3	16.6	35.6	46.4	19.5	204.8	39.6	8.9	26.7	25.7
C22orf31	"bK747E2.1, HS747E2A"	ENSG00000100249	"Chromosome 22 open reading frame 31"	O95567	22	29058672-29061844	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 3.0;testis: 8.7"	"Group enriched"	"Detected in some"	6	"Early spermatids: 70.0;Late spermatids: 43.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA000604, HPA068522"	Uncertain		Approved	"Nuclear membrane,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear membrane"	Cytosol	"HPA000604: AB_1079086, HPA068522: "																		0.1	0.3	1.7	0.0	2.3	0.0	0.3	2.3	2.7	0.3	1.3	0.3	0.2	0.3	0.9	0.3	0.3	0.0	0.1	1.9	1.5	0.4	0.0	0.2	0.0	1.5	1.6	0.6	0.0	3.0	0.4	0.0	1.5	0.2	0.2	0.3	0.4	0.1	0.2	0.4	0.3	0.1	1.2	0.1	0.4	8.7	1.7	1.0	0.2	0.2	0.1	0.3	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.3	2.3	2.7	1.9	1.5	1.5	1.6	1.5	1.2	1.7	1.6	0.0	0.0	0.0	8.5	0.0	0.1	0.2	0.2	0.0	0.5	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	70.0	0.3	1.6	0.1	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	43.3	0.9	0.0	1.8	1.0	0.0	3.3	0.0	0.5	0.1	0.0	0.0	0.7	0.0	0.1	0.1	0.2	0.0	0.0	0.0	3.7	0.2	1.0	0.5	0.2	0.9	0.0	0.1	1.0	0.1	0.1
CA8	"CALS, CARP"	ENSG00000178538	"Carbonic anhydrase 8"	P35219	8	60185412-60281400	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.3;parathyroid gland: 40.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.7;Enteroendocrine cells: 35.2;Gastric mucus-secreting cells: 40.2;Oligodendrocyte precursor cells: 129.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	24	"basophil: 76.2"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 76.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 10.1;JURKAT: 11.0;K-562: 20.3;NB-4: 12.3;OE19: 17.4"	"Region enriched"	"Detected in all"	38	"cerebellum: 1260.5"	"Region enriched"	"Detected in all"	9	"cerebellum: 86.3"	"HPA024748, CAB025545, CAB047309"	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB025545: , CAB047309: , HPA024748: AB_1846003"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.46e-3)"	"unprognostic (6.67e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.79e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	1.6	0.9	5.2	0.3	5.8	0.5	4.6	18.3	5.6	4.3	2.0	1.3	1.0	1.9	10.2	0.2	1.5	0.3	4.3	4.4	5.3	5.3	0.0	0.9	0.4	4.7	4.9	0.2	1.9	40.1	8.5	6.2	5.0	1.5	2.0	2.3	3.7	0.2	1.2	0.3	1.0	0.5	3.1	0.8	4.4	4.1	5.1	1.3	0.3	2.3	0.3	0.6	0.3	4.0	0.0	2.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.1	0.0	10.1	4.5	0.0	0.0	3.6	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	11.0	20.3	0.2	0.0	0.0	3.3	12.3	0.2	17.4	0.0	0.0	0.0	0.2	0.4	0.8	5.1	0.0	0.0	1.1	0.0	2.0	4.5	0.7	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.5	76.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.1	5.2	5.8	18.3	5.6	4.4	5.3	4.7	4.9	5.0	3.1	5.1	4.0	22.0	0.0	4.8	92.7	1.6	1.0	0.4	4.1	0.0	8.2	15.6	10.3	4.7	0.0	5.7	3.7	0.0	8.3	10.9	2.0	3.9	8.1	9.9	9.8	2.4	16.7	35.2	13.5	4.7	6.0	0.3	4.0	40.2	26.2	0.0	1.1	0.0	0.0	9.9	0.0	25.6	25.0	6.1	1.9	1.1	4.9	1.5	1.1	7.2	18.7	0.0	2.6	1.0	129.7	0.4	1.6	3.5	1.5	14.0	2.1	0.3	0.0	1.2	1.0	0.0	0.8	2.3	3.8	5.5	0.2	0.4	1.4	0.7	3.1	3.3	1.5
CALCA	"CALC1, CGRP, CGRP-alpha"	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966668-14972351	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, Transporters"		Hormone	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 178.3;thyroid gland: 154.2"	"Cell type enriched"	"Detected in some"	64	"Ionocytes: 2368.1"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 64.7"	"Region enhanced"	"Detected in many"		"pons: 34.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"pons and medulla: 57.9"					"HPA059886, HPA064453"	Enhanced	Supported			"Secreted to blood"	NA	NA	51500			"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA059886: , HPA064453: "			"unprognostic (1.97e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (5.99e-2)"		"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"		"unprognostic (6.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.02e-2)"	0.7	0.2	0.6	1.5	0.6	0.0	0.2	0.6	0.5	0.2	0.0	0.6	0.0	0.2	0.0	0.1	0.3	0.2	1.1	0.3	0.8	46.4	37.5	2.4	0.1	20.9	7.0	0.1	0.4	178.3	0.8	0.0	34.4	2.5	0.1	0.0	0.1	0.0	0.5	0.0	0.1	1.5	1.5	3.0	0.2	0.2	0.6	0.3	154.2	0.0	0.0	4.3	0.4	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.5	0.3	0.8	20.9	7.0	34.4	1.5	0.6	10.4	0.1	0.0	0.0	0.0	0.2	0.3	0.4	35.4	0.0	0.0	0.0	0.1	0.4	0.0	0.3	36.8	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.3	0.0	0.0	0.7	4.4	0.3	0.0	0.0	0.0	2368.1	0.0	4.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.2	0.0	0.0	0.4	5.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4
CASR	"FHH, GPRC2A, HHC, HHC1, NSHPT"	ENSG00000036828	"Calcium sensing receptor"	P41180	3	122183668-122291629	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"parathyroid gland: 654.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 25.6;Alveolar cells type 2: 20.2;Cholangiocytes: 27.1;Distal tubular cells: 13.7;Enteroendocrine cells: 11.5;Granulosa cells: 20.7;Respiratory ciliated cells: 15.3"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA039686, HPA050335"	Enhanced					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 40: Granulosa cells - Unknown function"			"HPA039686: AB_10673536, HPA050335: AB_2681092"		"unprognostic (1.97e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (8.55e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.32e-2)"		"unprognostic (7.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.91e-5)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.24e-2)"	0.1	0.1	1.5	0.1	1.0	0.8	0.0	1.7	1.6	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.1	4.2	0.0	1.0	0.6	22.4	0.2	0.0	0.2	0.6	1.1	0.5	9.6	654.4	0.2	0.0	0.8	0.1	0.2	1.5	0.1	0.0	0.1	0.2	0.5	0.0	0.2	0.1	2.8	0.2	1.7	0.1	0.7	0.0	0.2	0.3	0.0	1.7	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.8	0.3	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.5	1.0	1.7	1.6	1.0	0.6	0.6	1.1	0.8	0.2	1.7	1.7	0.0	25.6	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	27.1	5.6	3.7	0.0	0.0	0.0	0.0	13.7	4.3	0.5	0.0	0.0	0.5	11.5	0.0	0.3	0.2	0.0	1.6	0.0	0.0	1.3	20.7	0.0	0.1	0.1	0.0	0.1	0.6	0.0	1.0	0.0	1.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	0.0	0.0	0.0	0.2	15.3	1.0	0.0	0.0	1.5	0.0	0.5	0.0	0.0	0.0	0.9	0.8	0.0	0.0
CCDC28A	"C6orf80, CCRL1AP, DKFZp586D0623"	ENSG00000024862	"Coiled-coil domain containing 28A"		6	138773769-138793319	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 146.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055125	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	Nucleoplasm	"HPA055125: AB_2682705"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.80e-1)"	"unprognostic (8.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.11e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.37e-2)"	21.8	48.4	41.8	19.6	42.5	40.1	28.1	38.4	48.7	23.8	47.1	23.8	30.4	16.7	38.1	16.4	35.8	23.8	19.1	43.8	43.2	59.9	67.8	26.2	35.4	38.5	38.8	21.8	35.5	53.0	29.5	32.1	39.3	25.0	24.3	25.6	52.3	20.2	15.7	18.0	30.7	15.9	37.8	29.8	29.3	23.8	41.1	46.5	54.2	21.3	33.6	26.2	17.2	39.0	7.2	12.9	9.5	17.4	17.5	24.4	19.4	11.7	20.3	15.2	24.6	11.1	14.1	31.1	22.3	11.8	21.3	12.3	15.6	16.2	24.4	35.9	35.7	25.3	16.3	22.1	27.6	43.8	25.6	15.7	20.2	10.9	32.0	31.0	25.1	43.1	25.8	42.2	17.1	15.9	36.3	58.0	8.9	28.9	13.2	21.7	9.5	29.2	18.3	10.6	11.8	18.4	15.6	13.8	34.9	18.6	6.7	47.6	19.5	11.9	13.5	22.3	18.0	55.8	53.0	23.1	12.7	27.1	10.6	137.8	91.6	120.6	84.5	96.5	76.4	107.1	88.4	92.8	102.1	106.6	101.5	93.3	249.6	115.8	85.0	90.0	159.8	93.6	41.8	42.5	38.4	48.7	43.8	43.2	38.5	38.8	39.3	37.8	41.1	39.0	24.5	32.1	35.4	12.7	36.5	13.4	25.0	36.9	29.0	16.0	24.6	25.1	11.0	24.3	31.6	36.8	18.8	82.7	42.7	31.7	123.3	19.3	146.8	83.5	11.4	20.7	24.7	39.2	25.6	31.6	49.2	23.2	16.3	15.6	43.1	25.3	29.3	50.8	38.0	10.1	22.3	30.6	38.7	41.5	31.5	99.9	16.8	36.1	32.0	3.7	39.5	24.6	42.2	5.5	17.9	16.8	35.9	15.1	29.7	31.2	81.0	130.9	89.0	14.2	13.1	14.0	15.8	48.6	27.2	15.5	14.9	108.9	35.4	18.1	23.1	36.2
CCDC86	MGC2574	ENSG00000110104	"Coiled-coil domain containing 86"	Q9H6F5	11	60842113-60851081	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"parathyroid gland: 377.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041117, HPA041540"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA041117: AB_10794984, HPA041540: AB_10794299"	"unprognostic (2.93e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.36e-5)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.65e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.25e-2)"	25.6	26.7	12.0	14.3	13.3	10.2	20.8	13.1	14.2	12.9	11.2	14.1	11.4	16.7	3.5	19.4	15.2	6.9	16.0	12.7	13.5	19.2	13.7	11.8	11.6	13.2	13.5	13.8	23.9	377.6	24.9	11.6	13.7	23.9	5.8	8.2	12.2	8.6	34.7	22.7	12.3	10.4	12.3	12.7	16.4	48.9	12.7	8.8	12.9	13.7	8.5	20.2	14.5	14.1	83.4	110.2	26.5	76.1	21.8	35.7	36.3	54.3	42.4	98.1	52.4	95.0	53.7	98.9	100.7	31.0	69.7	73.3	94.2	65.7	48.2	35.7	101.3	51.0	45.8	133.2	70.7	80.7	82.6	39.5	48.7	90.2	61.8	14.3	75.8	53.5	166.0	46.9	50.3	97.3	125.2	122.6	107.0	48.6	156.3	81.4	39.6	253.5	37.2	33.8	59.9	38.9	34.7	79.5	64.6	17.6	80.8	30.3	45.9	93.6	59.6	131.6	118.2	41.0	66.5	109.2	78.2	86.0	118.6	1.7	13.5	4.2	9.1	29.4	9.7	9.4	9.6	8.3	29.8	9.0	11.5	10.2	1.0	6.9	9.3	16.6	9.7	10.1	12.0	13.3	13.1	14.2	12.7	13.5	13.2	13.5	13.7	12.3	12.7	14.1	9.3	0.0	2.2	2.0	8.9	37.0	22.2	5.7	28.5	12.1	9.9	10.3	0.6	4.3	4.0	1.8	8.4	17.2	5.7	5.3	7.9	18.6	25.6	6.8	9.4	12.7	7.2	8.8	2.0	12.2	20.4	10.2	9.7	7.7	5.1	7.9	3.6	3.1	18.4	3.3	1.7	5.7	6.1	2.5	16.5	15.0	11.5	7.3	16.0	1.0	5.3	3.9	4.1	1.0	1.3	19.2	3.6	6.0	8.6	24.0	4.4	7.3	1.3	8.3	19.7	10.7	19.1	74.6	18.8	21.2	31.0	8.2	7.0	12.5	11.3	18.8
CCT5	KIAA0098	ENSG00000150753	"Chaperonin containing TCP1 subunit 5"	P48643	5	10249929-10266389	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002238, HPA005958, CAB006271"	Enhanced					NA	NA		1400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"			"CAB006271: AB_425898, HPA002238: AB_1078427, HPA005958: AB_1846209"	"unprognostic (7.02e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (6.57e-11)"	"unprognostic (6.40e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (8.23e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.82e-2)"	85.3	79.5	68.6	95.3	70.4	82.0	74.7	73.2	112.4	58.2	79.2	85.7	67.5	66.8	53.3	100.8	77.4	48.1	74.8	72.7	82.4	76.0	74.1	58.7	96.3	71.5	74.7	50.8	58.4	175.6	46.1	85.8	78.7	52.3	97.2	48.9	60.3	52.9	128.2	60.5	62.2	89.5	74.5	62.3	62.6	104.3	76.0	106.6	63.2	90.8	118.4	105.8	63.7	83.8	350.5	489.8	405.1	463.7	250.9	188.5	568.4	454.1	288.6	704.0	492.6	657.8	372.2	537.6	490.4	326.4	615.9	332.8	770.4	492.7	774.2	504.5	527.9	440.2	1063.7	510.7	293.8	667.6	303.7	221.3	300.3	556.8	368.9	191.4	422.7	343.6	597.5	188.2	453.3	494.0	481.4	659.7	432.6	348.3	579.4	437.9	304.4	275.8	447.3	359.1	304.8	335.3	953.5	424.6	335.6	316.9	327.2	490.9	285.2	576.4	517.7	214.1	687.9	192.2	322.7	570.1	323.7	955.4	470.8	125.6	181.5	139.3	117.5	248.8	155.7	151.6	131.3	130.7	188.9	125.6	121.8	123.7	101.4	147.3	286.1	69.5	150.3	255.3	68.6	70.4	73.2	112.4	72.7	82.4	71.5	74.7	78.7	74.5	76.0	83.8	81.7	67.3	41.3	12.1	71.5	88.2	172.1	206.6	60.3	46.7	50.7	54.6	23.6	51.5	116.7	49.7	18.8	214.2	60.7	81.4	49.0	217.4	235.1	127.0	107.5	92.8	70.9	98.2	16.8	162.8	271.8	81.8	62.7	101.1	48.8	100.7	40.0	52.5	175.7	35.3	19.3	89.9	116.0	69.2	64.7	93.1	83.0	84.0	40.9	13.1	92.1	56.6	72.1	19.1	22.9	199.0	81.8	75.6	59.6	128.5	61.0	99.2	131.7	60.8	72.3	81.0	272.5	282.3	184.4	93.1	74.6	155.4	66.5	170.2	126.9	126.1
CCZ1B	"C7orf28B, DKFZP586I1023, H_NH0577018.2, MGC19819"	ENSG00000146574	"CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated"	P86790	7	6794134-6826770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 32: U-937 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA045114: AB_2679219, HPA050006: AB_2680989"	"unprognostic (8.06e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.96e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.24e-1)"	28.9	40.3	19.6	25.1	20.0	37.1	28.8	20.6	26.2	18.5	22.4	31.3	27.5	28.5	40.3	42.5	25.6	28.4	28.6	19.5	20.3	28.8	24.1	23.5	38.0	19.8	19.6	18.2	21.1	73.1	9.1	26.7	19.8	20.8	27.2	32.4	32.9	19.0	35.8	30.2	22.0	22.5	20.7	25.4	30.8	23.5	20.5	38.8	24.6	53.5	35.5	39.4	9.3	21.6	120.6	31.6	66.8	138.5	49.7	51.5	67.2	64.1	69.4	58.1	61.4	32.4	65.7	52.2	57.0	72.0	132.5	68.7	87.9	60.5	62.4	31.1	51.8	33.6	40.7	72.0	54.3	165.4	104.1	37.9	37.6	51.1	30.2	40.0	57.9	108.6	63.5	49.2	62.6	124.7	84.2	81.5	171.2	78.2	66.7	67.3	123.1	59.4	41.8	66.4	87.1	161.5	62.4	117.6	78.8	65.9	94.0	185.0	71.1	27.7	93.7	78.2	116.5	52.9	104.8	45.6	53.9	176.4	120.9	21.8	5.5	10.2	5.3	8.0	6.3	6.1	6.7	7.8	8.3	5.1	4.5	5.8	4.6	10.6	15.5	6.3	15.7	3.4	19.6	20.0	20.6	26.2	19.5	20.3	19.8	19.6	19.8	20.7	20.5	21.6	9.5	6.4	12.7	11.1	17.4	8.4	7.8	8.6	8.0	10.4	10.9	10.0	7.3	2.8	10.7	3.7	14.6	8.0	12.9	18.7	15.6	20.1	3.7	16.0	11.1	8.9	18.6	9.0	19.6	28.1	11.7	9.2	9.2	10.3	2.5	6.6	15.7	7.1	9.8	16.8	19.0	17.5	6.1	11.1	22.8	2.2	7.2	11.2	14.2	8.4	24.7	11.5	17.5	14.6	23.6	24.8	11.9	10.5	7.6	9.6	7.1	12.4	23.7	11.4	19.7	8.1	9.0	12.0	8.9	11.0	12.5	7.9	11.1	5.7	15.3	11.9
CD109	"CPAMD7, DKFZp762L1111, FLJ38569"	ENSG00000156535	"CD109 molecule"	Q6YHK3	6	73695785-73828316	"CD markers, Plasma proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"parathyroid gland: 330.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.3;Basal respiratory cells: 62.8;Hofbauer cells: 45.0;Squamous epithelial cells: 51.4;Suprabasal keratinocytes: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 206.4;BJ hTERT+: 126.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008992, HPA015723"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		180000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA008992: , HPA015723: AB_2732415"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (2.65e-4)"	"prognostic unfavorable (7.96e-5)"	"unprognostic (9.50e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (4.68e-4)"	8.6	1.1	2.3	2.4	2.5	2.8	5.5	2.1	2.1	9.9	0.7	6.9	1.3	12.5	5.6	10.2	3.2	4.1	5.8	2.0	4.0	7.0	1.1	6.6	1.0	3.2	3.6	0.7	0.5	330.4	0.4	6.5	3.5	3.6	2.9	0.2	3.4	2.5	1.2	18.9	2.2	12.6	3.7	2.1	1.1	1.8	2.5	3.1	1.3	3.3	2.2	4.5	7.4	3.1	35.6	29.4	1.5	0.1	48.2	206.4	0.0	30.5	126.0	9.0	18.4	0.1	20.2	0.0	19.7	63.5	19.5	96.5	3.5	60.9	12.1	8.5	5.5	11.5	21.0	5.8	10.1	0.0	0.3	60.7	52.4	18.6	68.7	34.2	71.6	3.9	0.0	0.2	45.0	0.8	0.8	0.0	2.4	0.3	18.9	2.6	8.4	40.6	4.8	3.6	0.0	0.1	68.6	0.7	30.8	1.3	0.8	5.8	68.7	96.8	10.1	17.2	28.5	0.7	17.9	0.1	40.3	0.1	89.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	2.3	2.5	2.1	2.1	2.0	4.0	3.2	3.6	3.5	3.7	2.5	3.1	65.3	3.2	1.7	39.8	1.1	41.4	8.4	62.8	35.9	0.3	2.2	2.2	13.0	0.0	16.3	0.0	0.0	0.4	1.2	0.1	1.9	0.1	23.4	10.8	10.5	38.0	0.0	7.6	4.0	0.0	0.5	25.0	0.5	15.0	2.5	0.0	21.0	0.6	45.0	0.0	3.3	0.1	4.1	2.7	28.5	21.0	0.6	13.5	23.2	19.7	3.3	0.0	0.0	1.5	1.0	0.4	0.0	0.0	1.7	10.8	0.0	23.5	16.0	0.2	0.0	7.4	13.2	1.0	3.5	51.4	43.8	1.4	4.6	1.4	0.2	7.2
CD226	"DNAM-1, DNAM1, PTA1, TLiSA1"	ENSG00000150637	"CD226 molecule"	Q15762	18	69831158-69961803	"CD markers, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 20.2;parathyroid gland: 62.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 52.1;Macrophages: 24.4;Microglial cells: 22.5;NK-cells: 90.6;Oligodendrocytes: 26.6;T-cells: 43.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 36.6;MAIT T-cell: 13.4;memory CD4 T-cell: 28.8;memory CD8 T-cell: 22.5;naive CD4 T-cell: 15.8;naive CD8 T-cell: 17.3;NK-cell: 29.7;T-reg: 11.3"	"Group enriched"	"Detected in many"	11	"NK-cells: 29.7;T-cells: 36.6"	"Group enriched"	"Detected in some"	6	"HEL: 100.0;HMC-1: 42.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA015715, HPA015865"	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	No		20000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA015715: AB_1846278, HPA015865: "	"unprognostic (1.42e-4)"	"unprognostic (1.30e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.49e-5)"	"unprognostic (4.15e-1)"	"unprognostic (9.52e-4)"	"unprognostic (3.68e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.31e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-2)"	1.1	0.6	1.1	5.7	6.4	4.4	1.5	1.5	2.4	1.1	0.0	1.8	2.3	1.3	0.5	1.6	1.3	3.0	0.5	0.7	2.0	1.5	4.2	4.2	9.7	3.1	3.3	0.9	0.5	62.4	0.6	0.5	3.2	1.0	2.4	1.4	1.5	0.4	0.7	0.3	3.1	1.6	2.2	20.2	3.2	1.2	5.5	6.4	0.7	0.6	7.1	3.1	0.4	3.2	0.0	0.1	0.3	0.3	0.0	0.0	0.1	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.4	0.2	5.3	0.1	100.0	0.3	0.1	0.0	0.7	42.6	0.0	1.1	0.2	0.6	0.2	0.0	0.9	0.3	9.3	0.4	0.0	0.8	0.4	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.5	0.8	0.3	0.1	0.2	11.5	0.4	0.0	0.3	0.2	0.5	0.3	0.1	1.2	36.6	1.0	13.4	0.8	28.8	22.5	2.9	0.1	15.8	17.3	1.6	29.7	1.3	0.1	11.3	13.2	1.1	6.4	1.5	2.4	0.7	2.0	3.1	3.3	3.2	2.2	5.5	3.2	0.6	3.2	3.6	3.3	3.2	0.0	0.3	0.0	0.0	3.4	0.5	0.8	2.5	0.0	0.7	0.0	0.0	0.1	52.1	0.2	0.0	0.0	8.4	0.9	1.7	1.0	0.0	3.2	4.6	0.4	0.0	1.3	3.1	0.5	13.9	1.3	3.3	0.4	1.6	0.0	3.1	0.1	0.0	16.7	2.7	8.2	0.9	24.4	0.0	22.5	14.7	0.8	90.6	2.0	26.6	0.2	0.1	0.7	13.4	0.3	0.0	0.3	1.5	3.6	0.0	1.8	0.6	0.4	0.8	0.0	0.4	0.0	43.2	0.5	0.1	0.2
CD46	"MCP, MGC26544, MIC10, TLX, TRA2.10"	ENSG00000117335	"CD46 molecule"	P15529	1	207752054-207795513	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Fertilization, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 296.7;eosinophil: 382.4;neutrophil: 401.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 401.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"CAB010401, HPA016903"	Enhanced		Approved	"Plasma membrane"		NA	NA		1000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"CAB010401: AB_2291289, HPA016903: AB_1846309"	"unprognostic (1.42e-2)"	"prognostic unfavorable (8.54e-5)"	"unprognostic (3.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.78e-3)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.76e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.49e-2)"	98.6	237.4	30.0	64.0	35.0	80.5	128.4	33.5	39.5	74.0	61.4	103.1	124.6	62.1	77.1	102.2	110.0	73.8	64.9	30.2	34.4	173.2	133.9	129.1	58.2	37.4	33.6	61.2	112.5	310.6	41.8	221.5	38.1	167.4	103.2	72.6	166.9	107.4	47.4	47.7	98.6	67.1	34.8	79.6	117.4	40.5	36.3	44.4	86.8	58.1	66.6	97.2	68.2	41.5	130.0	71.7	66.1	30.8	202.9	199.2	99.9	95.0	137.3	61.3	82.5	71.3	335.4	19.8	94.3	95.3	84.5	170.7	50.0	130.5	93.0	99.9	70.9	42.9	73.8	128.6	128.8	94.8	142.8	172.9	189.6	92.9	72.5	144.4	174.2	76.8	91.8	83.4	95.7	61.3	45.4	82.8	75.6	76.9	70.9	30.2	104.7	123.0	251.4	252.6	66.5	45.4	120.5	266.8	160.1	130.8	210.2	79.8	150.9	65.6	57.7	139.2	109.9	111.2	144.3	60.1	95.8	61.2	63.0	296.7	79.8	382.4	50.1	82.4	68.9	43.5	63.3	55.8	47.3	34.1	71.1	60.5	401.8	46.9	87.5	24.9	60.5	102.4	30.0	35.0	33.5	39.5	30.2	34.4	37.4	33.6	38.1	34.8	36.3	41.5	186.0	201.9	241.1	59.7	60.3	52.9	89.3	87.2	108.1	63.0	144.3	85.7	61.4	75.8	177.8	145.3	66.7	247.3	94.0	105.2	15.6	77.4	227.7	206.1	67.0	106.7	72.8	46.9	61.0	79.9	76.2	70.5	97.9	231.3	114.5	78.1	77.8	120.9	59.9	40.4	73.6	91.1	87.5	78.9	63.1	36.9	47.2	91.6	62.2	82.4	88.7	25.3	39.1	112.1	153.9	72.8	117.7	44.0	76.0	144.5	92.6	54.4	208.8	87.3	52.6	69.7	89.3	17.1	20.2	104.5	45.9	343.7	89.9	99.4	115.9	165.7
CEP104	"CFAP256, GlyBP, JBTS25, KIAA0562, ROC22, RP1-286D6.4"	ENSG00000116198	"Centrosomal protein 104"	O60308	1	3812086-3857396	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Cone photoreceptor cells: 458.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010126	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA010126: AB_10601583"	"unprognostic (3.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.35e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.70e-5)"	"unprognostic (7.06e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-1)"	9.0	9.1	7.0	6.6	11.6	3.1	6.4	9.3	7.7	6.9	12.0	8.1	5.2	7.1	4.3	7.6	7.9	6.2	7.6	5.4	7.9	11.3	8.7	7.5	7.1	10.1	11.4	7.5	8.8	14.0	8.1	6.6	10.2	7.7	6.6	9.0	7.8	8.6	9.5	7.1	7.1	9.3	7.7	6.6	7.6	9.6	10.1	8.4	9.9	6.9	8.7	8.1	6.7	9.1	13.4	10.8	8.8	11.8	20.9	15.9	6.8	14.0	11.2	19.5	12.8	8.0	11.4	15.7	17.6	14.8	14.0	12.8	20.3	13.1	23.1	22.1	15.5	15.8	12.7	10.2	13.5	15.5	13.3	8.0	13.0	17.9	28.0	13.6	16.6	17.3	19.6	15.7	18.3	6.2	22.8	6.3	6.3	18.9	20.2	14.1	12.3	17.1	12.7	7.8	22.1	8.8	21.7	23.8	15.0	10.8	10.2	8.0	19.1	14.0	6.5	23.6	11.4	13.0	20.6	22.5	7.9	17.4	5.6	0.3	0.1	1.5	0.6	0.2	0.5	0.2	0.4	0.6	0.3	0.7	0.7	0.1	0.2	0.7	0.4	0.9	0.2	0.1	7.0	11.6	9.3	7.7	5.4	7.9	10.1	11.4	10.2	7.7	10.1	9.1	13.7	25.6	25.9	15.7	14.7	15.9	14.2	9.2	12.0	24.8	12.8	9.1	14.1	12.8	13.9	25.8	458.7	16.3	18.6	16.2	7.9	26.0	74.9	34.3	14.4	15.4	11.3	10.7	23.7	19.6	24.4	12.9	12.2	18.9	10.8	12.6	8.9	18.4	13.2	58.9	24.6	13.5	4.1	14.6	7.8	91.7	12.5	14.3	19.6	12.2	21.0	13.8	22.6	12.1	34.1	24.3	11.7	20.7	23.2	19.2	16.6	18.5	28.7	55.2	19.7	19.8	16.1	63.7	23.5	15.0	20.0	11.4	17.2	18.2	12.7	13.7
CHGA		ENSG00000100604	"Chromogranin A"	P10645	14	92923150-92935285	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 6568.4"	"Cell type enriched"	"Detected in many"	7	"Enteroendocrine cells: 6553.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 114.8"	"Group enriched"	"Detected in many"	16	"cerebral cortex: 326.0;white matter: 124.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	151	"SCLC-21H: 489.5;SH-SY5Y: 1339.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000023, HPA017369, CAB040544, CAB055506, CAB058688"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA	295000000	100000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698"	"prognostic favorable (7.85e-5)"	"unprognostic (4.89e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.81e-13)"	"unprognostic (1.07e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (3.99e-4)"	14.5	1248.5	8.6	9.4	11.4	0.2	0.3	0.0	326.0	8.3	0.0	92.0	242.7	0.4	0.3	1.0	1.1	0.2	0.2	4.4	1.7	1.0	0.4	1.6	0.1	14.4	0.0	0.2	102.5	6568.4	446.2	0.0	4.1	12.2	105.2	11.0	0.2	0.3	0.1	0.6	179.9	0.9	0.0	0.1	364.5	77.7	4.3	0.6	24.6	0.0	0.0	1.3	1.2	124.4	0.0	0.5	2.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.8	2.7	0.0	0.0	0.2	0.0	1.4	0.0	0.0	489.5	1339.4	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	4.2	0.3	0.4	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	11.4	0.0	326.0	4.4	1.7	14.4	0.0	4.1	0.0	4.3	124.4	0.1	0.0	0.0	11.1	1.0	0.9	0.4	0.0	0.0	17.3	0.2	0.3	2.9	0.0	0.0	0.0	29.2	0.3	0.0	9.8	0.0	0.1	1.3	6.0	2.3	0.8	6553.1	0.0	59.5	0.4	0.1	4.1	195.7	0.5	0.0	0.5	0.0	0.0	1.5	16.8	37.7	820.4	14.2	0.0	0.0	7.9	39.7	0.1	7.2	15.9	2.0	3.7	0.0	10.6	12.8	46.5	137.8	137.3	0.0	6.6	36.7	0.0	0.0	16.2	0.0	0.0	0.2	4.7	2.2	0.0	0.0	0.3	0.2	0.4	25.9	5.1
CHM	"DXS540, REP-1, TCD"	ENSG00000188419	"CHM Rab escort protein"	P24386	X	85861180-86047561	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003231, CAB016171"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB016171: AB_2229397, HPA003231: AB_1078518"	"unprognostic (6.50e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.40e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.60e-3)"	9.3	11.1	2.7	7.3	3.4	2.4	7.7	2.7	4.4	9.3	3.6	6.1	4.6	8.8	4.6	6.7	11.0	7.2	7.2	3.9	2.5	12.1	7.7	7.0	7.1	2.9	2.2	7.8	5.9	14.2	3.8	9.5	3.0	7.6	6.4	9.3	5.6	7.1	6.4	4.2	4.7	8.7	1.3	8.1	7.3	4.6	2.9	8.5	10.9	10.5	6.3	7.6	3.5	3.2	16.8	10.9	10.9	7.2	17.4	18.4	6.9	19.3	16.2	13.2	14.4	8.8	15.0	5.7	24.3	14.0	46.1	9.4	23.9	10.9	22.5	10.9	11.4	3.4	14.6	8.4	13.8	14.3	23.8	14.1	10.1	21.4	26.9	14.6	22.9	9.4	11.9	19.0	20.7	4.8	8.8	5.2	16.2	11.6	17.5	9.0	19.5	8.8	12.2	9.5	9.6	14.8	23.3	7.1	18.3	14.9	6.0	6.7	16.4	16.7	11.0	59.0	9.7	7.2	27.7	7.9	18.0	11.9	14.9	2.2	1.9	0.9	1.6	2.3	1.5	1.8	1.3	1.7	1.5	2.1	1.7	1.8	1.0	1.6	1.9	1.4	1.7	1.2	2.7	3.4	2.7	4.4	3.9	2.5	2.9	2.2	3.0	1.3	2.9	3.2	34.5	3.2	11.0	33.6	22.3	6.9	17.6	18.9	15.9	35.2	14.2	10.3	11.9	15.7	15.9	16.5	8.4	9.6	26.5	10.2	19.6	16.3	0.7	13.8	29.5	22.2	18.7	12.6	82.5	12.4	9.6	21.6	15.3	18.4	16.5	18.2	14.6	12.5	15.5	23.5	94.7	11.8	10.2	23.0	9.1	2.1	15.5	21.4	5.4	52.5	19.6	27.5	18.6	78.4	76.5	15.7	11.4	12.4	17.3	18.9	7.5	35.2	17.7	20.9	46.0	28.0	27.8	3.7	12.2	12.8	7.4	18.3	22.1	28.7	9.4	15.6
CHPT1	CPT1	ENSG00000111666	"Choline phosphotransferase 1"	Q8WUD6	12	101696947-101744140	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 344.4;Late spermatids: 650.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 36.9;eosinophil: 14.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 36.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067643	Approved		Supported	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"HPA067643: "	"unprognostic (1.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.70e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.41e-4)"	"unprognostic (1.79e-1)"	39.8	47.7	48.6	17.7	49.1	62.0	102.9	43.8	65.6	50.5	41.9	49.4	88.1	19.2	56.1	24.9	33.4	40.2	91.3	46.1	47.3	73.5	157.4	38.4	20.0	50.0	51.2	18.7	25.0	92.4	12.4	22.8	44.9	35.0	48.9	4.8	130.0	50.0	27.8	28.0	75.7	18.8	50.0	23.5	56.0	28.1	54.4	9.0	38.0	28.3	21.2	32.4	26.2	48.9	11.3	51.2	13.7	29.3	106.6	35.7	38.9	40.2	46.2	39.7	25.5	19.3	7.7	17.3	22.1	55.1	54.3	16.9	83.8	14.2	37.3	26.2	70.1	69.7	25.7	112.6	59.4	34.8	13.5	33.6	4.1	18.0	32.7	59.0	20.0	36.4	102.8	43.1	39.4	27.6	20.8	118.5	36.2	53.8	67.4	15.9	26.8	12.4	17.9	43.4	13.8	10.4	37.2	52.3	103.2	21.4	53.8	23.6	14.7	36.1	18.7	28.5	39.9	24.3	7.9	21.2	28.4	39.7	53.4	36.9	2.2	14.6	0.6	1.7	0.6	4.4	1.2	0.9	2.9	2.6	0.4	0.6	3.1	4.6	2.2	3.7	0.6	0.5	48.6	49.1	43.8	65.6	46.1	47.3	50.0	51.2	44.9	50.0	54.4	48.9	27.1	48.1	27.6	159.6	135.1	37.5	313.3	4.2	21.6	19.3	243.8	76.7	45.3	102.9	13.1	64.4	29.2	123.9	32.6	61.7	70.5	8.1	344.4	17.1	50.2	22.5	21.1	168.6	95.8	13.8	56.1	75.4	69.8	21.0	10.8	15.3	31.1	189.7	56.4	35.3	95.6	53.4	2.0	102.9	55.7	650.9	85.4	81.2	145.9	36.5	27.0	68.1	5.2	65.9	10.2	9.6	113.3	89.1	55.4	172.1	174.1	183.7	4.3	16.0	19.7	88.2	37.8	193.8	43.2	43.1	43.2	60.3	41.3	3.4	90.7	291.6
CHRNA7		ENSG00000175344	"Cholinergic receptor nicotinic alpha 7 subunit"	P36544	15	31923438-32173018	"FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 7.8;intestine: 9.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 9.0;Gastric mucus-secreting cells: 26.0;Horizontal cells: 16.8;Inhibitory neurons: 30.7;Proximal enterocytes: 14.4"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.3;RT4: 12.9;SH-SY5Y: 8.3;SK-BR-3: 13.3;U-2 OS: 10.8"									"HPA029422, CAB033624"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB033624: AB_784835, HPA029422: AB_10600863"	"unprognostic (3.43e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.61e-4)"	"unprognostic (6.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.36e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.41e-3)"	"unprognostic (2.43e-1)"	0.3	7.8	1.2	0.4	1.1	0.9	1.0	1.8	1.8	0.4	2.1	1.5	4.4	0.5	0.3	0.3	0.4	0.9	0.5	1.0	4.5	0.4	0.1	0.5	0.7	4.5	3.9	1.6	2.4	6.4	1.0	0.0	7.0	1.2	2.3	2.5	0.5	0.7	0.5	0.3	9.7	0.4	1.5	1.2	6.6	2.5	3.3	0.4	2.2	0.8	0.7	1.5	0.7	1.1	0.0	1.3	2.7	6.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	3.1	0.0	0.0	0.0	1.7	0.6	0.0	2.2	0.0	0.4	1.0	0.0	0.0	0.2	0.0	0.1	0.4	2.5	0.0	0.2	0.3	0.2	0.0	0.2	1.5	3.7	0.0	0.0	4.2	0.3	0.5	12.9	0.5	8.3	0.2	13.3	0.0	0.7	0.0	0.5	1.2	0.0	10.8	0.3	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.2	1.1	1.8	1.8	1.0	4.5	4.5	3.9	7.0	1.5	3.3	1.1	0.5	0.0	0.0	1.0	0.0	0.3	3.0	0.0	7.4	1.8	1.1	1.3	1.1	2.8	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.3	0.1	0.2	0.3	1.5	3.0	0.0	9.0	2.5	0.0	0.4	26.0	0.6	1.3	4.6	0.7	0.0	0.1	16.8	30.7	8.9	0.0	0.0	0.9	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.5	1.1	1.6	2.9	0.0	0.2	0.7	14.4	0.2	0.0	0.0	0.0	0.4	0.3	0.2	5.9	3.2	0.0	0.0	0.1	0.2	2.0	1.2
CITED2	MRG1	ENSG00000164442	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2"	Q99967	6	139371807-139374648	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Stress response, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 685.3;Plasma cells: 619.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 27.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 618.3;fHDF/TERT166: 1070.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016157, CAB069879"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"CAB016157: AB_668099, CAB069879: AB_10003446"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.40e-4)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.03e-1)"	177.7	107.4	3.8	49.8	2.2	313.6	117.5	29.3	24.0	60.5	5.4	88.0	36.7	188.0	38.7	75.5	207.7	32.6	70.9	1.9	9.3	70.7	203.4	134.0	37.9	8.5	6.5	270.3	74.7	179.0	17.7	104.1	8.3	44.2	42.5	36.4	120.5	42.8	107.6	131.7	65.3	81.9	0.9	136.5	69.5	22.0	19.4	25.1	227.7	24.9	30.4	37.9	64.0	0.7	23.7	13.7	46.7	138.2	191.8	203.7	175.6	618.3	456.0	274.7	255.7	122.5	35.2	17.0	88.5	1070.3	58.5	28.0	14.2	14.5	192.4	467.0	45.8	346.9	76.0	10.1	157.1	103.1	36.5	164.6	64.4	121.3	91.4	177.9	51.2	10.1	132.9	80.1	359.2	51.0	17.5	128.3	43.8	15.0	21.2	24.7	34.2	152.3	131.7	52.5	51.8	0.8	45.2	167.6	21.2	106.8	72.3	348.3	283.6	219.9	69.5	66.4	35.0	23.4	22.6	26.3	68.0	86.9	15.8	3.1	8.2	27.7	3.4	4.6	5.0	1.2	5.4	4.9	3.6	3.1	4.7	2.4	4.0	3.0	6.6	1.6	3.6	3.3	3.8	2.2	29.3	24.0	1.9	9.3	8.5	6.5	8.3	0.9	19.4	0.7	157.1	115.4	272.8	3.6	138.8	35.8	111.5	12.7	347.8	30.6	164.4	180.0	114.1	80.1	36.5	103.0	12.5	173.1	156.5	159.6	185.9	20.5	1.5	122.6	131.7	68.9	99.7	274.3	6.9	14.9	685.3	200.3	121.8	262.3	46.9	133.9	61.1	65.5	372.6	30.3	22.2	111.6	20.3	124.4	67.7	7.7	99.4	188.9	83.6	9.4	44.2	51.9	55.6	1.0	1.3	23.1	97.7	60.9	619.4	46.6	88.8	121.0	27.4	52.5	98.6	107.9	179.1	1.8	20.8	200.8	33.8	269.3	291.8	272.9	112.6	38.4
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"		Yes	No		14000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924"	"unprognostic (1.56e-1)"	"prognostic unfavorable (7.35e-4)"	"prognostic favorable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.02e-4)"	105.4	95.2	42.1	89.7	54.9	96.3	81.6	67.3	103.9	92.3	36.7	121.7	74.1	83.1	126.4	82.1	67.8	88.9	90.7	60.7	65.1	125.5	117.7	82.1	75.5	95.5	52.4	73.2	56.8	186.8	51.6	139.6	95.2	97.8	128.3	163.6	68.6	104.2	88.4	81.3	73.3	121.0	43.8	78.8	91.2	71.3	68.2	76.0	114.1	83.9	86.8	101.1	51.6	55.0	293.3	426.1	207.6	207.0	345.8	280.5	240.0	305.7	321.7	268.2	278.9	264.7	175.2	200.6	340.1	436.4	296.9	186.2	313.6	255.1	356.2	214.4	166.8	328.2	248.8	414.0	262.3	228.5	182.3	266.9	154.6	408.0	262.3	211.4	302.0	99.9	334.4	280.4	429.1	511.1	135.6	65.1	179.6	263.3	248.2	118.7	343.6	244.9	297.5	404.1	184.1	216.7	188.3	122.9	180.4	270.5	290.3	142.3	385.6	492.4	287.9	237.0	317.8	213.3	320.3	181.4	357.7	151.6	305.3	16.6	33.1	21.3	17.5	36.3	21.7	13.7	16.1	19.2	36.5	12.9	13.4	15.0	19.9	18.9	32.5	22.8	22.1	23.3	42.1	54.9	67.3	103.9	60.7	65.1	95.5	52.4	95.2	43.8	68.2	55.0	62.6	99.3	107.9	80.3	46.3	63.9	44.4	75.6	28.5	91.9	58.5	34.7	77.9	71.4	103.3	77.3	60.5	109.1	60.7	184.0	27.4	76.2	23.3	95.5	95.6	79.7	120.6	115.9	137.7	97.7	47.7	84.5	99.4	106.1	68.4	75.5	120.7	185.4	182.5	85.8	135.9	120.7	77.3	195.0	93.2	77.2	74.0	128.3	53.4	79.6	102.8	53.9	38.1	73.4	124.2	106.2	76.1	93.6	83.0	86.3	102.7	132.4	128.0	65.2	78.9	66.0	82.8	52.7	38.0	60.5	79.3	107.9	45.9	81.3	127.8	91.6
CMTM4	CKLFSF4	ENSG00000183723	"CKLF like MARVEL transmembrane domain containing 4"	Q8IZR5	16	66614750-66696743	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 68.0;Granulosa cells: 67.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014704, HPA023890"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus, Vesicles, Plasma membrane"		"HPA014704: AB_1847005, HPA023890: AB_1847007"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.43e-1)"	"unprognostic (5.13e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.35e-3)"	"unprognostic (6.06e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.72e-9)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.00e-1)"	4.5	5.0	36.4	2.7	34.1	2.5	5.7	32.8	34.5	3.9	28.3	16.1	11.9	4.4	20.1	6.0	10.6	2.9	4.1	43.1	37.1	26.3	4.1	8.4	0.6	42.1	41.7	3.4	19.2	32.7	14.4	2.1	35.4	7.7	12.6	7.8	11.1	3.8	3.3	7.7	12.9	3.4	41.8	2.0	31.4	6.9	45.5	0.5	38.6	2.1	1.1	3.2	4.1	41.6	16.0	12.9	7.8	19.1	2.6	4.2	31.7	6.6	5.9	3.5	5.6	24.2	17.7	0.7	10.8	3.9	4.8	20.0	19.7	7.8	5.2	1.3	17.2	1.7	5.3	15.2	5.6	1.4	3.0	6.7	13.4	4.2	8.1	11.9	2.0	2.3	8.0	4.1	5.1	18.5	0.1	3.2	8.7	28.6	8.6	3.5	10.6	4.9	15.2	14.2	17.9	7.1	27.4	14.6	9.3	5.6	15.3	3.4	4.3	6.5	7.0	1.8	6.6	1.4	3.3	0.7	8.1	3.2	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	36.4	34.1	32.8	34.5	43.1	37.1	42.1	41.7	35.4	41.8	45.5	41.6	2.6	22.4	11.1	32.7	0.8	5.2	8.8	21.9	4.6	9.5	23.5	10.8	7.1	15.7	19.3	23.9	8.4	5.0	1.6	51.7	13.7	15.9	1.9	20.7	2.7	4.3	39.0	0.8	68.0	24.0	29.6	3.5	27.5	12.3	4.5	67.6	1.8	6.1	2.4	30.3	37.7	24.1	20.3	2.8	0.9	3.0	2.5	1.9	3.6	7.5	4.4	24.2	0.0	37.7	51.3	30.8	19.5	3.0	0.6	29.0	30.7	19.9	40.0	11.1	6.6	3.1	8.8	6.4	7.7	7.5	5.5	2.9	0.9	2.5	43.4	19.4
CNNM2	ACDP2	ENSG00000148842	"Cyclin and CBS domain divalent metal cation transport mediator 2"	Q9H8M5	10	102918294-103090222	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Epilepsy, Mental retardation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 37.9;parathyroid gland: 31.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 60.1;Excitatory neurons: 112.6;Inhibitory neurons: 146.9;Oligodendrocyte precursor cells: 92.5;Oligodendrocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059954, HPA071631"			Enhanced	Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA059954: AB_2684177, HPA071631: AB_2686427"	"unprognostic (2.18e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.80e-2)"	"unprognostic (4.51e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (2.39e-8)"	"unprognostic (2.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.56e-1)"	3.3	11.5	5.1	2.3	5.5	9.3	2.5	7.9	5.7	3.7	37.9	7.0	3.8	3.6	2.1	1.7	4.8	4.1	2.1	4.2	3.3	9.1	4.8	3.8	1.5	4.9	4.8	4.8	3.6	31.6	5.7	8.7	4.7	2.7	6.4	5.0	3.0	3.0	1.6	4.5	4.5	3.7	1.8	2.1	3.3	4.5	4.6	1.8	5.6	1.5	1.1	3.2	2.9	9.7	5.0	8.1	3.1	8.5	7.8	3.2	8.6	2.3	9.7	3.1	3.9	5.8	4.3	1.9	3.5	3.4	6.0	6.3	6.9	4.6	2.4	3.3	12.1	2.8	4.2	11.8	4.6	2.0	3.6	4.2	6.6	3.2	10.7	7.9	1.9	5.5	4.8	10.9	1.8	8.6	2.3	2.2	5.1	4.9	5.0	5.5	4.0	2.4	2.4	2.9	4.5	5.8	5.9	1.3	6.3	9.1	10.4	3.7	1.6	4.2	6.2	3.0	4.2	11.7	14.1	3.6	7.4	6.6	1.7	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.2	1.5	0.0	0.3	0.3	0.1	5.1	5.5	7.9	5.7	4.2	3.3	4.9	4.8	4.7	1.8	4.6	9.7	3.0	6.4	8.4	60.1	7.9	2.4	2.3	1.7	6.8	16.4	3.3	2.4	4.5	2.8	5.6	5.5	12.5	18.8	8.1	46.7	1.9	2.2	10.7	7.4	4.2	4.2	6.7	6.7	112.6	5.4	3.4	6.3	12.8	6.4	3.8	13.7	3.3	6.1	3.8	32.0	146.9	5.0	0.0	3.2	2.5	15.1	3.4	4.7	7.2	39.4	2.3	7.0	2.1	92.5	92.3	2.3	9.0	3.4	6.2	2.0	11.7	5.5	9.5	15.8	13.1	5.7	16.7	15.5	6.9	8.1	4.1	39.8	5.1	3.8	11.6	2.2
CNTN4	BIG-2	ENSG00000144619	"Contactin 4"	Q8IWV2	3	2098813-3057959	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 411.7;Excitatory neurons: 960.7;Inhibitory neurons: 1048.5;Oligodendrocyte precursor cells: 248.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 8.3;CACO-2: 9.0;HEK 293: 5.5;SH-SY5Y: 16.5;WM-115: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		170000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.64e-1)"	"unprognostic (7.17e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.41e-2)"	"prognostic favorable (1.00e-4)"	"unprognostic (1.22e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-1)"	3.4	0.5	2.2	1.1	6.4	0.0	2.5	13.5	12.3	8.7	0.0	4.6	1.8	8.3	1.9	3.1	4.2	5.1	2.5	1.8	2.7	4.2	2.9	2.4	1.1	0.5	5.4	1.0	1.6	22.6	1.9	7.9	1.2	4.3	3.3	19.8	0.9	5.6	0.7	0.7	4.1	4.5	4.2	1.0	3.6	13.4	7.7	2.2	10.3	4.0	2.6	3.6	1.7	4.0	0.0	0.0	1.1	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	16.5	0.0	0.0	0.1	1.2	0.1	0.2	0.0	0.0	1.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	6.4	13.5	12.3	1.8	2.7	0.5	5.4	1.2	4.2	7.7	4.0	0.4	9.6	3.6	26.8	0.1	0.8	1.3	0.0	1.8	96.5	2.0	1.8	1.4	7.2	5.6	0.0	0.0	0.1	0.0	1.8	0.0	4.4	411.7	0.3	9.1	1.9	7.8	0.0	960.7	0.0	0.1	18.1	0.0	0.3	0.0	6.9	0.7	0.4	0.3	101.0	1048.5	2.0	0.0	0.3	0.7	156.3	5.0	0.4	1.8	31.9	0.0	27.5	0.0	248.3	14.7	0.0	1.6	5.3	0.4	0.4	3.7	3.7	0.0	5.9	6.6	0.5	8.3	4.5	4.9	0.9	0.0	0.3	0.1	0.1	3.5	0.2
COG2	LDLC	ENSG00000135775	"Component of oligomeric golgi complex 2"	Q14746	1	230642481-230693982	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 71.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076994			Approved	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA076994: AB_2686823"	"unprognostic (2.21e-1)"	"unprognostic (7.35e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (2.91e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.59e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.62e-2)"	10.1	22.0	10.7	11.0	11.8	9.1	12.9	14.7	13.1	13.1	13.5	19.0	13.5	10.0	13.8	8.9	14.2	10.9	17.2	10.0	10.9	16.6	9.9	10.0	16.3	11.0	11.2	10.0	14.1	71.2	8.5	8.9	10.9	12.1	22.7	10.9	12.8	10.9	20.1	11.8	13.3	11.7	11.1	15.1	14.4	10.9	11.5	16.6	15.0	19.9	16.2	11.1	9.1	12.4	15.6	18.0	21.1	20.4	20.6	16.0	30.7	13.2	20.4	21.4	18.6	24.2	23.2	47.6	20.2	18.1	13.8	22.8	20.1	23.6	20.3	38.8	39.8	16.8	17.0	24.9	25.4	43.6	25.1	21.7	25.6	13.6	19.5	13.7	18.0	29.1	29.5	25.8	17.4	12.5	39.7	21.2	30.5	47.1	33.1	33.8	33.8	56.7	22.1	22.8	21.7	29.7	15.5	27.9	30.5	9.4	33.6	41.9	15.3	10.3	9.5	12.8	25.9	31.7	28.3	37.7	17.2	17.7	22.1	18.7	15.7	20.5	16.0	19.4	18.5	13.9	15.1	15.5	18.1	15.2	21.6	19.0	0.8	22.9	29.4	9.1	13.5	18.2	10.7	11.8	14.7	13.1	10.0	10.9	11.0	11.2	10.9	11.1	11.5	12.4	12.5	22.4	19.5	22.9	21.0	5.2	6.1	7.8	8.6	16.1	12.3	10.8	25.9	20.0	15.1	12.9	29.2	13.1	19.6	19.8	27.4	18.7	19.3	17.6	15.2	10.7	18.6	14.9	22.3	23.3	11.8	10.8	15.8	10.7	23.4	14.2	11.0	14.1	14.0	25.2	20.5	37.1	12.2	20.1	6.0	6.4	11.5	12.3	7.2	17.8	19.0	20.5	21.6	23.1	22.6	18.0	12.8	14.7	13.0	9.0	15.2	20.3	28.9	42.9	13.1	13.9	13.3	23.3	25.2	10.0	4.8	9.2	18.4	21.0	21.6	6.0
COL6A6		ENSG00000206384	"Collagen type VI alpha 6 chain"	A6NMZ7	3	130560334-130678155	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"parathyroid gland: 97.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.6;Fibroblasts: 20.6;Inhibitory neurons: 5.3;Oligodendrocytes: 4.6;Skeletal myocytes: 3.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SuSa: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"spinal cord: 10.0"	HPA045239	Uncertain				"Secreted to extracellular matrix"	NA	NA		700000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"			"HPA045239: AB_2679268"	"unprognostic (4.86e-3)"	"unprognostic (2.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.08e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.11e-5)"	"unprognostic (3.74e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.96e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.07e-1)"	1.8	0.0	0.0	0.0	0.2	0.2	2.5	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.3	0.9	0.3	0.1	3.3	0.0	0.0	0.0	0.8	7.3	0.0	0.0	0.0	0.2	0.0	97.8	3.6	0.7	0.0	0.0	0.0	0.3	1.5	0.0	0.1	0.4	0.0	0.5	0.0	1.2	0.1	0.4	0.1	1.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	1.1	1.3	0.0	0.9	0.0	0.0	0.0	1.1	0.2	0.4	2.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	2.9	0.1	0.0	0.0	4.6	0.0	0.0	20.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	5.3	0.0	0.0	0.0	1.5	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	3.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	3.3	0.8	0.0	0.4	0.0	0.9	0.1	0.2	0.0	0.0	0.0
CREB3L2	"BBF2H7, TCAG_1951439"	ENSG00000182158	"CAMP responsive element binding protein 3 like 2"	Q70SY1	7	137874979-138002086	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 141.1;Syncytiotrophoblasts: 144.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015068, HPA015534"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Endoplasmic reticulum"		"HPA015068: AB_1847224, HPA015534: AB_2669210"	"unprognostic (8.50e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.50e-1)"	"unprognostic (4.77e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.48e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.32e-2)"	20.7	29.7	8.3	18.5	13.9	23.8	22.8	8.3	12.2	30.3	46.5	22.4	22.3	33.9	26.8	15.0	22.6	15.0	25.9	8.1	9.6	19.6	12.5	19.3	12.8	13.2	10.8	29.0	30.1	59.5	25.1	39.4	12.1	21.6	17.6	5.0	28.7	23.2	6.1	8.7	22.9	29.2	9.6	13.0	17.4	9.0	16.1	10.0	65.3	9.4	20.4	19.5	19.9	17.3	13.1	19.9	37.6	0.6	62.9	61.7	28.1	65.1	104.0	44.4	44.7	27.5	11.7	2.6	16.8	71.1	24.1	6.9	21.9	47.1	86.9	19.1	10.8	83.4	26.7	67.6	41.4	25.3	115.5	25.4	29.2	56.0	65.3	45.5	59.7	6.5	43.8	37.4	52.9	23.5	8.0	31.6	13.6	17.9	13.7	17.5	19.8	22.1	35.3	13.2	9.4	22.3	21.1	54.0	29.1	21.7	7.9	18.9	63.1	59.5	8.7	72.3	24.2	43.9	16.2	16.9	70.9	71.3	135.0	10.4	5.5	6.0	7.3	3.0	9.8	3.9	5.4	8.2	5.7	3.9	2.0	3.4	2.0	7.2	1.6	11.9	12.5	3.2	8.3	13.9	8.3	12.2	8.1	9.6	13.2	10.8	12.1	9.6	16.1	17.3	30.6	6.4	25.9	18.6	27.3	12.2	9.7	18.9	8.0	12.0	32.0	25.4	17.5	21.5	34.9	23.9	10.4	62.6	39.5	24.7	13.7	10.2	56.3	18.1	86.6	31.6	15.7	12.0	7.5	17.6	93.0	49.6	16.3	42.4	49.4	27.8	29.6	24.3	56.3	15.2	10.6	21.0	20.3	34.9	25.6	18.7	61.8	30.7	26.6	63.7	21.4	5.4	40.2	55.8	48.0	14.4	18.2	103.0	141.1	35.1	66.2	7.9	22.4	12.3	39.5	62.3	50.2	3.4	7.4	9.5	7.1	144.5	26.6	11.1	17.0	44.0
DCAF10	"FLJ23201, MGC10765, WDR32"	ENSG00000122741	"DDB1 and CUL4 associated factor 10"	Q5QP82	9	37800554-37867666	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 182.4;Late spermatids: 325.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024160	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"		"HPA024160: AB_1858802"	"unprognostic (2.16e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.50e-3)"	"unprognostic (2.54e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.02e-6)"	"unprognostic (1.01e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.05e-2)"	7.0	11.2	3.3	4.5	3.7	6.1	7.7	5.1	4.1	7.0	5.1	8.0	5.4	7.5	7.6	7.8	6.5	4.5	5.6	3.5	3.5	8.5	11.4	5.5	5.1	3.1	3.4	7.1	8.4	14.1	5.5	6.2	3.1	7.0	6.4	7.2	7.3	7.0	9.9	7.2	5.5	7.5	3.3	5.2	6.4	17.6	3.5	5.2	9.0	5.7	5.2	7.4	6.8	3.7	11.7	5.7	7.1	6.1	12.2	16.4	7.1	9.6	10.6	5.8	7.3	2.2	4.4	12.2	4.0	12.7	6.6	4.5	6.7	7.9	8.3	9.4	5.3	5.6	9.8	4.1	21.0	7.4	4.2	14.9	17.4	6.4	26.0	13.2	10.3	7.8	17.9	5.9	10.7	4.9	7.1	3.9	6.1	18.2	4.0	6.6	3.4	6.2	11.1	5.9	6.8	9.5	9.1	11.9	8.5	8.5	8.1	16.1	11.1	6.1	3.7	8.1	6.7	5.4	9.2	6.8	10.2	8.1	8.8	0.3	0.3	0.5	0.5	0.3	0.4	0.4	0.4	0.5	0.2	0.6	0.6	0.5	0.7	0.6	0.8	0.3	0.3	0.1	3.3	3.7	5.1	4.1	3.5	3.5	3.1	3.4	3.1	3.3	3.5	3.7	21.4	16.0	28.7	54.2	21.4	40.8	28.3	24.6	28.5	28.6	26.9	17.5	16.5	17.2	27.4	12.9	25.0	17.8	15.9	21.8	9.8	22.7	182.4	18.9	26.8	26.8	19.2	41.9	89.9	21.9	17.1	26.5	21.4	23.9	5.1	35.7	23.6	43.0	15.3	25.2	90.2	20.7	24.4	15.5	23.3	325.7	28.0	16.4	26.6	38.4	19.3	23.4	22.6	82.4	80.6	22.9	16.1	38.4	18.3	42.4	20.5	28.7	18.3	27.3	39.5	32.5	24.0	100.9	11.3	31.7	52.4	22.8	17.7	40.4	25.2	30.1
DDB1		ENSG00000167986	"Damage specific DNA binding protein 1"	Q16531	11	61299451-61342596	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 352.3;Rod photoreceptor cells: 451.4;Syncytiotrophoblasts: 389.4;Theca cells: 303.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032821, HPA045174, HPA068456"	Approved		Enhanced	Nucleoplasm		NA	NA		440000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB032821: AB_639050, HPA045174: AB_2679242, HPA068456: AB_2685992"	"unprognostic (3.45e-1)"	"unprognostic (8.38e-2)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.51e-8)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.25e-3)"	52.8	164.8	30.2	44.0	32.5	47.2	59.0	29.5	30.2	61.3	42.5	50.0	53.2	48.0	79.7	49.7	78.3	39.9	65.1	31.9	36.4	64.8	55.9	43.1	47.0	31.8	33.5	89.3	42.5	232.1	44.5	129.7	36.9	56.6	52.3	162.5	54.1	70.9	133.1	60.6	49.9	61.9	31.9	41.9	44.4	69.1	33.5	81.2	65.0	125.1	66.6	58.6	39.2	36.1	160.3	168.1	159.0	142.2	151.4	139.2	237.8	140.9	193.6	174.4	129.2	188.7	130.7	237.6	126.8	203.4	107.4	141.4	245.5	177.5	188.0	115.7	131.3	128.0	144.3	192.0	109.4	182.7	112.6	169.1	121.7	174.0	146.2	123.5	195.7	86.0	278.4	119.9	158.9	194.7	238.4	77.4	214.5	104.3	146.3	197.9	198.5	254.3	119.7	177.3	140.3	143.0	154.6	183.8	145.9	144.8	226.0	85.6	150.9	120.9	113.6	138.2	106.4	139.5	157.0	194.7	134.9	103.7	121.1	38.4	43.6	36.5	46.7	47.1	61.1	35.8	42.0	47.3	60.5	30.5	37.8	43.3	4.6	46.4	45.3	34.2	49.6	54.6	30.2	32.5	29.5	30.2	31.9	36.4	31.8	33.5	36.9	31.9	33.5	36.1	34.2	28.9	69.9	46.4	48.8	52.6	53.6	61.1	51.2	87.0	52.0	39.9	105.6	34.3	54.5	53.3	352.3	283.5	57.5	45.0	17.6	43.9	15.7	46.6	40.8	48.1	74.2	102.3	27.8	42.4	130.1	50.6	46.4	51.3	30.9	102.7	45.0	67.4	75.5	87.5	31.6	55.4	44.7	45.3	33.5	18.8	85.1	38.3	42.7	30.0	61.1	64.4	71.1	24.1	31.0	52.6	36.4	62.1	65.4	55.7	63.2	46.7	64.4	451.4	32.9	51.5	44.5	114.0	120.9	52.3	59.8	389.4	46.0	303.8	60.0	57.1
DDIT3	"CHOP, CHOP10, GADD153"	ENSG00000175197	"DNA damage inducible transcript 3"	P35638	12	57516588-57521737	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Growth arrest, Stress response, Transcription, Transcription regulation, Unfolded protein response, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 170.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 784.2;hTERT-HME1: 399.9;SK-MEL-30: 409.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058416, HPA068416"	Uncertain		Supported	Nucleoplasm		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA058416: AB_2683712, HPA068416: AB_2685985"	"unprognostic (1.12e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.92e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (8.55e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.76e-2)"	65.3	66.2	90.6	16.1	97.8	196.5	64.3	97.4	145.5	51.0	92.9	52.0	20.7	39.1	109.3	31.6	41.2	32.1	85.1	89.0	99.2	106.4	81.7	55.4	18.8	95.9	98.4	57.4	37.3	80.5	81.4	37.6	97.1	45.5	26.6	123.1	43.3	25.8	44.8	48.7	28.0	29.2	95.5	34.2	44.4	40.9	106.4	17.8	182.1	55.4	17.5	56.2	49.5	129.5	17.8	16.1	10.1	34.5	90.7	61.0	53.8	48.2	106.0	70.1	65.4	57.2	45.7	25.3	46.9	14.3	186.7	21.4	38.5	7.3	72.2	21.0	15.5	19.9	19.9	42.3	784.2	31.8	29.3	175.7	152.7	118.6	399.9	81.7	16.9	26.5	86.4	94.0	31.2	10.8	21.1	41.5	19.7	37.3	37.5	11.8	220.7	22.3	25.0	22.3	20.9	15.3	14.2	16.2	409.0	37.2	34.4	82.8	9.9	47.5	20.2	45.4	42.0	164.4	60.3	26.8	57.4	29.1	85.8	121.1	17.9	48.8	25.1	16.6	22.7	48.3	17.9	23.6	12.8	44.8	34.1	31.1	170.7	35.6	19.4	15.9	23.8	18.0	90.6	97.8	97.4	145.5	89.0	99.2	95.9	98.4	97.1	95.5	106.4	129.5	237.9	19.2	55.1	17.0	96.6	56.3	176.5	93.1	177.0	114.9	86.3	265.7	177.9	37.1	56.7	22.0	91.8	42.3	101.8	265.7	115.4	43.3	9.5	111.3	39.4	62.3	230.7	12.8	9.6	16.0	17.5	115.7	74.5	82.4	204.0	26.3	27.5	20.1	45.7	55.5	14.5	218.4	101.7	30.4	81.6	6.3	28.0	81.5	88.9	6.5	8.2	156.1	17.5	14.1	23.0	33.0	300.0	38.0	43.2	115.1	61.7	61.6	38.1	160.0	13.1	56.9	122.2	77.7	15.6	91.5	45.7	107.8	89.7	37.2	127.2	65.1
DHRS7B	"CGI-93, DKFZp566O084, MGC8916, SDR32C1"	ENSG00000109016	"Dehydrogenase/reductase 7B"	Q6IAN0	17	21123364-21193265	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012132, HPA016873"	Uncertain		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cell Junctions, Cytosol"		"HPA012132: AB_1847658, HPA016873: AB_1847657"	"unprognostic (1.90e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.98e-8)"	"unprognostic (9.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.81e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.26e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.97e-1)"	19.0	18.8	18.5	8.1	18.6	2.9	19.2	19.6	28.3	17.8	19.9	15.1	15.6	11.4	25.7	12.8	15.9	11.9	22.2	18.6	19.2	22.8	20.2	13.4	7.7	19.3	19.2	8.4	20.2	32.9	7.9	13.2	19.4	15.1	15.8	10.8	18.3	10.2	30.8	18.7	14.5	9.6	19.3	9.2	18.1	24.0	18.3	6.8	16.6	19.5	9.0	12.4	11.1	20.7	17.2	19.9	7.1	15.6	18.5	12.7	12.4	16.0	8.9	11.4	20.7	25.2	17.6	7.2	23.8	13.7	9.0	23.7	10.6	26.2	16.1	13.8	33.9	9.9	13.8	21.8	10.2	5.5	7.0	10.0	17.0	14.6	22.1	5.6	11.3	12.5	6.0	8.6	13.5	35.2	6.0	21.6	9.9	55.4	8.5	10.0	18.8	12.7	39.1	20.5	3.9	8.3	19.8	17.4	17.9	56.8	11.7	11.2	5.6	9.4	6.4	28.7	18.3	4.7	7.9	13.6	14.9	20.3	14.4	19.2	34.3	29.3	6.7	33.9	6.0	7.6	6.5	4.6	21.6	5.9	7.0	6.1	25.0	8.4	40.8	9.4	10.9	14.4	18.5	18.6	19.6	28.3	18.6	19.2	19.3	19.2	19.4	19.3	18.3	20.7	31.1	16.0	18.1	29.4	11.9	16.3	26.7	59.0	11.4	21.3	19.8	17.4	14.1	25.8	38.5	29.5	31.3	52.9	11.3	25.9	17.6	47.2	69.5	38.1	13.6	23.7	7.2	21.9	32.9	39.0	31.8	18.9	14.3	22.2	8.8	13.8	27.5	20.5	29.4	18.5	37.3	28.5	48.8	17.9	15.5	24.4	22.4	14.3	19.6	14.0	20.8	27.6	22.6	36.7	36.2	30.0	24.8	35.0	10.5	29.0	44.4	25.2	50.7	40.1	6.6	15.1	18.2	71.5	22.3	10.7	18.6	51.6	11.2	27.3	22.2	25.1
DHX40	"ARG147, DDX40, FLJ22060, PAD"	ENSG00000108406	"DEAH-box helicase 40"	Q8IX18	17	59565558-59608345	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 103.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044350	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA044350: AB_10960560"	"unprognostic (1.58e-2)"	"unprognostic (3.10e-1)"	"prognostic favorable (4.05e-5)"	"unprognostic (4.09e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-1)"	17.9	22.0	14.9	12.9	15.7	26.5	26.9	16.9	16.6	22.1	25.1	15.4	14.6	25.7	21.1	17.4	27.3	17.1	18.2	14.3	17.7	32.9	14.9	18.7	16.3	15.1	16.9	32.3	21.1	57.7	21.7	19.7	16.0	21.3	17.1	21.5	17.0	21.6	17.4	21.2	13.9	20.8	15.5	15.5	16.7	29.8	15.1	25.0	30.6	22.3	18.4	19.2	13.5	20.9	28.7	51.7	64.0	42.5	39.4	39.5	36.0	25.3	48.2	37.9	42.8	20.5	28.0	37.7	69.3	37.2	40.0	20.9	46.5	36.2	58.6	29.9	68.8	34.3	35.1	23.4	30.7	42.3	15.3	31.2	33.1	32.3	31.4	62.3	42.0	36.2	29.3	33.9	26.5	53.5	51.8	26.4	24.8	36.0	37.8	48.8	45.1	42.3	39.0	22.9	45.5	113.5	45.7	18.4	48.6	31.3	58.4	24.8	34.5	45.8	56.3	16.6	25.2	41.2	47.5	23.9	53.5	28.9	32.0	9.2	6.8	11.6	7.9	6.6	10.3	4.7	5.6	5.6	7.1	4.9	5.5	6.6	19.4	4.5	4.9	3.7	6.2	7.5	14.9	15.7	16.9	16.6	14.3	17.7	15.1	16.9	16.0	15.5	15.1	20.9	27.3	9.6	20.9	10.1	19.7	19.4	10.4	16.7	26.2	12.6	31.9	26.7	24.3	28.6	25.3	47.8	18.8	8.8	35.5	14.2	11.7	18.4	43.0	68.8	37.8	22.4	18.5	29.8	10.9	16.9	9.3	21.1	20.9	41.8	3.8	41.8	27.5	25.0	9.2	50.5	14.3	19.0	8.2	21.6	14.7	16.7	25.1	18.8	19.6	3.7	14.8	21.7	14.4	7.1	14.6	13.2	11.9	26.7	18.0	13.4	12.6	46.2	57.7	14.6	32.9	17.4	22.8	103.9	51.4	15.3	22.0	12.6	19.1	36.5	17.8	10.9
DMRT3	DMRTA3	ENSG00000064218	"Doublesex and mab-3 related transcription factor 3"	Q9NQL9	9	976655-991732	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 10.2;parathyroid gland: 26.9;testis: 10.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.8;Smooth muscle cells: 2.3;Spermatocytes: 13.9;Spermatogonia: 5.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 4.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.0;HEK 293: 1.4;hTERT-RPE1: 2.1;THP-1: 2.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.1"	HPA077685	Approved					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA077685: AB_2732357"	"unprognostic (2.42e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.28e-1)"		"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.12e-3)"			"unprognostic (2.91e-2)"	"unprognostic (5.84e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.11e-1)"	3.3	0.0	0.7	0.0	0.2	0.0	1.7	0.0	1.0	0.0	10.2	0.1	0.0	0.1	0.0	0.3	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.0	0.2	0.2	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.6	0.0	0.2	0.1	0.0	0.0	10.1	0.0	0.1	5.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	1.0	1.4	0.0	0.2	0.2	0.0	0.1	0.0	1.4	1.5	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.3	0.5	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.3	13.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DNAH11	"CILD7, DNAHBL, Dnahc11, DNHBL, DPL11"	ENSG00000105877	"Dynein axonemal heavy chain 11"	Q96DT5	7	21543039-21901839	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"choroid plexus: 36.2;parathyroid gland: 71.3"	"Group enriched"	"Detected in many"	10	"Endometrial ciliated cells: 136.7;Oligodendrocyte precursor cells: 57.3;Respiratory ciliated cells: 128.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.9;U-2 OS: 1.0;U-2197: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 6.7"	"HPA045880, HPA056474"	Approved					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA045880: AB_10962003, HPA056474: AB_2683145"	"unprognostic (2.24e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.86e-3)"	"unprognostic (4.79e-3)"	0.1	1.8	1.5	0.0	1.5	0.0	0.0	0.7	0.3	0.4	36.2	0.1	0.0	0.3	0.3	0.6	5.2	0.1	0.4	2.0	1.8	0.2	0.3	1.1	0.0	8.9	5.6	0.3	0.1	71.3	0.1	0.3	4.1	0.4	0.0	0.0	0.1	0.1	0.3	0.7	0.3	0.0	6.4	0.0	0.1	0.5	1.8	0.3	1.0	0.0	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.3	0.5	0.0	0.7	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.3	1.0	1.3	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.5	0.7	0.3	2.0	1.8	8.9	5.6	4.1	6.4	1.8	3.2	0.2	6.4	3.9	4.6	0.4	2.4	4.2	6.4	1.2	0.2	0.7	0.3	3.6	5.7	10.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	3.8	136.7	1.0	0.8	0.0	0.4	3.0	0.0	2.1	0.7	0.0	3.9	0.0	0.1	0.0	0.3	0.1	6.7	3.5	0.0	4.1	0.3	1.1	2.3	0.3	0.6	1.8	3.7	0.6	0.0	1.0	57.3	7.3	0.1	0.0	0.4	0.0	8.3	0.0	0.1	128.8	0.1	0.0	3.8	1.9	0.7	1.9	0.3	0.3	1.6	0.3	0.1	0.1	1.5
EFCAB14	KIAA0494	ENSG00000159658	"EF-hand calcium binding domain 14"	O75071	1	46674659-46719146	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 159.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011224, HPA011938"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA		110000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Nucleoli, Golgi apparatus"	"HPA011224: AB_1852314, HPA011938: AB_1852317"	"unprognostic (2.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.00e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.46e-1)"	49.8	23.8	26.0	25.4	35.5	8.5	30.5	31.9	21.3	42.4	15.5	37.4	30.2	31.7	24.7	39.6	38.4	33.3	36.1	21.3	28.1	44.2	30.6	43.0	26.2	37.5	33.7	35.8	23.1	159.5	18.0	43.6	33.4	30.7	39.3	12.3	30.5	40.1	34.6	28.7	31.5	38.9	29.9	31.7	65.9	27.3	29.9	34.1	43.9	45.9	35.2	40.1	27.1	38.2	34.9	20.3	13.4	23.8	75.2	48.6	37.3	35.4	56.7	40.3	40.6	22.4	23.1	26.5	38.5	51.6	53.7	41.0	28.1	41.3	51.7	62.4	16.9	33.8	15.1	8.7	26.9	44.3	67.1	43.9	61.5	31.4	28.2	37.4	52.6	26.3	23.5	37.9	37.7	12.4	30.6	10.6	22.2	39.8	21.1	22.1	45.9	25.2	37.6	68.4	7.4	9.9	47.7	64.2	29.9	43.3	29.0	38.6	46.0	33.1	16.8	38.1	37.0	38.0	65.2	22.7	43.6	34.5	25.9	23.4	22.6	36.8	25.3	28.0	34.0	18.0	23.0	22.9	19.5	17.0	21.0	21.7	15.4	21.8	26.3	14.1	21.1	24.3	26.0	35.5	31.9	21.3	21.3	28.1	37.5	33.7	33.4	29.9	29.9	38.2	152.3	73.7	84.6	31.3	45.9	31.7	52.3	32.0	44.9	31.6	56.3	34.0	44.9	47.1	46.1	114.0	31.3	40.6	64.4	80.8	31.3	36.2	70.6	36.1	37.4	74.8	37.8	31.1	20.3	38.4	32.0	48.8	79.0	52.2	101.8	27.4	50.7	57.9	42.2	47.1	27.8	64.6	54.9	75.5	44.0	18.9	47.2	52.0	26.6	29.0	65.0	50.6	84.5	29.7	46.2	48.5	61.3	49.7	34.8	73.8	50.5	34.4	49.9	18.6	26.3	50.2	49.9	51.3	27.7	46.5	43.5	59.0	52.0	30.4	46.2	128.4
EI24	"EPG4, PIG8, TP53I8"	ENSG00000149547	"EI24 autophagy associated transmembrane protein"	O14681	11	125569280-125584684	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 461.9"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 575.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 760.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047165, HPA051029"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"	"Golgi apparatus"	"HPA047165: AB_2679965, HPA051029: AB_2681317"	"unprognostic (2.04e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.01e-1)"	53.4	32.6	61.1	36.2	62.5	23.2	72.6	59.7	72.4	51.3	59.8	77.8	49.6	46.2	57.4	80.8	50.8	46.3	55.7	60.2	61.5	61.0	248.4	45.0	28.4	60.2	62.5	42.4	101.8	461.9	30.6	48.5	60.2	49.6	80.4	39.4	75.3	58.0	119.5	70.2	49.3	62.5	62.4	30.5	59.7	33.1	64.4	35.3	40.5	104.6	42.3	78.9	48.4	61.0	156.6	115.6	129.5	160.5	207.7	155.9	162.4	159.6	116.8	104.3	93.4	178.9	303.4	158.0	264.0	146.5	110.8	176.1	199.0	326.8	135.2	42.0	142.6	760.9	77.2	179.9	154.1	170.9	78.4	147.5	292.7	157.4	230.2	102.8	223.9	85.1	351.1	61.1	149.4	113.8	79.0	96.4	173.6	398.3	139.5	113.9	155.4	132.8	177.0	272.4	120.1	116.9	187.1	215.5	63.4	212.3	436.4	165.7	195.2	133.8	93.3	94.7	128.7	39.7	84.8	200.5	58.5	256.1	182.2	4.3	7.0	5.9	7.2	6.7	7.2	8.4	5.7	9.0	10.9	6.3	8.1	6.7	0.8	6.5	4.9	14.5	9.1	5.3	61.1	62.5	59.7	72.4	60.2	61.5	60.2	62.5	60.2	62.4	64.4	61.0	73.5	32.1	38.3	13.4	34.8	120.6	130.3	132.6	120.1	58.9	148.8	100.6	61.9	124.4	69.5	110.3	37.5	166.9	32.4	66.4	144.8	178.6	31.1	34.4	59.3	87.1	98.4	102.7	25.1	181.8	201.2	80.1	87.7	46.5	27.3	76.2	74.6	575.0	110.5	82.4	24.0	115.3	105.8	49.8	96.1	49.7	71.4	40.9	90.7	11.2	40.9	107.1	50.4	13.0	23.0	182.1	67.6	72.2	79.1	270.0	68.5	122.7	43.9	36.9	46.0	60.8	80.1	95.9	112.3	176.3	181.4	140.1	31.0	71.3	135.7	189.4
EIF2B2	"EIF-2Bbeta, EIF2B"	ENSG00000119718	"Eukaryotic translation initiation factor 2B subunit beta"	P49770	14	75002921-75012366	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005841, CAB037105, HPA048028"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		12000	"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB037105: AB_1840834, HPA005841: AB_1078725, HPA048028: AB_2680235"	"unprognostic (1.10e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (4.15e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	2.7	5.3	4.0	2.9	4.5	3.2	3.6	8.7	4.8	3.9	2.2	3.0	3.0	3.6	4.9	3.8	3.1	4.0	3.9	3.6	6.1	4.9	3.3	2.7	4.0	4.5	4.2	2.9	4.0	8.5	3.5	4.8	4.5	4.1	3.8	6.8	2.8	4.5	5.5	4.0	2.8	3.4	2.9	2.7	2.6	3.9	4.8	3.9	11.5	7.1	4.2	4.0	2.6	6.9	5.9	7.0	5.6	6.4	6.3	5.2	7.4	3.7	6.1	7.1	8.2	9.0	5.9	5.2	2.3	5.8	4.5	4.4	8.8	8.7	10.6	3.2	6.5	4.6	6.3	6.2	8.2	3.4	5.3	4.8	8.2	9.1	9.3	6.1	24.8	4.5	4.2	4.9	15.5	17.4	5.5	4.3	4.0	7.3	10.3	3.4	6.6	4.3	10.1	7.0	6.0	4.8	3.9	5.5	8.4	6.9	9.0	3.2	6.4	5.4	5.2	2.4	4.8	8.4	7.5	6.2	5.9	4.3	4.2	4.2	1.8	1.4	3.0	1.9	2.5	2.1	2.6	2.5	2.4	2.0	1.9	2.0	1.0	3.3	1.8	2.0	4.0	2.5	4.0	4.5	8.7	4.8	3.6	6.1	4.5	4.2	4.5	2.9	4.8	6.9	18.9	19.2	11.5	6.2	14.1	17.7	19.5	28.9	18.2	28.2	15.4	17.0	18.2	22.8	21.5	25.8	45.9	51.5	16.1	15.3	41.1	36.2	12.1	17.0	14.5	32.1	15.6	20.8	5.3	33.1	56.5	18.3	12.8	12.8	21.5	17.5	13.2	11.9	33.7	28.6	5.4	9.0	20.3	19.1	11.9	12.7	15.8	18.8	14.2	1.9	28.0	27.3	28.8	2.5	8.5	28.1	11.7	16.1	11.3	17.5	19.0	50.8	17.2	29.4	26.3	16.9	27.9	84.2	27.4	27.3	21.9	165.5	14.9	30.5	19.7	19.2
EMILIN2	"FLJ33200, FOAP-10"	ENSG00000132205	"Elastin microfibril interfacer 2"	Q9BXX0	18	2847006-2916003	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 76.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 98.0;Hofbauer cells: 61.1;Kupffer cells: 52.9;Langerhans cells: 99.7;Macrophages: 97.5;monocytes: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 48.2;BEWO: 37.8;HL-60: 37.8;HMC-1: 60.6;HSkMC: 26.1;SuSa: 25.7;THP-1: 36.7;U-2197: 46.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 25.7"	HPA064576	Supported				"Secreted to extracellular matrix"	NA	NA		840000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA064576: AB_2732717"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.91e-3)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.96e-1)"	13.0	1.3	1.2	17.2	2.2	11.3	5.1	4.8	1.7	5.3	2.2	2.8	1.6	6.4	0.8	2.4	4.7	5.9	6.8	0.7	1.2	1.1	1.5	11.9	2.4	8.1	4.4	5.9	1.4	76.0	0.4	21.9	5.8	1.0	3.3	0.1	2.3	1.2	0.8	2.7	2.2	8.4	6.6	3.9	1.6	1.8	7.4	2.9	1.6	2.4	2.0	8.0	4.0	10.6	0.2	0.4	2.9	0.0	48.2	19.9	37.8	7.9	0.0	1.4	2.4	5.6	0.1	0.0	0.6	19.3	0.5	0.1	1.0	0.0	2.6	0.0	2.6	0.5	0.2	0.4	1.6	37.8	60.6	26.1	0.0	1.5	0.0	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.1	10.4	4.9	0.4	0.1	0.1	2.5	0.0	0.1	0.2	0.4	0.2	0.2	0.3	1.4	25.7	0.0	36.7	0.4	0.0	5.2	46.7	0.4	0.0	0.0	0.0	3.1	9.1	1.0	5.5	1.1	0.3	0.4	0.8	0.3	0.2	0.4	0.3	1.1	0.3	0.2	0.4	1.1	1.5	0.7	0.7	0.3	0.4	1.2	2.2	4.8	1.7	0.7	1.2	8.1	4.4	5.8	6.6	7.4	10.6	6.8	3.2	6.7	0.0	13.7	5.7	3.3	0.5	0.6	0.1	2.8	3.0	15.7	1.5	5.3	3.7	0.0	4.7	14.5	2.8	1.9	2.7	2.3	19.3	98.0	8.8	3.0	6.7	0.5	1.1	11.9	31.4	5.6	46.0	46.3	5.7	2.9	0.5	61.1	0.0	1.2	4.9	0.0	52.9	99.7	2.3	15.2	97.5	5.4	2.8	51.0	0.0	7.2	11.1	9.1	2.4	7.9	1.2	2.7	3.5	1.5	1.7	4.0	0.2	0.0	2.3	8.7	4.9	5.5	0.4	4.0	2.9	9.6	14.7	5.1	2.8
ENOPH1	"E1, MASA, mtnC"	ENSG00000145293	"Enolase-phosphatase 1"	Q9UHY7	4	82430590-82461177	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004985, HPA044607"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		240000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"CAB004985: AB_426046, HPA044607: AB_2679019"	"unprognostic (6.64e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.68e-3)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (9.99e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.52e-2)"	17.0	24.2	61.3	21.2	70.0	26.6	26.2	69.8	102.7	20.7	52.3	21.1	20.3	16.7	35.9	23.5	16.5	14.7	18.7	60.0	66.6	33.5	22.1	18.3	29.0	70.5	67.4	19.8	23.5	34.1	20.6	29.1	69.1	26.6	23.9	42.0	19.2	18.0	18.1	21.8	18.5	17.9	68.1	22.2	22.3	10.6	65.9	30.8	28.6	18.7	31.6	21.9	17.8	80.1	56.6	36.6	64.3	40.4	38.3	37.6	69.7	63.7	42.6	57.2	50.6	67.3	61.3	110.8	64.8	49.0	62.6	29.8	86.1	81.3	103.3	67.2	39.2	67.1	33.7	91.0	62.0	113.3	56.0	36.5	84.9	59.7	70.6	41.4	58.8	69.2	88.3	60.1	76.1	73.2	125.8	67.6	59.2	141.8	28.8	88.1	98.2	61.0	94.7	55.5	90.5	55.2	36.2	109.7	86.3	57.3	49.4	54.5	43.3	70.9	52.8	71.2	85.7	67.5	62.4	138.5	45.9	69.5	97.5	5.8	13.9	7.2	21.8	17.1	27.1	20.2	25.9	25.0	20.5	16.9	29.4	24.2	1.2	24.7	14.9	22.4	30.4	20.6	61.3	70.0	69.8	102.7	60.0	66.6	70.5	67.4	69.1	68.1	65.9	80.1	24.6	16.0	10.5	9.4	31.8	68.6	40.8	47.3	30.7	36.6	22.9	19.8	13.5	18.6	27.5	12.9	16.7	86.7	24.7	10.7	88.0	48.1	7.7	15.2	14.2	25.6	29.3	24.6	18.5	25.7	61.3	22.4	15.3	19.5	38.1	15.3	17.9	10.8	57.7	28.6	21.4	24.8	61.1	23.2	27.9	5.1	26.4	23.1	39.2	6.5	35.6	62.8	29.9	15.1	37.9	41.1	11.1	24.0	28.0	52.6	17.7	56.2	18.8	37.7	13.1	16.4	23.8	9.0	24.9	37.8	64.1	46.7	34.3	27.5	26.7	39.9
ENPP4	"AP3Aase, KIAA0879, NPP4"	ENSG00000001561	"Ectonucleotide pyrophosphatase/phosphodiesterase 4"	Q9Y6X5	6	46129989-46146688	"Enzymes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Oligodendrocytes: 125.3;Respiratory ciliated cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 21.9;U-266/84: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016594	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA016594: AB_1848171"	"unprognostic (9.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.51e-2)"	"unprognostic (4.36e-1)"	"prognostic favorable (6.95e-7)"	"unprognostic (1.82e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.56e-1)"	15.1	13.6	11.7	7.3	20.9	38.0	7.8	19.5	19.5	10.3	6.4	12.1	10.9	4.0	11.6	5.1	10.8	8.0	15.1	10.8	16.0	18.4	8.2	20.7	7.7	20.5	19.3	2.1	11.9	22.3	9.0	3.5	19.9	16.4	12.8	12.2	21.3	19.7	22.1	2.3	10.1	7.0	18.5	13.9	14.8	8.3	17.5	8.5	12.5	25.3	6.5	6.8	2.1	30.2	0.1	1.1	0.7	1.5	0.0	0.0	0.1	1.7	1.6	4.0	0.3	1.9	13.4	15.2	12.7	2.1	9.9	0.2	4.1	0.6	0.8	18.5	11.1	8.5	0.0	0.0	0.5	10.5	14.9	2.1	0.0	0.1	0.0	1.1	1.4	10.5	0.0	0.0	1.5	1.8	7.8	1.0	2.7	16.9	0.5	5.9	2.7	5.7	8.3	1.7	18.0	0.0	0.0	2.8	0.0	4.1	7.6	4.3	0.0	0.0	6.7	0.3	11.2	21.9	26.6	5.2	10.3	0.0	1.4	0.0	0.4	0.9	9.2	1.1	5.4	2.8	3.4	6.8	1.5	1.2	3.2	5.8	0.3	4.4	2.6	1.6	1.2	3.0	11.7	20.9	19.5	19.5	10.8	16.0	20.5	19.3	19.9	18.5	17.5	30.2	43.5	76.9	27.0	23.5	11.6	0.9	3.2	2.3	0.6	9.3	11.0	2.4	23.1	14.3	25.4	29.5	14.6	0.5	23.5	27.2	0.0	12.9	18.3	28.8	2.0	16.0	15.7	3.0	26.4	12.2	0.3	8.5	10.7	17.3	15.8	4.5	6.1	8.6	5.8	26.9	19.2	13.8	4.1	24.8	11.0	26.0	1.2	19.0	3.6	6.5	15.2	21.6	34.0	32.2	125.3	9.7	16.1	11.3	10.3	12.6	16.3	12.6	70.6	6.2	0.0	22.1	5.4	9.1	9.8	0.3	0.6	0.3	14.7	3.7	11.3	14.8
EPB41L3	"4.1B, DAL1, KIAA0987"	ENSG00000082397	"Erythrocyte membrane protein band 4.1 like 3"	Q9Y2J2	18	5392381-5630700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 171.9;Excitatory neurons: 306.8;Inhibitory neurons: 237.4;Late spermatids: 291.6;Oligodendrocytes: 159.2;Syncytiotrophoblasts: 214.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 7.7;non-classical monocyte: 12.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 12.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 62.8;HUVEC TERT2: 59.5;SCLC-21H: 65.5;TIME: 164.8;U-2 OS: 57.7;U-2197: 57.1;U-251 MG: 71.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028605	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions"		"HPA028605: AB_10611963"	"unprognostic (3.58e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.07e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.65e-3)"	"unprognostic (8.99e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	27.6	28.1	5.8	27.4	5.3	4.1	11.7	17.9	49.9	6.4	0.0	17.7	49.6	7.8	5.6	10.7	13.6	9.3	6.5	7.1	24.8	33.9	4.8	13.9	7.9	59.6	14.7	11.4	6.9	59.6	10.4	21.1	53.3	5.8	13.1	45.8	4.0	7.3	6.1	4.0	47.7	13.4	7.7	12.2	3.2	62.3	29.1	6.5	4.6	10.7	3.9	10.3	5.7	29.8	0.3	0.9	3.9	0.0	54.5	62.8	43.7	12.8	0.0	0.0	0.0	0.7	0.1	0.1	0.1	39.8	23.2	0.2	38.6	0.0	0.0	0.0	34.2	0.1	0.4	0.0	0.2	0.1	4.6	33.3	0.0	12.3	0.1	16.2	59.5	0.0	0.4	0.4	0.1	0.0	0.5	0.7	7.9	0.2	12.5	0.3	0.0	0.2	0.4	4.8	65.5	0.5	0.1	0.5	25.9	31.2	0.7	4.8	164.8	0.3	57.7	57.1	71.6	0.1	0.1	0.0	0.2	5.4	6.8	0.0	4.3	0.0	0.0	7.7	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.7	0.0	12.4	0.0	0.0	0.7	5.8	5.3	17.9	49.9	7.1	24.8	59.6	14.7	53.3	7.7	29.1	29.8	18.2	19.2	6.4	28.7	1.3	15.9	4.1	0.0	3.4	75.6	5.3	1.7	3.5	2.8	1.9	7.3	77.2	98.6	0.2	44.0	15.6	0.4	171.9	2.2	10.1	21.9	9.1	3.2	306.8	0.7	44.2	27.7	0.0	2.1	0.0	0.0	7.1	0.8	58.8	3.3	237.4	10.0	0.0	82.2	66.7	291.6	22.4	81.9	10.6	103.0	50.9	3.3	2.1	44.2	159.2	0.8	8.3	7.9	1.6	3.8	91.2	68.4	1.6	14.7	0.0	3.0	13.1	2.7	11.5	2.3	8.4	214.0	2.6	0.2	12.3	1.7
EPHA1	"EPH, EPHT, EPHT1"	ENSG00000146904	"EPH receptor A1"	P21709	7	143390289-143408856	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 57.2;parathyroid gland: 206.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.3;Gastric mucus-secreting cells: 13.3;Proximal enterocytes: 13.2;Squamous epithelial cells: 28.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 1.9;naive CD4 T-cell: 3.8;naive CD8 T-cell: 2.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 17.9;HaCaT: 16.6;HBEC3-KT: 13.5;MCF7: 15.0;NTERA-2: 54.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			CAB026144	Uncertain					NA	NA		32000000	"Cluster 32: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 61: Squamous epithelial cells - Keratinization"			"CAB026144: "	"unprognostic (1.54e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.58e-3)"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.24e-3)"	"prognostic favorable (1.14e-6)"	"unprognostic (3.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	0.1	0.0	0.0	1.3	0.0	0.3	2.2	0.4	0.1	11.2	1.2	3.7	8.4	0.3	1.2	57.2	3.4	1.5	0.0	0.0	0.0	5.8	15.6	2.3	2.0	0.0	0.0	0.0	5.7	206.5	2.5	0.6	0.0	4.0	1.6	0.0	11.0	1.2	0.0	19.7	6.2	0.1	0.0	0.9	4.2	1.9	0.0	3.4	5.4	0.0	3.5	1.9	25.8	0.1	8.7	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	17.9	7.1	0.0	0.1	0.0	0.0	16.6	0.0	13.5	0.0	0.0	0.0	1.8	0.0	1.7	0.0	0.8	0.1	0.0	4.4	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	15.0	0.0	1.9	54.4	8.8	0.0	0.0	0.0	0.0	1.1	6.7	0.3	0.0	0.0	8.2	0.0	3.2	3.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.2	0.0	3.8	2.9	0.1	0.1	0.0	0.4	0.1	1.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.2	0.3	0.1	2.0	6.3	6.5	6.8	0.0	3.3	5.0	1.0	2.8	9.9	7.3	0.0	2.0	0.2	4.2	0.0	4.4	23.3	4.0	1.0	0.2	1.2	0.0	0.6	4.3	2.6	0.5	13.3	6.6	0.0	0.0	0.4	8.8	0.4	0.0	0.3	4.7	2.0	0.3	0.3	9.9	0.6	0.3	0.0	1.0	0.0	0.3	0.0	0.5	0.2	6.3	8.8	0.0	0.6	2.0	13.2	1.5	2.1	0.2	0.0	0.4	0.4	0.5	1.9	28.7	3.7	1.0	4.4	0.0	7.6	5.5
EPHA7	Hek11	ENSG00000135333	"EPH receptor A7"	Q15375	6	93240020-93419687	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 24.6;parathyroid gland: 69.9"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 138.6;Inhibitory neurons: 172.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 12.0;HEK 293: 35.1;RH-30: 31.7;THP-1: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010496	Approved				"Intracellular and membrane"	NA	NA		660000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB010496: AB_2099673"	"unprognostic (3.34e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.62e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.82e-2)"	0.3	0.0	1.2	0.4	3.4	0.0	1.2	3.4	5.1	1.4	0.0	24.6	1.5	0.9	0.2	0.2	0.5	2.2	3.6	4.9	2.6	5.9	0.0	0.2	0.0	1.2	2.2	1.9	0.1	69.9	1.2	0.4	1.5	9.7	2.5	1.8	5.4	0.9	0.1	0.2	4.4	2.1	0.4	3.9	10.3	0.9	0.6	0.0	0.1	0.1	0.0	8.2	1.8	1.2	0.0	0.5	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	35.1	0.0	3.0	0.0	0.0	0.0	0.0	0.5	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.6	0.0	1.0	5.4	31.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	32.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.4	3.4	5.1	4.9	2.6	1.2	2.2	1.5	0.4	0.6	1.2	0.2	0.0	0.0	4.2	0.0	0.4	0.4	0.0	0.6	18.5	3.1	1.8	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	13.1	1.3	1.4	1.8	0.0	0.0	138.6	0.0	0.0	5.9	0.0	3.8	0.0	3.7	0.0	0.0	0.1	11.8	172.0	0.0	0.0	0.0	0.4	3.3	0.9	0.1	0.0	11.2	0.0	0.4	0.0	4.5	8.3	0.1	0.0	0.0	0.0	0.4	0.0	11.8	0.0	1.0	0.0	0.2	0.5	0.2	1.1	0.2	1.0	0.0	0.2	0.9	0.0	0.1
ERCC6	"ARMD5, CKN2, CSB, RAD26"	ENSG00000225830	"ERCC excision repair 6, chromatin remodeling factor"	"P0DP91, Q03468"	10	49454168-49539538	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 53.8;hTERT-RPE1: 123.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071297			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"HPA071297: AB_2732177"	"unprognostic (1.92e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.79e-3)"	"unprognostic (7.26e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	2.7	2.1	1.6	1.9	1.5	4.6	3.8	3.0	2.3	3.1	7.7	2.4	2.0	3.0	1.5	3.8	2.9	2.7	3.4	1.2	1.1	3.2	3.3	2.7	2.9	2.4	1.9	4.5	3.1	5.9	2.8	3.4	2.1	3.3	2.7	3.1	3.2	2.2	3.5	4.6	2.5	2.3	2.2	2.9	2.4	3.1	2.1	3.3	5.1	3.6	3.4	2.6	3.3	1.9	11.2	5.5	4.1	2.1	6.6	10.5	3.4	21.2	27.1	14.1	9.9	6.2	5.6	4.9	3.7	18.7	6.7	9.5	6.3	16.6	13.5	8.4	4.1	3.9	21.7	3.4	3.9	5.0	3.7	4.3	17.2	12.9	53.8	123.4	19.8	2.9	6.8	0.8	16.8	8.3	3.4	2.0	4.0	3.5	10.2	2.3	5.8	2.6	4.1	7.1	5.9	4.7	15.4	3.6	8.2	9.4	7.1	2.7	38.9	7.0	5.5	8.6	5.2	3.3	4.5	4.1	7.3	5.0	5.1	13.1	3.0	7.5	4.1	2.6	3.0	6.8	2.3	2.2	3.9	5.2	2.8	1.4	7.2	1.2	5.3	2.2	3.1	1.8	1.6	1.5	3.0	2.3	1.2	1.1	2.4	1.9	2.1	2.2	2.1	1.9	6.9	16.0	13.2	14.7	6.0	3.6	1.4	1.5	5.2	0.0	7.1	7.1	7.1	5.7	8.2	9.2	0.0	2.5	10.9	4.8	5.9	5.2	11.3	8.1	8.7	5.1	1.2	1.3	24.3	6.0	2.1	4.9	2.0	10.1	7.6	8.9	5.3	4.3	2.6	0.0	21.7	5.3	0.0	4.4	2.6	15.3	2.8	8.0	1.8	23.4	11.2	0.0	4.1	17.6	16.6	5.2	2.6	2.2	3.6	2.5	5.0	3.6	9.0	0.0	6.6	4.4	4.2	5.3	5.0	3.5	4.1	1.8	7.4	11.4	2.8	1.9
ERMP1	"FLJ23309, FXNA, KIAA1815"	ENSG00000099219	"Endoplasmic reticulum metallopeptidase 1"	Q7Z2K6	9	5765076-5833117	"Enzymes, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 50.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 73.5;Granulosa cells: 53.4;Oligodendrocytes: 88.8;Urothelial cells: 66.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 76.8;RT4: 154.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055582	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA055582: "	"unprognostic (1.93e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.59e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.81e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.83e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (5.83e-10)"	"unprognostic (1.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	3.9	7.9	4.2	3.7	10.4	2.0	6.3	10.9	3.7	10.8	14.4	11.3	4.4	5.6	2.6	14.9	6.4	11.3	10.0	2.9	6.1	24.9	4.6	6.3	3.5	10.1	10.3	4.5	3.9	50.1	1.5	7.8	8.8	6.0	11.4	2.2	19.1	4.1	7.6	9.3	6.5	3.8	6.5	3.1	13.3	4.7	8.9	4.6	26.6	9.9	6.4	17.1	4.8	13.1	45.1	43.1	1.8	5.2	22.6	20.7	22.6	5.1	11.1	2.3	1.9	10.4	27.2	10.7	19.2	8.4	25.9	32.2	9.6	29.4	3.3	55.6	7.6	56.2	20.0	20.4	4.8	16.0	21.3	10.5	12.9	2.1	13.3	28.6	30.1	4.6	6.9	9.9	2.8	20.7	0.6	6.2	6.6	28.0	8.4	1.7	5.3	14.1	76.8	154.6	9.9	3.3	7.1	52.2	8.1	24.5	33.7	20.5	18.0	1.5	5.0	3.4	16.1	8.9	13.6	5.5	6.7	13.0	4.1	0.2	0.1	0.3	0.4	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	1.6	0.0	0.1	0.1	0.1	4.2	10.4	10.9	3.7	2.9	6.1	10.1	10.3	8.8	6.5	8.9	13.1	3.4	6.4	1.1	24.8	2.2	2.9	18.3	13.3	2.8	4.0	11.1	5.8	13.7	12.8	22.8	73.5	10.4	6.8	5.2	32.1	0.0	4.6	22.3	11.4	10.9	6.3	11.4	6.3	21.0	3.0	7.1	4.6	13.7	13.8	8.9	53.4	2.9	6.1	5.7	3.3	32.8	8.9	10.2	1.6	2.2	41.8	3.1	4.5	1.8	24.4	2.1	3.0	8.2	22.1	88.8	3.5	22.5	4.9	4.1	7.0	9.2	3.3	16.6	2.9	6.6	5.8	4.3	8.8	4.6	17.5	4.5	4.1	5.9	39.8	15.7	66.9
ERVMER34-1	envMER34	ENSG00000226887	"Endogenous retrovirus group MER34 member 1, envelope"	Q9H9K5	4	52722618-52751586	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 12.9;placenta: 10.8"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 74.4;Extravillous trophoblasts: 102.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 46.9;hTCEpi: 32.5;RPTEC TERT1: 24.2"									"HPA011423, HPA024053"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		6000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA011423: AB_2668510, HPA024053: "	"unprognostic (5.34e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (4.08e-4)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.88e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-1)"	0.1	0.5	1.0	0.2	0.7	0.0	0.9	0.7	1.2	0.8	0.7	0.2	0.2	0.6	0.6	1.2	0.5	0.2	2.6	0.8	0.8	3.5	0.1	0.6	0.2	0.9	0.7	1.3	0.5	12.9	0.0	10.8	1.0	0.4	0.4	0.0	0.4	0.8	0.0	0.3	0.1	0.2	0.9	0.5	0.4	0.7	0.8	0.0	0.4	0.0	0.4	0.5	0.6	1.0	7.6	0.3	1.5	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	46.9	9.9	0.0	1.0	0.1	0.7	0.5	0.0	3.4	0.0	0.0	0.4	0.0	0.1	0.5	0.6	0.0	0.0	2.1	32.5	0.0	4.8	0.0	0.0	0.0	2.7	0.0	0.1	0.5	0.0	0.0	3.1	3.0	1.4	0.0	0.0	0.0	24.2	0.7	2.0	0.4	3.1	1.3	0.0	4.7	4.1	0.7	0.0	0.0	3.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.7	1.2	0.8	0.8	0.9	0.7	1.0	0.9	0.8	1.0	0.1	0.0	0.0	0.0	0.5	0.5	1.8	2.3	2.2	0.0	2.2	1.9	2.9	0.0	0.6	7.3	0.0	74.4	0.0	0.1	0.0	2.5	4.2	0.6	0.9	1.3	0.0	0.0	0.4	0.8	102.9	1.5	0.0	1.7	0.0	2.6	0.0	0.0	7.4	0.0	0.2	0.3	2.0	0.0	0.0	3.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.0	0.0	3.7	0.0	3.0	0.1	0.0	0.0	0.2	0.5	0.2	0.4	2.8	0.1	17.4	0.0	0.2	0.4	1.4
ESRRG	"ERR-gamma, ERRg, NR3B3"	ENSG00000196482	"Estrogen related receptor gamma"	P62508	1	216503246-217137755	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.6;parathyroid gland: 46.3;retina: 36.1;stomach 1: 35.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 330.7;Excitatory neurons: 415.2;Inhibitory neurons: 495.5;Oligodendrocyte precursor cells: 391.6;Oligodendrocytes: 218.7;Syncytiotrophoblasts: 214.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 23.0;SH-SY5Y: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044678	Uncertain		Approved	Nucleoplasm		No	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044678: AB_10963215"	"unprognostic (6.48e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.06e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (1.13e-11)"	"unprognostic (3.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.65e-4)"	"unprognostic (2.05e-1)"	0.4	6.4	1.1	0.2	3.1	0.0	3.6	16.9	12.3	1.5	7.4	0.5	5.3	0.4	0.9	1.6	2.5	0.7	10.6	4.4	2.3	29.0	0.7	0.5	0.2	45.4	4.9	0.7	5.7	46.3	1.5	10.6	49.6	3.1	0.3	36.1	16.0	0.7	5.8	0.8	5.0	0.2	1.6	1.1	35.1	1.1	3.5	0.6	5.9	10.2	0.3	0.7	0.2	6.1	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.2	0.0	0.2	0.0	0.0	23.0	3.4	2.5	8.1	42.4	0.0	0.4	0.0	2.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	3.1	16.9	12.3	4.4	2.3	45.4	4.9	49.6	1.6	3.5	6.1	0.2	0.0	1.8	330.7	0.2	0.3	3.8	0.6	0.6	29.5	9.5	5.2	51.2	10.0	1.8	23.9	58.4	35.4	0.0	0.0	54.8	5.0	5.1	15.9	2.0	1.3	8.3	0.0	415.2	2.4	4.7	3.0	70.3	3.5	0.0	0.5	1.1	0.6	4.8	48.8	495.5	1.7	14.2	0.3	0.4	8.1	0.3	0.5	8.8	36.5	0.0	13.3	0.0	391.6	218.7	0.4	1.3	0.7	0.1	4.9	16.3	29.0	16.0	41.3	0.0	10.3	0.4	1.6	0.3	0.8	0.3	214.9	0.3	1.1	2.6	1.7
ETV5	ERM	ENSG00000244405	"ETS variant transcription factor 5"	P41161	3	186046314-186110318	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 94.0;Oligodendrocyte precursor cells: 169.9;Syncytiotrophoblasts: 88.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 50.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 178.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009590, HPA063065, HPA073889"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB009590: AB_2101008, HPA063065: AB_2684936, HPA073889: "	"unprognostic (3.85e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (7.85e-9)"	"unprognostic (3.52e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.84e-3)"	6.8	39.3	17.1	6.9	22.4	1.4	15.0	17.7	24.4	4.9	9.4	3.4	6.1	8.1	7.3	4.2	5.1	5.6	11.5	17.8	16.8	8.9	7.9	29.6	5.2	20.5	17.1	2.2	17.5	42.2	25.4	17.1	17.7	7.4	3.2	15.9	6.5	5.8	11.9	6.4	3.0	7.4	14.7	10.9	14.8	9.3	17.2	4.8	21.9	7.0	4.2	4.3	4.1	19.6	42.4	28.6	36.1	79.2	21.9	22.7	2.6	35.7	39.7	27.7	29.6	31.7	25.4	1.1	46.4	34.7	41.3	7.1	0.8	27.2	40.7	9.3	1.0	12.4	1.0	36.4	36.3	31.2	22.1	19.9	4.4	44.3	53.7	32.9	41.0	4.4	11.6	14.6	47.5	19.8	4.1	47.7	54.2	12.1	32.4	86.6	36.0	28.7	23.0	9.9	1.6	45.8	8.7	0.4	178.3	14.4	0.1	17.3	40.0	15.0	24.3	38.2	70.5	11.1	49.9	0.3	45.8	24.6	91.6	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.1	17.1	22.4	17.7	24.4	17.8	16.8	20.5	17.1	17.7	14.7	17.2	19.6	5.7	3.2	68.5	26.1	5.6	15.7	10.6	8.2	45.5	17.8	9.4	30.4	5.7	17.2	2.4	0.0	12.5	57.6	3.1	0.6	3.9	9.4	24.6	2.0	4.3	9.2	10.7	1.7	94.0	9.4	18.8	12.5	15.8	4.7	8.2	0.8	10.4	9.0	56.4	5.0	43.7	2.8	0.0	64.4	19.4	49.0	9.0	27.1	16.0	45.9	2.1	60.4	1.0	169.9	47.5	12.5	1.1	15.4	4.9	3.6	1.5	22.9	1.3	18.8	0.0	25.4	13.6	16.9	14.4	8.7	5.3	88.8	1.9	3.1	1.5	2.7
EZR	VIL2	ENSG00000092820	Ezrin	P15311	6	158765741-158819368	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004035, HPA021616, CAB047324, CAB075739"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		42000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"		"CAB004035: AB_2100309, CAB047324: , CAB075739: AB_2665745, HPA021616: AB_1848342"	"unprognostic (4.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (5.59e-2)"	"prognostic favorable (9.56e-8)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-2)"	"unprognostic (9.00e-2)"	88.2	186.6	100.7	98.4	99.5	135.2	59.8	86.0	96.8	77.1	224.4	133.5	158.8	35.6	78.4	260.3	114.6	116.1	116.3	96.2	95.6	159.1	57.9	173.2	185.6	97.6	105.3	44.7	112.6	447.4	42.8	233.0	91.7	81.4	103.6	10.7	89.9	72.2	46.9	187.8	257.1	36.6	99.3	75.6	273.7	55.9	98.9	108.8	126.1	25.5	216.3	219.0	98.6	91.1	668.3	355.4	86.5	125.0	9.3	10.3	502.7	204.7	67.1	225.7	189.2	420.9	357.7	667.1	197.2	235.2	108.5	497.7	172.2	228.0	259.5	235.3	111.2	14.0	204.9	187.5	223.2	167.7	98.9	16.6	172.9	212.9	205.1	191.4	150.2	90.8	134.9	316.7	132.3	175.9	239.3	199.6	144.5	180.6	117.6	176.9	40.7	152.5	462.1	198.6	156.3	127.2	358.5	507.7	37.9	391.5	124.1	218.5	195.3	72.6	233.4	101.1	319.9	216.5	212.8	566.9	45.4	84.9	88.5	177.2	83.4	103.7	195.9	190.8	233.2	466.5	205.6	245.1	181.9	389.7	108.6	146.3	36.2	133.6	202.9	84.5	385.7	298.2	100.7	99.5	86.0	96.8	96.2	95.6	97.6	105.3	91.7	99.3	98.9	91.1	47.4	951.9	547.8	111.3	799.6	614.7	809.5	202.4	247.0	11.2	240.4	144.4	311.0	154.4	726.2	156.3	0.0	406.1	372.4	806.8	97.8	302.3	10.2	782.9	75.4	71.0	159.9	46.5	0.4	256.1	560.3	213.1	500.5	844.5	119.0	40.8	25.4	37.5	113.3	0.0	0.5	415.3	179.0	79.1	820.5	32.8	135.5	297.5	321.9	12.2	110.5	35.7	62.8	2.0	0.7	618.3	631.2	294.2	564.9	416.7	694.2	238.1	1248.4	5.1	249.8	205.5	136.3	52.5	61.7	430.4	726.5	1243.4	483.8	102.3	312.9	1142.8
FAXDC2	"C5orf4, FLJ13758"	ENSG00000170271	"Fatty acid hydroxylase domain containing 2"	Q96IV6	5	154818492-154859252	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 304.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.8;Erythroid cells: 93.5;Oligodendrocytes: 164.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.8;ASC TERT1: 26.3;HSkMC: 23.2;hTERT-RPE1: 25.3;SK-MEL-30: 24.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 6: Erythroid cells - Oxygen transport"				"unprognostic (6.38e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (3.87e-5)"	"unprognostic (8.29e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.42e-2)"	"prognostic favorable (9.71e-10)"	"unprognostic (1.67e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.94e-1)"	34.7	37.5	49.9	5.8	79.0	34.4	27.0	73.6	57.1	24.3	63.0	46.3	8.8	34.7	55.7	16.9	37.4	30.4	34.0	49.0	57.9	25.4	139.7	36.7	7.3	76.4	72.0	59.4	15.0	304.9	12.1	12.6	74.8	28.0	17.8	10.2	40.5	31.0	12.5	21.9	16.2	37.8	60.4	13.3	17.7	12.1	66.6	5.9	36.7	24.3	4.1	19.5	17.2	101.9	1.6	1.3	5.0	10.5	34.8	26.3	3.9	3.7	10.5	1.4	6.4	1.3	13.5	1.9	2.2	5.8	0.3	1.3	0.1	1.7	1.3	1.1	1.7	20.5	3.5	7.4	5.1	2.6	1.7	23.2	6.6	3.3	0.8	25.3	7.9	1.4	11.8	0.3	8.8	0.5	1.5	3.9	2.4	5.0	0.4	1.6	3.3	0.7	2.3	1.4	0.5	9.0	1.6	0.9	24.6	10.6	0.6	0.6	2.8	3.6	2.2	1.5	1.1	1.5	1.1	1.3	5.0	1.5	2.2	3.5	0.8	1.3	0.4	0.6	0.4	0.4	0.5	0.4	1.1	1.1	0.4	0.6	4.2	2.4	0.5	0.6	0.3	6.6	49.9	79.0	73.6	57.1	49.0	57.9	76.4	72.0	74.8	60.4	66.6	101.9	14.3	41.7	11.8	58.8	1.3	2.9	12.3	2.0	7.4	1.6	7.1	8.8	17.8	12.8	6.8	9.2	0.0	4.2	0.3	4.0	9.8	3.4	12.9	6.9	14.9	14.3	3.0	93.5	5.5	0.7	0.4	22.6	2.0	1.9	6.3	14.5	21.8	44.3	2.1	3.3	4.7	29.8	2.0	11.6	9.1	11.2	47.2	17.0	5.4	37.5	2.6	46.8	3.1	51.3	164.8	12.8	5.5	50.8	0.2	4.0	4.2	2.9	15.0	1.8	0.0	24.5	9.4	2.5	0.8	0.7	3.7	1.4	1.9	11.9	1.2	3.8
FCHSD1	FLJ00007	ENSG00000197948	"FCH and double SH3 domains 1"	Q86WN1	5	141639302-141651418	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 50.8"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043795	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	Cytosol	"HPA043795: AB_10963435"	"prognostic favorable (8.62e-4)"	"unprognostic (4.08e-2)"	"unprognostic (6.17e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.50e-3)"	"unprognostic (8.56e-3)"	"unprognostic (5.34e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (6.19e-6)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (4.12e-3)"	"prognostic favorable (1.21e-4)"	8.3	6.7	4.0	19.6	5.2	19.7	8.8	5.7	5.3	16.0	2.8	9.2	11.1	12.5	3.4	9.0	11.0	11.3	5.6	3.1	7.5	7.5	2.8	10.7	23.0	7.2	6.0	17.4	7.7	50.8	13.1	6.7	7.6	10.5	5.2	3.6	11.2	6.3	1.9	21.3	17.2	6.1	3.7	22.2	11.7	3.9	7.1	11.0	11.1	1.9	16.9	11.7	14.3	7.3	13.5	8.3	11.0	23.1	9.2	11.5	19.3	28.5	14.5	25.1	39.3	15.7	28.1	5.6	14.0	22.1	4.0	7.5	3.5	15.8	11.2	23.9	6.0	11.7	12.9	5.8	7.0	3.7	38.1	14.2	12.3	19.8	6.4	21.1	14.6	0.4	7.4	10.3	2.9	11.8	3.0	7.1	3.2	4.7	7.6	0.1	0.1	5.5	8.6	19.8	1.2	12.2	0.5	10.6	16.5	8.3	12.9	11.0	29.8	0.4	6.9	10.3	12.1	12.2	4.4	2.9	21.8	13.1	12.2	5.8	1.2	4.0	4.3	1.3	3.3	3.3	2.4	4.6	1.2	1.7	2.2	3.1	6.5	1.6	2.1	1.2	3.5	2.4	4.0	5.2	5.7	5.3	3.1	7.5	7.2	6.0	7.6	3.7	7.1	7.3	4.0	0.0	2.2	5.5	11.6	2.7	3.7	4.7	9.6	4.9	3.5	4.1	0.6	2.8	3.6	3.7	12.5	1.1	11.4	6.3	0.0	4.7	7.1	1.8	2.9	3.8	4.2	1.3	1.7	6.5	4.3	5.3	9.2	3.4	8.9	4.9	3.9	0.6	5.6	53.8	3.9	4.6	8.2	1.9	1.9	6.6	4.1	5.6	3.6	4.7	3.5	1.9	15.5	0.5	8.6	7.4	3.4	3.8	8.2	2.4	4.3	0.7	3.6	1.7	6.6	2.4	3.8	2.3	4.0	4.4	2.8	1.4	14.4	3.5	2.6	2.3
FHDC1	"INF1, KIAA1727"	ENSG00000137460	"FH2 domain containing 1"	Q9C0D6	4	152936323-152979671	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.7;parathyroid gland: 17.6;thyroid gland: 15.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 85.9;Erythroid cells: 71.1;Syncytiotrophoblasts: 80.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.6;RT4: 10.5;SK-BR-3: 14.4;WM-115: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008527	Uncertain					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA008527: AB_2104099"	"unprognostic (5.42e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.95e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (4.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.30e-1)"	0.7	0.3	1.0	1.2	3.7	14.7	2.1	2.1	2.2	1.6	0.5	3.9	3.5	0.6	1.2	4.9	1.4	1.8	0.3	0.5	1.7	2.0	0.4	8.6	0.8	2.4	1.5	0.3	1.0	17.6	1.5	6.7	2.4	7.2	4.7	1.0	3.9	0.8	0.3	7.9	4.1	0.6	0.7	3.5	4.7	1.2	2.8	0.4	15.7	0.3	2.1	1.6	2.8	1.2	5.7	0.5	1.0	0.8	0.4	0.3	30.6	0.4	1.1	1.2	0.1	0.3	3.4	0.2	0.2	0.5	1.0	1.1	0.3	2.3	0.4	0.6	0.3	0.6	3.5	0.4	0.1	0.2	0.9	0.2	2.8	0.0	0.7	1.2	0.0	0.5	1.4	0.6	0.4	3.5	0.1	0.1	6.3	0.5	0.4	0.1	0.3	0.1	5.6	10.5	5.5	0.2	1.9	14.4	2.1	6.9	2.2	0.4	0.2	0.4	0.9	2.6	1.3	0.8	0.5	0.1	0.2	0.1	10.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	1.0	3.7	2.1	2.2	0.5	1.7	2.4	1.5	2.4	0.7	2.8	1.2	0.5	16.0	85.9	5.5	0.5	5.9	2.8	16.3	3.4	0.1	4.8	4.1	0.9	2.8	18.8	3.7	2.1	11.9	0.3	11.1	0.0	0.9	2.0	4.5	2.4	2.0	13.8	71.1	10.7	3.1	13.1	2.6	15.3	15.6	3.8	0.5	0.0	0.0	2.1	0.0	13.7	9.3	4.1	0.0	0.8	0.2	0.9	0.6	0.0	7.5	0.0	0.0	0.0	13.0	8.7	7.5	6.2	0.7	0.1	4.7	7.7	0.1	9.3	0.1	0.0	0.5	1.2	1.1	0.8	4.7	7.1	80.0	0.6	1.5	7.6	3.2
FUCA2	"dJ20N2.5, MGC1314"	ENSG00000001036	"Alpha-L-fucosidase 2"	Q9BTY2	6	143494812-143511720	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 165.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031659, HPA031661"	Approved				"Secreted to blood"	NA	NA		56000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA031659: AB_10600661, HPA031661: AB_10601681"	"unprognostic (1.83e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (2.70e-9)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.76e-3)"	"unprognostic (9.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.07e-2)"	28.9	41.4	13.5	25.4	16.4	25.8	26.3	16.0	15.3	29.2	30.2	41.5	42.6	25.6	44.9	14.2	23.7	27.8	27.9	12.4	16.5	54.8	52.3	28.9	17.2	17.1	14.2	30.4	34.6	165.8	15.8	50.5	17.8	21.9	52.8	6.1	25.4	25.8	6.9	12.3	39.3	27.6	16.4	24.6	38.3	12.6	15.9	6.6	32.0	11.6	17.0	33.5	20.4	20.9	97.4	55.7	47.6	86.9	69.0	134.4	90.1	89.9	95.4	108.1	182.0	107.1	94.8	0.2	66.1	120.8	33.9	0.6	24.1	11.7	148.9	87.2	92.6	32.6	100.1	163.2	99.3	0.3	15.8	72.3	69.4	96.6	41.5	91.6	111.4	0.2	117.6	49.3	123.2	114.6	0.2	75.9	62.1	44.2	76.0	0.2	99.7	72.1	129.0	59.5	36.0	23.6	98.7	65.3	82.3	36.3	32.1	79.6	65.9	64.1	54.0	161.6	175.4	18.3	21.3	0.7	74.1	59.1	22.5	38.8	84.9	26.2	13.2	84.0	15.0	11.3	9.8	11.3	65.4	8.3	4.4	7.9	5.5	29.6	62.0	10.3	19.8	51.9	13.5	16.4	16.0	15.3	12.4	16.5	17.1	14.2	17.8	16.4	15.9	20.9	27.3	41.7	35.9	9.1	13.5	11.2	12.6	30.3	9.1	3.7	19.2	12.6	28.0	38.6	37.9	25.8	0.0	52.5	10.3	47.6	11.7	81.9	2.0	26.8	55.2	25.0	9.6	18.7	8.7	124.9	109.8	62.6	34.7	28.9	37.4	38.1	23.6	35.2	110.3	1.7	11.8	38.1	46.8	57.5	29.2	2.6	66.8	51.7	42.7	9.4	49.1	11.1	13.4	5.5	14.5	74.6	38.2	45.5	47.7	13.8	60.3	51.4	34.8	1.1	6.6	33.8	35.0	4.8	4.6	13.2	8.0	46.4	11.5	78.8	50.4	18.4
GAD1	GAD	ENSG00000128683	"Glutamate decarboxylase 1"	Q99259	2	170813213-170861151	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 98.5;parathyroid gland: 46.3;retina: 29.7"	"Group enriched"	"Detected in many"	8	"Inhibitory neurons: 392.8;Oligodendrocyte precursor cells: 146.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 20.1;HEL: 64.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 547.6"	"CAB004415, HPA048871, HPA058412, CAB078176"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane, Cytosol"		"CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710"	"unprognostic (1.28e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.97e-7)"	"unprognostic (1.51e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.27e-4)"	"unprognostic (6.75e-2)"	"unprognostic (9.18e-3)"	"unprognostic (6.90e-5)"	"unprognostic (2.93e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.08e-3)"	0.2	3.0	22.1	0.0	29.9	3.3	0.1	15.5	33.0	1.0	0.0	0.0	0.0	1.6	4.3	0.4	0.2	0.1	0.0	17.1	98.5	4.8	0.1	0.2	0.1	12.4	41.6	0.2	0.2	46.3	5.0	0.4	17.6	0.8	0.1	29.7	0.1	0.3	0.0	0.2	0.1	0.0	12.7	0.1	0.0	3.2	31.1	0.8	0.1	0.0	0.2	0.6	0.4	14.2	18.2	0.7	0.0	7.3	0.0	0.0	0.1	0.4	0.0	2.6	1.7	4.6	6.7	0.0	0.9	0.5	2.9	20.1	2.3	0.6	1.6	2.8	13.4	64.5	6.0	0.2	0.0	0.3	1.1	0.0	5.5	0.0	2.3	0.6	0.1	0.5	17.0	0.3	0.8	1.5	0.0	0.0	8.1	9.7	6.7	1.0	4.6	0.4	8.5	9.4	6.7	2.1	12.6	0.0	3.5	0.6	0.2	0.0	0.0	12.0	1.7	2.4	7.0	0.0	0.0	0.1	11.5	3.2	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	29.9	15.5	33.0	17.1	98.5	12.4	41.6	17.6	12.7	31.1	14.2	0.0	0.0	0.0	14.7	0.0	0.3	2.1	7.7	2.2	32.5	0.1	0.1	1.3	0.0	3.6	0.0	10.4	0.0	0.0	0.2	7.9	4.5	5.6	4.4	0.4	0.4	3.0	5.5	2.6	5.6	0.1	0.2	0.0	2.9	0.0	5.5	0.0	0.0	4.0	5.0	392.8	0.3	2.0	0.8	0.4	6.2	0.6	0.5	0.0	7.5	0.0	4.9	0.0	146.8	7.6	2.9	0.0	0.0	0.1	0.9	0.0	0.0	4.7	6.0	0.0	0.0	1.2	4.4	7.7	0.6	0.1	0.5	0.0	0.1	0.1	0.4
GBA	"GBA1, GLUC"	ENSG00000177628	"Glucosylceramidase beta"	P04062	1	155234452-155244699	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease variant, Gaucher disease, Ichthyosis, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 65.2;Syncytiotrophoblasts: 59.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006667, CAB037171, CAB037289"	Supported				"Intracellular and membrane"	NA	NA		470000	"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"			"CAB037171: AB_1078958, CAB037289: AB_1078957, HPA006667: AB_1078979"	"unprognostic (6.03e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.00e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.94e-2)"	23.9	37.9	22.5	24.8	24.4	41.7	25.1	25.9	24.3	26.7	27.4	35.1	23.9	22.9	50.2	27.6	20.5	28.3	19.1	26.1	27.7	33.6	33.7	28.3	19.9	27.3	28.0	16.9	33.4	103.1	43.8	39.2	36.2	23.3	39.8	12.4	26.8	33.6	9.1	33.4	22.5	29.7	25.0	29.0	22.7	8.8	29.2	19.7	37.7	13.6	28.0	27.1	21.9	29.5	38.0	72.2	25.1	34.2	254.8	55.8	29.3	65.4	230.4	95.3	119.0	43.2	135.7	26.3	70.4	153.7	152.0	76.2	35.9	46.4	50.3	55.5	25.1	21.8	45.1	23.2	73.6	25.8	87.0	73.4	38.2	199.7	30.2	100.2	85.6	22.2	23.4	42.9	113.5	82.6	32.5	11.9	16.3	61.9	51.2	26.8	41.9	108.1	63.9	29.0	23.9	33.5	57.4	136.4	145.3	45.6	102.6	63.3	65.7	71.7	31.7	91.9	53.7	86.2	78.6	20.4	126.6	23.4	56.4	21.4	36.0	15.3	20.8	35.8	13.2	11.1	15.7	13.8	22.4	7.8	11.0	11.7	28.9	11.6	37.2	12.5	23.4	23.3	22.5	24.4	25.9	24.3	26.1	27.7	27.3	28.0	36.2	25.0	29.2	29.5	6.8	3.2	5.1	3.3	8.8	6.0	5.8	9.5	4.6	4.0	12.7	6.5	8.8	17.2	8.1	12.9	2.1	30.7	6.2	36.1	3.9	30.5	1.4	12.3	9.7	12.2	14.6	7.4	3.4	32.4	27.9	18.6	20.9	17.9	7.0	7.9	17.2	23.2	65.2	5.0	2.7	11.6	4.1	33.3	9.9	2.8	9.9	26.8	26.6	1.0	22.8	11.7	12.3	0.5	3.3	29.5	15.8	9.1	19.8	6.7	28.6	20.6	8.5	6.0	0.0	9.4	21.6	22.5	12.5	8.6	4.4	59.4	8.5	6.0	10.4	6.5
GCM2	"GCMB, hGCMb"	ENSG00000124827	"Glial cells missing transcription factor 2"	O75603	6	10873223-10882041	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	358	"parathyroid gland: 262.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.3;Early spermatids: 2.6;Excitatory neurons: 2.3;Inhibitory neurons: 1.7;Oligodendrocyte precursor cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"								"unprognostic (1.55e-1)"					"unprognostic (4.94e-1)"				"unprognostic (2.18e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.63e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	262.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GCNT1	"C2GNT, NACGT2, NAGCT2"	ENSG00000187210	"Glucosaminyl (N-acetyl) transferase 1"	Q02742	9	76419850-76651203	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 49.9;parathyroid gland: 84.1;stomach 1: 39.0;thyroid gland: 21.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 93.8;Kupffer cells: 42.2;Proximal enterocytes: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 21.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 46.2;HSkMC: 39.4;U-2197: 33.9"	"Group enriched"	"Detected in all"	6	"cerebellum: 7.6;olfactory bulb: 24.9"	"Low region specificity"	"Detected in all"			"HPA003522, HPA003523, HPA031151"	Uncertain		Supported	"Nuclear speckles"		NA	NA		84000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"		"HPA003522: , HPA003523: , HPA031151: AB_10602904"	"unprognostic (3.14e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (5.53e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.96e-4)"	4.0	0.8	1.8	5.0	2.2	5.1	4.6	4.8	1.7	10.6	1.3	8.7	49.9	5.9	0.7	1.8	1.5	2.9	1.2	2.0	0.9	0.9	1.9	4.2	6.7	1.0	1.0	0.7	2.1	84.1	0.9	2.9	1.0	6.3	9.3	0.1	3.8	1.3	0.3	1.1	32.3	4.8	1.0	7.3	39.0	1.6	1.5	3.0	21.5	0.7	4.7	2.2	0.8	1.4	4.7	0.4	0.3	0.1	5.5	26.5	6.7	18.8	8.4	15.0	10.5	4.7	1.1	3.3	1.8	14.1	2.9	4.0	9.5	7.8	16.6	2.3	1.6	8.2	0.4	0.8	46.2	6.0	2.7	39.4	2.0	14.5	15.5	12.2	13.9	4.1	0.0	3.2	15.1	7.1	3.2	9.7	8.8	11.9	1.1	5.3	9.3	1.6	17.5	8.3	2.0	0.0	2.3	2.5	0.1	6.6	0.0	4.1	5.6	9.3	5.9	33.9	8.4	4.7	0.9	0.0	18.7	10.1	2.3	6.1	3.2	21.6	1.5	7.8	0.5	1.9	1.7	1.5	5.8	10.2	0.3	1.1	1.1	5.8	7.3	2.8	2.5	2.1	1.8	2.2	4.8	1.7	2.0	0.9	1.0	1.0	1.0	1.0	1.5	1.4	2.9	0.0	1.7	2.0	8.3	0.9	5.0	34.4	0.6	0.0	8.8	4.2	1.0	0.0	15.6	3.7	0.0	2.1	10.7	16.6	0.0	1.0	20.1	15.1	4.2	5.1	27.6	17.9	11.8	24.3	27.1	3.4	93.8	24.6	10.8	0.6	6.4	0.3	8.1	0.0	1.7	21.3	16.2	42.2	8.5	12.9	0.0	18.6	1.8	15.0	6.7	0.1	8.2	0.5	0.8	12.9	14.5	1.2	2.2	6.8	40.7	1.4	17.0	0.4	0.0	0.9	1.8	1.8	3.3	1.0	0.3	19.0	10.6	0.2	38.4	1.5
GDPD1	"FLJ37451, GDE4"	ENSG00000153982	"Glycerophosphodiester phosphodiesterase domain containing 1"	Q8N9F7	17	59220467-59275970	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.3;Early spermatids: 47.2;Excitatory neurons: 65.1;Inhibitory neurons: 63.9;Oligodendrocyte precursor cells: 34.2;Oligodendrocytes: 36.5;Spermatocytes: 52.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 22.3;K-562: 12.5;SCLC-21H: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (8.33e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.68e-2)"	"unprognostic (5.98e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.85e-6)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.28e-3)"	0.8	1.8	4.7	0.9	4.3	1.5	1.8	7.0	8.4	1.1	1.9	1.8	5.7	1.5	0.7	0.8	1.4	1.8	1.1	5.1	4.7	2.0	1.0	2.3	0.9	5.9	5.4	0.9	1.1	5.9	1.8	1.3	6.3	2.0	1.5	5.8	2.3	1.5	1.7	1.4	4.2	1.3	2.8	1.5	5.2	8.6	5.1	1.6	2.6	0.7	1.1	1.3	0.8	5.4	0.8	1.0	4.2	3.2	0.6	0.2	2.6	0.5	1.6	0.4	3.3	0.0	1.3	2.0	4.7	0.1	3.0	0.6	6.6	1.1	1.9	2.6	6.8	22.3	0.7	3.2	2.0	1.0	3.2	0.6	5.4	2.1	0.6	1.9	1.9	4.9	12.5	1.3	0.8	1.0	3.9	0.4	0.8	6.6	1.1	2.4	0.4	2.1	2.0	1.2	12.5	3.4	1.0	0.4	4.6	1.3	3.0	1.4	1.6	0.2	1.3	0.2	0.4	3.7	2.3	0.7	1.0	1.2	1.4	2.4	0.5	0.3	0.5	0.7	0.4	0.3	0.4	0.6	0.2	0.5	0.5	0.7	0.9	0.8	0.7	0.7	0.3	0.3	4.7	4.3	7.0	8.4	5.1	4.7	5.9	5.4	6.3	2.8	5.1	5.4	1.6	3.2	8.2	34.3	1.3	0.5	1.5	1.2	1.8	6.1	1.6	1.0	3.1	0.0	8.7	5.5	10.4	0.4	3.2	0.9	0.0	2.2	47.2	1.8	0.4	1.4	1.2	11.3	65.1	1.8	5.5	1.1	9.2	0.7	0.0	4.0	0.7	0.6	1.9	6.7	63.9	3.1	6.1	2.6	1.0	8.3	0.6	3.0	1.8	2.8	2.7	2.3	3.1	34.2	36.5	1.6	2.0	1.5	0.9	1.2	7.6	0.5	5.6	4.4	0.0	1.6	5.7	52.4	17.7	0.5	0.4	2.3	2.5	2.2	1.2	1.6
GLA	GALA	ENSG00000102393	"Galactosidase alpha"	P06280	X	101393273-101408012	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 229.9;Plasma cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 328.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000237, HPA000966"	Enhanced				"Intracellular and membrane"	NA	NA		1300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA000237: AB_1078968, HPA000966: AB_1078969"	"unprognostic (7.27e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (2.53e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.73e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.21e-1)"	15.6	21.5	5.2	12.7	5.4	25.1	26.7	6.6	6.9	13.8	6.2	13.0	22.4	10.9	17.5	9.3	15.2	11.8	9.9	5.6	6.2	15.6	12.7	17.2	13.2	7.0	7.3	9.2	6.7	31.7	9.9	22.1	7.3	7.9	15.3	6.9	10.0	39.3	6.2	9.2	13.5	15.4	6.5	13.2	9.3	3.8	6.9	12.0	7.9	6.5	15.6	14.7	9.1	8.1	30.5	117.9	30.8	31.9	68.9	26.8	13.8	34.1	51.9	63.5	176.3	64.7	45.9	33.6	70.0	35.3	151.8	70.3	65.9	38.3	53.8	19.3	47.1	18.3	87.9	78.4	19.2	26.7	328.1	24.3	11.3	72.9	21.6	17.4	50.9	18.2	28.6	71.2	60.8	52.3	24.4	53.7	48.2	72.5	46.4	18.2	39.5	81.5	95.1	61.9	11.5	19.4	78.6	34.6	30.9	54.4	15.2	51.2	29.9	20.7	23.8	52.6	27.0	23.0	26.3	25.4	36.9	39.9	23.1	22.5	37.3	11.9	6.9	38.5	9.0	8.8	5.6	8.8	29.8	9.0	5.6	6.9	21.6	5.6	40.6	10.9	7.3	20.4	5.2	5.4	6.6	6.9	5.6	6.2	7.0	7.3	7.3	6.5	6.9	8.1	31.5	16.0	10.2	3.3	65.8	30.2	32.6	23.7	45.5	4.0	34.0	23.2	7.7	4.3	19.3	11.0	6.2	38.4	25.5	26.5	17.6	22.5	3.9	57.6	19.5	30.8	33.9	12.6	3.2	18.7	26.3	66.1	39.8	97.6	31.0	9.6	8.9	7.1	93.0	8.4	3.9	15.9	20.3	28.5	229.9	0.9	11.1	115.7	88.9	4.7	30.3	17.5	14.4	3.0	3.9	14.4	25.3	18.0	171.4	20.5	30.9	9.5	29.9	5.3	6.6	22.6	70.8	6.4	5.8	31.0	23.7	75.5	33.2	19.8	19.2	27.9
GLRB		ENSG00000109738	"Glycine receptor beta"	P48167	4	157076125-157172090	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;parathyroid gland: 33.0"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 168.6;Inhibitory neurons: 110.7;Oligodendrocyte precursor cells: 110.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 28.6;hTERT-RPE1: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052363	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA052363: AB_2681800"	"unprognostic (7.36e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.89e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.66e-2)"	4.7	7.0	16.5	1.1	17.7	0.2	10.6	7.4	35.5	9.0	4.5	3.3	0.6	2.9	5.2	1.0	7.3	3.2	11.1	18.0	12.9	3.8	1.2	3.1	0.3	9.4	6.9	1.2	15.2	33.0	7.5	2.6	10.8	6.2	0.9	8.5	19.5	4.7	3.3	1.8	1.4	3.7	5.7	0.0	2.9	1.6	9.8	1.1	1.0	4.9	0.2	1.4	1.5	13.5	8.0	3.4	9.5	28.6	18.0	7.2	0.0	16.0	10.1	7.6	14.4	0.0	24.0	0.0	3.7	16.2	9.4	0.0	7.2	2.5	14.3	0.0	9.7	5.0	3.8	0.3	8.1	6.2	0.0	6.4	2.2	13.4	1.9	37.8	6.9	5.1	0.0	0.0	14.1	0.0	0.8	0.0	0.6	0.0	2.3	0.0	13.0	0.0	20.6	1.5	10.3	6.1	0.0	7.3	1.2	1.4	6.8	1.6	10.5	4.5	13.2	7.6	15.3	0.0	0.0	0.0	10.7	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	16.5	17.7	7.4	35.5	18.0	12.9	9.4	6.9	10.8	5.7	9.8	13.5	0.5	0.0	1.1	26.1	0.0	1.1	0.9	3.1	1.2	10.8	7.8	4.8	13.9	4.3	3.5	0.0	2.1	0.4	0.4	0.1	0.0	8.8	0.3	6.9	3.4	2.1	0.0	1.7	168.6	1.8	0.0	3.9	0.0	2.0	1.3	7.0	3.3	0.0	0.1	1.7	110.7	0.0	4.1	0.3	1.9	0.3	0.3	0.1	3.6	15.9	0.6	13.2	0.0	110.1	31.5	1.5	0.0	3.4	0.0	0.6	0.0	0.5	10.4	2.2	0.0	8.5	2.2	1.3	3.3	0.4	0.3	0.1	0.1	1.3	0.1	0.2
GPR160	"GPCR1, GPCR150"	ENSG00000173890	"G protein-coupled receptor 160"	Q9UJ42	3	170037995-170085392	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 107.9;parathyroid gland: 216.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 194.8;Proximal enterocytes: 362.1;Proximal tubular cells: 151.4;Rod photoreceptor cells: 153.2;Undifferentiated cells: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 123.9;SK-BR-3: 95.8;THP-1: 197.2;U-266/70: 206.2;U-266/84: 127.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006970	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA006970: AB_1849275"	"unprognostic (1.70e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (5.71e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (4.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.61e-4)"	12.2	1.7	0.7	15.9	1.0	107.9	22.5	1.0	1.6	11.2	0.9	72.0	73.8	5.8	57.9	2.9	5.4	18.6	1.0	0.6	0.7	59.8	4.1	15.0	27.9	1.4	0.9	0.6	18.4	216.6	1.4	4.1	1.1	26.7	72.6	104.7	19.3	6.3	1.3	1.2	98.6	4.4	0.8	25.2	43.0	5.2	0.9	9.5	6.7	2.7	30.4	26.8	1.0	1.2	64.2	1.5	0.3	0.5	0.3	0.4	15.6	0.4	0.5	0.4	1.9	11.7	8.1	29.4	12.9	0.6	4.0	0.7	8.8	0.5	1.0	45.9	17.7	19.1	1.0	24.3	0.2	38.2	24.8	0.2	0.9	2.0	2.3	2.8	1.4	13.7	6.4	73.9	0.4	41.5	2.9	8.4	10.3	39.1	2.4	5.3	1.1	123.9	32.3	86.8	6.1	1.8	0.8	95.8	4.5	8.2	55.9	197.2	1.9	0.2	0.4	7.1	4.8	206.2	127.9	51.4	0.8	40.3	2.8	2.9	1.1	9.3	0.5	0.4	1.0	8.0	1.0	0.4	2.4	12.3	3.0	1.1	11.3	0.4	0.2	3.2	0.3	1.2	0.7	1.0	1.0	1.6	0.6	0.7	1.4	0.9	1.1	0.8	0.9	1.2	35.2	9.6	51.1	0.7	25.9	0.4	3.2	4.1	0.0	9.5	48.5	18.3	1.0	28.6	22.7	62.5	39.6	3.1	11.6	88.9	54.8	10.3	33.7	20.6	4.4	8.7	194.8	0.4	1.5	72.0	21.1	1.0	50.0	54.0	1.3	0.1	20.0	0.9	7.4	15.2	0.6	133.9	18.3	11.7	11.2	36.3	0.6	17.0	28.4	7.5	62.3	16.6	0.0	1.0	0.9	60.3	118.6	0.4	56.8	25.4	362.1	151.4	27.9	153.2	0.0	0.8	1.4	7.4	13.1	0.9	0.9	27.2	4.2	1.2	199.7	35.5
GPR32	RVDR1	ENSG00000142511	"G protein-coupled receptor 32"	O75388	19	50770464-50771732	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	32	"parathyroid gland: 58.0"	"Group enriched"	"Detected in some"	12	"Extravillous trophoblasts: 6.3;Syncytiotrophoblasts: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"BEWO: 37.4"					"Not detected"	"Not detected"									NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"																		"unprognostic (4.77e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0
GRIP1		ENSG00000155974	"Glutamate receptor interacting protein 1"	Q9Y3R0	12	66347431-67069162	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 16.4"	"Cell type enriched"	"Detected in many"	7	"Inhibitory neurons: 2829.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"myeloid DC: 4.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 4.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.4;HaCaT: 48.7;REH: 30.7;RT4: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038856	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA038856: AB_10673297"	"unprognostic (6.25e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.00e-2)"	"unprognostic (4.14e-1)"	"unprognostic (2.82e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.27e-4)"	"unprognostic (8.57e-3)"	0.5	4.3	8.5	2.7	6.6	0.5	3.0	0.0	14.2	1.2	0.0	3.1	1.1	3.5	4.7	7.3	4.2	1.6	2.7	3.9	12.4	3.3	0.3	0.8	0.7	0.7	7.6	1.2	2.0	16.4	3.3	8.2	2.2	4.6	1.7	4.8	6.0	9.3	1.0	9.8	1.9	2.8	0.0	2.6	0.8	6.2	3.0	0.7	5.0	0.6	1.3	2.6	2.0	3.7	11.1	10.1	17.7	2.1	0.0	0.0	44.4	3.2	0.0	5.4	2.5	0.3	3.3	1.4	4.2	0.0	9.5	48.7	4.9	3.3	2.4	0.0	12.0	0.0	0.1	0.3	0.0	1.2	0.1	0.0	8.0	0.0	0.8	8.3	0.0	8.0	0.0	0.1	0.0	4.0	0.4	0.4	16.1	1.4	3.6	30.7	0.1	0.6	5.6	31.0	10.8	1.4	14.8	7.1	1.4	11.3	8.7	1.8	0.0	0.0	12.7	0.1	9.0	1.5	0.3	1.0	12.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.1	0.1	0.2	0.0	1.0	0.0	0.3	0.0	0.1	8.5	6.6	0.0	14.2	3.9	12.4	0.7	7.6	2.2	0.0	3.0	3.7	0.1	0.0	1.1	74.7	0.1	13.3	2.3	2.9	2.2	5.5	4.1	2.4	3.4	1.5	1.7	7.3	0.0	7.8	0.7	0.3	0.0	2.2	38.5	8.1	2.2	0.4	1.8	0.0	390.2	1.5	4.3	1.1	0.0	13.7	0.0	2.3	0.0	0.0	1.0	47.1	2829.7	0.7	0.0	2.4	1.6	34.0	0.6	2.1	7.2	20.6	1.0	0.5	0.0	158.3	44.4	1.9	0.5	0.7	0.1	3.8	0.2	0.4	1.1	1.8	0.0	1.0	0.6	0.3	1.2	2.3	17.8	16.6	0.8	1.2	0.7	3.1
GRM7	"GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87"	ENSG00000196277	"Glutamate metabotropic receptor 7"	Q14831	3	6770001-7741533	"G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"	"Cardiomyopathy, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1;parathyroid gland: 4.4"	"Group enriched"	"Detected in some"	14	"Excitatory neurons: 773.1;Inhibitory neurons: 597.7;Oligodendrocyte precursor cells: 1189.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"SH-SY5Y: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015964			Uncertain	Cytosol		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA015964: "	"unprognostic (2.04e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.37e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.84e-6)"	"unprognostic (1.45e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.59e-2)"	0.2	2.0	2.8	0.0	2.9	0.0	0.1	0.1	3.8	0.9	0.0	0.1	0.2	0.9	0.0	0.0	0.2	0.0	0.0	3.9	5.1	0.0	0.1	0.1	0.0	2.0	3.0	0.1	0.0	4.4	0.0	0.1	1.7	0.3	0.1	1.1	0.7	0.3	0.0	0.0	0.0	2.3	3.7	0.1	0.0	1.1	5.0	0.3	0.1	0.0	0.0	0.2	0.1	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.9	0.1	3.8	3.9	5.1	2.0	3.0	1.7	3.7	5.0	1.7	0.1	0.0	0.0	29.4	0.0	0.1	1.2	0.1	0.0	24.1	0.1	0.5	1.1	4.3	0.7	0.0	8.4	0.0	0.1	0.0	1.9	0.0	32.7	0.1	2.7	0.2	0.0	0.0	773.1	0.0	0.1	1.6	0.0	0.1	1.3	0.1	0.0	0.0	0.1	1.7	597.7	0.0	0.0	0.0	1.2	41.7	0.3	0.4	0.0	13.1	0.1	1.3	0.0	1189.3	56.9	0.0	0.0	0.0	0.0	0.7	0.0	0.1	8.0	3.5	6.6	0.7	0.4	2.7	0.8	0.0	0.0	0.0	0.1	0.5	0.0	0.7
HCAR1	"FKSG80, GPR104, GPR81, HCA1, LACR1, TA-GPCR"	ENSG00000196917	"Hydroxycarboxylic acid receptor 1"	Q9BXC0	12	122726076-122730844	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 11.5;parathyroid gland: 40.4"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 8.7;Breast myoepithelial cells: 5.2;Club cells: 3.2;Early spermatids: 9.6;Extravillous trophoblasts: 3.7;Late spermatids: 6.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 7.9"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.1;MCF7: 8.1;RT4: 35.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"				"prognostic unfavorable (3.61e-5)"	"unprognostic (8.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.80e-4)"	"unprognostic (5.43e-4)"	"unprognostic (1.41e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.87e-2)"	5.5	0.3	0.4	0.2	0.4	1.0	11.5	1.7	0.7	0.7	0.4	0.1	0.3	0.4	1.2	0.2	1.7	0.2	0.2	0.6	0.1	0.8	0.1	0.4	0.4	0.3	0.1	0.4	0.1	40.4	0.3	1.0	0.3	1.0	0.1	0.6	5.0	5.1	1.2	0.7	0.3	0.2	0.1	2.3	2.0	0.8	0.2	0.3	1.3	0.1	0.1	1.2	0.3	1.2	0.1	0.3	0.2	0.3	0.0	0.0	1.9	0.1	0.0	0.0	0.1	2.5	12.1	0.3	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.6	1.8	0.2	0.3	0.2	0.6	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.6	0.1	8.1	0.2	0.4	0.3	3.0	0.6	0.3	0.2	0.3	0.1	35.3	2.6	0.2	0.1	4.2	0.0	0.3	3.4	0.1	0.3	0.4	0.2	0.2	0.2	0.4	0.1	0.4	0.2	0.2	0.3	2.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	1.2	0.4	0.1	0.3	0.1	0.1	0.4	0.4	1.7	0.7	0.6	0.1	0.3	0.1	0.3	0.1	0.2	1.2	1.3	0.0	0.5	0.0	0.0	0.1	1.4	0.2	0.0	0.3	8.7	5.2	0.4	0.0	3.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	9.6	0.2	0.2	0.3	0.0	0.0	0.0	0.0	3.7	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	6.5	0.3	0.3	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	1.0
HMGXB3	"HMGX3, KIAA0194, SMF"	ENSG00000113716	"HMG-box containing 3"	Q12766	5	150000046-150053142	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"parathyroid gland: 117.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005967			Approved	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoli		"HPA005967: AB_1080044"	"unprognostic (3.66e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (3.37e-5)"	"unprognostic (9.72e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.89e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-2)"	13.9	17.0	10.4	9.5	11.4	20.0	17.3	10.2	12.0	14.1	14.2	11.8	8.0	14.2	15.3	10.6	14.5	12.4	12.7	11.0	10.6	14.6	13.5	16.5	11.8	10.5	11.4	15.3	13.6	117.1	17.1	12.5	10.3	20.2	11.0	11.6	13.3	12.5	14.6	15.2	11.6	11.4	10.1	16.1	14.1	14.3	12.9	14.9	16.0	13.3	12.0	12.4	11.8	12.3	23.5	27.2	19.4	30.6	27.2	22.6	32.8	22.2	41.1	33.0	41.7	39.7	28.5	22.3	25.4	31.3	70.7	17.0	36.9	39.9	29.0	20.9	26.0	19.4	30.8	20.1	38.3	38.0	42.8	30.1	29.3	48.9	39.1	42.6	24.5	17.8	26.2	23.2	36.4	19.5	23.5	20.9	14.4	16.1	41.2	20.6	26.1	21.9	20.8	29.6	24.1	24.6	19.3	48.2	51.4	16.8	22.3	25.6	20.5	49.3	21.0	24.2	42.2	27.0	27.0	31.5	57.2	29.2	26.0	3.5	2.5	2.3	3.3	3.1	2.6	3.0	2.8	2.4	3.2	2.6	2.1	2.4	0.2	1.2	2.1	2.5	4.4	2.1	10.4	11.4	10.2	12.0	11.0	10.6	10.5	11.4	10.3	10.1	12.9	12.3	34.8	9.6	12.8	14.0	22.0	11.3	27.0	14.2	17.6	29.5	33.2	26.7	8.0	11.5	17.0	9.2	35.5	16.3	36.1	13.3	21.5	22.2	6.2	47.7	37.5	24.7	15.5	12.8	20.4	21.9	12.6	23.9	30.1	47.5	18.3	36.7	15.0	12.6	27.9	72.3	20.0	12.8	6.1	11.9	13.7	3.1	13.4	18.9	3.6	16.9	23.5	19.8	29.9	15.1	18.5	34.3	8.4	12.4	29.5	41.1	7.4	13.8	24.7	43.1	13.1	23.5	19.5	28.9	24.4	15.6	12.1	15.5	23.3	42.8	15.6	29.4
HNRNPH2	"FTP3, hnRNPH', HNRPH', HNRPH2"	ENSG00000126945	"Heterogeneous nuclear ribonucleoprotein H2"	P55795	X	101408222-101414133	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 302.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, CAB004436, HPA016884"	Supported		Enhanced	Nucleoplasm		NA	NA		640000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB004436: AB_627737, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (1.00e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.99e-1)"	"prognostic favorable (7.37e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.68e-2)"	60.1	70.3	53.5	63.0	57.7	78.0	72.3	53.6	69.6	59.2	58.4	57.2	60.1	61.6	66.1	55.5	55.2	48.7	59.1	57.4	56.8	79.0	77.7	57.4	58.3	56.1	55.5	53.0	42.7	124.0	52.8	71.8	55.6	63.1	60.9	79.4	45.6	72.7	90.4	63.8	59.7	68.7	55.7	59.5	49.0	25.6	55.0	73.0	63.1	77.8	73.2	71.9	47.2	59.8	105.0	72.1	137.8	83.2	119.4	104.0	66.0	87.3	123.5	82.0	166.6	62.1	91.9	107.9	86.6	125.5	112.3	93.8	160.6	122.5	111.9	104.9	78.0	80.1	173.7	84.8	102.2	100.4	74.7	106.1	111.0	80.8	79.3	98.5	113.5	58.1	82.9	150.6	126.8	136.9	83.3	88.7	86.6	171.7	69.7	76.9	146.2	105.1	177.8	140.7	63.1	114.6	130.0	61.3	104.5	97.3	78.9	94.7	122.0	45.0	81.4	129.7	36.2	49.8	76.9	75.0	93.2	114.6	57.5	138.8	104.6	165.1	59.2	112.3	62.9	56.7	56.6	59.3	99.4	54.5	58.7	61.3	247.6	79.5	114.5	41.9	57.4	92.2	53.5	57.7	53.6	69.6	57.4	56.8	56.1	55.5	55.6	55.7	55.0	59.8	46.3	28.9	61.2	0.0	47.7	70.9	94.1	119.0	21.1	40.5	42.6	24.9	48.1	45.8	88.5	90.1	12.5	137.7	37.5	52.0	99.7	99.1	3.2	41.4	35.6	56.1	60.6	41.0	0.0	73.4	65.0	49.0	28.1	44.6	82.4	26.2	52.1	85.3	84.3	16.8	0.0	45.7	83.4	75.4	75.8	6.1	55.3	66.0	69.4	0.0	97.8	44.1	55.6	0.0	0.0	64.5	65.8	59.0	24.6	45.3	58.4	146.2	75.0	34.1	78.9	57.2	64.6	17.6	33.1	28.2	72.0	302.5	42.0	44.3	46.0	64.5
HSD17B12	"KAR, SDR12C1"	ENSG00000149084	"Hydroxysteroid 17-beta dehydrogenase 12"	Q53GQ0	11	43680680-43856617	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016427	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA016427: AB_1844347"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-3)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.31e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.16e-2)"	"unprognostic (7.54e-2)"	"prognostic favorable (2.10e-8)"	"unprognostic (6.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	60.9	65.4	42.0	31.4	50.4	25.1	48.8	58.1	63.0	51.3	71.5	65.8	67.3	37.4	50.6	36.3	41.3	35.6	69.5	42.0	54.3	91.3	122.9	51.4	28.5	58.8	52.1	45.3	43.5	134.3	28.5	41.6	58.9	52.8	59.5	47.0	46.9	41.5	27.8	30.0	41.7	48.6	52.8	34.8	56.1	33.5	48.9	22.3	66.8	51.6	32.3	31.4	26.8	61.9	40.2	64.3	68.4	69.6	226.8	211.5	45.0	96.7	97.8	67.3	73.0	75.7	80.7	97.4	69.4	91.5	111.7	151.6	48.7	125.5	82.6	19.0	89.2	46.4	28.3	66.2	114.6	132.3	125.4	131.1	93.6	68.1	193.6	85.9	96.1	60.4	43.9	157.9	59.4	22.9	38.6	63.1	126.0	49.9	45.3	63.9	102.3	110.8	129.5	95.9	24.5	56.5	132.0	110.7	100.2	64.6	80.2	112.5	92.4	73.9	28.3	189.3	117.6	81.6	110.3	58.3	78.5	25.0	55.4	8.8	13.4	7.0	12.1	14.8	13.5	12.7	9.6	10.5	21.3	15.2	15.6	13.9	11.2	16.4	8.2	18.4	6.2	11.6	42.0	50.4	58.1	63.0	42.0	54.3	58.8	52.1	58.9	52.8	48.9	61.9	73.6	64.1	111.1	96.6	45.4	31.7	47.1	92.8	57.5	77.1	46.1	36.4	80.7	74.4	81.4	51.5	77.2	60.4	30.6	82.2	27.4	100.2	61.8	36.9	47.5	70.9	138.2	40.8	126.9	82.3	42.1	59.7	60.6	37.0	155.9	37.3	76.1	214.0	63.5	121.1	155.6	75.5	87.5	50.9	43.7	24.1	34.2	45.3	39.2	59.0	37.2	128.2	30.9	128.7	97.5	71.4	62.5	56.8	61.4	61.3	54.2	50.1	75.8	67.8	78.9	45.4	60.2	17.5	14.5	66.0	45.7	74.8	29.4	95.5	115.5	48.6
HTR7	5-HT7	ENSG00000148680	"5-hydroxytryptamine receptor 7"	P34969	10	90740823-90858039	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 7.6;parathyroid gland: 13.1;testis: 8.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 7.0;Excitatory neurons: 5.9;Inhibitory neurons: 24.2;Spermatocytes: 13.1"	"Group enriched"	"Detected in some"	5	"cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	12	"myeloid DC: 1.4"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 11.3;hTCEpi: 10.1;hTERT-HME1: 33.4;LHCN-M2: 13.5;U-251 MG: 9.6;U-87 MG: 10.2;WM-115: 13.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022708, HPA073617"	Approved	Supported	Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB022708: , HPA073617: AB_2732228"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	0.5	0.2	2.4	0.9	1.4	0.3	0.3	0.0	2.5	0.4	0.4	0.6	0.5	0.2	0.1	0.7	0.2	0.9	0.1	2.7	7.1	0.1	0.4	0.2	0.6	1.5	3.2	0.1	0.2	13.1	0.1	0.3	1.9	0.2	0.9	0.1	0.3	0.1	0.9	0.5	1.4	0.3	0.5	1.1	0.7	8.7	7.6	0.2	0.1	0.5	0.3	2.3	0.6	0.8	0.3	0.0	0.0	0.0	0.2	0.9	0.0	0.7	0.3	0.7	1.0	0.0	1.2	0.0	0.0	0.1	2.0	4.7	1.3	11.3	2.8	0.0	0.2	0.0	0.0	0.0	5.1	0.0	0.6	7.8	10.1	3.3	33.4	6.3	0.0	0.0	0.1	0.0	13.5	0.0	0.0	0.2	1.2	0.0	1.6	1.0	0.1	0.0	0.0	1.2	0.4	0.0	0.5	0.0	5.4	0.6	0.0	0.2	0.3	6.1	0.0	0.1	9.6	0.0	0.0	0.0	10.2	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	1.4	0.0	2.5	2.7	7.1	1.5	3.2	1.9	0.5	7.6	0.8	0.1	0.0	0.0	0.7	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.3	0.0	0.0	0.4	5.9	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.4	0.0	1.7	0.0	24.2	0.0	2.0	2.2	0.0	2.7	0.0	2.5	0.0	0.0	0.4	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.1	13.1	1.3	0.0	0.1	0.1	0.2	0.0	0.0	0.3
ICE2	"BRCC1, FLJ11896, NARG2"	ENSG00000128915	"Interactor of little elongation complex ELL subunit 2"	Q659A1	15	60419609-60479160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 34.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040058			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA040058: AB_10795686"	"unprognostic (3.80e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.59e-3)"	"unprognostic (8.78e-3)"	"unprognostic (2.71e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.74e-2)"	5.5	5.5	3.0	6.2	4.0	5.5	8.4	4.5	3.2	5.0	5.8	4.8	4.4	8.0	5.5	6.6	6.4	6.5	5.3	2.6	3.2	6.5	7.0	4.9	9.1	3.9	3.3	9.9	6.3	34.6	4.2	7.9	4.2	6.6	7.1	4.8	6.0	5.4	4.4	5.0	5.4	6.4	3.4	7.7	5.3	6.8	3.2	12.7	9.3	5.1	9.8	6.1	3.6	6.7	14.7	25.5	21.1	20.3	15.6	16.9	11.0	8.5	13.1	13.3	14.4	20.0	10.6	25.5	18.3	9.2	25.2	27.2	28.3	11.4	18.3	30.9	12.6	25.8	17.4	11.8	8.4	28.8	17.6	8.5	13.6	11.0	19.7	17.7	22.2	24.9	39.9	23.3	16.7	6.3	22.9	7.6	26.3	26.8	17.1	27.1	16.7	22.4	10.7	18.0	23.8	22.8	12.0	12.2	15.1	24.8	19.7	14.6	10.5	18.4	16.0	15.8	26.5	11.0	31.6	37.7	12.1	32.4	17.4	4.0	4.5	5.3	5.7	6.3	9.7	7.6	7.0	7.6	5.9	10.5	9.3	9.1	0.7	4.2	5.8	4.9	8.1	6.0	3.0	4.0	4.5	3.2	2.6	3.2	3.9	3.3	4.2	3.4	3.2	6.7	32.5	19.2	19.6	34.6	30.6	0.0	20.4	0.0	16.5	31.3	24.4	27.7	20.2	15.7	17.3	20.2	39.6	22.7	32.4	8.8	21.5	12.2	15.5	25.6	27.5	25.1	19.2	28.0	39.9	10.4	14.9	21.1	25.0	21.8	29.8	70.6	29.6	20.6	14.0	30.3	42.6	16.1	0.0	16.8	0.0	17.4	25.4	21.1	0.0	49.6	25.3	19.6	25.7	49.3	83.6	14.6	13.7	17.7	15.9	23.0	11.6	18.1	19.7	33.3	0.0	31.4	17.5	22.1	34.8	21.3	0.0	14.6	31.3	39.3	19.4	19.2
ID2	"bHLHb26, GIG8"	ENSG00000115738	"Inhibitor of DNA binding 2"	Q02363	2	8678845-8684461	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1209.7"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 2393.2;monocytes: 1987.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1038.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 731.4;HEK 293: 459.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027612			Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nuclear bodies"	Centrosome	"HPA027612: AB_10599729"	"unprognostic (2.53e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.24e-1)"	"prognostic favorable (9.95e-4)"	"unprognostic (4.39e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.92e-3)"	160.8	175.9	86.6	73.9	88.5	390.3	82.6	83.8	118.2	97.4	68.5	149.9	99.1	69.7	21.0	35.3	108.3	150.8	177.4	89.6	86.8	128.2	562.5	108.1	92.6	80.2	82.9	213.1	60.1	1209.7	65.7	70.3	85.2	125.1	124.7	69.7	114.3	142.4	18.9	69.6	99.4	85.3	81.4	107.4	66.7	13.8	90.1	73.8	223.5	41.2	47.4	110.2	76.2	95.8	2.0	132.4	56.0	68.6	86.8	13.9	208.5	156.6	18.3	68.4	29.1	266.0	7.3	4.1	175.1	262.5	16.9	115.9	36.0	1.0	20.7	731.4	459.5	101.3	81.7	333.9	24.8	76.5	266.3	23.4	3.1	30.5	1.9	19.2	1.4	6.7	6.2	113.9	109.1	45.3	7.8	9.0	102.4	338.5	102.9	9.7	38.4	75.6	71.3	60.5	103.5	146.6	8.4	117.8	12.1	142.0	19.3	44.9	27.5	83.9	14.5	126.5	9.4	8.9	7.9	88.7	106.6	230.2	46.5	110.3	76.0	1038.0	356.7	221.7	214.2	3.6	108.1	251.9	223.8	1.6	133.7	262.1	96.6	880.8	248.9	10.3	9.2	200.1	86.6	88.5	83.8	118.2	89.6	86.8	80.2	82.9	85.2	81.4	90.1	95.8	429.9	141.1	237.9	316.7	41.4	131.3	143.0	494.8	138.9	9.8	231.2	218.4	179.5	316.0	211.2	101.2	16.7	260.3	604.5	337.7	555.7	471.0	12.0	601.1	344.6	281.1	425.9	59.8	23.5	160.3	142.4	276.0	189.1	647.2	973.6	17.1	487.6	554.7	700.3	6.7	13.8	548.0	494.4	415.8	2393.2	21.7	124.2	528.4	282.8	15.9	1987.9	519.9	1070.1	26.7	3.2	69.6	301.9	32.7	86.0	130.1	231.3	264.1	66.7	27.4	19.7	166.6	185.6	2.1	39.9	97.6	104.6	666.0	690.0	16.7	323.1	51.3
IFIT5	RI58	ENSG00000152778	"Interferon induced protein with tetratricopeptide repeats 5"	Q13325	10	89414568-89421605	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 109.1;BJ hTERT+ SV40 Large T+ RasG12V: 128.0"					"Low region specificity"	"Detected in all"			"HPA037957, HPA062180"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA037957: AB_10672499, HPA062180: AB_2684705"	"unprognostic (2.17e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.73e-1)"	13.3	11.6	11.9	11.1	14.3	16.1	9.7	18.7	13.5	11.4	25.0	9.4	9.4	10.2	9.1	7.4	11.2	12.6	14.6	10.8	14.5	14.2	14.1	17.1	13.2	14.7	13.0	14.1	9.2	22.8	3.7	14.6	14.4	9.7	8.9	9.0	12.2	10.5	3.7	5.5	11.1	14.2	19.2	18.6	9.1	6.3	12.5	10.5	10.8	6.4	11.3	12.3	4.6	16.8	41.8	12.5	17.3	56.9	46.7	43.4	3.7	33.2	59.5	109.1	128.0	1.0	19.0	1.8	12.1	38.7	42.8	34.8	20.9	19.3	26.0	17.8	13.1	5.0	8.9	7.8	52.4	0.4	3.1	34.9	7.4	32.0	23.7	30.8	6.2	10.8	0.0	29.4	30.8	7.7	12.6	3.8	2.2	0.0	21.9	11.0	20.0	4.6	23.7	5.1	1.9	11.1	18.2	6.6	51.6	4.7	6.2	3.5	15.5	14.0	10.3	23.2	20.0	3.8	0.6	0.2	24.2	3.3	11.6	24.7	15.7	19.3	13.9	25.6	16.4	21.4	14.7	13.0	14.2	18.1	16.8	14.1	45.2	8.3	32.1	1.3	14.1	12.3	11.9	14.3	18.7	13.5	10.8	14.5	14.7	13.0	14.4	19.2	12.5	16.8	24.8	6.4	14.8	3.6	12.8	8.5	35.7	15.2	13.6	8.3	4.4	4.3	8.9	11.5	12.4	9.2	0.0	6.3	7.5	7.2	11.7	13.7	0.1	11.2	17.1	23.1	4.9	2.1	3.6	9.1	11.5	17.9	6.1	13.3	15.2	6.2	12.1	16.5	11.0	35.3	7.2	5.5	6.1	8.9	6.0	1.0	21.1	10.8	7.2	4.7	12.3	14.6	7.2	4.5	10.2	10.5	5.9	17.3	6.8	21.0	7.5	17.0	9.6	5.3	19.7	15.4	14.2	17.2	14.4	7.7	3.8	4.5	9.3	4.7	2.5	29.1
IGDCC3	"HsT18880, PUNC"	ENSG00000174498	"Immunoglobulin superfamily DCC subclass member 3"	Q8IVU1	15	65327127-65378002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.3;parathyroid gland: 5.1;placenta: 6.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 33.3;Cytotrophoblasts: 104.8;Early spermatids: 37.6;Late spermatids: 98.6;Syncytiotrophoblasts: 41.3"	"Group enriched"	"Detected in many"	5	"glioma: 2.2;testis cancer: 5.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 105.8;CACO-2: 27.4;Hep G2: 87.8;SuSa: 41.9"	"Low region specificity"	"Detected in many"							HPA015713			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles"		"HPA015713: "	"unprognostic (7.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.24e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.67e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.77e-5)"	"unprognostic (4.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-2)"	0.0	0.2	2.3	0.0	2.0	0.0	0.8	4.3	3.2	1.0	0.0	0.4	0.0	0.7	0.1	0.0	0.6	0.1	0.1	2.6	1.9	0.2	0.0	0.0	0.0	2.4	2.7	0.8	0.0	5.1	1.9	6.0	2.4	0.1	0.0	1.0	0.0	0.1	0.1	0.1	0.1	0.2	1.6	0.0	0.2	2.8	3.0	1.4	0.9	0.0	0.0	0.1	0.4	1.9	0.0	0.0	105.8	4.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	27.4	0.2	0.0	0.3	0.0	0.0	0.0	7.2	0.0	0.0	0.0	1.0	0.0	0.2	87.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	16.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	2.2	1.5	0.1	0.1	0.0	41.9	3.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.0	4.3	3.2	2.6	1.9	2.4	2.7	2.4	1.6	3.0	1.9	0.1	0.0	0.0	15.3	0.0	0.0	0.2	0.0	0.0	4.1	2.2	1.0	0.6	0.0	0.0	1.8	33.3	104.8	0.0	0.4	0.0	0.0	37.6	0.4	4.8	1.0	0.0	0.0	2.8	0.0	4.3	3.0	0.0	0.6	0.0	0.1	0.0	0.0	7.2	0.0	7.0	0.0	0.0	0.0	0.0	98.6	0.6	0.1	0.0	1.0	0.0	3.7	0.0	16.1	8.9	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.7	0.4	1.3	11.0	0.0	0.0	41.3	0.1	0.1	0.2	0.0
IL1RAPL2	"IL-1R9, IL1R9, IL1RAPL-2, TIGIRR-1"	ENSG00000189108	"Interleukin 1 receptor accessory protein like 2"	Q9NP60	X	104566199-105767829	"Enzymes, Predicted membrane proteins"		"Hydrolase, Receptor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 1.4;parathyroid gland: 1.0"	"Group enriched"	"Detected in some"	22	"Excitatory neurons: 191.3;Inhibitory neurons: 117.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.4;hTERT-HME1: 5.6;NTERA-2: 1.0;RT4: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.62e-1)"	"unprognostic (1.50e-1)"		"unprognostic (1.66e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.48e-4)"	"unprognostic (9.32e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-5)"	"unprognostic (1.78e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.91e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.84e-2)"	0.0	1.4	0.1	0.0	0.1	0.0	0.4	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.4	0.2	0.0	1.0	0.0	0.4	0.1	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.1	0.0	0.0	6.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	2.4	0.1	0.2	0.1	0.0	0.0	191.3	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	117.4	0.0	0.0	0.0	0.0	0.2	5.9	0.0	0.0	2.8	0.0	0.0	0.0	3.0	4.6	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	2.6	0.0	1.4	0.0	0.4
INPP5J	"INPP5, PIB5PA, PIPP"	ENSG00000185133	"Inositol polyphosphate-5-phosphatase J"	Q15735	22	31122731-31134697	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 123.2;thyroid gland: 204.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 35.0;Distal enterocytes: 24.0;Inhibitory neurons: 19.5;Muller glia cells: 25.2;Proximal enterocytes: 62.3"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 63.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 19.6;SK-BR-3: 41.1;T-47d: 25.7;U-698: 18.1"	"Region enhanced"	"Detected in all"		"olfactory bulb: 131.0"	"Low region specificity"	"Detected in all"			HPA034539			Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Nucleoli fibrillar center"	"HPA034539: AB_10670974"	"unprognostic (1.76e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-3)"	"prognostic favorable (1.47e-5)"	"unprognostic (6.81e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.29e-4)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (2.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.39e-2)"	0.8	2.1	3.2	0.8	4.8	0.1	8.9	17.3	13.2	4.0	2.4	10.4	16.3	3.0	0.6	2.4	2.3	1.2	27.8	11.5	15.2	32.1	0.4	2.3	0.5	6.0	4.0	1.2	15.7	123.2	10.1	0.1	5.2	9.2	3.7	5.3	33.1	12.1	2.8	4.4	26.2	1.5	1.4	0.3	13.6	4.4	8.3	0.2	204.2	2.6	0.4	2.7	2.4	5.7	2.1	2.0	1.2	2.3	0.3	0.2	1.1	0.8	0.8	4.1	4.0	1.2	1.3	0.1	1.0	0.4	0.4	2.4	2.5	1.2	1.7	0.0	6.5	0.0	9.7	0.4	0.8	19.6	0.2	0.2	1.3	3.4	0.4	2.7	0.3	0.1	1.8	2.8	0.1	6.4	0.1	0.1	2.3	2.8	0.4	0.0	0.4	4.5	1.7	2.5	9.9	7.5	1.6	41.1	0.5	1.1	25.7	1.6	0.0	0.2	7.3	0.8	0.5	0.1	3.5	18.1	0.7	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	4.8	17.3	13.2	11.5	15.2	6.0	4.0	5.2	1.4	8.3	5.7	0.7	0.0	4.1	3.3	0.0	0.9	2.3	0.3	1.2	9.5	15.8	7.5	6.1	0.0	1.1	35.0	0.0	0.0	0.2	24.0	11.7	1.4	0.4	1.9	0.4	0.5	0.0	0.0	5.5	2.2	0.2	0.6	4.6	2.7	0.0	0.8	0.0	0.0	0.1	5.0	19.5	6.4	0.0	0.0	1.9	0.6	0.0	0.3	0.0	1.0	0.6	25.2	0.0	2.0	1.0	0.8	12.3	0.0	0.1	2.5	62.3	0.5	0.5	3.1	0.0	0.5	1.3	2.4	1.2	1.1	1.3	0.1	0.4	0.4	8.8	1.6
INSC		ENSG00000188487	"INSC spindle orientation adaptor protein"	Q1MX18	11	15112424-15247208	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"parathyroid gland: 25.3"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Early spermatids: 4.6;Exocrine glandular cells: 3.1;Oligodendrocyte precursor cells: 8.0;Pancreatic endocrine cells: 10.9;Proximal tubular cells: 8.9"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.7;hTERT-HME1: 6.0;Karpas-707: 3.3;LHCN-M2: 3.6;TIME: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA039769	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039769: AB_10697556"	"unprognostic (1.64e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.00e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.88e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.00e-2)"	0.2	0.8	0.2	1.0	0.1	0.6	0.2	0.1	0.2	1.1	0.1	4.7	2.1	0.1	0.1	0.5	0.3	0.6	1.2	0.1	0.2	0.3	0.2	0.9	0.0	0.3	0.2	0.1	0.9	25.3	0.2	0.0	0.2	1.0	1.8	0.0	0.5	1.0	0.0	0.1	3.0	0.5	0.2	0.1	2.4	0.7	0.1	0.2	0.3	0.1	0.0	0.8	0.8	0.2	0.0	0.0	0.0	0.0	0.3	11.7	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.4	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.6	6.0	0.0	0.0	0.0	0.0	3.3	3.6	0.0	0.0	0.2	0.0	0.1	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	1.0	0.0	0.0	1.5	0.2	0.0	0.5	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.9	0.1	4.6	0.2	0.0	0.1	1.8	0.0	0.5	3.1	0.0	0.9	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.0	0.0	10.9	0.0	0.0	0.1	0.2	0.0	8.9	0.0	0.0	0.0	0.0	1.1	1.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.6
IPO8	"IMP8, RANBP8"	ENSG00000133704	"Importin 8"	O15397	12	30628988-30695869	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018439, HPA023765"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA018439: AB_1851771, HPA023765: AB_1851773"	"unprognostic (1.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (2.66e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (8.62e-5)"	"unprognostic (9.75e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.24e-1)"	20.1	21.6	17.8	23.0	21.8	16.5	22.2	25.3	19.9	22.1	26.1	29.4	26.6	23.9	17.1	24.2	17.2	21.4	16.7	19.1	21.4	32.2	34.6	23.1	28.1	22.0	19.8	26.6	27.8	51.9	15.5	22.5	20.9	21.8	32.2	22.8	19.8	25.4	18.5	24.3	23.7	26.8	18.1	25.2	24.1	24.5	20.9	29.3	31.7	21.7	27.5	23.9	15.5	22.8	41.2	46.8	44.3	32.9	40.9	46.8	62.3	44.4	42.5	34.9	40.6	32.9	41.8	52.9	38.1	54.8	37.0	25.8	49.7	48.4	50.5	62.0	35.1	43.1	56.0	29.8	26.8	63.3	32.8	37.8	29.8	55.5	47.1	62.5	58.5	36.4	39.2	38.7	49.9	21.0	47.6	39.3	86.7	56.5	18.1	38.5	93.1	42.7	43.6	55.5	27.3	33.7	46.6	33.7	25.0	78.6	53.8	22.7	52.4	33.2	29.0	72.3	39.3	38.0	54.9	78.4	40.6	37.4	58.7	3.4	1.9	2.4	1.9	2.5	2.8	2.4	2.1	2.0	1.4	3.2	2.2	3.0	2.5	2.6	2.6	1.4	2.8	1.3	17.8	21.8	25.3	19.9	19.1	21.4	22.0	19.8	20.9	18.1	20.9	22.8	18.4	9.6	21.0	22.2	17.3	9.6	6.7	6.3	12.5	13.4	12.2	7.4	20.3	8.6	16.6	11.0	12.5	11.8	13.5	17.2	3.9	10.1	51.5	14.3	17.5	17.5	6.7	14.5	38.8	14.0	6.8	13.4	16.8	14.2	12.0	25.0	21.0	25.1	16.1	8.4	35.0	13.8	8.2	24.8	10.8	11.9	8.7	17.4	8.8	30.9	16.7	12.7	18.6	59.8	35.7	14.1	8.1	13.2	17.5	7.6	15.0	15.7	9.9	14.3	13.1	17.0	14.8	17.4	5.2	23.4	9.2	17.9	13.6	11.1	14.8	9.0
JKAMP	"C14orf100, CDA06, HSPC213, HSPC327, JAMP"	ENSG00000050130	"JNK1/MAPK8 associated membrane protein"	Q9P055	14	59484443-59505410	"Cancer-related genes, Predicted membrane proteins"	"Unfolded protein response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 174.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031172, HPA071650"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Nucleoplasm	"HPA031172: AB_10670563, HPA071650: AB_2686429"	"unprognostic (1.48e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (3.09e-6)"	"unprognostic (2.68e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.14e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.73e-1)"	25.9	34.9	23.6	17.7	26.5	22.9	32.5	29.5	30.3	23.0	34.2	29.6	17.3	30.5	26.4	17.8	31.2	30.8	25.9	22.9	30.2	44.5	34.0	30.7	25.2	30.1	29.8	25.8	20.7	56.6	28.6	33.8	31.3	29.9	29.5	34.7	25.4	27.0	17.1	17.9	24.0	27.7	28.7	23.0	24.4	30.4	26.1	22.1	34.6	21.1	20.7	26.4	16.2	32.0	54.8	68.0	57.3	46.8	40.9	59.0	42.8	85.9	76.6	52.6	62.9	21.8	108.1	27.7	75.6	85.5	55.3	40.0	41.2	52.8	72.1	82.8	24.0	30.3	38.5	42.3	56.0	45.6	53.6	60.9	56.6	45.9	32.6	82.1	55.7	35.8	25.4	54.9	100.7	54.1	25.6	37.8	31.2	45.9	60.4	31.4	73.6	27.9	92.1	59.3	23.7	40.9	82.8	68.4	45.1	40.0	66.4	32.3	72.4	54.9	65.6	53.0	58.0	21.7	45.5	32.7	80.7	33.2	68.0	86.3	59.3	82.3	34.4	74.8	34.3	36.1	37.0	37.0	51.9	34.1	38.9	36.5	89.4	50.2	83.0	70.5	47.0	57.8	23.6	26.5	29.5	30.3	22.9	30.2	30.1	29.8	31.3	28.7	26.1	32.0	25.5	22.4	31.2	29.7	23.6	30.0	32.8	132.9	54.1	30.3	31.6	27.1	10.2	41.5	66.3	46.0	18.8	64.2	42.0	27.4	7.9	45.4	174.5	43.3	31.7	26.9	31.2	40.8	30.3	54.8	64.8	37.4	27.5	20.9	34.9	28.0	26.4	41.9	57.8	28.6	26.8	26.7	89.5	60.3	31.4	61.2	35.4	40.4	48.0	19.7	34.2	40.1	29.9	28.1	34.5	51.4	21.3	31.6	50.2	26.3	22.4	53.0	110.6	30.3	13.1	27.5	58.8	85.1	41.1	30.7	29.1	29.8	27.6	30.3	24.6	20.9
KANSL1L	"C2orf67, FLJ23861, FLJ32349, KIAA1267L, MSL1v2"	ENSG00000144445	"KAT8 regulatory NSL complex subunit 1 like"	A0AUZ9	2	210021421-210171409	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"parathyroid gland: 198.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 113.6;Inhibitory neurons: 117.9;Microglial cells: 103.0;Oligodendrocyte precursor cells: 190.5;Oligodendrocytes: 158.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043102, HPA046790"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA043102: AB_2678316, HPA046790: AB_2679808"	"unprognostic (3.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.55e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.99e-3)"	"unprognostic (4.65e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.75e-2)"	"unprognostic (5.95e-3)"	"unprognostic (7.44e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.30e-3)"	11.6	8.3	10.7	6.2	13.5	5.5	10.3	14.3	9.2	14.4	8.9	9.9	6.5	18.7	17.4	6.9	13.2	15.7	9.7	9.7	11.7	22.7	9.4	11.9	6.7	11.3	12.6	28.5	15.2	198.9	10.0	8.3	12.0	16.9	6.8	12.5	10.0	17.0	12.1	13.3	6.7	13.3	10.6	6.3	12.4	25.3	10.8	26.7	19.7	18.4	5.2	13.6	11.3	17.7	2.7	1.4	14.5	6.1	11.7	8.7	4.0	4.1	5.4	2.7	7.4	2.7	10.9	7.9	5.5	2.8	6.5	3.8	3.4	1.5	4.3	3.4	2.7	6.3	6.1	4.6	7.3	7.4	4.3	5.5	6.5	2.7	1.9	11.5	6.1	7.2	4.5	7.1	4.1	2.7	8.5	19.7	8.4	4.8	1.9	6.1	3.9	6.1	16.0	4.0	9.0	8.5	3.7	2.3	2.9	14.4	2.5	16.1	4.9	5.3	4.3	1.9	3.1	4.9	2.2	7.7	7.0	3.5	7.1	0.2	0.3	0.5	0.2	0.4	0.2	0.1	0.2	0.2	0.4	0.3	0.3	0.3	0.4	0.6	0.1	0.3	0.1	0.1	10.7	13.5	14.3	9.2	9.7	11.7	11.3	12.6	12.0	10.6	10.8	17.7	12.8	28.9	20.1	113.6	4.6	7.4	6.7	3.9	11.4	8.6	5.4	6.7	9.2	20.0	6.6	31.3	14.6	1.7	1.5	2.3	3.9	13.2	30.3	22.3	17.0	8.8	6.0	4.6	79.0	5.5	0.9	14.2	9.2	14.7	10.8	23.6	6.4	7.4	2.7	5.0	117.9	3.2	8.2	2.8	6.7	22.2	14.6	8.5	7.2	103.0	5.5	9.6	4.1	190.5	158.9	6.7	4.7	30.1	3.0	7.0	2.0	15.8	36.0	8.7	13.1	31.1	15.6	44.9	7.8	5.5	11.1	1.9	2.7	6.6	2.8	4.1
KCNJ16	"BIR9, Kir5.1"	ENSG00000153822	"Potassium inwardly rectifying channel subfamily J member 16"	Q9NPI9	17	70053429-70135608	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 196.1;parathyroid gland: 269.2;thyroid gland: 139.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 54.3;Collecting duct cells: 244.6;Distal tubular cells: 41.1;Oligodendrocyte precursor cells: 54.8;Proximal tubular cells: 95.2"	"Group enriched"	"Detected in many"	10	"renal cancer: 37.2;thyroid cancer: 80.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 279.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059563	Approved		Uncertain	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA059563: AB_2684065"	"unprognostic (2.81e-3)"	"unprognostic (2.10e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.38e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (9.61e-7)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (6.58e-4)"	"unprognostic (3.88e-1)"	0.3	0.4	10.0	0.4	14.0	0.6	3.8	22.7	11.6	0.1	2.3	0.6	0.7	0.5	15.9	0.3	5.1	18.8	0.6	6.8	39.5	196.1	1.3	0.9	0.8	39.7	37.6	0.2	44.2	269.2	1.0	0.9	25.7	0.2	0.2	1.2	11.8	21.7	0.3	0.8	2.5	0.0	29.9	1.5	23.4	1.7	27.3	0.2	139.4	0.0	0.1	0.0	0.0	20.8	0.1	0.4	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	1.2	0.5	0.0	0.2	0.0	0.0	0.0	0.2	1.2	0.8	0.3	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.3	0.6	0.1	0.0	12.7	0.0	0.0	279.8	0.2	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.1	0.1	0.0	0.2	0.8	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.3	0.3	0.3	0.1	0.0	0.3	0.2	0.2	1.6	0.3	0.0	0.1	0.3	0.1	10.0	14.0	22.7	11.6	6.8	39.5	39.7	37.6	25.7	29.9	27.3	20.8	0.1	0.0	0.0	12.1	0.0	0.0	0.0	2.7	0.0	0.0	2.3	1.1	0.4	54.3	2.6	244.6	0.0	0.0	0.0	0.0	41.1	12.4	0.0	2.8	0.1	0.0	0.0	0.0	1.0	1.4	0.0	0.3	3.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	54.8	0.1	6.0	0.0	0.0	0.0	0.0	1.0	95.2	9.8	0.0	0.0	0.2	0.3	0.2	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0
KCNJ2	"IRK1, Kir2.1, LQT7"	ENSG00000123700	"Potassium inwardly rectifying channel subfamily J member 2"	P63252	17	70168673-70180044	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 42.9;parathyroid gland: 36.0"	"Group enriched"	"Detected in many"	4	"Horizontal cells: 240.6;Oligodendrocytes: 164.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 30.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 30.4"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 8.9;HUVEC TERT2: 6.3;REH: 7.5;RH-30: 29.2;U-138 MG: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029109	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 62: Horizontal cells - Visual perception"			"HPA029109: AB_10602913"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.60e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.49e-3)"	1.9	0.8	7.2	5.1	19.5	1.9	4.9	13.4	13.1	0.9	0.0	3.9	0.9	0.9	0.6	2.9	6.6	1.4	9.8	5.9	11.8	1.0	1.3	2.1	1.3	18.6	16.2	0.7	0.4	36.0	0.6	6.3	18.2	1.8	3.2	7.6	1.3	1.8	9.7	4.7	1.4	1.0	10.5	7.3	0.8	0.3	14.5	1.8	1.2	8.4	1.5	1.9	1.8	42.9	0.0	0.9	1.8	0.0	1.9	0.5	0.0	0.6	4.5	0.1	0.1	0.0	0.0	0.0	0.4	0.5	1.2	0.5	0.1	0.3	0.1	0.0	0.2	0.0	0.6	0.0	5.4	0.0	0.0	2.0	0.1	2.8	0.3	8.9	6.3	0.0	0.0	0.0	1.9	0.0	0.7	0.0	0.2	0.8	0.2	7.5	29.2	0.0	0.7	0.0	0.4	0.8	0.5	0.1	0.0	3.5	0.3	0.5	0.1	10.6	0.1	0.1	2.4	0.0	0.0	0.1	2.3	0.0	1.5	4.2	3.5	5.6	0.0	6.9	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	30.4	0.0	7.3	0.2	0.0	0.8	7.2	19.5	13.4	13.1	5.9	11.8	18.6	16.2	18.2	10.5	14.5	42.9	12.0	0.0	3.2	0.0	0.6	8.2	4.1	4.9	16.5	43.5	5.8	9.3	19.3	0.0	1.9	1.8	0.0	0.5	0.1	13.5	0.0	0.1	0.3	2.3	0.2	16.0	10.7	0.4	3.8	0.0	0.4	1.7	4.1	1.6	0.0	0.1	3.3	0.1	6.8	240.6	16.2	2.7	0.0	36.9	7.4	0.0	1.5	7.8	3.6	2.8	8.2	5.8	0.0	1.5	164.7	0.0	12.3	1.2	0.0	2.2	0.9	0.1	4.9	5.2	0.0	3.9	2.6	0.1	0.9	6.9	3.3	1.4	0.8	0.2	8.5	0.3
KCNK13	"K2p13.1, THIK-1, THIK1"	ENSG00000152315	"Potassium two pore domain channel subfamily K member 13"	Q9HB14	14	90061994-90185853	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 5.6;parathyroid gland: 6.0;testis: 9.2"	"Cell type enriched"	"Detected in some"	4	"Microglial cells: 41.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.2"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.0;RT4: 1.9;SuSa: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003514	Approved		Approved	"Nuclear speckles,Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles, Cell Junctions"		"HPA003514: AB_2666978"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.65e-2)"	0.3	0.8	1.7	1.7	1.5	0.0	0.2	0.9	1.9	0.1	5.6	0.4	0.5	0.2	1.0	0.2	0.3	0.4	1.6	1.6	1.4	3.9	0.5	0.4	0.6	1.6	2.3	0.1	0.3	6.0	0.3	0.2	1.8	0.1	0.5	0.0	0.2	0.4	0.0	0.1	0.5	0.3	1.8	0.6	0.4	9.2	2.2	1.1	1.9	0.0	0.5	0.5	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	1.9	0.7	0.2	0.0	0.7	0.5	2.9	0.0	0.7	0.0	0.0	0.8	0.0	0.3	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.7	1.5	0.9	1.9	1.6	1.4	1.6	2.3	1.8	1.8	2.2	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.4	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	6.3	0.0	0.4	0.0	0.0	6.0	0.0	4.4	0.0	0.0	4.0	8.1	0.6	0.0	3.2	0.0	41.2	9.0	0.0	0.0	3.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	0.3	0.1	0.1	0.4	0.0	0.1
KIAA1549L	"C11orf41, C11orf69, G2, MGC34830"	ENSG00000110427	"KIAA1549 like"	Q6ZVL6	11	33376108-33674102	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 26.4;parathyroid gland: 33.5"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 366.9;Inhibitory neurons: 193.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.4"	"Group enriched"	"Detected in many"	141	"amygdala: 8.6;basal ganglia: 14.9;cerebral cortex: 26.4;hippocampal formation: 12.3;white matter: 7.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 42.4;U-138 MG: 53.8;WM-115: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010132, HPA051594"			Approved	Nucleoplasm,Vesicles		NA	NA		160000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA010132: AB_1078313, HPA051594: "	"unprognostic (3.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.34e-5)"	"unprognostic (2.63e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.89e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.59e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.08e-3)"	"unprognostic (8.46e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.09e-1)"	0.2	0.4	8.6	0.2	14.9	0.0	0.7	0.0	26.4	0.1	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.3	0.1	12.3	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.3	33.5	0.7	1.1	0.0	0.0	0.1	0.9	0.3	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.7	0.3	0.2	7.9	0.1	1.9	6.1	0.2	1.0	6.5	0.0	24.7	14.4	3.8	2.1	0.0	0.6	18.7	0.3	21.9	19.2	1.4	0.9	7.3	5.7	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.1	6.4	11.0	13.4	16.9	0.5	0.2	20.5	15.1	0.0	0.2	0.0	1.4	0.0	9.1	0.0	1.6	0.0	0.0	9.6	2.2	2.2	0.3	0.0	6.2	0.2	0.0	0.0	42.4	53.8	11.8	1.3	19.6	0.0	0.0	0.0	14.7	0.0	37.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	14.9	0.0	26.4	12.3	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.2	0.0	0.0	18.3	0.1	2.0	0.6	0.6	0.0	5.6	2.2	2.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.8	1.1	0.2	0.1	0.7	0.0	0.0	366.9	0.0	0.2	1.0	0.0	0.6	0.0	0.2	5.0	0.2	0.3	3.3	193.5	0.0	0.0	0.0	0.9	1.2	0.0	0.1	17.8	18.7	0.0	0.1	0.0	40.2	7.2	1.2	0.0	0.4	0.0	1.2	0.0	0.1	0.1	0.4	0.0	0.1	1.8	0.0	1.8	0.6	0.3	0.0	0.0	0.1	0.0	0.7
KIF13B	"GAKIN, KIAA0639"	ENSG00000197892	"Kinesin family member 13B"	Q9NQT8	8	29067278-29263124	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"brain: 64.5;parathyroid gland: 161.5"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 140.2;Oligodendrocytes: 371.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025023, HPA049655"	Enhanced					NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA025023: AB_1852471, HPA049655: AB_2732555"	"unprognostic (1.37e-1)"	"unprognostic (4.31e-1)"	"prognostic favorable (8.92e-4)"	"unprognostic (1.35e-3)"	"unprognostic (2.27e-1)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (9.76e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.27e-1)"	7.4	11.7	25.9	6.8	47.6	5.1	9.2	34.9	30.6	8.7	16.6	18.3	16.1	6.7	9.4	8.4	7.1	8.4	5.3	20.0	29.4	18.5	10.2	8.5	4.3	47.3	43.7	7.2	10.9	161.5	10.0	3.8	42.1	10.9	13.8	7.9	15.6	8.5	4.7	20.0	15.7	5.5	29.3	8.9	19.2	6.6	40.1	5.1	9.0	3.0	4.6	9.5	6.1	64.5	12.4	13.2	4.6	3.8	7.5	4.3	6.7	0.7	2.9	3.9	6.2	8.3	6.9	2.6	6.9	0.8	7.1	8.2	3.7	2.1	5.1	3.9	3.6	6.6	1.8	8.4	7.2	1.8	19.2	5.0	3.9	8.9	3.6	8.3	17.1	4.9	8.6	9.5	12.9	3.8	9.7	3.1	2.3	17.4	2.2	5.5	10.6	4.9	17.0	13.2	1.3	9.1	2.4	8.0	11.7	4.8	5.9	3.7	22.8	2.8	7.6	0.8	5.6	6.9	11.1	4.4	16.4	3.4	13.2	0.1	1.5	1.7	1.5	1.1	0.7	1.4	0.6	0.9	0.5	0.8	0.5	0.6	0.7	0.9	0.6	2.2	0.6	0.5	25.9	47.6	34.9	30.6	20.0	29.4	47.3	43.7	42.1	29.3	40.1	64.5	22.2	44.8	24.8	30.0	16.5	4.5	13.8	17.2	5.2	13.3	23.5	11.2	5.3	20.0	36.8	35.0	60.5	6.4	35.8	95.8	11.7	25.7	8.0	55.3	12.7	14.2	25.2	7.4	26.7	25.0	0.9	10.0	55.0	140.2	41.0	10.6	13.9	18.6	8.9	16.8	35.3	44.1	36.7	25.7	6.3	3.5	8.1	24.4	7.2	41.2	12.1	9.5	12.3	47.3	371.1	39.7	58.0	20.3	42.5	28.1	34.7	17.8	34.9	26.2	6.6	36.4	7.4	6.3	7.7	9.8	6.8	5.1	31.8	5.9	36.0	32.5
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016423-33066143	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Glycosidase, Hormone, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 47.1;kidney: 128.7;parathyroid gland: 135.2"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 123.3"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HMC-1: 2.4;SK-BR-3: 4.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.3;cerebral cortex: 6.7;hippocampal formation: 7.4;medulla oblongata: 4.2"						"Secreted to blood"	NA	NA	510000			"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	3.3	1.4	0.9	0.8	3.1	0.1	2.5	0.8	1.5	1.8	47.1	2.1	2.7	1.2	8.8	1.1	0.8	1.3	1.1	4.2	1.1	128.7	0.4	3.5	1.0	0.5	0.5	0.1	1.2	135.2	0.3	30.4	0.5	8.0	0.9	0.0	0.8	2.5	0.7	0.6	2.6	1.2	0.6	2.4	2.0	0.5	0.8	0.5	1.3	1.5	0.5	1.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.1	0.8	1.5	4.2	1.1	0.5	0.5	0.5	0.6	0.8	0.5	15.8	0.0	0.5	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.6	0.3	1.0	0.0	0.7	12.9	0.0	0.2	0.0	0.4	5.9	0.0	1.8	0.1	2.5	10.2	16.3	0.4	1.2	0.0	0.1	1.6	0.0	0.1	0.0	0.1	1.1	0.2	2.8	0.0	0.5	1.1	0.0	0.9	1.0	0.8	0.3	1.9	0.0	6.5	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	3.6	1.8	123.3	0.7	0.0	0.0	1.1	2.3	1.4	0.5	0.0	0.1	0.1	1.1	0.1	1.9	0.1
KLHDC10	"KIAA0265, slim"	ENSG00000128607	"Kelch domain containing 10"	Q6PID8	7	130070534-130135705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020119	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA020119: AB_2249467"	"unprognostic (2.83e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.24e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.64e-2)"	12.3	17.3	19.4	9.5	19.8	7.9	14.6	27.0	17.2	12.4	21.6	12.8	11.1	13.0	13.7	12.6	14.9	9.5	13.5	18.5	26.3	21.2	23.2	11.9	8.4	17.4	25.1	14.4	15.4	30.7	14.0	13.9	21.5	12.6	12.7	15.4	10.6	12.2	24.0	13.2	10.4	11.5	16.5	10.8	11.7	38.0	31.1	11.8	18.1	22.0	9.3	8.6	8.9	15.8	24.5	22.5	15.3	83.8	19.9	21.8	7.0	22.9	17.5	17.1	17.7	12.4	18.3	20.7	15.8	21.2	28.4	18.8	24.6	14.6	21.4	16.9	14.8	12.2	24.7	14.6	15.6	22.5	14.4	13.8	24.8	26.2	16.4	21.2	24.4	14.2	59.9	12.7	19.4	20.7	19.5	21.9	2.6	18.0	14.6	15.8	28.6	15.1	23.5	16.7	24.6	19.7	36.8	65.2	18.5	18.5	15.9	16.6	27.7	21.8	9.5	29.5	27.6	16.7	23.6	19.2	45.7	21.4	30.0	0.0	0.4	0.5	0.6	0.6	0.5	0.4	0.4	0.7	0.5	1.1	0.3	0.7	0.4	0.1	0.5	0.4	0.9	0.1	19.4	19.8	27.0	17.2	18.5	26.3	17.4	25.1	21.5	16.5	31.1	15.8	18.6	19.2	20.2	53.8	9.7	23.2	7.8	13.6	14.2	20.1	31.0	20.1	23.1	30.0	19.7	35.0	39.6	11.3	12.6	18.2	3.9	18.3	66.7	31.2	24.9	19.0	19.9	18.7	85.7	23.8	9.6	22.2	13.3	18.4	6.3	19.6	37.9	42.3	12.2	35.3	86.1	15.8	20.3	23.0	12.8	17.4	15.2	11.7	17.8	72.1	15.5	18.4	7.2	82.4	59.9	20.5	9.2	24.5	9.8	13.0	16.2	27.5	27.2	22.1	0.0	30.6	14.7	36.2	6.3	17.5	29.1	11.2	9.6	22.7	20.4	12.2
KLHDC7B	MGC16635	ENSG00000130487	"Kelch domain containing 7B"	Q96G42	22	50545899-50551023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.2;parathyroid gland: 13.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 5.2;Collecting duct cells: 5.5;granulocytes: 5.7;Kupffer cells: 5.2;monocytes: 21.1;NK-cells: 10.3;T-cells: 5.7"	"Group enriched"	"Detected in many"	4	"cervical cancer: 42.3;head and neck cancer: 11.4;urothelial cancer: 40.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 97.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000518, HPA076540"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"HPA000518: AB_1079213, HPA076540: "	"prognostic favorable (1.30e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.96e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	0.2	0.2	0.2	2.1	0.1	1.0	0.3	0.1	0.2	0.5	0.1	0.3	0.4	0.2	0.3	0.4	0.1	0.3	0.0	0.1	0.2	3.7	0.4	0.7	2.3	0.5	0.2	0.0	0.1	13.7	1.0	0.1	0.3	0.4	0.1	0.0	1.3	0.2	0.0	0.3	1.1	0.1	0.2	2.7	0.5	0.2	0.4	5.2	2.0	0.0	1.3	1.5	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.8	0.0	0.8	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.0	0.2	97.7	0.1	1.2	0.0	0.2	0.1	0.0	0.0	0.0	11.6	0.0	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.3	0.0	0.1	1.1	1.1	0.1	2.0	1.9	1.4	1.9	2.1	2.6	0.9	1.3	2.3	2.0	0.2	0.7	1.4	0.3	2.0	1.5	0.2	0.1	0.1	0.2	0.1	0.2	0.5	0.2	0.3	0.2	0.4	0.2	0.0	0.0	0.6	0.0	5.2	0.1	0.0	1.6	0.0	0.0	3.0	1.4	0.5	0.0	1.6	5.5	0.0	0.0	2.5	0.1	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.7	0.1	0.2	0.5	0.3	5.7	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	5.2	1.2	0.0	0.0	2.7	0.0	0.0	21.1	0.0	10.3	0.0	0.0	1.3	0.0	0.0	2.8	0.1	0.0	0.3	1.6	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.2
LGI2	"FLJ10675, KIAA1916"	ENSG00000153012	"Leucine rich repeat LGI family member 2"	Q8N0V4	4	24998847-25030946	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"parathyroid gland: 127.8"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 5.5;Inhibitory neurons: 33.3;Oligodendrocyte precursor cells: 10.1;Skeletal myocytes: 8.6;Smooth muscle cells: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 28.2;HAP1: 5.2;RPMI-8226: 13.3;SCLC-21H: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017140	Approved		Uncertain	Centrosome	"Secreted to blood"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Centrosome		"HPA017140: AB_1852833"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.20e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-5)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.03e-3)"	3.4	1.6	2.7	7.5	3.5	0.0	0.8	5.7	4.1	1.5	1.0	3.1	0.7	6.7	2.7	1.4	7.8	7.1	3.3	1.9	9.2	4.3	0.3	1.0	2.9	12.0	13.1	2.1	1.7	127.8	0.3	3.9	6.7	0.5	1.6	2.3	0.3	1.2	0.2	0.3	1.8	13.6	4.0	0.9	1.4	0.7	4.2	2.3	1.1	0.4	8.4	3.0	0.7	3.3	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.8	0.0	0.2	0.0	5.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.6	0.0	1.0	0.0	1.2	13.3	0.5	0.0	18.2	0.0	0.0	0.0	0.0	2.9	0.0	0.4	0.0	0.3	2.0	0.0	0.8	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.5	5.7	4.1	1.9	9.2	12.0	13.1	6.7	4.0	4.2	3.3	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.0	3.7	0.0	0.0	5.5	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	2.0	2.1	0.0	0.0	3.0	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.7	0.0	4.8	1.7	33.3	0.0	0.0	0.6	0.5	0.1	0.6	1.0	0.0	2.8	0.0	0.5	0.0	10.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	8.6	8.5	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.1
LMBR1	"ACHP, C7orf2, FLJ11665, ZRS"	ENSG00000105983	"Limb development membrane protein 1"	Q8WVP7	7	156668946-156893216	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 110.7;Inhibitory neurons: 128.7;Microglial cells: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016592	Approved		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA016592: AB_1852943"	"unprognostic (8.81e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.77e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (3.35e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.10e-2)"	10.0	26.0	8.8	8.4	10.4	7.8	10.7	11.3	13.2	13.6	7.8	8.9	8.0	13.2	18.1	9.9	14.1	10.2	11.2	9.7	13.2	15.7	13.8	9.1	9.4	11.0	10.0	16.5	8.8	38.0	7.5	10.1	11.2	12.2	10.3	14.3	8.4	10.7	6.7	8.4	9.3	13.2	8.9	7.6	11.9	17.7	10.6	11.8	17.6	11.4	8.7	11.9	6.0	8.5	26.9	20.6	27.5	33.4	21.1	24.0	16.6	14.5	20.5	14.2	16.8	15.4	42.4	25.3	27.6	19.7	27.3	20.4	28.4	28.9	29.1	19.5	25.5	19.1	11.6	19.7	13.6	23.8	13.6	19.3	27.0	20.4	27.3	22.8	29.6	23.4	35.7	23.8	26.9	24.3	25.1	20.5	29.4	30.4	18.7	13.1	18.1	31.6	22.8	25.1	26.1	51.9	20.4	27.8	15.6	17.8	19.1	14.3	38.4	25.1	9.3	82.7	19.6	25.6	22.6	24.0	40.0	30.2	16.4	1.8	0.7	1.0	0.7	0.4	1.4	0.6	1.2	1.2	1.3	0.8	1.5	1.0	0.6	0.2	0.7	0.9	0.9	0.6	8.8	10.4	11.3	13.2	9.7	13.2	11.0	10.0	11.2	8.9	10.6	8.5	25.6	3.2	8.1	54.5	23.7	10.5	13.7	9.9	43.3	11.5	12.8	8.5	17.1	11.5	7.2	12.9	2.1	14.3	8.4	8.6	5.9	11.0	7.4	17.0	8.6	24.8	8.3	17.4	110.7	10.1	5.6	15.2	23.0	15.7	5.7	43.2	9.3	19.2	10.2	8.4	128.7	9.9	10.2	10.1	8.0	9.7	10.5	9.3	7.2	99.3	8.2	6.7	3.1	72.4	70.4	12.6	6.1	8.6	23.4	20.0	9.7	12.2	9.7	10.9	0.0	11.9	11.0	18.0	28.7	30.9	12.8	23.1	18.0	26.2	11.1	16.6
LRP2	"DBS, gp330"	ENSG00000081479	"LDL receptor related protein 2"	P98164	2	169127109-169362534	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Hearing, Neurogenesis, Transport"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 70.5;kidney: 34.8;parathyroid gland: 44.7;retina: 29.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Cytotrophoblasts: 63.2;Oligodendrocytes: 300.1;Proximal tubular cells: 283.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 29.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"AF22: 39.4;CACO-2: 64.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA005980, HPA064792"	Enhanced		Approved	Vesicles,Mitochondria		No	NA		74000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Mitochondria"		"HPA005980: AB_1079278, HPA064792: AB_2685353"	"unprognostic (1.87e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.38e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.62e-2)"	1.5	0.0	5.5	0.0	23.4	0.1	9.6	18.9	13.5	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.2	7.5	14.6	34.8	0.3	1.2	0.0	30.5	17.5	0.0	0.0	44.7	0.1	7.5	31.9	0.0	0.0	29.3	0.9	0.0	0.1	0.1	0.0	0.0	14.5	0.0	0.0	0.2	18.7	0.0	17.3	0.0	0.0	0.0	0.0	70.5	0.0	0.0	39.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	23.4	18.9	13.5	7.5	14.6	30.5	17.5	31.9	14.5	18.7	70.5	0.2	6.4	43.7	1.0	3.0	0.3	0.2	0.0	0.0	2.8	22.9	15.1	2.1	2.8	2.5	3.7	87.6	63.2	0.2	0.0	17.6	0.0	3.1	0.1	0.1	0.5	0.0	0.0	1.8	0.0	2.2	1.8	0.0	0.1	2.5	0.0	0.0	0.8	5.1	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	2.5	0.0	1.9	0.0	33.1	0.0	1.5	300.1	0.0	0.0	0.0	0.0	0.0	0.0	283.9	2.2	19.5	0.0	0.0	0.3	0.1	0.8	0.0	0.0	23.1	1.7	0.0	0.0	0.2
LRRC52	FLJ25811	ENSG00000162763	"Leucine rich repeat containing 52"	Q8N7C0	1	165544000-165563957	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 16.7"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 185.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (9.09e-2)"			"unprognostic (1.76e-2)"	"unprognostic (6.48e-2)"			"unprognostic (3.79e-2)"	"unprognostic (8.45e-2)"	"unprognostic (6.70e-4)"						"unprognostic (6.05e-4)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.4	0.0	0.0	4.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LZTS1	FEZ1	ENSG00000061337	"Leucine zipper tumor suppressor 1"	Q9Y250	8	20246165-20303963	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.8;parathyroid gland: 54.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 17.6;Excitatory neurons: 26.2;Horizontal cells: 20.2;Melanocytes: 19.6;Rod photoreceptor cells: 18.5;Sertoli cells: 65.7;Smooth muscle cells: 15.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 59.2"	"Group enriched"	"Detected in many"	5	"amygdala: 13.1;basal ganglia: 11.6;cerebral cortex: 14.8;hippocampal formation: 14.5;white matter: 9.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 19.7;SK-MEL-30: 75.0;U-698: 23.2;WM-115: 50.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"amygdala: 23.2;basal ganglia: 66.8;cerebral cortex: 45.5;hippocampal formation: 36.3;olfactory bulb: 26.7"	"HPA006294, HPA022046"	Approved		Approved	"Nucleoli,Plasma membrane"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Nucleoli	"HPA006294: AB_1079288, HPA022046: AB_1853455"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.06e-3)"	"unprognostic (6.81e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (9.28e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.82e-3)"	3.7	1.7	13.1	1.5	11.6	0.1	3.0	0.0	14.8	2.0	0.0	1.3	0.5	2.9	0.9	5.3	1.6	3.5	5.0	14.5	0.6	4.7	0.7	7.0	1.1	0.0	0.1	1.2	1.5	54.2	2.2	6.5	0.3	2.8	0.4	3.5	1.4	1.1	1.9	4.6	0.9	2.5	0.0	0.5	1.4	7.5	2.3	1.9	2.7	2.0	0.5	2.3	1.7	9.2	0.1	0.0	9.7	8.3	0.0	0.0	1.2	5.0	0.1	4.3	3.7	0.3	0.1	11.1	3.5	3.1	1.6	0.2	0.5	0.2	2.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	1.7	0.9	0.1	1.8	0.0	0.6	0.0	11.7	0.0	0.1	14.4	0.0	19.7	0.1	12.2	0.0	0.0	0.0	15.6	0.0	2.7	0.4	14.8	12.9	0.0	0.0	75.0	8.2	0.1	0.4	0.0	5.1	3.5	0.1	1.5	0.1	0.1	23.2	0.1	1.1	50.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.1	11.6	0.0	14.8	14.5	0.6	0.0	0.1	0.3	0.0	2.3	9.2	3.9	0.0	0.0	1.6	0.0	1.3	0.8	1.0	17.6	1.8	0.3	11.3	4.6	0.0	0.1	0.0	4.2	7.1	0.4	0.0	1.9	0.0	0.5	0.6	1.3	3.2	0.0	0.0	26.2	0.0	2.3	2.4	0.0	0.5	0.0	3.5	0.0	0.0	0.9	20.2	2.9	0.0	2.0	0.0	0.0	0.8	1.2	0.2	19.6	1.9	0.0	0.9	0.0	6.0	0.8	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0	18.5	65.7	1.1	15.4	0.2	1.1	7.3	0.1	0.8	1.4	2.5	0.0	0.0
MAFB	KRML	ENSG00000204103	"MAF bZIP transcription factor B"	Q9Y5Q3	20	40685848-40689236	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 273.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 264.0;Hofbauer cells: 377.6;Kupffer cells: 672.8;Macrophages: 456.7;Squamous epithelial cells: 361.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 88.3;non-classical monocyte: 121.4"	"Lineage enriched"	"Detected in many"	15	"monocytes: 121.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 28.6;hTCEpi: 61.2;SCLC-21H: 16.7;SiHa: 15.6;U-138 MG: 16.4;U-2197: 24.4;U-87 MG: 16.0"	"Low region specificity"	"Detected in many"							HPA005653	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Nucleoli, Golgi apparatus, Cytosol"	"HPA005653: AB_1079293"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (9.16e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-2)"	35.3	13.8	4.8	37.3	4.9	59.2	27.3	4.4	10.5	16.5	6.9	9.5	7.8	9.3	5.4	33.0	11.3	24.4	10.7	3.7	5.7	17.5	29.3	20.9	27.8	14.3	6.3	6.8	15.8	273.1	3.1	13.2	7.2	8.3	7.2	0.6	18.3	4.7	15.8	85.3	13.2	14.2	9.0	96.3	11.0	3.9	13.1	6.7	50.1	16.7	12.7	13.9	21.9	15.8	0.0	0.0	0.0	2.6	1.5	0.2	0.4	0.3	0.1	0.3	0.1	0.4	0.2	0.0	1.9	0.4	0.0	3.8	0.0	0.0	0.0	0.0	1.4	0.0	1.2	0.2	0.9	0.0	0.1	28.6	61.2	0.2	2.1	0.0	0.4	0.0	0.0	0.0	0.1	0.9	0.3	7.4	2.6	6.2	0.0	0.0	0.0	0.0	0.5	0.4	16.7	1.4	15.6	1.5	3.9	5.4	1.5	0.3	0.5	16.4	0.3	24.4	0.0	0.0	0.0	0.0	16.0	0.6	0.0	0.4	24.3	0.0	0.0	88.3	0.0	0.0	0.0	0.1	7.9	0.1	0.0	0.0	2.1	0.0	121.4	0.1	0.0	10.6	4.8	4.9	4.4	10.5	3.7	5.7	14.3	6.3	7.2	9.0	13.1	15.8	70.0	22.4	37.9	1.6	7.8	68.6	50.5	17.1	264.0	12.0	112.2	217.8	208.9	7.2	16.8	51.5	25.0	9.8	7.6	117.1	1.9	2.3	0.8	15.7	64.4	39.1	57.7	4.0	0.8	3.4	2.8	172.7	49.5	27.6	10.8	0.9	34.6	36.1	377.6	3.3	25.4	50.7	6.1	672.8	91.7	2.8	29.5	456.7	21.4	6.5	65.3	21.9	3.1	2.0	1.3	4.9	30.9	24.5	5.6	29.7	89.5	1.3	2.4	8.3	13.1	160.6	102.4	0.8	1.7	361.5	88.2	12.4	9.5	114.6	39.0	19.2
MAP9	"ASAP, FLJ21159"	ENSG00000164114	"Microtubule associated protein 9"	Q49MG5	4	155342658-155376970	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.3;parathyroid gland: 33.9"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 114.4;Respiratory ciliated cells: 125.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (8.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.54e-2)"	4.2	5.8	20.5	3.9	21.4	1.8	4.4	26.4	46.3	5.8	26.2	3.1	0.9	7.3	7.6	2.9	9.6	7.9	7.0	23.5	35.1	9.7	0.7	5.0	3.2	31.6	23.9	6.0	5.5	33.9	7.8	5.1	31.3	12.4	1.8	16.3	2.4	8.9	0.2	0.5	1.6	5.7	20.9	2.4	6.1	12.8	28.7	3.4	15.5	0.8	2.4	3.2	1.6	22.1	0.0	10.3	11.0	9.6	11.7	14.0	2.2	11.3	10.2	6.6	5.7	0.1	0.0	7.5	14.7	8.3	24.6	0.0	11.7	12.0	10.8	0.0	9.4	4.7	0.1	0.0	8.6	0.0	0.0	12.0	6.5	9.3	5.7	20.2	0.0	2.9	0.1	0.0	7.5	4.6	8.8	0.1	8.7	3.7	13.3	0.0	0.0	0.2	22.2	8.9	15.1	43.4	0.0	19.4	0.6	7.3	15.7	0.1	1.6	8.8	15.6	0.2	8.4	9.1	0.0	8.2	25.8	0.0	14.3	0.0	0.0	0.0	2.7	0.3	2.1	2.9	1.5	2.5	0.1	4.8	1.3	1.8	0.1	0.8	0.0	2.6	1.0	0.5	20.5	21.4	26.4	46.3	23.5	35.1	31.6	23.9	31.3	20.9	28.7	22.1	3.8	16.0	37.4	34.6	17.0	1.3	13.4	18.7	12.5	67.0	15.2	20.8	33.1	17.2	25.7	25.8	79.2	9.0	10.2	0.4	33.2	35.4	39.3	114.4	44.8	3.5	21.1	5.0	59.0	16.0	3.4	24.5	13.7	24.7	2.5	16.5	1.8	0.6	1.0	72.3	58.3	0.7	26.4	0.9	0.8	14.1	45.7	2.0	5.4	14.0	1.3	53.5	9.2	23.6	27.4	15.9	0.2	49.2	3.8	11.7	0.0	49.1	125.0	92.5	13.1	28.0	31.1	69.4	53.1	2.8	1.1	2.3	14.2	40.1	0.6	4.1
MCIDAS	"IDAS, MCI, MCIN"	ENSG00000234602	"Multiciliate differentiation and DNA synthesis associated cell cycle protein"	D6RGH6	5	55219564-55227315	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation"	Activator	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"parathyroid gland: 2.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Collecting duct cells: 1.8;Endometrial ciliated cells: 1.2;Respiratory ciliated cells: 3.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 4.9;HeLa: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049981, HPA058073"	Uncertain		Supported	"Nuclear bodies"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear bodies"		"HPA049981: , HPA058073: AB_2683596"	"unprognostic (3.11e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.67e-1)"	"unprognostic (2.90e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.70e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	2.9	0.4	0.0	0.6	0.0	0.0	4.9	0.0	0.0	0.4	0.7	4.0	4.4	0.0	0.4	0.0	1.2	0.7	2.9	0.2	0.0	0.2	4.0	0.0	6.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	1.9	1.4	0.0	0.0	1.6	0.0	0.1	0.2	0.7	2.2	0.8	1.5	0.0	1.7	2.6	1.3	0.0	2.1	0.5	2.2	0.0	4.0	0.4	0.0	0.0	3.4	0.2	0.1	3.3	4.2	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.7	0.0	0.9	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1
MFSD14A	"DKFZP564L0864, HIAT1"	ENSG00000156875	"Major facilitator superfamily domain containing 14A"	Q96MC6	1	100038095-100083377	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 131.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 303.1;Late spermatids: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA073127, HPA073681"	Approved		Approved	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA073127: , HPA073681: AB_2686625"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.15e-2)"	29.1	28.5	18.1	26.2	21.1	90.3	27.4	21.2	24.7	25.9	20.8	26.8	19.6	35.3	26.0	29.0	26.6	25.2	19.6	18.2	21.1	29.7	29.5	28.8	28.4	23.3	20.2	30.5	31.5	131.4	18.7	34.1	22.1	33.4	21.8	19.6	23.0	31.4	15.0	24.9	19.6	35.5	21.9	28.4	22.4	35.3	20.0	31.1	27.9	20.1	29.2	33.5	24.0	25.7	54.3	22.2	48.9	25.4	56.0	52.8	41.3	38.9	65.9	51.5	59.9	18.9	37.0	40.5	61.7	50.6	34.1	51.0	44.0	42.8	49.2	35.6	34.8	40.1	32.8	28.6	49.4	65.0	50.2	43.3	64.1	45.5	57.9	45.3	40.2	45.1	49.8	77.2	48.1	16.0	49.3	38.1	56.4	26.2	32.4	34.1	59.6	39.8	54.8	46.9	50.7	45.2	43.8	63.0	66.6	30.9	24.6	65.3	44.5	42.3	29.6	44.9	40.9	72.8	82.4	56.0	46.1	46.6	18.6	80.1	56.0	54.6	49.5	51.4	55.9	46.2	49.6	54.4	55.2	38.8	54.8	51.5	94.8	59.9	45.2	25.6	60.3	72.0	18.1	21.1	21.2	24.7	18.2	21.1	23.3	20.2	22.1	21.9	20.0	25.7	4.5	6.4	11.5	0.0	33.5	0.0	47.5	0.0	43.3	17.8	3.4	1.5	0.0	27.1	3.7	3.7	10.4	37.5	7.8	6.5	1.9	10.1	303.1	1.0	1.7	20.8	13.3	35.8	0.0	7.2	33.5	19.5	18.3	1.5	2.5	0.6	19.6	17.1	23.1	13.5	0.0	9.4	0.0	26.4	0.0	373.8	22.7	15.8	0.0	0.0	22.2	25.1	33.0	0.0	0.0	6.5	17.1	30.5	41.9	56.3	8.1	1.1	5.8	11.6	13.1	25.6	12.8	28.2	22.5	43.4	0.0	58.3	33.7	0.4	9.6	52.3
MFSD14B	"FLJ14753, HIATL1"	ENSG00000148110	"Major facilitator superfamily domain containing 14B"	Q5SR56	9	94374569-94461042	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017978			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA017978: AB_2116836"	"unprognostic (3.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.96e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.12e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.01e-2)"	24.4	32.3	25.5	26.1	28.0	18.4	24.6	26.6	33.1	24.0	34.6	24.4	18.8	24.1	29.0	40.2	26.7	20.7	20.8	24.0	26.3	21.9	15.2	32.0	29.4	29.1	28.5	19.0	18.1	95.1	12.7	33.3	28.5	21.3	28.5	17.9	20.8	21.3	12.4	42.4	21.3	23.8	28.5	25.2	24.9	14.1	27.3	30.7	25.7	14.1	34.6	34.7	27.6	29.8	76.4	48.3	36.9	28.8	79.3	56.4	58.4	72.5	62.7	63.3	61.6	24.4	88.9	91.2	42.2	63.1	73.0	163.9	44.6	46.3	61.0	65.7	23.9	31.6	43.0	36.8	56.2	100.0	55.8	52.2	68.5	67.1	51.2	35.4	54.9	49.3	60.6	52.5	85.2	57.8	73.7	56.6	54.2	111.0	38.4	36.6	84.6	29.6	68.2	57.8	35.4	46.4	61.6	71.6	79.6	44.0	32.9	58.3	59.4	65.6	46.1	102.1	68.2	57.6	77.2	24.8	58.6	48.1	60.1	0.5	6.1	4.9	4.1	9.2	3.7	3.3	3.6	4.2	6.2	2.1	3.6	5.1	8.0	3.1	6.3	6.0	4.0	3.0	25.5	28.0	26.6	33.1	24.0	26.3	29.1	28.5	28.5	28.5	27.3	29.8	21.6	6.4	20.0	0.0	17.3	0.0	23.2	0.0	22.2	12.2	29.4	15.6	0.0	14.3	6.8	44.1	4.2	14.2	20.6	16.2	7.9	16.8	3.6	32.2	20.7	18.9	7.3	30.7	0.0	19.0	26.4	17.3	16.3	32.7	3.8	14.1	26.4	13.5	28.9	5.0	0.0	22.9	0.0	66.1	0.0	3.1	16.8	31.0	0.0	0.0	39.1	19.5	15.5	0.0	0.0	26.7	12.1	16.1	12.7	38.5	11.7	7.6	7.3	9.9	13.1	18.1	14.9	14.1	18.2	37.6	0.0	19.2	15.7	17.7	14.4	42.6
MIGA1	"FAM73A, FLJ35093"	ENSG00000180488	"Mitoguardin 1"	Q8NAN2	1	77779624-77879539	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.2;Alveolar cells type 1: 35.3;Breast glandular cells: 28.1;Glandular and luminal cells: 29.1;Proximal tubular cells: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017589	Approved		Supported	Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA017589: AB_1848409"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.31e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.75e-2)"	8.8	7.9	6.0	5.4	10.3	6.8	14.2	8.2	9.1	7.2	0.0	6.2	7.3	8.8	5.2	6.3	6.5	7.7	6.5	6.7	9.3	14.9	8.5	6.1	5.3	10.8	9.0	9.0	6.1	18.9	3.4	7.7	11.0	9.6	5.7	5.6	9.2	6.6	7.1	4.6	8.1	7.4	9.5	5.9	7.5	5.2	8.5	4.5	16.5	9.4	4.2	6.0	3.6	19.3	11.8	7.5	4.6	5.9	11.1	14.3	12.1	16.7	7.8	9.6	9.8	7.7	8.0	5.1	18.0	11.5	11.6	7.9	6.3	9.9	18.0	7.4	6.4	6.0	8.9	3.9	11.4	5.6	4.5	10.4	10.5	19.7	14.2	13.8	9.8	4.5	3.4	6.7	14.8	1.9	5.5	3.2	3.9	5.8	9.2	2.9	11.3	2.6	11.6	12.5	9.2	7.4	7.7	11.4	21.8	7.6	4.4	3.6	15.8	13.7	6.3	20.9	17.6	4.0	6.0	3.2	12.1	4.8	6.0	3.7	2.2	2.7	2.1	2.7	2.2	1.7	1.6	1.7	1.5	2.1	2.4	2.1	1.2	2.4	1.7	1.1	1.7	1.2	6.0	10.3	8.2	9.1	6.7	9.3	10.8	9.0	11.0	9.5	8.5	19.3	33.2	35.3	26.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	28.1	20.6	0.0	0.0	10.5	23.9	0.0	17.0	16.5	0.0	5.9	16.4	0.0	15.6	27.0	9.9	0.0	0.0	0.0	14.7	14.0	12.9	0.0	29.1	12.6	18.8	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	2.6	0.0	0.0	0.0	0.0	18.9	0.0	0.0	5.5	0.0	0.0	31.2	8.7	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	13.3	7.5	16.2	0.0	0.0
MLH3		ENSG00000119684	"MutL homolog 3"	Q9UHC1	14	75013769-75051532	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Disease variant, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 106.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060570			Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA060570: AB_2684323"	"unprognostic (2.94e-1)"	"unprognostic (6.70e-3)"	"unprognostic (7.14e-3)"	"unprognostic (7.35e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.11e-2)"	4.3	9.4	7.2	5.6	11.7	2.3	7.9	12.7	8.6	7.2	5.8	5.8	5.3	7.4	7.5	5.3	6.5	6.1	6.0	6.3	9.3	7.5	7.3	5.2	6.6	8.1	8.8	8.1	5.3	12.6	5.1	5.8	9.3	7.6	6.6	8.5	5.4	8.6	6.6	4.7	4.8	5.5	7.9	6.4	4.5	6.7	9.0	6.4	11.1	7.8	7.7	5.3	3.2	19.8	13.1	13.5	10.3	1.7	10.6	17.0	10.4	4.5	4.2	7.0	6.3	11.7	16.5	14.2	3.7	5.5	9.2	9.2	0.2	4.3	10.4	14.1	0.2	9.3	8.7	7.1	8.6	4.0	6.3	6.3	10.4	7.2	0.5	8.7	12.0	0.1	8.8	11.4	15.8	11.3	6.3	4.5	8.7	10.6	7.6	11.3	6.3	3.1	17.4	13.4	14.9	10.5	14.4	9.9	0.9	10.3	13.1	9.0	6.1	2.9	5.9	4.3	4.5	14.4	15.0	15.4	10.7	0.4	13.2	5.1	2.6	1.7	4.6	2.1	3.5	3.0	2.5	4.2	2.9	5.9	4.1	3.3	1.1	6.3	1.5	2.4	3.1	5.9	7.2	11.7	12.7	8.6	6.3	9.3	8.1	8.8	9.3	7.9	9.0	19.8	19.4	25.6	17.3	47.3	16.6	7.9	23.3	14.3	8.6	49.8	11.6	11.0	19.5	27.1	15.6	36.8	43.8	16.2	15.0	8.5	7.9	16.4	6.0	13.6	35.3	18.5	13.1	6.7	43.4	11.1	6.8	25.8	6.6	10.8	23.5	40.8	13.6	15.6	10.3	35.3	52.9	12.4	12.2	9.1	6.1	7.9	39.7	47.7	16.0	31.9	14.6	28.5	29.9	51.8	106.7	12.3	12.0	51.1	8.7	16.9	29.2	17.1	17.6	59.3	46.0	29.7	23.3	54.4	10.8	7.9	8.7	10.1	13.6	31.0	18.9	12.2
MSX2	"CRS2, FPP, HOX8, MSH, PFM, PFM1"	ENSG00000120149	"Msh homeobox 2"	P35548	5	174724582-174730896	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 25.8;placenta: 33.6;urinary bladder: 17.5"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 162.6;Endometrial ciliated cells: 65.7;Glandular and luminal cells: 62.2;Syncytiotrophoblasts: 233.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 18.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"BEWO: 322.0"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.2"	"Low region specificity"	"Detected in many"			HPA005652	Uncertain		Supported	"Nuclear speckles"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear speckles"		"HPA005652: AB_1079418"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.08e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-4)"	"unprognostic (7.64e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.12e-6)"	"unprognostic (1.43e-2)"	2.1	0.3	0.7	0.5	1.0	0.0	8.1	4.3	1.1	2.7	1.1	0.9	0.3	6.8	0.0	0.6	0.9	0.9	1.6	1.2	1.4	0.3	0.0	0.8	0.1	7.8	1.3	0.2	0.4	25.8	0.3	33.6	4.1	2.5	0.1	0.0	0.8	0.8	1.9	6.9	0.8	1.4	5.4	0.8	2.8	5.6	1.3	0.1	0.7	1.8	0.1	17.5	1.8	5.4	0.4	4.0	1.1	3.2	0.0	0.0	322.0	2.2	3.6	0.7	0.1	56.6	23.0	0.0	8.6	0.2	19.6	6.2	17.6	6.4	0.2	0.0	10.7	0.0	1.4	0.0	2.4	0.0	3.0	3.7	4.5	3.1	3.5	0.0	0.0	0.0	0.0	0.0	5.0	27.7	0.0	0.4	2.5	38.3	8.5	0.0	8.8	0.1	4.0	35.3	0.0	2.5	0.0	43.0	2.9	69.6	25.7	0.2	0.0	1.1	5.5	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	4.3	1.1	1.2	1.4	7.8	1.3	4.1	5.4	1.3	5.4	1.5	0.0	0.0	2.3	0.0	9.6	2.4	0.1	3.4	0.2	15.8	18.9	1.7	0.0	0.1	0.0	0.0	162.6	0.2	0.3	0.0	0.6	0.2	65.7	4.9	0.7	0.0	0.0	0.0	0.0	13.9	5.3	5.1	62.2	4.5	0.1	0.4	0.0	11.3	0.0	0.0	1.9	0.0	0.6	2.9	0.6	0.0	1.0	1.8	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.3	1.9	0.1	0.1	0.0	0.0	8.9	4.8	1.4	4.5	2.0	11.4	233.8	1.0	0.6	1.2	9.8
MYO5A	"GS1, MYH12, MYO5, MYR12"	ENSG00000197535	"Myosin VA"	Q9Y4I1	15	52307283-52529050	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.1;parathyroid gland: 47.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 353.0;Inhibitory neurons: 241.0;Oligodendrocyte precursor cells: 330.8;Oligodendrocytes: 404.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 201.0;RPMI-8226: 140.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001356	Enhanced		Approved	"Focal adhesion sites,Centriolar satellite"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Focal adhesion sites, Centriolar satellite"		"HPA001356: AB_1079441"	"unprognostic (1.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.74e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (4.22e-4)"	10.3	8.3	17.0	12.1	20.8	21.8	6.5	3.0	39.1	6.8	0.0	6.1	3.8	5.0	3.7	5.3	4.0	8.5	5.8	19.0	3.6	5.3	2.9	8.8	15.0	9.6	4.2	5.7	5.2	47.4	8.9	6.3	9.8	5.1	5.9	26.1	5.2	3.5	5.4	11.8	5.0	9.4	0.0	9.5	4.7	5.9	6.6	11.0	8.4	5.0	13.1	9.7	5.3	20.8	19.5	33.7	17.6	21.3	16.2	19.3	19.0	34.7	31.1	18.1	14.0	3.2	7.8	18.7	8.9	41.8	26.5	15.7	40.7	35.6	22.3	105.5	9.6	16.7	8.8	4.2	8.3	9.0	16.3	13.0	21.9	26.6	52.4	17.6	106.8	12.0	0.7	201.0	34.8	34.4	8.2	1.2	8.1	0.5	26.6	14.5	27.8	140.8	15.1	14.0	12.7	7.8	32.3	26.2	59.4	13.1	14.0	9.1	52.0	36.4	15.7	17.1	34.1	20.9	49.9	22.0	39.4	25.1	53.5	0.4	2.4	3.1	1.4	1.7	2.1	1.1	1.3	0.9	2.7	0.7	0.2	0.4	3.0	0.3	1.4	1.5	2.2	1.1	17.0	20.8	3.0	39.1	19.0	3.6	9.6	4.2	9.8	0.0	6.6	20.8	11.2	12.8	11.4	68.2	19.8	20.8	9.3	10.5	7.4	75.1	6.7	5.5	12.1	2.8	19.8	14.7	39.6	0.6	18.4	0.3	0.0	5.4	18.0	9.3	8.0	12.7	1.2	2.5	353.0	6.3	0.4	7.5	3.1	6.7	22.8	5.0	2.5	1.3	24.4	26.9	241.0	0.2	2.0	27.1	28.0	10.8	3.7	50.2	97.8	52.5	36.7	6.0	15.5	330.8	404.2	6.1	2.5	1.9	32.4	10.2	0.0	2.8	11.1	28.7	6.6	16.7	10.8	14.0	9.4	3.9	11.6	1.1	23.7	2.1	0.3	7.3
NAA40	"FLJ13848, NAT11"	ENSG00000110583	"N-alpha-acetyltransferase 40, NatD catalytic subunit"	Q86UY6	11	63938959-63957319	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 102.6;Late spermatids: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037816, HPA056142"	Uncertain		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA037816: AB_10672289, HPA056142: "	"unprognostic (3.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (1.43e-7)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.29e-3)"	"unprognostic (3.42e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.25e-2)"	3.3	8.9	5.1	3.9	5.1	2.5	4.4	4.5	5.7	4.0	5.7	5.2	5.7	3.0	3.3	6.7	6.8	3.6	9.5	5.3	4.9	9.1	3.8	3.6	7.5	5.6	5.3	2.7	6.5	15.1	10.4	6.7	5.2	4.2	4.7	7.2	6.6	4.0	4.7	2.7	5.7	3.1	5.0	8.8	4.8	15.3	5.2	10.0	6.1	8.5	7.3	4.2	3.6	5.0	15.5	17.3	21.7	11.8	6.0	5.9	13.8	11.3	12.0	27.3	19.1	14.8	19.3	9.5	13.6	10.2	18.9	13.7	18.3	8.2	20.1	12.5	11.2	13.0	11.1	16.9	7.9	20.9	10.8	6.0	7.4	17.0	4.6	10.6	18.0	16.1	22.4	6.9	12.9	11.8	22.3	16.3	20.2	14.3	11.8	21.9	19.5	12.1	18.5	11.8	28.7	15.1	17.7	15.2	9.2	15.8	25.1	9.2	11.6	15.1	18.3	8.9	9.3	8.3	5.6	16.5	9.2	8.9	11.9	2.3	0.5	2.7	6.9	0.4	2.4	2.7	1.8	3.3	2.7	2.4	1.1	2.6	0.1	5.2	0.2	3.5	0.5	2.3	5.1	5.1	4.5	5.7	5.3	4.9	5.6	5.3	5.2	5.0	5.2	5.0	4.3	3.2	4.8	12.1	8.1	2.8	2.0	4.5	10.8	30.9	11.5	7.0	14.8	5.7	9.4	18.4	33.3	9.6	12.1	13.6	0.0	5.7	46.3	20.0	7.4	7.6	17.5	7.4	14.3	5.4	12.8	4.8	6.1	8.5	1.3	14.3	9.7	5.2	9.5	102.6	15.6	6.1	10.2	10.3	5.3	130.5	4.7	7.3	1.8	15.0	4.4	8.6	17.5	11.6	10.1	5.9	3.5	7.2	12.2	2.1	10.6	4.1	22.5	23.9	0.0	4.3	4.4	27.4	16.5	6.5	2.8	4.1	8.9	10.4	7.3	1.8
NCKIPSD	"AF3P21, DIP1, ORF1, SPIN90, WASLBP, WISH"	ENSG00000213672	"NCK interacting protein with SH3 domain"	Q9NZQ3	3	48673844-48686364	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 121.9"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019267, HPA050005"			Enhanced	"Plasma membrane"		NA	NA		110000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"		"CAB019267: , HPA050005: AB_2680988"	"unprognostic (1.55e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.50e-3)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.20e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"	18.6	17.7	25.5	6.3	28.5	5.9	17.0	16.4	47.6	14.9	2.4	13.7	10.0	12.9	11.4	11.1	16.3	12.4	37.5	26.3	23.0	19.3	14.3	16.5	8.5	23.1	16.4	31.1	11.8	121.9	20.1	11.1	22.5	17.5	9.8	11.3	14.1	15.8	12.6	19.8	12.5	11.7	13.1	11.5	11.6	16.4	23.7	6.3	13.6	10.0	7.0	12.6	14.6	29.3	20.9	18.0	18.0	18.6	24.0	14.5	25.0	20.5	22.8	22.2	28.2	26.6	12.4	15.3	10.9	12.2	25.4	13.8	23.2	27.1	12.7	17.3	28.3	27.4	73.2	21.5	20.9	18.8	29.6	14.0	23.3	30.9	19.3	25.2	12.8	19.1	9.5	19.8	18.1	15.3	17.1	15.8	21.0	20.6	31.5	8.6	8.3	25.8	12.3	21.2	18.7	15.1	21.4	19.9	17.4	16.3	17.7	22.7	7.2	19.0	21.3	22.8	27.5	17.7	14.1	17.0	21.7	24.6	29.8	0.6	2.9	0.1	2.1	3.4	1.5	2.9	2.4	2.4	3.6	1.4	3.5	2.4	0.2	3.4	1.8	5.2	2.9	2.9	25.5	28.5	16.4	47.6	26.3	23.0	23.1	16.4	22.5	13.1	23.7	29.3	15.9	0.0	6.9	7.2	2.9	2.5	3.7	8.1	1.8	9.2	3.8	5.5	17.0	5.7	4.0	1.8	12.5	9.6	4.5	10.8	5.9	7.0	2.4	4.7	5.5	8.1	8.4	4.8	11.8	4.6	10.5	5.4	6.6	5.8	5.7	7.6	23.6	6.4	8.6	11.8	10.9	6.0	6.1	6.5	6.1	2.5	18.3	6.4	1.8	1.9	4.5	3.5	0.0	2.5	8.3	7.5	6.2	47.4	3.9	2.3	13.8	7.6	3.9	6.3	13.1	4.0	6.4	5.6	18.4	2.8	1.7	8.2	3.3	8.6	8.7	2.3
NLRP5	"CLR19.8, MATER, NALP5, PAN11, PYPAF8"	ENSG00000171487	"NLR family pyrin domain containing 5"	P59047	19	55999726-56061810	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	50	"parathyroid gland: 22.4"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"Karpas-707: 1.3;U-2 OS: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047260, HPA056271"	Uncertain		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Vesicles	"HPA047260: , HPA056271: AB_2683083"	"unprognostic (9.67e-2)"			"unprognostic (2.22e-2)"								"unprognostic (5.03e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.72e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	22.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPC1	SLC65A1	ENSG00000141458	"NPC intracellular cholesterol transporter 1"	O15118	18	23506184-23586506	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 110.6"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 70.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 273.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026618, CAB070132, HPA077445"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"		"CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: "	"unprognostic (1.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-3)"	17.5	76.7	35.1	16.9	69.6	42.6	20.0	55.3	47.8	16.7	28.6	13.7	14.5	16.7	15.0	20.5	13.4	15.3	11.5	41.1	44.3	16.8	15.2	29.0	20.4	73.3	55.8	16.0	11.9	72.6	15.0	27.8	66.6	13.1	12.0	28.0	36.8	13.2	22.9	24.3	17.8	15.1	49.8	17.1	20.4	13.7	55.8	12.2	11.8	14.1	15.6	15.8	18.0	110.6	21.5	41.4	17.8	29.3	55.8	44.6	40.7	37.3	81.1	38.8	84.3	28.1	30.7	18.4	28.0	55.0	132.8	59.3	22.6	63.2	35.2	15.0	17.9	6.8	35.7	63.2	79.2	25.0	28.5	42.2	61.3	81.7	273.2	76.8	40.3	20.7	20.1	47.5	44.2	32.4	10.6	14.9	12.5	24.4	37.3	15.3	28.1	45.0	88.8	51.9	7.5	14.5	44.6	62.0	54.3	27.7	15.9	19.5	50.0	81.1	15.3	32.4	32.3	29.7	97.1	12.2	177.7	21.8	37.1	4.4	9.0	8.8	29.7	8.7	20.5	5.0	12.4	20.7	4.0	6.7	5.5	15.0	7.9	10.5	13.8	70.9	17.4	10.6	35.1	69.6	55.3	47.8	41.1	44.3	73.3	55.8	66.6	49.8	55.8	110.6	18.4	25.6	56.1	32.7	9.6	9.3	34.1	16.5	8.0	6.7	10.5	9.4	4.4	11.5	21.8	9.2	18.8	15.1	61.0	24.8	0.0	11.2	1.2	23.3	12.2	16.4	3.6	2.5	23.8	15.1	7.8	13.0	15.3	53.9	10.8	31.6	6.8	9.8	28.9	3.3	20.2	7.3	2.0	11.9	6.5	1.5	9.0	21.0	12.4	59.0	7.2	15.1	25.7	39.2	182.0	34.4	22.6	10.5	15.6	41.5	8.3	5.4	10.0	12.7	0.0	10.3	14.4	13.9	25.1	17.6	14.5	23.8	19.1	52.4	7.6	64.0
NPM2		ENSG00000158806	"Nucleophosmin/nucleoplasmin 2"	Q86SE8	8	22024125-22036897	"Predicted intracellular proteins"	Fertilization	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.0;parathyroid gland: 39.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 29.4;Cone photoreceptor cells: 20.9;Excitatory neurons: 21.3;Inhibitory neurons: 21.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 17.7;HEL: 14.5;Hep G2: 32.4;JURKAT: 9.5;THP-1: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041070	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nucleoli"		"HPA041070: AB_2677285"	"unprognostic (1.40e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.18e-6)"	"unprognostic (8.05e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.30e-1)"	0.6	18.4	11.0	0.1	16.9	1.2	2.1	7.4	40.0	4.9	2.2	1.1	2.2	5.0	0.9	1.0	3.2	1.9	2.3	12.4	9.2	6.6	1.6	1.8	0.6	7.5	7.6	1.5	11.0	39.2	18.5	0.5	10.0	6.6	1.0	5.7	2.7	1.4	0.3	2.2	1.2	3.6	2.3	12.5	1.9	5.1	7.1	2.9	25.3	0.3	0.4	2.0	2.3	13.5	3.9	0.5	0.2	0.2	0.9	0.0	1.5	0.5	0.5	2.4	4.9	1.6	3.6	0.0	1.1	0.0	0.2	17.7	0.5	0.0	1.4	0.1	0.5	14.5	1.0	32.4	3.1	1.9	1.3	0.5	2.3	0.0	0.3	3.7	0.0	9.5	0.5	0.0	0.1	0.0	0.2	3.9	0.7	6.4	0.4	0.3	1.4	0.8	5.6	0.1	3.8	0.2	0.0	0.1	4.6	0.0	0.7	11.2	0.0	0.0	0.3	0.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.7	0.0	0.2	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	11.0	16.9	7.4	40.0	12.4	9.2	7.5	7.6	10.0	2.3	7.1	13.5	0.1	0.0	1.1	1.0	0.7	0.1	9.7	3.7	0.6	29.4	3.1	5.2	2.1	5.7	8.8	0.0	20.9	0.1	0.5	0.6	3.9	9.4	15.1	1.1	0.3	0.6	11.4	0.4	21.3	8.0	0.2	1.7	1.5	1.1	0.0	1.4	2.5	0.5	4.6	6.7	21.9	2.1	2.0	0.0	0.3	14.4	0.6	0.9	10.6	1.9	1.0	0.9	0.0	2.5	1.6	4.3	0.8	0.4	0.6	3.4	0.5	14.6	7.7	4.2	0.0	0.4	1.6	0.5	0.9	1.1	1.1	0.3	2.7	7.6	1.2	5.8
OR7A5	HTPCR2	ENSG00000188269	"Olfactory receptor family 7 subfamily A member 5"	Q15622	19	14826241-14835185	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;epididymis: 4.5;parathyroid gland: 7.0"	"Cell type enhanced"	"Detected in single"		"Spermatocytes: 1.3"	"Cancer enriched"	"Detected in single"	8	"melanoma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA053823	Uncertain					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA053823: AB_2682274"	"unprognostic (3.26e-4)"	"unprognostic (1.44e-1)"		"unprognostic (7.46e-2)"	"unprognostic (6.19e-3)"	"unprognostic (4.89e-2)"		"unprognostic (1.49e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.01e-7)"	"unprognostic (6.45e-2)"	"unprognostic (9.64e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.47e-3)"	0.0	0.1	0.8	0.0	2.7	0.0	0.7	2.7	2.0	0.1	0.4	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.9	1.5	0.0	0.0	0.0	0.0	3.0	1.8	0.0	0.0	7.0	1.3	0.0	3.3	0.5	0.0	0.0	0.2	0.6	0.0	0.7	0.0	0.0	0.9	0.0	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.7	2.7	2.0	0.9	1.5	3.0	1.8	3.3	0.9	2.5	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2
OR7C1	"OR19-5, OR7C4"	ENSG00000127530	"Olfactory receptor family 7 subfamily C member 1"	O76099	19	14789260-14835376	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 6.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.2;Club cells: 2.5;Glandular and luminal cells: 1.4;granulocytes: 1.3;Melanocytes: 1.8;Respiratory ciliated cells: 1.5"	"Cancer enriched"	"Detected in single"	9	"melanoma: 1.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"											HPA047127	Uncertain					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 11: Alveolar cells - Smell perception"			"HPA047127: AB_2679944"	"unprognostic (7.68e-4)"	"unprognostic (1.31e-1)"			"unprognostic (2.13e-1)"	"unprognostic (1.71e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.39e-1)"			"unprognostic (4.30e-2)"	"unprognostic (6.11e-4)"		"unprognostic (1.90e-1)"	"unprognostic (6.80e-2)"	"unprognostic (6.91e-2)"	0.1	0.7	0.3	0.2	0.3	0.6	0.4	0.7	0.6	0.1	0.2	0.0	0.2	0.1	1.8	0.1	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.3	0.2	0.1	0.1	6.0	1.7	0.1	0.5	0.8	0.0	0.5	0.2	0.8	1.3	0.8	0.1	0.0	0.0	0.2	0.1	1.9	0.3	0.1	0.2	0.0	0.1	0.0	0.2	0.9	0.1	0.2	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.3	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1.3	0.3	0.6	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	1.6	0.1	0.5	0.1	0.0	0.1	0.3	0.3	0.7	0.6	0.3	0.2	0.3	0.2	0.5	0.0	0.3	0.9	0.1	0.0	3.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.4	0.5	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	1.4	1.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.1
PAX1		ENSG00000125813	"Paired box 1"	P15863	20	21705659-21718486	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"parathyroid gland: 162.1"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 7.7"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"SCLC-21H: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (9.74e-2)"				"unprognostic (3.45e-2)"	"unprognostic (3.01e-1)"		"unprognostic (2.64e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.12e-1)"		"unprognostic (1.21e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.08e-2)"		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	162.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.1	0.9	0.0	19.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.5	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0
PBX3		ENSG00000167081	"PBX homeobox 3"	P40426	9	125747345-125967377	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 153.1"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 192.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 13.9"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 13.9"	"Cell line enhanced"	"Detected in many"		"THP-1: 90.1"	"Region enhanced"	"Detected in all"		"olfactory bulb: 167.4"	"Group enriched"	"Detected in all"	5	"basal ganglia: 46.3;olfactory bulb: 161.9"	HPA003881	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA003881: AB_1855020"	"unprognostic (1.97e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.03e-2)"	"unprognostic (6.29e-2)"	10.9	56.0	10.4	12.9	14.6	6.9	10.0	17.4	13.2	27.2	7.0	47.9	6.8	9.8	20.0	11.8	14.2	22.5	38.0	7.2	15.0	7.1	18.1	13.0	8.0	19.7	21.0	58.2	18.8	153.1	12.6	6.7	19.4	30.9	13.7	28.0	11.8	28.0	8.5	19.4	14.3	22.6	18.8	12.8	21.5	8.2	15.3	16.7	35.1	5.7	6.9	20.7	21.9	21.7	11.6	11.0	50.0	43.1	13.1	19.1	8.5	29.9	16.8	19.2	14.5	14.3	21.1	11.3	3.6	22.1	20.8	8.5	28.3	12.3	38.3	12.4	20.5	9.7	7.9	5.8	17.2	9.6	15.5	9.5	13.7	14.5	10.0	45.3	23.1	7.2	0.4	10.3	43.5	5.9	10.0	4.9	35.8	14.2	7.4	18.9	73.3	1.5	15.6	6.4	25.9	45.1	20.2	3.8	9.4	18.8	15.7	90.1	26.6	40.0	10.2	23.8	57.1	7.2	12.8	11.5	19.7	15.2	20.6	2.3	1.7	2.2	0.8	1.4	0.9	1.0	0.9	0.7	1.9	1.5	1.7	0.7	1.4	3.2	1.3	13.9	0.8	1.0	10.4	14.6	17.4	13.2	7.2	15.0	19.7	21.0	19.4	18.8	15.3	21.7	7.3	9.6	16.7	17.9	10.0	22.7	10.3	3.0	6.8	7.5	11.5	8.3	60.3	2.8	8.6	12.9	37.5	0.6	20.7	1.3	7.9	13.5	15.2	1.1	14.0	11.9	11.5	6.3	44.3	2.5	0.9	23.4	5.6	1.5	16.5	9.4	9.7	12.6	15.3	42.1	19.3	5.7	6.1	29.0	23.7	11.4	19.9	22.9	7.2	91.8	13.6	11.5	6.2	136.2	192.2	3.1	12.1	11.3	3.8	13.0	0.9	2.8	8.5	43.1	0.0	5.3	13.0	33.7	16.0	10.4	26.3	0.4	10.5	8.7	3.4	8.7
PCDHA13	"CNR5, CNRN5, CNRS5, CRNR5, PCDH-ALPHA13"	ENSG00000239389	"Protocadherin alpha 13"	Q9Y5I0	5	140882124-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 4.1;parathyroid gland: 3.5;retina: 1.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Bipolar cells: 2.8;Horizontal cells: 1.7;Rod photoreceptor cells: 1.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 3.7;WM-115: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (1.07e-1)"			"unprognostic (5.25e-2)"	"unprognostic (5.58e-2)"		"unprognostic (1.70e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.64e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.36e-1)"		0.2	0.1	0.7	0.1	0.8	0.0	0.1	4.1	1.2	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.5	0.4	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.6	3.5	0.4	0.0	0.4	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	4.1	1.2	0.5	0.4	0.2	0.1	0.4	0.3	0.1	0.8	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.2	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHAC1		ENSG00000248383	"Protocadherin alpha subfamily C, 1"	Q9H158	5	140926299-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 29.8"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.7;EFO-21: 2.5;hTCEpi: 5.9;PC-3: 4.2;SCLC-21H: 2.9"	"Low region specificity"	"Detected in all"							HPA052775			Approved	Nucleoplasm,Nucleoli,Vesicles		No	No				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli"	Vesicles	"HPA052775: AB_2681942"	"unprognostic (2.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.29e-2)"	0.4	0.4	0.6	0.5	0.7	0.0	0.1	4.5	1.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	1.0	0.0	0.5	0.5	0.2	0.1	0.7	1.2	2.0	3.1	0.0	1.2	29.8	0.7	0.0	2.3	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.7	0.7	0.0	0.9	0.0	0.6	0.0	0.0	0.6	0.0	5.7	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.7	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	4.2	0.0	0.0	0.0	0.1	0.3	2.9	1.7	0.0	0.4	0.0	0.5	0.3	0.0	0.0	0.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	4.5	1.0	0.5	0.5	2.0	3.1	2.3	0.0	0.7	0.6	0.1	6.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.2	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHAC2	PCDH-ALPHA-C2	ENSG00000243232	"Protocadherin alpha subfamily C, 2"	Q9Y5I4	5	140966470-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.9;parathyroid gland: 42.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 1.3;Hepatic stellate cells: 2.2;Respiratory ciliated cells: 1.6;Rod photoreceptor cells: 1.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076190			Approved	Nucleoplasm,Mitochondria		NA	NA		1100000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Mitochondria	"HPA076190: AB_2686785"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.31e-4)"	"unprognostic (3.89e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.46e-4)"	"unprognostic (9.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-3)"	0.6	1.1	4.0	0.5	4.6	0.0	0.1	3.5	6.6	0.9	0.0	0.3	0.1	0.6	0.1	0.0	0.2	2.6	0.7	4.9	1.7	0.4	0.7	2.2	2.1	0.8	16.9	0.1	0.4	42.9	1.6	1.8	6.0	0.3	0.3	9.7	0.6	0.1	0.0	0.1	0.2	1.0	0.0	1.7	0.5	1.6	2.8	0.0	1.2	0.0	0.6	0.2	0.0	2.3	0.0	13.1	1.2	58.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	3.7	0.0	2.5	0.1	1.3	6.9	0.0	0.0	0.2	0.0	13.7	0.0	0.8	0.0	0.0	0.2	8.8	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.5	0.0	2.3	0.0	0.0	0.0	1.7	0.1	2.7	10.6	0.0	0.0	0.1	1.2	2.6	0.4	0.0	1.1	1.2	0.0	0.6	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.6	3.5	6.6	4.9	1.7	0.8	16.9	6.0	0.0	2.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	1.4	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PCDHGB5	PCDH-GAMMA-B5	ENSG00000276547	"Protocadherin gamma subfamily B, 5"	Q9Y5G0	5	141397987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 20.3"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;Bipolar cells: 1.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 66.3;ASC TERT1: 49.6;BJ hTERT+ SV40 Large T+: 29.2;BJ hTERT+ SV40 Large T+ RasG12V: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (2.71e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.69e-4)"	"unprognostic (9.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.25e-4)"	2.8	2.7	3.6	1.1	3.6	0.0	1.8	5.8	3.1	2.0	3.3	1.7	0.7	3.1	2.0	1.9	2.8	1.6	2.9	3.9	6.4	2.2	2.1	2.7	0.4	5.1	4.7	5.7	3.8	20.3	1.7	4.8	5.4	3.0	0.9	3.1	4.7	3.9	2.1	3.8	0.8	2.8	5.3	1.3	1.5	1.9	4.9	1.3	4.5	1.9	0.8	1.9	2.1	6.1	0.0	2.4	0.3	0.0	66.3	49.6	1.3	18.3	0.0	29.2	32.5	2.9	10.0	10.6	23.4	20.5	0.0	13.9	0.0	7.6	16.4	0.0	3.1	0.0	0.0	0.1	6.9	0.0	6.5	17.6	1.5	1.7	9.4	12.6	9.0	0.0	0.2	0.0	1.0	8.1	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	1.6	5.5	0.0	0.1	0.0	0.1	0.0	2.0	19.1	0.1	9.2	0.0	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.6	5.8	3.1	3.9	6.4	5.1	4.7	5.4	5.3	4.9	6.1	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.2	1.5	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.6	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.8	0.5	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.1
PCYOX1L	MGC3265	ENSG00000145882	"Prenylcysteine oxidase 1 like"	Q8NBM8	5	149358037-149369653	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 17.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 50.2;RPMI-8226: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037463, HPA038402"	Approved		Approved	Nucleoplasm,Mitochondria	"Secreted to blood"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Mitochondria"		"HPA037463: AB_10673632, HPA038402: AB_2675997"	"unprognostic (1.34e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.83e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.77e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.28e-1)"	3.2	4.6	2.3	5.3	2.4	3.9	3.3	2.4	4.5	5.1	0.2	3.2	1.8	4.9	0.6	3.5	5.3	4.7	3.9	2.9	4.4	2.0	0.5	3.4	6.6	3.7	2.5	5.7	3.1	17.5	4.9	4.2	5.0	3.9	0.7	7.6	2.9	4.5	0.8	5.4	4.8	5.2	1.0	4.0	3.7	6.4	2.3	4.6	2.7	1.8	3.2	3.8	3.8	2.3	4.3	2.7	9.2	20.3	7.8	7.9	4.9	9.0	4.0	7.8	13.2	0.8	7.6	17.9	27.1	6.7	36.1	7.7	8.8	20.3	0.7	8.4	8.2	8.4	0.0	0.7	17.3	7.3	9.1	14.9	3.0	10.7	12.6	9.4	17.3	16.6	4.9	50.2	0.4	17.9	8.1	11.2	4.7	15.8	16.3	10.7	6.7	50.8	4.9	2.0	13.3	13.6	17.9	11.9	14.6	10.0	20.0	12.4	8.2	6.8	5.5	14.7	4.2	20.1	29.2	10.6	11.2	38.3	14.6	3.0	7.1	4.0	2.8	9.6	3.7	1.6	5.3	2.1	13.2	1.0	6.3	4.4	1.2	4.8	9.6	0.9	7.3	4.7	2.3	2.4	2.4	4.5	2.9	4.4	3.7	2.5	5.0	1.0	2.3	2.3	4.5	9.6	1.7	2.9	2.3	1.0	1.0	3.2	2.8	5.2	2.4	1.8	5.3	4.3	3.6	1.8	0.0	6.0	1.9	0.6	0.0	3.0	3.3	3.2	2.4	4.6	0.0	2.5	10.5	2.3	6.6	5.0	2.0	2.3	2.5	9.6	2.5	0.4	7.6	11.8	12.4	1.8	6.1	8.2	1.4	1.5	3.4	6.9	1.8	4.7	7.0	7.8	1.0	5.5	4.9	2.1	1.7	2.6	1.3	0.8	2.6	0.6	2.8	14.2	0.0	2.5	2.7	1.2	3.5	1.9	1.6	1.2	5.6	9.7	2.3	0.9
PDE11A		ENSG00000128655	"Phosphodiesterase 11A"	Q9HCR9	2	177623244-178072777	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Cushing syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 6.3;parathyroid gland: 9.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.0;Hepatocytes: 11.1;Late spermatids: 46.4;Oligodendrocytes: 14.9"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.6;fHDF/TERT166: 2.4;HAP1: 1.4;Hep G2: 2.8"									HPA034560	Approved				"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA034560: AB_10602140"	"unprognostic (1.02e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.61e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-4)"	"unprognostic (1.64e-3)"	2.3	0.3	0.8	0.1	2.0	0.2	1.7	1.9	1.2	0.6	0.6	0.5	0.8	1.2	0.4	0.0	0.3	0.4	0.3	0.6	2.1	0.5	6.3	0.0	0.0	2.5	2.1	0.4	1.1	9.8	0.9	0.0	2.7	5.2	0.4	1.4	1.4	0.8	4.4	0.1	0.5	1.1	3.7	0.1	0.4	2.8	1.9	0.1	1.3	1.3	0.0	0.0	0.1	3.2	0.0	0.4	0.2	0.1	0.0	0.0	0.0	1.1	0.2	0.0	0.3	0.2	1.6	0.0	0.6	2.4	0.3	0.1	1.4	0.0	0.0	0.0	0.9	1.1	0.1	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	0.2	0.4	0.1	0.6	0.0	0.3	0.2	0.0	0.2	0.0	0.5	0.0	0.3	0.7	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.8	2.0	1.9	1.2	0.6	2.1	2.5	2.1	2.7	3.7	1.9	3.2	0.1	0.0	0.0	2.3	0.2	0.6	1.4	0.1	0.0	1.7	4.2	0.8	0.0	1.5	0.1	0.0	0.0	0.1	0.3	0.8	0.0	0.8	37.0	0.3	0.2	0.6	6.7	2.7	1.6	6.7	0.0	0.6	0.0	0.2	0.0	0.0	1.4	11.1	0.1	0.0	8.2	0.9	6.1	1.2	2.1	46.4	1.5	0.3	0.0	0.0	0.0	4.7	0.0	6.0	14.9	2.3	0.0	0.7	0.0	5.4	0.6	1.3	0.1	1.0	0.0	2.0	0.6	6.8	6.9	0.0	1.3	0.3	0.3	0.3	1.3	1.0
PDGFC	"fallotein, SCDGF"	ENSG00000145431	"Platelet derived growth factor C"	Q9NRA1	4	156760454-156971799	"Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 20.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 98.6;Granulosa cells: 124.1;Microglial cells: 85.3;Oligodendrocyte precursor cells: 233.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 60.0;hTERT-RPE1: 56.8;U-138 MG: 41.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009134	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		37000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA009134: AB_10601981"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.35e-5)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (3.17e-4)"	4.8	4.0	0.9	1.3	1.0	0.6	7.5	0.4	1.0	9.2	0.7	2.3	2.0	9.9	2.1	3.3	6.7	4.8	2.6	1.0	0.8	5.5	5.1	3.1	1.1	0.8	0.7	7.7	4.3	20.3	0.4	4.5	0.7	8.7	2.0	0.7	8.4	7.0	1.2	1.6	2.8	9.4	0.9	1.3	2.8	0.9	1.1	2.0	6.5	1.2	1.0	3.2	1.2	1.0	2.5	3.7	38.6	25.4	7.0	13.4	1.0	21.5	21.5	12.0	16.1	2.2	9.4	0.0	3.8	60.0	9.2	2.6	10.8	13.4	16.5	0.0	5.0	25.5	3.2	2.4	18.3	3.9	0.3	14.2	6.6	30.6	21.7	56.8	6.0	0.1	0.1	0.1	30.2	0.1	0.0	0.0	0.4	0.0	1.7	0.0	8.1	0.0	22.5	0.9	0.0	0.0	0.0	0.2	0.4	6.0	3.1	1.3	28.3	41.7	0.4	10.9	17.3	0.0	0.0	0.0	16.1	0.0	1.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	1.0	0.4	1.0	1.0	0.8	0.8	0.7	0.7	0.9	1.1	1.0	2.4	6.4	14.2	98.6	0.7	49.6	22.7	12.4	25.0	2.0	14.7	13.6	16.8	58.6	7.8	12.9	0.0	0.6	3.4	0.5	0.0	15.4	30.5	6.9	15.0	7.3	0.0	5.5	64.4	7.1	0.3	18.6	8.2	11.4	1.3	124.1	10.0	15.9	13.0	0.0	32.1	2.1	4.1	34.4	21.6	23.8	5.3	32.1	10.6	85.3	14.2	6.3	0.0	233.2	3.0	18.0	0.5	23.0	1.4	8.7	2.4	18.6	3.5	0.5	6.6	34.8	18.2	0.7	2.9	3.4	13.5	0.5	0.9	13.8	2.1	4.8
PDRG1	"C20orf126, dJ310O13.3"	ENSG00000088356	"P53 and DNA damage regulated 1"	Q9NUG6	20	31944337-31952046	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 55.4"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 86.8;Theca cells: 170.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047084, HPA063542"	Approved		Approved	"Actin filaments"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Actin filaments"		"HPA047084: AB_2679925, HPA063542: AB_2685035"	"unprognostic (2.17e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.82e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.00e-2)"	9.0	12.7	17.7	7.7	18.1	17.0	11.0	20.6	19.2	10.1	19.0	11.1	8.3	8.9	12.8	13.8	10.0	5.7	11.8	18.2	18.2	15.7	14.3	8.2	11.8	19.9	18.3	9.5	9.8	55.4	11.3	11.1	19.9	11.6	6.9	9.6	8.7	15.1	15.2	11.5	8.9	7.6	18.8	13.2	9.7	38.0	18.3	12.3	10.4	15.9	12.5	10.0	10.1	20.0	36.6	29.2	17.8	19.7	10.0	7.4	32.9	28.8	16.1	42.3	23.8	107.7	17.9	36.4	21.6	13.6	31.1	23.2	37.8	28.9	34.1	13.4	25.2	50.8	21.7	37.8	25.3	29.3	20.2	9.1	20.9	29.8	30.5	17.9	17.8	37.9	51.7	18.2	17.8	44.3	38.3	34.3	36.7	37.6	61.0	29.6	53.6	19.2	27.8	19.5	42.1	20.2	87.2	27.8	53.6	18.3	48.5	35.5	16.3	34.2	40.3	31.7	36.8	13.3	14.9	40.0	22.9	103.4	22.9	13.4	10.4	16.7	19.0	14.9	18.4	35.4	20.2	20.8	15.8	36.2	27.0	23.6	4.3	28.7	21.6	29.9	21.2	18.2	17.7	18.1	20.6	19.2	18.2	18.2	19.9	18.3	19.9	18.8	18.3	20.0	22.9	19.2	9.7	4.2	23.4	25.5	16.1	14.0	23.9	21.2	26.7	22.7	17.6	14.3	9.1	11.0	14.6	45.8	29.4	9.6	33.2	24.8	11.8	16.7	20.2	22.9	22.0	13.9	6.3	21.2	26.7	22.3	6.6	18.8	33.0	27.7	12.5	7.9	26.2	16.8	5.9	12.6	10.2	9.1	17.8	17.4	16.1	12.4	12.4	5.6	37.4	23.2	13.4	4.0	5.9	23.8	15.0	17.0	14.8	17.8	13.9	19.3	10.0	21.2	26.3	17.2	22.7	86.8	38.1	18.0	28.6	20.4	18.4	170.9	13.4	14.7
PDZD11	PDZK11	ENSG00000120509	"PDZ domain containing 11"	Q5EBL8	X	70286595-70290514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003972	Approved				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA003972: AB_1855165"	"unprognostic (1.51e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.75e-1)"	"unprognostic (3.52e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.72e-3)"	27.6	35.6	67.6	19.5	67.6	11.0	33.4	67.9	85.9	30.5	67.9	39.5	33.4	26.1	43.2	41.3	31.1	27.8	51.2	66.6	71.9	44.2	35.4	21.4	27.7	68.3	70.1	26.4	22.8	53.2	29.4	22.3	73.1	31.1	44.7	51.8	30.4	32.6	24.1	32.8	31.7	35.2	67.4	23.0	27.9	10.9	70.7	36.2	37.8	40.8	35.8	37.5	28.8	70.5	75.5	83.7	56.1	63.0	90.6	107.3	47.8	79.4	88.0	115.4	107.0	80.6	92.9	40.2	95.7	140.4	130.0	55.7	92.4	107.2	130.4	56.5	75.6	26.4	79.2	62.1	80.9	36.4	34.8	110.8	73.4	128.0	78.6	108.7	95.0	49.7	42.5	140.9	187.8	113.0	58.9	49.2	44.4	167.6	148.1	41.4	113.3	79.6	99.7	67.4	60.5	61.0	87.7	67.3	86.1	66.5	62.2	31.8	75.5	82.9	70.5	128.2	79.0	30.8	58.8	42.1	120.0	52.1	99.0	17.9	25.6	18.2	40.1	47.6	44.9	37.1	41.3	45.5	38.5	37.0	25.2	36.5	10.6	36.5	62.1	28.9	77.4	34.8	67.6	67.6	67.9	85.9	66.6	71.9	68.3	70.1	73.1	67.4	70.7	70.5	26.6	12.8	11.8	4.6	12.3	24.6	28.8	76.2	22.8	26.0	30.4	42.7	45.0	24.3	36.6	33.1	4.2	42.0	16.7	39.0	117.4	46.1	0.6	25.1	32.4	25.4	18.5	20.2	3.2	41.1	61.0	35.0	16.8	25.7	26.6	29.8	20.0	20.5	62.6	32.0	3.6	48.2	48.8	27.5	18.8	1.0	30.4	22.1	30.2	4.7	27.9	71.3	16.5	3.5	2.5	55.9	52.3	38.0	23.2	18.6	66.7	92.0	27.7	21.7	39.5	19.9	40.4	7.7	19.8	44.9	28.1	26.8	22.1	52.5	43.9	33.8
PIGH	GPI-H	ENSG00000100564	"Phosphatidylinositol glycan anchor biosynthesis class H"	Q14442	14	67581955-67600286	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Autism spectrum disorder, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Muller glia cells: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031624	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"			"HPA031624: AB_10601046"	"unprognostic (1.59e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.25e-3)"	"unprognostic (8.69e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.39e-1)"	"prognostic favorable (2.68e-7)"	"unprognostic (7.42e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.73e-1)"	15.4	34.2	19.9	8.2	23.6	27.2	19.2	23.4	26.4	25.9	22.5	14.2	12.6	14.0	36.6	14.0	15.5	13.6	15.1	19.4	23.4	34.7	23.9	13.7	11.9	23.9	22.4	23.8	29.2	66.7	13.6	12.5	23.9	28.9	11.6	47.6	26.2	16.0	32.2	19.9	16.1	10.9	22.6	16.5	19.6	20.7	22.7	11.8	28.8	24.7	13.3	16.4	14.4	27.4	24.5	15.6	14.7	30.3	32.1	12.3	12.4	13.3	16.1	18.2	17.7	25.4	8.3	16.5	12.9	9.1	30.4	17.5	26.3	18.9	20.1	25.4	34.8	17.3	12.4	26.1	25.2	12.8	19.9	17.9	23.8	13.7	21.0	5.6	11.8	28.5	39.7	11.5	13.3	21.4	18.8	21.4	2.7	33.8	41.9	6.3	14.8	9.9	19.6	20.0	18.3	22.1	10.1	19.4	33.8	10.8	22.0	12.5	6.1	18.1	23.2	23.8	15.8	21.9	15.2	11.2	13.9	27.1	25.7	42.0	24.8	52.5	44.9	35.1	58.5	61.8	46.5	41.8	25.4	72.0	48.3	45.0	12.1	51.5	45.7	29.6	48.2	35.0	19.9	23.6	23.4	26.4	19.4	23.4	23.9	22.4	23.9	22.6	22.7	27.4	14.8	3.2	14.1	5.5	23.6	20.6	20.4	37.1	19.4	35.5	22.8	25.9	4.9	22.8	17.8	22.0	35.5	29.8	28.7	9.5	29.4	22.3	12.1	20.3	10.5	16.1	7.2	13.2	8.0	37.1	28.7	20.8	9.2	10.9	7.0	13.4	13.9	14.6	22.7	26.9	10.4	14.9	26.4	7.6	12.9	9.4	21.5	12.3	35.6	7.5	7.0	96.6	23.7	8.5	10.3	24.3	10.6	21.1	31.2	26.8	29.4	31.3	12.2	45.5	0.0	22.7	18.7	78.8	59.5	17.7	20.9	56.4	20.7	34.6	14.1	18.2
PIGO	"DKFZp434M222, FLJ00135"	ENSG00000165282	"Phosphatidylinositol glycan anchor biosynthesis class O"	Q8TEQ8	9	35088688-35096601	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014905			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoli	Nucleoplasm	"HPA014905: AB_1855369"	"unprognostic (1.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.98e-3)"	"unprognostic (4.14e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.81e-2)"	8.6	12.9	5.4	9.2	7.5	5.9	10.9	7.6	6.1	9.8	9.6	11.7	14.5	10.5	11.2	10.5	15.5	9.5	7.7	5.3	6.0	14.7	15.3	10.0	9.1	7.8	6.8	12.5	16.4	33.2	9.4	12.3	7.6	12.5	12.9	10.5	13.0	11.9	6.8	10.0	11.3	8.6	6.8	11.3	13.1	12.2	6.2	11.4	20.0	4.7	10.2	9.4	8.6	9.8	30.5	51.5	14.4	20.8	12.5	13.8	25.6	12.7	22.0	30.0	24.5	19.0	30.2	17.1	22.7	15.4	41.8	21.6	24.2	39.6	18.0	19.0	15.7	10.3	31.2	14.5	24.5	13.9	17.1	17.1	42.8	26.8	43.7	23.9	15.8	25.1	11.4	23.7	24.9	16.8	16.5	15.9	9.2	18.9	20.8	16.9	11.6	18.8	32.9	20.8	11.9	16.1	17.5	42.8	10.0	15.7	32.2	9.1	9.7	21.8	19.1	11.8	23.6	14.4	22.9	7.1	23.4	10.3	27.8	5.3	5.1	6.3	6.4	6.7	6.6	3.5	3.5	7.3	10.4	4.8	4.5	5.4	1.8	5.7	4.6	7.3	6.0	3.5	5.4	7.5	7.6	6.1	5.3	6.0	7.8	6.8	7.6	6.8	6.2	9.8	6.3	3.2	13.9	4.6	7.9	2.5	4.5	7.9	8.6	9.1	6.1	3.8	3.1	14.3	12.2	16.5	2.1	21.0	10.2	13.3	0.0	13.6	1.2	11.3	5.5	5.2	3.0	2.1	1.7	14.0	16.0	5.6	11.7	10.1	7.0	7.9	4.2	11.7	11.6	11.8	1.9	7.4	8.2	6.6	4.2	1.0	4.4	5.8	3.6	2.8	6.7	14.3	5.2	1.5	3.9	8.4	7.7	3.0	8.7	3.7	11.4	7.4	16.1	11.8	6.6	5.1	4.8	20.0	10.4	6.7	2.0	22.6	7.2	7.2	10.8	4.0
PIK3C2A	PI3K-C2alpha	ENSG00000011405	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha"	O00443	11	17077730-17207983	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Endocytosis, Exocytosis"	"Kinase, Transferase"	"Cataract, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037641, HPA037642"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA037641: AB_10671878, HPA037642: AB_10697081"	"unprognostic (2.35e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	22.5	13.7	16.3	12.3	25.9	9.4	15.9	22.5	14.6	16.1	17.4	13.2	14.9	18.0	15.7	15.4	14.5	19.0	12.4	10.5	14.0	23.5	15.5	16.6	11.3	16.6	16.1	14.1	12.3	43.6	10.3	23.1	17.0	16.4	13.0	22.4	11.8	14.8	6.4	12.3	11.8	18.3	13.8	13.0	18.0	19.3	19.6	9.4	30.7	12.1	10.9	14.9	12.0	15.8	53.8	24.1	39.6	24.8	28.0	28.3	35.3	33.2	35.7	23.9	33.2	58.9	6.0	15.6	16.2	28.6	39.1	34.8	31.9	25.4	42.1	13.5	27.6	9.8	28.4	23.3	30.6	12.3	14.9	22.2	17.5	23.6	45.8	22.2	57.7	9.9	23.4	14.7	18.6	16.6	6.6	7.7	22.6	30.1	18.5	6.9	41.1	11.0	29.6	47.0	23.2	20.5	50.6	21.4	23.2	33.0	12.7	12.3	72.5	19.1	27.4	50.1	20.4	5.9	14.1	12.8	22.8	11.3	22.6	1.7	1.5	1.1	1.7	1.0	1.1	1.4	1.3	1.3	2.1	1.5	1.7	1.0	2.3	1.8	3.2	1.4	0.9	0.6	16.3	25.9	22.5	14.6	10.5	14.0	16.6	16.1	17.0	13.8	19.6	15.8	93.2	76.9	62.0	217.4	25.0	35.3	26.1	18.7	24.5	49.1	34.7	25.0	29.7	25.8	33.1	36.8	70.9	29.6	29.5	22.6	19.6	19.8	35.9	51.8	35.1	87.6	28.7	11.2	57.0	25.1	17.9	28.6	45.3	72.4	32.2	22.8	106.7	32.4	19.2	35.3	81.1	23.5	18.3	46.3	33.1	18.6	25.7	27.0	19.6	69.3	19.6	73.0	17.5	62.8	79.4	26.1	13.1	31.2	29.9	42.7	15.2	22.4	26.4	40.4	39.5	33.7	35.1	52.6	26.8	23.5	34.0	143.5	25.3	25.1	20.7	37.3
PJA2	"KIAA0438, Neurodap1, RNF131"	ENSG00000198961	"Praja ring finger ubiquitin ligase 2"	O43164	5	109334713-109409974	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040347, HPA057636"	Supported		Enhanced	"Intermediate filaments"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Intermediate filaments"		"HPA040347: AB_10795631, HPA057636: AB_2683485"	"unprognostic (5.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (4.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.94e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.00e-2)"	59.3	67.9	63.3	44.4	72.9	87.9	57.0	44.9	89.8	68.9	22.1	56.1	33.4	74.5	62.2	50.8	46.2	48.3	65.8	78.6	77.0	61.1	77.3	51.4	41.4	52.6	52.1	87.8	38.8	88.1	36.8	58.2	56.2	78.4	52.5	64.2	49.2	91.9	39.0	30.6	40.6	77.1	58.9	54.7	33.1	47.0	58.6	53.8	92.1	54.2	44.6	53.7	36.9	68.9	36.0	24.6	96.2	74.6	93.4	101.3	52.4	57.9	86.5	44.6	72.6	22.9	47.6	46.0	78.1	111.8	71.8	20.5	57.0	71.3	81.1	39.5	21.7	53.5	47.4	31.1	66.2	40.2	75.8	70.4	58.1	59.7	85.1	80.0	72.4	40.8	37.2	84.0	73.0	21.9	48.8	36.9	19.2	21.9	16.3	31.1	84.6	77.5	69.5	31.9	18.4	47.1	59.8	21.5	70.5	64.2	48.6	58.7	84.6	63.4	30.7	58.8	27.5	56.4	51.6	53.5	66.8	54.8	42.6	32.9	19.2	29.3	14.4	19.7	14.4	16.5	14.1	13.4	19.3	11.7	18.0	13.4	49.0	17.8	27.7	8.0	20.5	18.5	63.3	72.9	44.9	89.8	78.6	77.0	52.6	52.1	56.2	58.9	58.6	68.9	85.2	67.3	58.4	71.2	76.9	63.5	56.2	59.8	58.1	102.1	53.0	58.5	127.5	51.5	51.7	57.0	62.6	24.1	78.2	85.9	49.0	40.8	22.5	42.8	97.5	70.3	67.6	32.1	159.0	33.3	31.0	86.7	32.1	68.2	47.5	99.3	70.6	94.8	54.5	77.4	126.0	53.1	36.7	91.5	78.5	20.7	85.1	77.1	60.5	66.5	73.4	93.0	68.0	60.8	111.6	30.9	30.4	92.6	72.0	59.2	46.8	58.7	48.4	91.3	78.9	105.0	110.1	73.4	42.9	43.7	58.2	26.3	68.7	61.6	39.3	44.0
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828949-186988981	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 87.2;seminal vesicle: 48.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 33.4;Glandular and luminal cells: 28.1;Microglial cells: 115.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 6.8;eosinophil: 7.8;intermediate monocyte: 8.4;myeloid DC: 7.7;non-classical monocyte: 4.0;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.7;granulocytes: 7.8;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 52.4;OE19: 84.4;RPMI-8226: 73.4;U-2197: 66.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Vesicles,Cytosol		NA	NA		35000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Cytosol	Vesicles	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417"	"prognostic favorable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	9.9	12.7	2.4	6.3	3.4	4.8	6.5	2.8	3.7	14.5	3.2	11.9	11.1	10.2	11.7	7.5	24.9	6.2	6.3	2.4	3.3	10.8	2.1	5.9	5.3	4.4	3.5	6.4	7.6	87.2	2.0	5.8	4.0	8.8	8.1	0.8	6.3	48.3	0.5	9.5	8.2	10.5	4.1	6.6	5.3	2.8	3.1	1.5	2.6	2.1	2.9	29.1	8.4	3.9	0.0	39.7	0.2	0.0	23.8	9.5	0.0	1.5	15.1	1.8	3.2	0.3	15.5	0.0	0.0	0.0	6.8	2.8	24.6	7.4	0.8	12.5	0.6	7.6	52.4	0.0	14.7	11.1	3.8	5.4	5.0	19.5	4.0	2.4	16.5	3.4	16.7	5.9	0.0	0.0	0.0	0.0	2.1	84.4	5.1	0.0	0.0	73.4	0.1	5.4	0.2	0.0	5.9	2.0	7.3	0.7	0.8	15.0	3.3	14.3	1.9	66.3	3.2	2.3	0.0	0.0	5.3	32.4	20.7	0.2	6.8	7.8	0.0	8.4	0.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.6	1.1	4.0	3.1	0.0	1.7	2.4	3.4	2.8	3.7	2.4	3.3	4.4	3.5	4.0	4.1	3.1	3.9	0.6	0.0	1.1	0.3	0.2	21.4	4.3	4.6	10.2	0.2	2.9	2.9	2.3	0.0	4.9	0.0	0.0	0.1	3.2	1.6	1.9	2.1	0.9	33.4	1.7	6.6	1.2	3.0	8.1	0.0	0.1	11.2	7.1	28.1	10.8	3.3	1.1	0.2	6.6	0.0	5.8	2.6	2.0	7.9	8.3	1.3	10.5	11.5	5.4	115.2	3.7	0.0	1.0	2.0	0.4	1.7	7.3	14.7	0.0	2.3	2.0	0.3	2.3	0.5	0.0	1.2	5.0	0.6	0.3	5.2	8.9	0.0	1.0	1.2	4.8	13.4
PLAT		ENSG00000104368	"Plasminogen activator, tissue type"	P00750	8	42174718-42207709	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 246.0;urinary bladder: 181.4"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 763.3;Urothelial cells: 992.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 604.7;HMC-1: 425.2;hTERT-RPE1: 344.9;LHCN-M2: 298.2;U-2197: 441.2;WM-115: 806.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003412, CAB009335"	Supported		Approved	"Actin filaments"	"Secreted to blood"	NA	NA	9900000	110000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"		"CAB009335: AB_2237146, HPA003412: AB_1858205"	"prognostic favorable (7.57e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.88e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (8.72e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (6.09e-2)"	58.9	44.0	14.0	35.6	13.7	0.1	35.1	14.6	17.4	21.8	10.3	55.3	29.9	49.6	16.8	33.7	49.8	40.4	19.3	12.5	16.6	91.9	5.3	41.3	2.3	15.4	15.4	21.5	16.0	246.0	13.3	44.4	16.6	54.0	25.0	2.1	15.6	29.1	8.8	6.2	34.6	32.9	16.0	2.0	41.8	11.9	18.8	4.4	30.9	9.8	2.7	181.4	33.1	14.0	4.2	1.4	29.0	9.1	43.1	61.9	0.9	125.8	216.4	54.2	43.4	1.4	604.7	0.0	4.4	17.1	28.4	14.5	0.3	23.9	78.5	64.6	8.4	0.7	1.0	0.6	253.9	0.2	425.2	65.6	0.4	140.3	6.0	344.9	103.9	0.2	4.6	0.8	298.2	0.0	0.6	0.5	42.3	0.3	48.2	0.2	103.5	0.3	12.6	0.4	0.3	7.4	0.2	0.4	158.7	39.7	1.0	0.3	189.3	11.6	43.1	441.2	15.6	0.2	1.1	0.2	9.7	0.2	806.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	14.0	13.7	14.6	17.4	12.5	16.6	15.4	15.4	16.6	16.0	18.8	14.0	63.5	0.0	13.7	0.0	2.9	10.8	763.3	155.9	7.4	4.7	103.9	66.3	7.4	1.5	19.1	0.0	4.2	0.6	0.9	0.1	0.0	9.3	0.9	4.8	104.2	98.2	0.0	0.0	1.6	0.6	1.3	136.5	2.0	5.1	164.0	89.7	36.4	0.8	1.9	1.7	4.0	0.0	4.1	1.0	17.7	1.5	3.7	4.7	23.2	25.3	1.6	2.1	1.0	42.7	0.3	52.0	0.0	2.6	2.8	193.3	0.2	0.3	4.0	3.8	13.1	10.8	48.3	1.1	0.6	13.6	13.5	0.7	6.0	0.5	0.5	992.1
PLEKHB2	"EVT2, FLJ20783"	ENSG00000115762	"Pleckstrin homology domain containing B2"	Q96CS7	2	131104847-131353709	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075014	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA075014: AB_2732275"	"unprognostic (1.99e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.78e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (9.33e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.72e-8)"	"unprognostic (1.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.65e-1)"	27.0	55.5	52.7	38.3	55.4	64.8	26.1	61.4	56.2	25.4	53.4	59.9	46.8	16.6	30.7	30.3	26.7	29.7	33.5	57.8	73.1	111.8	22.4	44.4	37.0	64.8	69.4	11.7	20.8	88.5	26.2	31.0	81.3	34.6	60.9	81.1	26.0	26.3	35.6	23.5	56.2	25.9	56.8	42.5	58.5	36.1	60.0	31.2	48.7	30.6	34.5	38.3	18.2	63.1	85.3	65.4	48.6	38.1	37.4	36.2	79.2	94.4	80.0	88.9	73.8	140.0	83.4	68.2	97.5	92.0	64.4	58.8	89.0	81.5	98.8	40.0	48.6	119.4	31.0	81.4	51.9	115.4	88.8	31.9	67.2	105.2	96.9	54.6	71.1	36.5	57.5	53.0	166.9	46.7	71.4	57.0	73.9	80.8	99.1	52.5	37.7	72.7	138.6	89.7	60.3	39.7	29.6	166.3	107.6	64.9	23.6	89.0	86.6	89.2	60.4	76.7	86.5	51.2	85.6	46.5	130.8	76.6	82.8	27.5	54.9	29.0	24.4	69.2	23.9	15.5	18.2	23.2	52.7	17.1	19.4	23.2	32.3	26.5	78.2	18.7	23.6	48.3	52.7	55.4	61.4	56.2	57.8	73.1	64.8	69.4	81.3	56.8	60.0	63.1	37.8	60.9	53.9	14.4	50.0	114.3	35.6	47.2	64.9	85.6	57.6	26.5	28.6	34.3	59.5	64.4	125.1	44.9	59.5	174.4	158.5	62.4	66.4	108.8	44.2	57.2	56.8	44.2	38.9	43.1	51.0	29.6	62.2	164.1	58.9	25.4	31.4	20.9	106.3	101.0	41.5	67.6	128.1	111.0	169.5	22.1	14.3	117.9	76.5	26.2	86.2	46.0	49.4	15.1	32.0	81.5	68.4	24.0	35.8	58.6	120.2	193.4	52.1	78.8	13.1	26.1	35.9	92.3	65.9	97.6	140.4	92.9	59.1	51.0	76.1	70.7
POLR3B	"C128, FLJ10388, RPC2"	ENSG00000013503	"RNA polymerase III subunit B"	Q9NW08	12	106357748-106510198	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036466	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA036466: AB_10671842"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	4.5	8.7	3.1	4.8	4.4	5.2	5.0	4.3	4.6	4.7	3.7	5.3	4.2	4.6	5.2	8.6	5.1	3.6	5.8	3.4	2.9	6.8	9.0	4.7	4.1	2.2	2.3	7.5	4.9	11.1	2.4	6.7	2.3	5.6	5.7	6.2	4.7	4.0	6.5	11.0	3.4	5.4	2.7	3.3	5.4	6.1	3.2	4.7	6.0	8.3	5.6	4.9	4.3	3.6	16.2	7.6	16.4	7.8	13.9	13.1	22.9	21.9	13.0	15.2	11.6	14.0	4.4	20.6	7.7	14.2	5.6	14.8	19.5	19.2	18.5	16.6	13.1	15.7	10.1	12.0	9.2	26.1	17.0	11.7	13.4	15.1	17.3	10.3	11.5	9.8	24.5	6.5	11.2	12.0	19.1	8.7	17.8	11.9	28.5	11.6	9.8	13.5	8.6	21.8	17.3	9.6	13.6	18.2	13.4	10.8	17.0	7.9	11.0	8.3	10.0	13.6	13.1	8.1	22.4	30.3	3.8	15.9	9.2	5.6	2.0	1.5	2.0	2.2	2.7	2.1	2.2	2.2	2.6	1.3	3.0	1.9	1.3	2.1	2.2	0.9	2.7	1.7	3.1	4.4	4.3	4.6	3.4	2.9	2.2	2.3	2.3	2.7	3.2	3.6	2.4	0.0	9.2	14.4	4.7	1.8	1.7	4.5	4.6	6.0	3.4	3.7	10.3	2.8	7.0	5.5	6.2	11.0	3.8	3.8	1.9	5.1	7.1	3.9	7.0	3.3	4.2	3.8	22.3	4.6	9.3	4.4	9.2	3.9	5.1	4.8	3.6	11.0	3.1	3.3	24.1	5.6	2.0	1.6	0.3	5.2	3.7	2.4	3.6	9.4	1.0	2.4	2.1	17.1	22.4	3.8	1.1	4.9	4.9	1.5	1.7	3.4	7.2	7.2	6.6	6.9	4.1	16.5	10.9	8.9	3.0	7.4	4.1	7.2	5.1	1.2
PPFIBP2	Cclp1	ENSG00000166387	"PPFIA binding protein 2"	Q8ND30	11	7513298-7657127	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.4;Extravillous trophoblasts: 56.2;Oligodendrocytes: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 80.5;OE19: 100.4;RT4: 105.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001935, HPA003911"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA001935: AB_1079667, HPA003911: AB_1079666"	"unprognostic (4.14e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.20e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.26e-5)"	"unprognostic (6.66e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (5.39e-8)"	"unprognostic (1.78e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.52e-2)"	"prognostic favorable (1.34e-5)"	10.8	11.7	21.5	12.0	34.2	7.6	16.6	24.9	24.4	14.7	51.3	22.4	26.4	6.7	33.5	27.3	17.2	15.7	13.0	21.8	26.2	19.0	35.4	11.6	15.2	27.4	29.8	14.3	9.4	66.5	4.8	21.0	29.0	18.2	26.5	2.8	54.8	32.8	33.4	33.2	26.0	5.4	20.6	11.1	44.1	31.5	31.7	4.5	37.5	21.4	25.0	29.5	21.8	43.8	2.0	32.7	5.3	3.1	6.1	0.4	80.5	7.1	16.1	4.1	4.0	26.7	4.6	9.7	3.7	4.1	15.1	14.2	21.0	2.1	3.7	3.9	2.4	0.0	0.3	17.1	8.4	19.6	9.3	10.7	7.6	0.0	4.5	0.4	1.5	2.0	0.9	26.5	4.0	15.9	0.0	19.0	37.8	100.4	0.1	3.3	0.1	17.4	0.1	105.0	1.5	12.4	1.1	28.9	21.9	14.6	4.0	14.7	0.5	1.9	2.8	6.4	0.7	14.1	11.1	8.3	2.3	4.5	13.0	3.4	9.1	6.5	3.1	11.2	2.3	12.7	5.0	2.1	8.3	7.2	6.6	5.2	4.2	2.6	14.4	0.6	1.1	5.2	21.5	34.2	24.9	24.4	21.8	26.2	27.4	29.8	29.0	20.6	31.7	43.8	1.7	16.0	13.6	3.9	21.2	5.5	18.7	4.5	10.2	1.5	10.1	7.7	5.2	11.5	13.7	14.7	18.8	9.1	1.6	29.8	9.8	5.8	53.4	6.7	4.8	3.2	3.6	0.0	3.8	9.6	56.2	7.7	40.2	35.7	7.0	0.6	1.1	17.3	7.1	0.0	6.0	23.2	8.2	10.4	7.2	47.2	4.7	11.3	16.0	17.8	15.7	1.7	3.1	49.8	70.5	6.9	22.8	7.2	9.0	13.4	26.8	19.7	7.5	3.3	0.0	5.7	10.2	22.2	2.6	10.7	9.9	4.8	2.0	1.2	18.0	18.6
PPM1H	"ARHCL1, FLJ13253, KIAA1157, NERPP-2C"	ENSG00000111110	"Protein phosphatase, Mg2+/Mn2+ dependent 1H"	Q9ULR3	12	62643994-62935150	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;parathyroid gland: 42.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 123.5;Glandular and luminal cells: 81.6;Inhibitory neurons: 162.1;Microglial cells: 89.9;Oligodendrocytes: 341.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 80.6;HMC-1: 62.7;SK-BR-3: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020694, HPA044244, HPA058777"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB020694: , HPA044244: AB_2678871, HPA058777: AB_2683816"	"unprognostic (3.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.14e-1)"	2.2	1.5	12.0	1.2	12.7	3.1	4.9	30.0	16.0	7.5	5.7	2.4	3.1	6.2	6.7	0.6	6.5	6.7	2.4	13.3	15.7	10.6	3.4	2.7	1.2	11.1	11.3	9.6	3.9	42.4	8.2	6.5	14.9	13.4	3.0	26.7	11.4	6.0	1.1	0.8	1.7	1.5	7.8	0.9	5.7	0.9	16.5	4.3	3.2	1.3	1.7	2.1	0.3	16.2	1.2	12.4	2.2	0.2	0.5	0.0	26.5	2.9	2.9	1.8	0.6	80.6	5.7	0.0	2.7	1.4	1.8	1.6	8.7	0.2	1.1	0.2	4.3	15.2	2.4	18.4	0.1	4.6	62.7	0.1	0.3	0.0	0.7	1.9	0.3	2.7	4.0	0.0	1.3	9.5	1.5	2.2	15.9	4.1	5.9	2.1	5.6	23.0	18.1	28.3	6.9	0.0	5.0	35.6	12.1	8.5	19.6	2.7	0.2	0.5	1.5	0.2	0.9	3.3	21.4	4.1	0.2	0.1	1.2	2.9	0.7	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.1	12.0	12.7	30.0	16.0	13.3	15.7	11.1	11.3	14.9	7.8	16.5	16.2	4.6	6.4	4.7	25.5	1.0	0.1	0.3	3.0	0.0	9.4	9.5	3.4	2.4	12.8	5.9	16.5	27.1	22.2	0.0	0.7	3.9	4.2	8.5	27.6	25.3	6.5	9.0	3.8	123.5	6.3	2.1	1.3	7.7	81.6	14.5	0.3	9.7	6.1	6.1	11.8	162.1	2.0	6.1	1.6	2.1	10.1	0.9	2.1	3.6	89.9	2.1	6.4	0.0	41.7	341.4	4.5	2.1	1.5	0.5	4.3	0.1	8.5	14.0	10.9	0.0	0.6	1.7	0.0	0.5	0.5	0.1	6.8	1.3	2.8	2.4	0.5
PPME1	"ABDH19, PME-1"	ENSG00000214517	"Protein phosphatase methylesterase 1"	Q9Y570	11	74171267-74254703	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 432.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004541, HPA043900, HPA064396"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		45000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Nuclear bodies"	"CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: AB_2685254"	"unprognostic (2.99e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (2.31e-2)"	"unprognostic (7.92e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.33e-3)"	14.7	25.1	16.8	10.0	18.1	16.9	14.9	8.5	21.3	17.3	7.8	15.2	11.0	16.8	29.1	20.8	24.1	14.0	21.4	18.8	19.4	18.6	10.1	13.0	9.3	12.7	14.5	18.3	15.4	62.5	14.5	14.9	17.5	23.8	15.7	23.8	20.1	24.9	29.7	28.7	11.5	21.4	9.8	8.1	13.4	31.9	13.4	18.8	23.1	24.1	14.7	22.3	13.9	14.0	50.5	62.3	42.4	45.9	45.4	36.0	41.3	71.8	48.4	134.8	103.6	139.1	32.3	26.3	47.7	55.1	73.6	79.9	63.4	50.3	123.1	36.4	23.8	38.7	66.6	64.1	96.7	28.9	33.2	34.6	41.8	69.7	32.7	54.8	39.1	37.5	93.0	22.5	236.6	34.1	38.0	36.1	34.4	71.2	50.3	39.9	432.4	39.9	56.7	33.9	57.2	49.2	85.1	38.7	108.4	46.2	72.7	29.1	23.5	52.1	67.6	51.5	55.2	41.4	54.6	46.9	39.2	26.7	43.4	1.4	8.7	11.3	10.4	10.5	13.2	7.2	13.4	12.6	11.2	8.3	13.3	10.9	4.9	13.7	9.5	11.8	10.9	9.2	16.8	18.1	8.5	21.3	18.8	19.4	12.7	14.5	17.5	9.8	13.4	14.0	16.1	28.9	12.8	28.7	10.8	20.3	24.4	30.5	23.3	31.3	18.5	17.7	18.0	7.2	28.5	35.0	37.5	14.1	11.2	15.4	17.6	16.9	51.4	44.9	32.8	15.0	25.7	96.4	65.3	13.4	38.9	19.1	23.9	24.2	8.2	21.2	10.8	9.7	13.6	33.7	59.3	13.5	34.6	6.7	14.8	13.4	13.7	11.1	3.6	20.6	10.8	15.2	16.5	35.7	40.5	16.6	12.0	25.2	8.2	19.2	10.3	11.6	40.9	18.8	6.6	19.0	33.0	61.9	45.6	21.5	24.9	15.5	12.4	18.8	13.4	17.3
PPP1R21	"CCDC128, FLJ16566, KLRAQ1"	ENSG00000162869	"Protein phosphatase 1 regulatory subunit 21"	Q6ZMI0	2	48440598-48515391	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 99.6;Oligodendrocytes: 190.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036791, HPA036792"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"HPA036791: AB_10671713, HPA036792: AB_2675317"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.44e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (4.59e-6)"	"unprognostic (9.23e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (9.87e-4)"	"unprognostic (6.60e-2)"	9.3	10.6	10.6	10.5	13.4	9.9	8.5	8.2	13.4	8.5	10.7	8.8	7.9	12.7	19.6	12.1	14.5	10.8	10.1	9.7	9.4	28.1	11.6	11.2	13.3	11.1	11.0	13.4	8.1	33.5	9.6	12.8	10.2	11.4	10.6	12.0	5.7	10.6	5.7	10.5	9.9	13.0	8.7	13.0	9.0	9.4	11.7	13.9	21.4	4.8	12.2	9.5	7.6	18.9	17.3	8.2	6.8	8.5	17.1	12.5	18.3	10.0	11.0	6.1	7.2	4.5	10.6	11.8	16.4	14.2	11.7	9.3	5.8	9.1	12.4	15.1	4.8	12.6	7.2	10.8	11.6	5.5	9.8	15.9	8.1	11.0	13.2	15.1	15.3	5.9	5.2	19.2	16.7	9.5	10.9	9.5	17.7	12.3	8.4	9.1	18.8	13.1	11.9	10.8	9.2	5.7	19.0	4.8	18.1	18.2	8.6	9.0	13.9	6.4	7.8	5.6	8.0	14.3	4.1	10.5	10.2	12.5	8.6	18.6	4.7	8.1	3.7	5.4	2.9	5.4	4.3	4.4	5.0	6.8	6.4	5.5	11.6	3.8	4.8	3.1	4.6	2.3	10.6	13.4	8.2	13.4	9.7	9.4	11.1	11.0	10.2	8.7	11.7	18.9	14.5	22.4	16.5	37.5	23.6	10.5	32.9	8.6	13.6	9.1	6.9	6.7	11.0	14.3	9.2	25.8	2.1	21.7	8.5	11.7	5.9	11.0	3.9	10.2	11.5	10.9	18.7	10.3	99.6	8.4	16.3	15.0	25.5	12.3	12.0	12.4	10.8	13.6	35.2	28.6	49.6	10.7	10.2	26.1	12.2	5.7	12.2	19.3	12.4	44.0	24.3	21.2	19.6	69.9	190.3	12.2	9.3	20.7	19.4	17.0	10.7	59.3	20.0	6.8	13.1	9.6	14.2	9.8	10.8	17.4	14.1	27.1	20.5	12.1	8.4	27.2
PRDM4	PFM1	ENSG00000110851	"PR/SET domain 4"	Q9UKN5	12	107732871-107761272	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024322, HPA067437"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA024322: AB_1855691, HPA067437: AB_2685839"	"unprognostic (4.64e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.11e-3)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (9.64e-2)"	"unprognostic (9.06e-3)"	"unprognostic (5.31e-2)"	"prognostic favorable (3.15e-7)"	"unprognostic (9.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.62e-3)"	12.8	8.6	12.8	11.9	13.3	16.9	11.7	14.5	13.5	12.0	13.1	15.0	13.2	15.2	13.4	15.6	11.8	11.2	8.9	12.3	12.8	21.0	7.0	12.9	12.4	13.2	12.8	15.0	10.2	44.5	8.1	12.5	13.5	11.5	16.4	20.9	11.5	12.1	12.5	12.3	13.8	13.9	11.1	12.3	12.7	11.6	14.7	11.4	12.6	12.8	14.0	11.5	13.2	14.3	19.2	20.9	22.4	23.4	23.7	24.3	17.1	25.6	33.2	25.4	19.2	14.7	8.1	24.6	10.6	27.2	23.7	13.4	23.5	18.7	27.4	18.1	24.1	19.5	15.5	15.8	30.5	28.1	19.3	29.8	35.3	28.7	49.1	27.6	33.5	22.7	24.0	29.0	30.6	20.1	15.9	24.9	11.7	12.4	28.2	12.8	22.4	24.2	26.2	29.0	27.6	25.8	19.3	13.5	23.5	15.2	16.5	14.1	34.1	19.4	14.0	26.1	21.7	20.3	21.5	17.2	14.2	13.1	14.7	1.1	0.8	1.4	1.9	3.0	1.3	2.6	1.0	1.7	2.3	2.1	1.6	2.0	0.3	1.2	4.2	1.2	2.2	0.8	12.8	13.3	14.5	13.5	12.3	12.8	13.2	12.8	13.5	11.1	14.7	14.3	10.6	9.6	6.4	4.9	38.3	14.5	9.0	4.2	8.0	13.6	7.6	6.7	7.3	4.3	6.3	12.9	14.6	6.3	9.8	13.3	9.8	14.8	23.4	12.3	19.8	11.2	12.6	6.9	12.0	11.4	7.5	9.7	10.2	21.8	3.8	11.0	11.0	4.6	11.4	33.7	12.2	10.3	2.0	10.3	7.2	28.4	6.2	9.0	8.8	15.0	12.1	7.5	12.3	9.5	12.9	16.6	8.1	4.9	8.2	12.4	14.6	9.7	7.2	11.7	6.6	12.4	10.6	6.3	12.5	12.5	16.9	4.8	11.1	6.4	12.0	10.2
PRMT9	"FLJ46629, PRMT10"	ENSG00000164169	"Protein arginine methyltransferase 9"	Q6P2P2	4	147637785-147684163	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 112.6;Rod photoreceptor cells: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036844, HPA042537"	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Microtubules	"Nucleoplasm, Cytosol"	"HPA036844: AB_10672341, HPA042537: AB_2678043"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (3.58e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.30e-2)"	3.2	9.9	1.4	2.8	1.8	8.5	4.1	3.1	2.4	2.8	1.8	2.3	1.4	4.6	3.1	2.9	3.3	3.0	2.8	2.0	1.8	4.3	3.4	3.2	3.5	1.4	1.6	11.3	3.3	6.1	3.6	3.0	1.5	3.4	2.6	5.2	2.7	3.3	3.3	2.8	1.8	2.7	1.6	2.8	3.1	7.1	1.7	4.5	5.7	2.5	3.0	2.5	2.3	1.6	2.8	1.8	4.3	3.3	3.3	5.6	3.8	3.1	4.9	4.6	4.8	1.4	3.1	9.8	1.3	2.7	2.3	1.9	5.1	2.6	6.3	3.5	3.0	5.4	3.6	2.3	2.5	8.0	2.8	3.9	2.7	2.8	2.5	3.7	3.9	4.8	5.4	5.5	3.9	1.6	6.8	3.1	2.2	2.7	3.2	4.5	3.7	3.6	3.7	2.2	2.7	4.1	4.9	3.8	2.5	2.8	1.6	1.7	3.3	2.9	2.4	3.3	3.4	6.2	5.3	6.1	3.3	4.8	2.2	6.1	4.2	8.6	4.7	4.7	4.6	7.4	5.7	5.8	3.0	7.2	7.1	6.2	2.8	4.3	3.5	4.4	5.5	2.1	1.4	1.8	3.1	2.4	2.0	1.8	1.4	1.6	1.5	1.6	1.7	1.6	8.7	0.0	5.3	9.8	40.4	0.0	4.2	0.0	26.7	56.5	11.7	21.8	5.9	7.2	0.6	35.0	112.6	14.5	51.6	6.2	5.9	7.0	73.1	9.2	9.5	8.4	17.4	10.3	29.8	6.5	14.8	12.9	11.2	13.0	33.7	15.6	12.8	6.9	17.2	50.5	29.8	7.2	0.0	36.5	0.0	13.4	18.0	63.7	0.0	17.8	10.9	48.1	16.5	20.6	16.3	7.4	6.2	17.0	18.4	4.1	7.4	5.5	1.5	81.1	13.1	6.2	18.5	36.5	19.6	4.3	0.0	15.2	61.2	18.5	6.3	2.0
PRPS2		ENSG00000101911	"Phosphoribosyl pyrophosphate synthetase 2"	P11908	X	12791355-12824222	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 147.8;parathyroid gland: 182.0"	"Group enriched"	"Detected in many"	7	"Leydig cells: 1431.5;Peritubular cells: 1995.0;Sertoli cells: 624.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA051269, HPA067599, CAB070417"	Enhanced		Approved	"Nuclear speckles,Vesicles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nuclear speckles"	"CAB070417: AB_11152035, HPA051269: , HPA067599: AB_2685869"	"unprognostic (7.50e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (2.09e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.64e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	11.0	46.0	6.3	24.5	7.3	24.2	19.7	1.9	12.0	54.5	2.5	30.3	14.0	32.8	26.5	16.1	29.7	28.1	5.4	6.9	2.9	28.0	26.1	13.1	36.8	3.0	6.5	147.8	62.8	182.0	3.4	6.1	2.2	21.9	31.3	1.3	27.9	84.0	2.1	21.9	15.8	24.3	4.4	15.6	32.5	131.1	8.8	44.6	18.1	4.2	31.5	22.5	21.2	6.4	114.2	63.7	22.1	40.3	26.7	31.8	14.6	54.4	26.8	53.1	51.1	46.3	78.7	34.9	24.2	23.5	45.3	79.9	43.1	53.7	61.5	89.7	108.0	41.7	49.6	43.3	24.7	77.3	38.9	30.5	35.0	39.1	51.7	26.9	22.1	86.8	30.4	39.8	45.2	68.5	117.6	34.7	49.9	81.0	107.3	61.5	102.7	79.5	33.0	81.7	46.1	33.6	64.9	2.1	38.9	30.2	58.8	32.4	24.9	41.8	32.0	162.5	55.5	103.6	41.3	76.8	44.4	39.4	67.4	25.9	20.1	9.4	17.2	19.4	19.9	27.8	25.0	16.4	28.2	30.6	31.7	23.0	8.0	24.3	12.3	19.9	22.6	28.2	6.3	7.3	1.9	12.0	6.9	2.9	3.0	6.5	2.2	4.4	8.8	6.4	12.2	3.2	8.7	0.7	25.4	64.0	48.5	16.2	41.5	0.6	53.1	15.9	2.0	11.5	12.4	55.2	0.0	1.1	18.5	21.1	72.4	19.3	12.1	24.7	62.5	14.5	21.8	28.4	14.8	39.2	7.3	25.8	31.1	26.4	27.9	16.2	10.4	13.7	24.4	0.0	6.3	27.9	8.2	21.4	44.3	65.8	1431.5	20.7	40.9	3.7	18.2	1.2	18.6	3.5	5.1	24.6	17.4	1995.0	30.7	52.2	6.0	10.4	20.3	0.2	624.5	9.4	19.2	10.3	8.1	29.2	43.8	0.4	27.2	179.2	50.2	36.9
PRRT3	FLJ33674	ENSG00000163704	"Proline rich transmembrane protein 3"	Q5FWE3	3	9945542-9952408	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 11.6;fallopian tube: 7.6;parathyroid gland: 15.3;pituitary gland: 11.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.2;MCF7: 23.1;SK-BR-3: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035127, HPA035128, HPA069859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		83000	"Cluster 32: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: "	"unprognostic (1.55e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.15e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.09e-1)"	0.9	1.8	3.9	1.1	5.0	1.5	1.2	10.1	11.6	1.3	0.3	1.3	0.4	1.2	1.2	1.2	7.6	1.1	1.1	4.4	1.1	1.3	0.4	0.9	1.2	5.1	1.9	1.3	1.8	15.3	11.0	0.3	5.3	2.5	0.3	2.2	2.3	1.7	1.4	2.3	0.9	0.9	0.0	0.9	1.1	2.1	3.6	1.3	2.2	0.2	1.3	1.8	1.1	4.8	0.4	1.0	3.6	4.7	17.2	2.3	1.2	1.8	3.4	2.0	4.5	0.3	3.4	2.0	0.4	4.2	2.1	0.3	1.3	4.5	0.9	9.8	2.0	0.7	1.9	0.2	1.7	0.4	1.7	4.4	0.3	1.7	0.7	9.7	0.8	6.0	1.0	4.7	2.5	23.1	4.4	0.4	8.5	0.1	2.1	2.8	0.4	1.9	1.0	0.4	6.6	4.4	1.8	33.6	0.7	1.4	9.1	0.4	0.7	0.4	4.6	0.9	1.3	6.1	6.6	0.6	10.9	0.3	1.3	0.5	0.2	0.2	1.2	0.1	1.4	0.5	1.3	1.2	0.0	0.6	1.4	1.3	0.3	0.7	0.1	0.6	0.2	0.4	3.9	5.0	10.1	11.6	4.4	1.1	5.1	1.9	5.3	0.0	3.6	4.8	3.3	0.0	2.0	3.9	2.9	2.7	3.8	3.7	3.4	22.8	7.4	6.2	3.0	7.2	3.4	11.0	14.6	0.7	4.4	4.5	3.9	2.9	4.3	5.0	5.4	3.3	11.3	2.1	14.7	5.0	0.5	5.2	5.6	4.9	1.3	7.9	2.2	2.9	3.8	15.2	10.8	5.4	2.0	2.5	2.6	3.5	5.6	2.2	1.8	2.8	11.3	8.6	11.3	5.5	3.7	3.1	1.0	2.6	2.2	4.2	6.4	8.0	12.4	21.6	0.0	7.2	5.3	10.4	6.4	3.4	2.3	0.4	5.6	7.8	4.7	3.0
PTCH2		ENSG00000117425	"Patched 2"	Q9Y6C5	1	44819844-44843253	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ovary: 24.6;parathyroid gland: 59.1;salivary gland: 75.2;testis: 25.6"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 107.8;Peritubular cells: 68.1;Plasma cells: 67.1;Theca cells: 138.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA046839			Supported	"Nucleoli,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	Nucleoli	"HPA046839: "	"unprognostic (6.54e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.89e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.67e-2)"	"prognostic favorable (5.74e-5)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-6)"	"unprognostic (1.55e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.81e-2)"	4.2	3.1	6.1	0.8	3.5	9.4	3.4	6.8	6.8	5.1	3.6	3.6	1.0	6.4	1.6	0.9	4.3	2.5	1.3	3.1	4.4	1.3	1.3	1.0	2.3	2.9	4.8	24.6	1.0	59.1	9.9	0.3	2.0	3.0	0.9	3.6	75.2	1.3	2.0	3.6	1.8	1.2	1.6	2.4	2.0	25.6	6.5	0.8	4.6	0.8	0.7	3.1	3.4	4.8	0.2	0.3	1.0	2.5	0.8	0.9	1.0	0.8	1.6	0.5	0.4	0.2	0.4	1.1	0.4	0.4	0.5	0.0	1.1	0.0	0.2	2.1	1.9	0.6	1.0	0.8	0.3	0.7	1.1	0.3	0.4	1.0	0.1	1.7	0.1	1.0	0.7	1.1	0.0	0.5	1.4	2.1	0.3	0.1	0.4	1.0	0.2	0.5	0.2	0.0	1.5	0.6	0.3	0.4	0.8	0.5	0.2	1.2	0.1	0.2	0.5	1.3	0.5	1.9	11.6	3.2	0.6	3.0	0.4	2.5	1.9	0.1	0.5	0.9	1.0	1.0	0.6	0.6	1.2	1.4	0.7	0.6	0.6	0.9	0.9	3.6	0.3	0.2	6.1	3.5	6.8	6.8	3.1	4.4	2.9	4.8	2.0	1.6	6.5	4.8	2.8	0.0	1.1	14.0	13.4	0.5	0.7	1.0	0.6	0.8	4.8	8.0	1.0	7.2	1.0	1.8	2.1	2.4	6.8	7.8	0.0	5.5	2.3	9.3	13.5	2.7	11.5	1.3	23.7	1.8	1.6	14.3	28.1	8.5	0.0	4.4	0.7	7.9	6.7	8.4	27.3	4.9	2.0	24.5	2.2	8.0	107.8	17.3	0.0	5.6	3.9	2.4	2.1	9.5	2.6	2.1	2.5	68.1	67.1	0.8	13.6	0.2	1.7	1.2	13.1	5.4	5.6	5.0	3.6	0.6	1.6	2.3	7.5	138.7	5.5	0.2
PTH	PTH1	ENSG00000152266	"Parathyroid hormone"	P01270	11	13492054-13496181	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	245	"parathyroid gland: 50184.7"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 1.0;Oligodendrocyte precursor cells: 1.0;Oligodendrocytes: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000072, CAB023409, CAB026363, HPA048540"	Enhanced				"Secreted to blood"	NA	NA	28000			"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB000072: , CAB023409: AB_619175, CAB026363: , HPA048540: AB_2680435"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	50184.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.2	205.2	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTN	"HBGF8, HBNF, NEGF1"	ENSG00000105894	Pleiotrophin	P21246	7	137227341-137343774	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 280.4;parathyroid gland: 383.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 672.0;Extravillous trophoblasts: 416.0;Horizontal cells: 526.6;Muller glia cells: 548.5;Oligodendrocyte precursor cells: 322.7;Squamous epithelial cells: 439.9"	"Cancer enriched"	"Detected in all"	11	"glioma: 514.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"AF22: 1717.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017685, HPA073913"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	167000	1400000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	"Endoplasmic reticulum"		"CAB017685: AB_1128556, HPA073913: "	"unprognostic (1.51e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	26.2	18.2	212.9	4.1	206.4	0.1	82.3	217.0	280.4	100.0	182.0	31.4	5.4	76.8	55.3	78.2	19.2	55.9	87.7	209.6	205.2	38.4	8.5	18.4	7.4	220.3	200.5	19.0	8.4	383.5	126.1	36.2	196.3	116.1	21.6	63.4	37.4	52.5	2.2	9.1	10.1	54.0	204.2	40.4	15.7	53.8	207.6	21.4	18.9	18.8	11.4	24.8	65.1	209.1	1.2	0.0	1717.6	21.2	0.4	0.9	140.6	45.3	134.3	25.1	34.3	0.4	0.2	0.0	0.2	60.0	15.6	1.0	0.0	0.0	18.9	0.0	1.4	0.0	0.0	0.0	7.7	0.0	0.5	1.9	0.0	16.6	0.2	24.6	0.0	0.0	0.0	8.2	7.0	0.0	0.0	0.6	133.5	0.0	1.1	0.1	2.8	0.4	0.7	0.0	8.0	116.5	0.0	0.0	0.2	24.1	0.2	0.2	0.0	37.4	32.9	1.8	99.4	0.7	0.0	0.0	119.7	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.9	206.4	217.0	280.4	209.6	205.2	220.3	200.5	196.3	204.2	207.6	209.1	10.1	0.0	0.0	303.3	1.3	23.2	1.7	85.0	209.5	27.7	244.6	117.3	14.6	2.8	20.9	1.8	6.2	220.0	2.2	0.0	9.8	1.1	24.5	53.4	672.0	32.0	0.0	0.0	4.9	0.0	416.0	248.8	0.5	24.6	0.0	1.1	7.1	0.3	20.4	526.6	18.1	0.0	0.0	0.3	20.6	14.0	172.7	4.0	44.4	102.1	0.0	548.5	0.0	322.7	218.4	0.3	0.0	185.5	2.5	18.6	0.0	7.5	7.2	32.3	59.2	3.0	91.4	4.0	2.4	439.9	13.9	193.3	4.4	144.7	0.0	2.2
PTPRA	"HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA"	ENSG00000132670	"Protein tyrosine phosphatase receptor type A"	P18433	20	2864184-3039076	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029412, CAB034366, HPA069480"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: AB_2686141"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.43e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.24e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.29e-6)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.19e-1)"	48.8	36.6	83.9	31.9	89.3	39.6	47.4	84.2	96.1	56.4	59.5	41.6	31.0	53.0	36.7	46.1	52.7	43.7	29.5	87.7	83.5	44.2	28.6	45.4	38.9	74.7	81.9	55.8	31.2	81.9	44.8	60.8	78.3	46.3	40.6	61.5	36.3	41.9	16.9	45.8	32.7	52.4	76.3	39.4	34.5	43.4	92.6	59.6	65.5	30.7	44.3	46.6	38.9	81.1	74.0	44.2	124.7	38.4	134.4	243.3	26.5	54.1	105.1	65.5	79.6	53.1	99.5	48.1	41.6	73.1	66.1	77.2	51.0	77.4	73.4	74.7	32.7	68.5	18.3	68.0	48.1	69.5	31.1	109.8	78.2	54.4	56.8	80.3	92.0	67.7	69.9	59.7	65.8	30.4	80.8	78.3	48.3	66.0	35.0	61.0	60.5	60.3	55.1	56.2	68.7	65.7	52.3	87.8	81.4	54.0	55.2	58.7	66.5	58.1	28.6	65.6	48.5	43.4	64.7	62.7	26.9	64.5	55.7	5.7	2.8	4.8	6.1	2.9	4.9	5.3	4.0	4.4	2.1	2.6	4.0	4.8	3.3	4.0	4.3	3.2	4.9	2.3	83.9	89.3	84.2	96.1	87.7	83.5	74.7	81.9	78.3	76.3	92.6	81.1	87.0	22.4	19.2	128.6	46.7	15.8	34.0	15.0	34.7	88.9	49.0	43.9	10.1	54.3	24.5	46.0	31.3	35.3	111.7	39.8	27.4	14.8	17.0	62.0	109.0	39.7	44.3	42.3	138.2	15.8	40.5	67.5	25.0	55.3	22.9	60.3	43.5	33.6	39.4	70.7	136.4	27.9	24.4	37.6	20.4	17.2	60.3	40.1	37.4	52.5	29.9	88.3	110.2	102.5	147.5	16.6	30.2	48.9	58.6	32.9	27.1	23.6	26.6	60.5	39.5	53.3	61.8	68.7	84.1	32.9	17.2	32.7	59.7	41.4	30.4	31.5
PTPRD	"HPTP, PTPD"	ENSG00000153707	"Protein tyrosine phosphatase receptor type D"	P23468	9	8314246-10612723	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.8"	"Group enriched"	"Detected in many"	12	"Excitatory neurons: 4579.7;Inhibitory neurons: 1152.9;Oligodendrocyte precursor cells: 1170.2;Oligodendrocytes: 3151.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.1;HAP1: 4.3;HSkMC: 6.3;RH-30: 8.1;SCLC-21H: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054829	Uncertain		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		20000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA054829: AB_2682618"	"unprognostic (4.74e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.45e-6)"	"unprognostic (3.56e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.08e-3)"	2.1	0.6	10.8	0.3	24.7	0.1	0.9	12.2	26.2	5.6	0.0	3.3	1.8	2.4	0.2	0.6	2.2	1.0	2.5	14.4	7.2	6.6	3.6	4.6	0.0	14.6	10.1	12.1	1.3	18.7	4.3	5.3	19.1	1.9	2.5	6.4	0.5	0.6	0.9	0.7	5.0	1.0	10.4	0.4	0.9	1.6	17.6	0.7	3.4	0.8	0.0	2.2	3.4	70.8	0.0	0.1	21.1	0.0	0.3	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	2.7	3.6	0.5	0.0	0.0	0.0	0.1	6.3	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.6	0.0	3.4	0.0	3.2	2.3	8.1	0.0	1.8	0.0	4.8	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	24.7	12.2	26.2	14.4	7.2	14.6	10.1	19.1	10.4	17.6	70.8	0.5	0.0	3.2	199.2	0.1	0.5	0.4	3.2	6.2	134.2	0.3	0.1	6.5	27.1	1.8	5.5	16.7	0.3	0.0	16.4	0.0	3.6	15.8	0.8	15.0	1.2	35.4	0.0	4579.7	0.0	0.3	15.5	0.5	1.0	0.0	9.2	1.4	13.5	1.3	5.0	1152.9	13.2	0.0	0.8	0.0	6.5	15.8	1.6	0.0	85.3	0.1	36.1	0.0	1170.2	3151.1	0.2	9.2	0.0	2.7	2.1	18.3	26.3	0.2	7.8	0.0	4.0	5.8	2.4	3.2	0.4	0.9	0.3	0.8	6.0	8.7	0.1
PVALB	D22S749	ENSG00000100362	Parvalbumin	P20472	22	36800684-36819479	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 2129.3"	"Group enriched"	"Detected in some"	7	"Distal tubular cells: 641.8;Horizontal cells: 1527.7"	"Cancer enriched"	"Detected in many"	4	"renal cancer: 59.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.6"	"Cell line enriched"	"Detected in some"	291	"RPMI-8226: 1561.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 2120.1"	"Low region specificity"	"Detected in all"			"CAB002515, HPA048536"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		No	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Nucleoli, Cell Junctions"	"CAB002515: AB_563948, HPA048536: AB_2680433"	"unprognostic (4.41e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.65e-2)"	"unprognostic (8.99e-3)"	0.4	1.0	82.5	0.7	40.2	0.1	15.0	255.6	86.5	0.1	8.6	0.3	0.2	1.4	0.8	0.1	0.1	0.3	0.2	9.3	100.5	82.1	5.7	2.2	2.4	127.4	85.7	0.5	0.2	2129.3	1.2	2.4	105.7	0.3	0.3	373.5	2.7	0.7	13.6	0.1	0.3	0.5	50.9	3.2	0.8	1.5	275.5	0.3	5.0	0.4	3.1	3.8	0.2	51.8	0.0	0.0	3.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.1	0.4	1561.0	0.0	5.3	2.3	0.0	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	4.6	0.0	0.0	0.9	0.3	15.1	82.5	40.2	255.6	86.5	9.3	100.5	127.4	85.7	105.7	50.9	275.5	51.8	0.0	0.0	0.0	3.9	0.3	0.0	0.0	0.0	0.0	51.3	2.4	2.0	0.6	0.0	0.0	38.6	10.4	0.3	0.0	0.0	641.8	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	11.4	0.2	30.0	0.2	53.8	1527.7	29.7	0.0	0.0	2.9	0.0	0.1	0.6	15.7	0.0	2.8	0.1	37.4	0.0	3.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	150.5	0.0	1.0	0.0	0.0	3.6	0.0	0.0	0.4	0.9	0.0	0.0	0.1
RAB15		ENSG00000139998	"RAB15, member RAS oncogene family"	P59190	14	64945814-64973226	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 51.3;Inhibitory neurons: 28.0;Intestinal goblet cells: 35.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 83.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 128.1;RH-30: 151.2;RT4: 116.1;SK-BR-3: 116.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041177	Uncertain		Approved	"Vesicles,Centriolar satellite"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Centriolar satellite"		"HPA041177: AB_10794547"	"unprognostic (9.80e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.82e-2)"	2.8	4.9	30.0	6.2	35.0	0.8	8.4	28.2	43.2	7.3	13.4	13.5	12.7	4.2	5.6	4.3	4.7	6.2	33.4	38.9	22.6	19.3	21.2	9.9	3.8	21.2	20.7	2.2	12.6	39.4	9.6	16.1	28.6	10.9	20.2	5.8	36.5	4.6	10.0	7.2	13.1	11.8	17.2	2.8	10.9	1.7	25.5	7.7	6.7	1.2	3.0	17.9	5.0	31.5	10.9	57.0	20.3	20.3	4.5	6.4	57.6	6.7	9.3	13.5	11.8	26.8	28.4	0.6	3.9	16.5	6.2	10.9	128.1	1.3	9.5	3.6	6.2	12.3	1.1	23.5	0.6	0.6	7.5	4.4	2.5	5.9	1.2	3.5	42.6	29.2	0.4	2.0	23.9	61.8	15.2	11.3	45.8	65.6	8.2	18.5	151.2	1.0	15.8	116.1	65.4	12.7	3.4	116.7	15.0	23.6	33.2	11.8	11.2	11.5	49.0	5.5	8.7	0.6	0.4	5.8	2.4	0.3	8.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.9	0.1	0.0	30.0	35.0	28.2	43.2	38.9	22.6	21.2	20.7	28.6	17.2	25.5	31.5	1.7	6.4	3.9	5.9	0.8	2.5	3.2	1.3	0.6	2.9	12.4	7.4	22.2	4.3	4.2	16.5	0.0	24.7	5.0	5.5	3.9	7.9	0.5	6.6	2.8	3.7	1.2	0.0	51.3	12.2	16.0	2.0	2.6	13.6	1.3	4.1	4.6	8.7	2.7	11.8	28.0	35.2	0.0	0.3	1.3	1.1	0.3	0.9	0.0	4.7	1.0	2.0	1.0	10.6	4.9	13.0	5.5	1.5	0.2	5.6	2.9	5.9	1.3	2.9	0.0	2.4	5.2	0.9	0.4	1.6	1.1	17.9	1.5	1.5	12.0	14.1
RAB5A	RAB5	ENSG00000144566	"RAB5A, member RAS oncogene family"	P20339	3	19947097-19985175	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Endocytosis, Phagocytosis, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004567, HPA049354"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Vesicles"		"CAB004567: AB_628191, HPA049354: AB_2680725"	"unprognostic (2.49e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	35.7	27.3	39.2	27.0	39.9	41.4	33.2	42.1	49.5	30.5	36.6	29.7	29.6	22.7	42.4	42.3	21.1	32.2	36.3	38.6	43.1	33.6	42.8	29.5	24.3	42.7	42.5	19.9	27.2	53.8	20.5	49.2	42.2	30.7	30.5	35.4	35.8	28.8	29.1	36.0	28.2	28.0	44.0	24.2	32.6	18.0	41.1	28.9	41.1	30.3	29.1	35.4	29.7	46.1	29.8	26.8	38.5	26.4	65.8	57.8	38.9	51.3	59.7	47.8	55.0	31.9	45.7	21.8	30.3	56.7	27.6	18.4	29.0	38.2	55.7	37.9	24.1	31.9	24.9	31.1	82.2	45.0	38.1	53.6	71.0	56.1	81.9	59.9	61.6	28.5	37.1	34.1	57.9	46.2	34.8	31.9	48.4	40.8	42.6	25.8	27.2	32.2	98.9	38.8	12.0	39.6	36.9	45.3	60.3	57.0	35.4	35.8	61.6	34.5	30.1	44.4	44.2	42.0	73.5	28.6	55.0	40.4	57.1	28.7	18.0	31.3	7.9	19.6	10.6	7.9	9.3	9.6	18.1	5.8	8.5	8.1	36.0	20.3	26.3	11.8	10.9	11.5	39.2	39.9	42.1	49.5	38.6	43.1	42.7	42.5	42.2	44.0	41.1	46.1	114.8	60.9	45.1	33.0	43.6	170.0	129.5	48.8	62.0	34.0	57.0	35.9	57.0	27.1	52.6	42.3	31.3	74.7	44.2	68.7	103.7	52.2	21.2	45.9	44.4	72.4	62.0	55.3	33.7	45.3	67.2	65.2	66.3	72.0	85.0	39.1	41.7	39.3	54.2	15.2	31.4	59.4	65.1	44.4	158.8	15.9	36.7	60.9	83.6	28.1	43.1	86.1	41.2	65.9	44.1	65.2	55.9	35.3	50.7	109.7	49.4	62.3	48.1	36.8	52.6	86.5	72.4	24.6	27.1	65.0	188.0	164.3	60.6	37.1	41.5	151.0
RAB6C	WTH3	ENSG00000222014	"RAB6C, member RAS oncogene family"	Q9H0N0	2	129979666-129982738	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.6;breast: 2.5;parathyroid gland: 3.6"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 10.3;Oligodendrocytes: 3.3"	"Group enriched"	"Detected in some"	5	"breast cancer: 0.7;prostate cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.5;HMC-1: 2.2;REH: 5.4;T-47d: 3.2;U-266/70: 2.1"									HPA059131	Uncertain		Uncertain	"Golgi apparatus"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 6: T47d - Mammary gland"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Golgi apparatus"		"HPA059131: AB_2683916"	"unprognostic (3.84e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.48e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.78e-1)"	0.1	0.6	1.4	0.1	2.2	0.0	2.5	0.7	1.9	1.9	0.7	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.2	1.3	1.6	0.1	0.0	0.0	0.0	1.2	1.2	0.1	0.0	3.6	0.2	0.3	1.3	1.7	0.0	0.3	0.0	0.4	0.1	0.0	0.1	0.0	0.7	0.5	0.0	0.9	1.6	0.0	0.1	0.0	0.0	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.4	0.1	0.5	3.2	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.7	1.9	1.3	1.6	1.2	1.2	1.3	0.7	1.6	3.6	0.1	0.0	0.0	0.3	0.1	0.8	0.3	0.3	0.0	0.0	0.9	0.1	10.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.1	1.7	1.0	0.0	0.0	0.7	0.0	1.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.4	0.0	0.3	0.4	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.7	0.0	0.6	0.7	0.0	0.1	0.0	0.0	0.6	1.4	1.4	1.3	0.0	1.1	0.5	0.1	0.1	0.1	0.3
RAB6D	"RAB6CL, WTH3DI"	ENSG00000233087	"RAB6D, member RAS oncogene family"	Q53S08	2	131361111-131364142	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"parathyroid gland: 7.4"	"Cell type enriched"	"Detected in single"	15	"Respiratory ciliated cells: 1.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MOLT-4: 2.2"									HPA059131	Uncertain		Approved	"Golgi apparatus"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"		"HPA059131: AB_2683916"	"unprognostic (4.19e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.08e-1)"	"unprognostic (4.79e-2)"		"unprognostic (4.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.12e-1)"	0.0	0.2	0.6	0.1	0.5	0.0	0.0	0.0	0.8	0.1	0.0	0.9	0.2	0.1	0.3	0.0	0.1	0.2	0.0	0.6	0.9	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	7.4	0.0	0.0	0.5	1.4	0.8	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.0	0.0	1.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.3	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.8	0.6	0.9	0.3	0.2	0.5	0.2	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RALB		ENSG00000144118	"RAS like proto-oncogene B"	P11234	2	120240064-120294710	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Cell division"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"parathyroid gland: 335.7"	"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 138.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 378.4"	"Group enriched"	"Detected in all"	4	"granulocytes: 378.4;monocytes: 176.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026010, HPA065232"	Enhanced					NA	NA		440000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB026010: , HPA065232: AB_2685440"	"unprognostic (5.16e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.77e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (2.29e-2)"	"unprognostic (8.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.72e-2)"	53.8	35.9	30.6	57.2	30.8	60.0	39.9	32.8	38.7	44.3	33.1	59.2	50.5	37.5	15.8	73.3	45.7	44.8	51.0	32.3	37.7	56.5	34.2	50.7	35.8	30.8	33.6	28.7	25.6	335.7	16.6	63.1	30.6	51.0	51.8	25.8	36.2	31.7	30.1	25.7	44.8	46.5	31.3	54.2	39.3	29.9	37.9	27.5	30.8	43.9	35.0	51.0	49.1	32.8	179.8	47.7	46.8	29.5	71.2	115.5	66.7	121.4	105.8	93.3	70.5	99.4	118.0	7.1	63.9	131.6	88.2	64.1	22.5	93.1	85.7	293.3	25.8	84.4	36.3	71.3	46.0	45.1	144.9	60.3	99.0	97.2	74.0	77.1	272.9	6.3	66.5	28.1	108.2	91.9	5.9	100.0	31.7	71.6	101.9	1.2	59.3	38.1	97.5	45.6	13.3	32.1	50.4	137.9	85.1	39.3	43.3	66.3	168.4	91.1	69.8	93.9	48.8	16.2	9.1	12.8	72.7	57.5	95.6	101.8	80.9	230.5	19.0	117.7	18.5	45.0	18.0	19.0	65.4	59.6	11.9	13.7	378.4	25.5	176.1	6.9	24.6	59.5	30.6	30.8	32.8	38.7	32.3	37.7	30.8	33.6	30.6	31.3	37.9	32.8	69.3	9.6	27.0	6.5	23.8	19.4	30.1	22.4	7.4	4.1	23.2	7.9	55.8	18.6	21.9	11.0	12.5	6.0	11.8	95.3	66.5	84.9	18.8	28.4	22.8	77.8	18.6	8.4	12.9	55.0	128.5	32.7	17.9	26.7	106.1	90.6	78.5	9.8	53.6	13.5	9.7	19.1	18.3	54.3	59.4	23.0	19.9	66.7	35.6	16.9	62.6	26.3	21.6	10.1	5.4	138.1	62.1	31.2	6.7	28.5	44.6	104.4	46.3	7.5	19.7	18.3	33.4	13.1	16.2	16.4	18.9	36.7	19.5	12.9	31.3	32.2
RALGAPB	"DKFZp781M2411, KIAA1219, RalGAPbeta"	ENSG00000170471	"Ral GTPase activating protein non-catalytic subunit beta"	Q86X10	20	38472816-38578859	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051454	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA051454: AB_2681490"	"unprognostic (1.06e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.51e-2)"	"prognostic favorable (7.25e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	9.6	10.6	7.6	12.1	9.5	12.3	16.1	13.4	10.8	12.1	14.3	11.9	12.1	12.0	12.7	13.9	10.9	10.7	10.5	9.6	9.4	14.4	8.5	11.1	12.2	8.7	8.0	11.6	11.7	24.2	10.5	14.3	8.5	14.4	13.3	18.7	10.8	12.7	12.1	13.7	11.9	12.9	7.6	11.1	12.4	20.8	9.7	17.6	18.1	14.4	14.9	15.3	9.3	9.8	25.3	23.4	23.8	17.5	22.5	25.9	25.3	20.3	23.6	24.8	24.3	42.3	18.6	23.7	18.9	23.7	36.5	29.2	22.6	30.8	34.8	13.6	9.6	36.2	21.0	24.3	21.3	29.6	18.4	18.5	39.1	29.3	32.0	19.7	32.9	20.0	26.8	22.9	24.2	16.5	34.1	12.5	17.5	24.9	30.1	19.4	34.0	15.9	16.5	46.7	25.1	27.6	44.9	59.8	37.4	27.2	34.8	15.0	39.2	49.9	19.9	28.6	20.8	26.6	34.9	21.1	36.1	14.2	22.5	1.2	0.9	2.4	1.2	0.7	1.6	1.3	1.7	1.5	1.4	1.0	1.5	1.2	1.7	2.0	1.3	0.9	0.8	0.6	7.6	9.5	13.4	10.8	9.6	9.4	8.7	8.0	8.5	7.6	9.7	9.8	23.1	22.4	17.1	47.7	18.6	13.9	7.4	12.4	17.1	24.4	19.5	12.3	20.0	10.0	17.7	31.3	27.1	10.4	23.4	26.9	3.9	9.4	11.8	24.3	20.2	17.4	12.6	14.9	63.3	9.3	7.8	15.7	30.5	28.8	16.5	19.4	23.2	12.1	9.7	20.2	66.0	16.1	16.2	17.7	11.6	8.7	16.8	14.7	10.6	49.6	15.1	10.0	16.5	58.3	81.0	15.2	20.4	18.8	16.7	16.1	26.9	9.0	20.9	18.3	13.1	16.8	13.5	31.8	24.0	19.7	18.0	15.2	19.4	15.9	15.8	14.2
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719482-108785809	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA		160000	"Cluster 38: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear membrane"	"Nucleoplasm, Vesicles"	"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.3	24.3	8.6	16.3	11.6	42.1	19.7	14.4	17.1	18.1	20.3	15.6	13.4	17.7	20.5	14.3	14.6	13.7	14.9	11.8	9.4	18.1	17.4	14.0	18.6	9.2	8.1	24.4	20.2	30.1	21.5	16.5	9.5	20.9	15.2	26.5	16.4	17.2	30.3	17.2	13.4	15.2	8.6	15.0	17.6	21.3	8.2	23.3	28.4	23.6	18.0	16.9	12.1	12.2	40.5	24.2	34.1	31.0	38.7	34.5	32.9	35.5	28.0	28.7	25.1	60.7	18.9	63.2	26.8	37.2	35.3	33.1	58.9	36.9	41.5	38.9	28.5	65.9	30.3	43.2	22.5	77.9	21.3	29.1	27.5	44.9	34.7	28.3	44.5	27.1	71.9	34.0	38.4	22.3	34.8	31.6	43.0	20.3	28.7	32.3	52.3	30.7	25.3	49.6	49.4	22.6	31.5	26.7	34.7	20.4	17.2	35.4	53.5	29.8	39.6	21.2	40.2	27.9	44.4	55.8	23.1	34.4	23.5	5.4	2.6	2.7	3.7	1.7	4.1	2.7	3.0	3.4	2.2	2.7	2.9	3.3	3.9	2.2	3.6	2.6	2.7	1.4	8.6	11.6	14.4	17.1	11.8	9.4	9.2	8.1	9.5	8.6	8.2	12.2	54.5	76.9	85.3	48.6	91.5	55.7	34.5	39.1	61.5	51.2	34.1	25.8	103.9	38.6	63.0	58.8	73.0	28.8	96.1	28.9	1.9	34.7	77.3	83.6	65.3	55.7	106.4	50.5	125.5	50.9	17.5	56.5	68.3	142.1	84.9	52.2	31.4	56.6	47.9	32.0	92.2	59.5	44.7	44.9	80.7	32.9	38.5	114.0	48.0	55.3	57.0	20.0	34.0	44.2	80.0	41.5	29.9	56.1	118.4	44.1	28.8	15.6	67.0	40.5	46.0	56.9	59.0	78.3	65.4	53.3	67.8	40.6	104.8	25.3	38.3	38.7
RAPGEF5	"GFR, KIAA0277, MR-GEF"	ENSG00000136237	"Rap guanine nucleotide exchange factor 5"	Q92565	7	22118236-22357154	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 152.1;parathyroid gland: 387.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 504.6;Inhibitory neurons: 193.4;Microglial cells: 138.7;Oligodendrocytes: 640.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 21.1;HUVEC TERT2: 45.0;SCLC-21H: 34.1;TIME: 25.8;U-698: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057821, HPA076772"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA057821: AB_2683538, HPA076772: AB_2686814"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (3.52e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.26e-3)"	21.0	12.7	30.7	7.0	82.9	0.9	16.4	76.1	58.5	8.9	2.9	9.5	7.5	8.8	4.8	13.9	8.3	16.8	16.8	45.7	46.9	16.7	21.8	37.5	14.3	115.3	71.8	6.5	20.1	387.8	7.4	67.2	107.1	5.1	11.0	4.2	7.6	5.7	5.1	9.2	8.3	12.1	82.0	50.9	7.0	6.4	59.8	15.7	11.7	11.1	10.7	9.3	11.9	152.1	2.8	0.0	4.6	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	5.5	1.4	21.1	1.1	0.3	0.7	13.0	2.8	1.9	0.0	0.0	4.2	0.3	0.0	5.4	0.1	0.0	0.1	0.5	2.4	1.3	0.7	0.7	45.0	5.9	4.8	0.1	0.0	1.2	3.0	0.1	3.6	5.4	4.0	5.2	0.0	7.4	4.2	1.9	34.1	9.0	0.5	6.0	0.1	0.7	3.0	0.1	25.8	0.0	1.0	0.4	1.1	10.9	2.5	37.4	0.5	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	82.9	76.1	58.5	45.7	46.9	115.3	71.8	107.1	82.0	59.8	152.1	125.5	9.6	16.5	13.4	3.1	11.0	4.2	2.4	86.0	30.6	8.8	5.5	10.0	15.7	3.8	0.0	0.0	0.3	0.6	16.0	1.9	6.5	61.5	3.3	1.2	70.1	7.2	0.4	504.6	7.0	0.1	5.3	16.3	10.8	8.2	0.1	86.0	6.3	0.2	23.5	193.4	18.3	2.0	3.1	2.0	65.2	1.8	0.9	7.2	138.7	0.0	0.6	0.0	28.1	640.8	5.0	20.3	4.9	12.9	3.0	18.1	0.3	0.5	1.6	85.5	1.4	21.5	1.2	1.6	19.8	11.2	0.3	2.4	1.9	10.1	4.4
RASAL1	RASAL	ENSG00000111344	"RAS protein activator like 1"	O95294	12	113098819-113136239	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 59.8;salivary gland: 28.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 36.8;Excitatory neurons: 14.0;Gastric mucus-secreting cells: 57.1;Oligodendrocytes: 46.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.3;EFO-21: 19.3;REH: 22.3;RPMI-8226: 50.0;RPTEC TERT1: 19.0;U-698: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041650	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA041650: AB_2677598"	"unprognostic (9.95e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (1.27e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-1)"	0.0	15.4	10.9	1.2	13.8	0.5	1.0	0.5	19.1	3.5	1.1	1.7	0.4	0.1	0.1	22.6	1.6	0.3	0.0	23.6	4.0	17.2	0.1	0.2	1.1	1.7	4.3	0.0	1.1	59.8	5.0	0.2	1.8	0.2	1.1	0.5	28.5	3.9	0.0	11.4	0.5	0.0	0.6	0.2	10.6	0.7	7.7	0.2	10.1	0.0	2.7	0.2	5.3	12.1	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	3.9	15.3	19.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	4.3	0.0	0.0	0.6	5.5	0.0	22.3	0.0	50.0	19.0	0.0	0.5	0.0	0.0	7.2	0.0	0.1	2.9	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	42.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	13.8	0.5	19.1	23.6	4.0	1.7	4.3	1.8	0.6	7.7	12.1	0.0	0.0	0.0	1.3	0.8	0.5	0.0	0.4	0.0	0.5	2.4	2.0	4.3	2.8	1.0	36.8	0.0	1.1	0.0	1.9	0.0	1.4	0.1	1.8	0.6	0.3	1.2	0.0	14.0	0.0	0.2	0.3	57.1	4.6	2.5	0.0	0.0	0.0	0.4	0.0	1.0	4.8	0.0	0.0	5.5	0.2	0.0	1.2	1.8	0.0	1.0	2.7	0.0	0.0	46.5	5.2	3.3	0.0	0.6	0.0	0.1	5.2	0.5	0.0	0.0	0.0	0.2	0.1	0.7	4.6	1.1	1.2	0.4	0.1	3.3	0.6
RCAN1	DSCR1	ENSG00000159200	"Regulator of calcineurin 1"	P53805	21	34513142-34615113	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 256.2;parathyroid gland: 453.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 245.5;Endometrial ciliated cells: 336.9;Glandular and luminal cells: 504.9"	"Cancer enhanced"	"Detected in all"		"glioma: 41.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"SK-MEL-30: 1323.8;WM-115: 815.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037218, HPA068436"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB037218: AB_2179743, HPA068436: "	"unprognostic (3.83e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.27e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.60e-3)"	58.5	22.0	59.0	50.3	68.2	6.3	65.0	64.6	79.8	86.4	69.9	39.0	31.6	28.7	8.9	24.5	12.4	57.4	61.6	57.5	65.7	89.8	256.2	38.6	12.9	68.1	65.3	8.7	64.1	453.5	30.7	95.6	68.3	24.1	39.5	13.1	20.4	15.1	34.4	29.1	27.6	48.7	67.4	14.6	34.9	10.5	72.7	82.2	61.0	31.8	9.7	101.3	20.9	75.0	47.7	9.5	47.9	29.6	25.7	15.9	29.1	175.8	181.3	71.1	70.5	54.1	44.7	0.8	8.1	103.4	139.5	4.1	34.4	35.6	94.5	26.8	21.2	9.5	16.5	25.8	98.1	15.3	28.9	41.4	31.9	84.4	58.7	17.9	23.8	32.5	18.1	45.7	47.7	23.1	145.4	12.2	27.4	48.0	23.5	53.9	37.5	22.2	22.8	81.1	23.0	10.1	128.4	82.2	1323.8	43.3	111.4	25.4	25.8	237.5	24.7	39.9	43.1	38.9	26.4	8.5	77.4	44.4	815.5	0.0	1.1	5.0	0.7	2.1	1.0	1.1	0.8	0.7	1.6	0.8	0.3	0.7	0.5	0.1	2.4	3.0	1.1	0.5	59.0	68.2	64.6	79.8	57.5	65.7	68.1	65.3	68.3	67.4	72.7	75.0	158.3	96.1	52.4	15.3	8.2	94.6	20.7	20.5	38.1	19.4	245.5	142.4	24.9	21.5	32.7	206.0	27.1	10.9	11.8	204.9	21.5	82.0	48.3	336.9	46.4	175.4	3.6	7.4	28.3	18.9	15.3	60.3	23.4	504.9	8.8	3.9	25.0	187.8	58.9	3.3	54.2	30.7	4.1	19.6	74.0	13.1	7.2	39.8	56.9	15.9	29.5	10.9	3.1	41.7	71.3	26.3	140.5	9.8	6.1	16.3	41.2	142.3	14.1	7.5	0.0	30.3	68.9	10.8	2.6	12.3	79.3	11.1	11.5	10.5	16.3	50.4
RCBTB1	"CLLD7, CLLL7, FLJ10716"	ENSG00000136144	"RCC1 and BTB domain containing protein 1"	Q8NDN9	13	49531946-49585558	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Cone photoreceptor cells: 64.6;Oligodendrocyte precursor cells: 75.4;Oligodendrocytes: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056783			Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA056783: AB_2683234"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.52e-2)"	"prognostic favorable (5.51e-5)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (1.17e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.49e-2)"	10.9	22.7	24.3	9.9	30.5	14.4	13.2	26.8	30.1	9.2	21.3	7.5	6.5	16.7	20.1	5.6	13.1	9.8	16.2	22.5	30.6	19.0	8.9	13.2	14.8	28.1	28.3	7.7	11.3	48.6	14.5	13.1	27.4	11.2	8.6	49.6	7.9	19.1	7.7	8.3	8.0	14.7	27.1	14.9	10.7	9.2	28.5	19.5	44.2	16.0	11.3	9.5	6.8	31.2	5.7	12.9	27.8	25.3	36.2	31.4	16.2	21.2	21.0	15.7	16.1	10.9	14.0	19.3	4.6	17.5	13.6	7.9	20.8	32.6	26.9	28.5	16.2	23.1	10.7	28.1	43.5	18.6	17.6	28.1	19.6	13.1	20.8	20.7	27.7	37.3	10.4	8.2	31.9	5.3	27.1	10.8	29.0	19.1	7.8	34.8	20.9	12.3	19.6	15.3	14.6	19.4	10.8	8.2	21.7	23.4	11.0	13.3	19.7	11.8	9.5	24.8	10.5	8.4	10.9	31.1	10.5	18.3	16.9	17.1	6.0	6.4	2.7	7.4	3.3	4.5	4.5	2.2	7.6	2.8	2.8	2.7	3.0	2.8	8.9	1.0	9.1	3.5	24.3	30.5	26.8	30.1	22.5	30.6	28.1	28.3	27.4	27.1	28.5	31.2	6.9	44.8	10.8	11.8	6.7	3.7	2.5	2.8	20.5	10.2	7.4	4.4	18.9	8.6	9.3	1.8	64.6	3.0	5.3	1.5	7.9	7.4	0.4	6.3	16.3	10.4	16.2	8.0	13.0	5.0	3.5	4.7	3.6	5.8	2.5	12.1	6.4	7.8	8.8	10.1	13.9	2.9	2.0	14.1	5.5	0.7	3.4	9.0	8.8	23.4	8.3	6.0	3.1	75.4	76.8	5.0	0.7	5.7	6.3	3.5	0.7	12.8	10.3	37.7	39.5	3.1	10.2	1.9	6.0	2.3	2.4	1.1	6.4	35.4	2.1	2.3
REEP5	"C5orf18, D5S346, DP1, POB16, TB2, Yip2e"	ENSG00000129625	"Receptor accessory protein 5"	Q00765	5	112876385-112922289	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003895, HPA069960"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 6: T47d - Mammary gland"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA003895: AB_1845723, HPA069960: AB_2686221"	"unprognostic (3.26e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (5.23e-6)"	"unprognostic (8.29e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.05e-5)"	"unprognostic (2.88e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.24e-2)"	76.9	105.4	97.1	50.5	100.2	27.3	130.6	92.7	120.7	87.1	76.8	66.6	56.8	58.4	120.0	52.1	64.7	60.8	133.2	107.3	110.5	148.0	124.3	80.4	48.2	112.2	104.8	72.2	123.0	140.7	41.5	66.6	115.2	98.9	58.1	81.5	147.7	84.2	114.3	59.1	58.1	55.0	96.4	54.3	70.2	28.3	120.0	32.1	239.4	99.6	56.7	73.2	49.1	98.3	101.7	90.9	29.7	72.5	136.0	115.9	104.7	102.2	92.6	96.4	103.4	74.9	138.1	42.5	179.6	105.1	112.5	107.5	66.8	138.9	88.5	190.6	116.4	42.8	56.3	63.5	126.8	36.9	77.4	81.3	136.0	82.2	78.0	94.5	113.7	38.7	26.0	84.5	121.3	100.0	15.7	60.7	43.4	73.5	75.3	22.4	84.3	116.6	229.1	108.4	56.9	43.1	148.5	244.6	99.8	75.5	287.3	58.9	142.4	83.4	32.0	126.5	126.4	97.6	126.2	33.8	142.6	65.4	47.8	224.4	222.9	234.3	140.1	249.5	149.4	175.7	112.7	133.9	189.0	149.2	52.5	94.6	253.0	112.7	316.2	133.6	177.9	236.4	97.1	100.2	92.7	120.7	107.3	110.5	112.2	104.8	115.2	96.4	120.0	98.3	141.2	166.7	102.3	30.0	131.1	93.0	177.7	291.6	89.4	83.5	225.3	188.1	217.3	145.8	213.7	195.0	89.6	296.0	138.4	77.0	82.2	275.1	231.5	111.8	97.0	130.5	118.0	34.9	78.6	414.1	352.8	182.3	65.7	141.6	108.9	76.0	118.2	197.0	267.1	87.5	95.0	127.5	256.3	135.0	159.9	42.0	116.2	168.8	206.3	36.5	188.6	97.2	101.0	44.7	71.5	316.5	141.1	133.9	271.6	225.3	134.1	146.1	170.6	80.0	111.7	92.6	253.0	162.8	63.9	118.1	101.6	489.8	123.7	100.3	104.5	214.8
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077064-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 20.8;brain: 27.3;parathyroid gland: 31.8"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 79.1;Ionocytes: 26.4;Skeletal myocytes: 23.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 74.6;NB-4: 42.2;SH-SY5Y: 329.3;THP-1: 95.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"midbrain: 53.3;spinal cord: 19.4"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA		2100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	20.8	1.0	1.3	0.9	0.4	1.1	5.1	5.6	1.0	0.2	3.4	1.4	0.6	0.3	0.4	0.5	0.6	2.2	0.3	5.5	0.9	3.0	0.4	0.6	14.4	27.3	0.4	1.3	31.8	5.3	0.5	12.0	1.8	1.4	4.7	5.1	2.0	5.9	0.9	1.4	1.0	4.8	0.2	2.2	2.7	7.6	1.6	0.8	3.1	0.2	0.6	1.4	5.8	0.1	0.4	0.1	1.7	0.0	0.0	0.1	0.7	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	5.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.6	0.0	42.2	7.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	329.3	0.1	0.0	0.1	0.5	4.1	95.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.0	1.0	0.9	5.1	5.6	0.3	5.5	14.4	27.3	12.0	4.8	7.6	5.8	0.4	0.0	0.5	1.6	0.0	0.3	0.8	0.0	0.0	1.7	6.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	1.5	0.0	0.3	1.1	0.0	0.0	4.2	0.2	2.3	6.8	0.0	0.0	1.3	0.5	0.0	1.2	0.1	79.1	8.6	1.9	26.4	0.0	0.6	1.5	0.3	0.5	0.0	1.0	0.0	0.8	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.8	1.7	0.0	23.1	1.2	1.1	4.7	0.0	0.6	0.0	0.2	0.3	0.2	0.1
RHOC	"ARH9, ARHC"	ENSG00000155366	"Ras homolog family member C"	P08134	1	112701127-112707434	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1020.9;Pancreatic endocrine cells: 1304.7;Paneth cells: 945.4;Proximal enterocytes: 952.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 1396.1"	"Lineage enriched"	"Detected in all"	4	"monocytes: 1396.1"	"Cell line enhanced"	"Detected in all"		"WM-115: 2444.5"									HPA051461	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA051461: AB_2681493"	"unprognostic (2.31e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (2.08e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.79e-3)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.51e-3)"	265.2	201.7	183.2	122.7	184.1	20.8	239.2	177.4	207.7	204.7	169.7	297.2	293.2	254.7	312.7	105.1	200.5	185.9	333.8	176.1	209.5	304.7	144.7	278.8	55.3	209.2	192.0	189.1	120.1	643.1	110.0	226.9	194.8	232.1	250.5	87.6	149.3	282.7	85.8	165.7	311.4	253.0	192.8	231.6	150.2	93.9	204.6	88.8	160.8	119.9	50.5	218.8	179.8	180.3	774.3	314.4	178.1	203.7	334.3	571.7	204.7	672.2	825.1	476.1	402.8	253.8	236.1	10.6	281.8	1000.8	221.5	217.5	136.2	630.2	456.9	181.7	83.9	89.1	201.2	202.9	559.5	14.3	394.1	687.8	421.1	804.3	535.4	543.3	1286.4	108.3	180.5	157.1	876.7	410.2	38.7	72.4	49.5	300.7	567.0	65.7	208.7	34.8	572.1	212.8	8.3	79.6	346.2	218.5	436.6	348.5	482.0	66.6	1113.9	651.1	459.7	905.9	505.9	99.8	90.4	33.0	739.2	59.1	2444.5	1.7	68.8	1.8	216.7	805.0	144.6	49.5	41.6	87.5	244.1	65.9	10.1	65.9	18.2	346.9	1396.1	185.7	51.3	315.6	183.2	184.1	177.4	207.7	176.1	209.5	209.2	192.0	194.8	192.8	204.6	180.3	576.7	16.0	33.3	10.4	28.2	184.4	308.2	443.8	63.2	2.2	224.6	231.8	84.4	92.9	180.1	239.1	4.2	328.5	118.2	1020.9	164.4	755.7	13.2	73.0	132.3	424.6	84.9	21.0	0.2	839.7	495.0	181.4	62.2	102.4	62.7	75.5	335.2	50.3	162.4	6.7	0.2	248.7	166.8	92.7	290.7	39.2	150.1	146.3	245.5	11.2	299.1	550.3	289.4	11.1	1.1	1304.7	945.4	206.9	12.6	380.2	952.7	705.3	71.1	15.3	216.9	95.3	292.6	13.6	42.0	54.8	168.6	258.6	108.8	205.5	209.6	422.0
RLN3	"H3, RXN3, ZINS4"	ENSG00000171136	"Relaxin 3"	Q8WXF3	19	14028148-14031551	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"parathyroid gland: 1.6;testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"midbrain: 11.7;pons and medulla: 27.2"	"Region enriched"	"Detected in many"	9	"pons: 23.6"						"Secreted to blood"	NA	NA	60000000		"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 43: Cardiomyocytes - Nuclear processes"											"unprognostic (1.96e-2)"		"unprognostic (2.54e-2)"					"unprognostic (3.94e-1)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNF180		ENSG00000164197	"Ring finger protein 180"	Q86T96	5	64165843-64372869	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 25.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 90.5;Inhibitory neurons: 151.6;Oligodendrocyte precursor cells: 162.3"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006897	Approved		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA006897: AB_1856348"	"unprognostic (7.46e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (3.68e-2)"	"prognostic favorable (6.81e-5)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.81e-3)"	5.4	5.1	3.2	1.5	3.9	0.3	3.6	2.6	5.1	4.1	2.9	3.3	1.7	7.7	7.7	4.2	4.9	4.2	7.0	2.8	8.2	8.1	4.5	3.7	1.3	3.9	5.8	7.6	4.2	25.3	3.5	0.6	4.7	7.3	1.3	6.0	4.6	10.6	2.7	4.1	1.4	5.7	4.4	3.0	2.6	3.4	6.6	0.7	14.0	4.1	0.9	3.3	2.3	4.5	0.0	0.1	1.4	0.0	0.0	0.0	0.3	1.2	0.5	1.2	0.7	0.0	0.1	0.0	0.1	0.9	0.7	0.2	0.0	0.5	0.2	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.3	0.1	3.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	2.5	0.4	0.0	0.0	0.6	0.0	1.4	0.1	3.7	29.4	2.1	0.3	0.3	0.1	0.0	0.3	0.0	1.8	1.5	0.1	0.1	0.0	3.5	0.1	3.3	0.0	0.0	0.0	0.6	0.0	3.9	1.2	0.6	1.7	0.6	0.2	0.9	0.5	1.0	1.1	0.2	0.8	1.4	1.3	1.0	0.8	0.3	0.4	0.7	0.0	3.2	3.9	2.6	5.1	2.8	8.2	3.9	5.8	4.7	4.4	6.6	4.5	9.5	16.0	12.3	51.6	0.5	4.6	8.9	1.3	7.4	16.6	8.1	4.2	10.9	10.0	4.9	16.5	14.6	0.0	0.0	0.0	7.9	5.8	12.5	14.2	6.1	6.3	1.2	0.0	90.5	2.6	0.1	7.9	6.1	32.9	0.0	5.7	14.3	5.9	0.1	11.8	151.6	1.9	0.0	0.6	1.1	8.8	34.5	0.5	5.4	32.8	0.0	30.1	0.0	162.3	50.1	3.1	2.7	25.2	0.0	6.4	1.2	15.9	1.9	16.9	39.5	24.2	20.4	18.9	12.0	2.9	7.4	0.0	0.3	4.1	1.6	4.5
RNF213	"ALO17, C17orf27, KIAA1554, KIAA1618, MYMY2, NET57"	ENSG00000173821	"Ring finger protein 213"	Q63HN8	17	80260866-80398786	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Ubl conjugation pathway"	"Hydrolase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 396.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003347, HPA026790"	Approved		Supported	Cytosol		NA	NA		3500	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA003347: AB_1079204, HPA026790: AB_10602296"	"unprognostic (8.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.97e-3)"	"prognostic unfavorable (4.65e-5)"	"unprognostic (7.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-3)"	"unprognostic (8.92e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.56e-2)"	7.4	9.9	6.8	18.6	12.9	25.6	7.0	9.0	11.3	8.0	13.0	9.0	8.7	7.8	8.7	7.1	8.6	10.7	6.5	5.1	6.9	10.5	6.2	13.2	17.9	23.5	11.4	9.0	7.8	34.2	6.6	10.0	18.3	7.1	7.8	12.0	10.8	6.8	6.6	8.8	10.6	9.1	13.8	18.7	11.1	3.4	16.5	20.2	11.0	7.6	14.5	11.0	7.1	17.3	40.1	69.7	6.9	4.9	24.4	37.0	5.1	9.9	21.4	43.7	37.1	7.5	18.1	2.6	8.3	20.8	46.6	22.7	9.3	12.9	14.7	90.8	4.3	6.3	29.9	13.3	10.5	6.7	6.2	20.5	8.6	24.6	10.6	13.7	34.3	28.3	11.8	14.5	16.5	9.7	26.7	2.8	5.1	7.5	16.0	18.0	15.9	3.1	12.1	34.1	6.6	9.2	24.1	50.3	17.3	15.3	11.6	8.2	44.5	24.2	19.0	14.4	10.3	6.3	6.3	7.0	18.2	7.6	8.9	19.5	20.8	10.4	26.2	18.5	17.5	15.3	18.6	21.6	5.4	15.5	14.6	18.2	84.5	26.1	17.1	32.0	15.4	4.8	6.8	12.9	9.0	11.3	5.1	6.9	23.5	11.4	18.3	13.8	16.5	17.3	76.1	89.8	56.9	56.8	89.9	35.8	37.2	39.2	43.3	21.2	59.9	41.7	32.6	75.8	50.3	101.2	50.1	21.0	240.8	117.4	13.7	120.3	1.4	58.7	58.9	90.7	46.0	30.3	23.6	162.4	31.5	50.8	158.0	93.4	46.7	140.7	74.3	56.4	98.0	23.5	15.5	68.2	32.6	136.5	94.9	3.7	60.9	128.9	30.2	87.1	194.6	26.1	396.5	32.2	70.4	166.1	76.2	51.6	167.6	100.8	116.3	92.2	66.2	68.5	65.7	52.3	53.7	1.4	8.2	43.0	34.4	21.8	211.6	84.7	54.9	66.5
RNF217	"C6orf172, dJ84N20.1, IBRDC1, MGC26996"	ENSG00000146373	"Ring finger protein 217"	Q8TC41	6	124962545-125092633	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 42.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 127.8;Oligodendrocytes: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029598	Uncertain					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA029598: AB_10602297"	"unprognostic (2.96e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.07e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.22e-3)"	"unprognostic (4.94e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (4.60e-5)"	"unprognostic (8.29e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.92e-4)"	8.0	3.0	3.4	2.0	2.5	11.0	6.0	3.0	2.3	6.3	4.9	7.2	1.3	4.4	2.0	5.0	7.4	4.2	5.1	3.0	2.7	1.9	5.7	6.3	0.7	3.0	1.8	8.6	2.8	42.7	2.9	3.9	2.4	3.5	1.3	3.6	4.7	3.6	7.6	9.1	2.5	4.1	1.1	1.8	3.5	6.9	2.6	1.5	5.8	5.9	0.4	5.3	5.7	5.4	4.9	5.0	1.7	0.6	6.1	2.4	9.7	6.6	8.9	4.4	5.8	0.0	4.6	0.0	9.0	6.3	10.1	7.0	1.0	5.9	6.2	0.0	5.5	2.7	7.6	1.5	5.7	0.0	0.2	6.5	5.4	3.3	9.7	5.2	5.0	0.0	14.0	0.0	7.8	0.0	0.0	0.0	1.5	0.0	1.3	0.1	6.8	0.0	4.5	2.2	0.8	0.0	2.9	0.7	2.5	4.8	4.8	0.8	8.1	3.6	11.5	0.0	14.3	0.0	0.0	0.0	2.7	0.0	4.4	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.5	3.0	2.3	3.0	2.7	3.0	1.8	2.4	1.1	2.6	5.4	25.0	22.4	21.0	49.0	0.6	48.2	15.8	17.5	18.2	6.3	10.0	10.7	14.4	4.3	12.1	5.5	16.7	24.2	0.9	1.3	0.0	8.1	127.8	11.4	21.5	19.0	3.0	6.5	56.3	9.6	29.7	23.1	4.6	22.8	1.3	9.0	15.7	26.9	9.8	21.9	65.0	2.4	12.2	14.6	20.9	62.1	25.7	11.3	19.6	51.5	9.8	4.2	1.0	37.7	102.1	11.8	2.0	21.1	0.4	21.6	6.9	2.3	9.6	5.7	6.6	44.9	12.3	1.7	2.9	17.5	47.0	17.9	1.8	5.3	4.3	16.3
ROR1	NTRKR1	ENSG00000185483	"Receptor tyrosine kinase like orphan receptor 1"	Q01973	1	63774017-64181498	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Receptor, Transferase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 26.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 51.3;Astrocytes: 81.0;Inhibitory neurons: 69.7;Microglial cells: 36.5;Oligodendrocytes: 109.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 40.5;ASC TERT1: 50.3;CACO-2: 36.8;HHSteC: 38.3;HSkMC: 41.6;NTERA-2: 43.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA		7700000	"Cluster 40: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (5.15e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.15e-2)"	4.4	1.1	0.6	2.2	1.4	0.4	3.7	3.0	0.8	7.5	4.6	4.5	2.2	7.1	1.4	5.2	2.5	5.2	7.5	0.7	0.6	2.3	0.5	7.0	1.2	0.7	0.9	8.3	5.5	26.9	0.5	3.1	0.5	5.4	4.0	1.5	1.2	6.4	2.3	2.3	1.7	7.7	0.3	3.2	6.4	1.5	1.2	2.5	1.4	1.6	1.1	4.2	2.3	1.1	15.5	12.2	5.9	0.8	40.5	50.3	4.0	2.9	8.3	1.6	4.3	36.8	4.9	0.3	6.6	7.2	2.9	3.2	0.1	2.9	1.1	0.0	3.7	0.0	1.6	0.5	38.3	0.0	0.0	41.6	10.9	21.7	25.2	8.4	0.7	0.5	0.0	0.3	11.0	0.2	0.2	0.1	43.0	11.3	6.1	0.2	0.2	9.8	8.7	0.3	3.4	13.6	0.8	0.2	6.4	19.9	0.1	0.0	8.4	3.3	5.7	23.0	6.2	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.6	1.4	3.0	0.8	0.7	0.6	0.7	0.9	0.5	0.3	1.2	1.1	1.1	51.3	10.5	81.0	1.8	3.8	2.2	0.5	29.0	4.7	3.0	2.0	11.4	1.5	1.3	1.8	0.0	0.2	0.1	1.3	0.0	5.6	9.6	1.2	9.2	1.8	21.5	0.0	11.6	15.2	1.0	14.5	16.8	1.9	0.0	1.1	0.7	0.0	7.6	0.0	69.7	2.2	2.0	0.6	4.9	8.1	27.7	0.5	3.6	36.5	0.0	5.3	0.0	3.5	109.9	15.3	0.8	14.7	0.1	1.4	0.0	3.4	0.8	0.3	6.6	6.8	8.5	1.4	1.8	11.5	4.5	0.3	0.2	0.3	3.3	0.8
RPL17-C18orf32		ENSG00000215472	"RPL17-C18orf32 readthrough"		18	49481681-49492479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 153.8;Alveolar cells type 2: 154.3;Club cells: 96.6;granulocytes: 65.6;Respiratory ciliated cells: 117.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043724, HPA046385"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum, Cytosol"		"HPA043724: AB_2678637, HPA046385: AB_2679646"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-2)"			"unprognostic (1.70e-3)"	"unprognostic (3.83e-4)"		"unprognostic (1.95e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"		"unprognostic (2.38e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.87e-1)"		"unprognostic (5.42e-2)"		41.7	77.7	109.4	35.7	111.6	49.1	49.6	117.5	159.2	36.5	113.7	43.7	51.3	32.2	70.3	25.7	31.1	38.6	63.6	106.0	119.4	96.0	85.0	42.2	35.1	116.3	112.8	34.4	51.8	84.3	9.4	35.3	116.2	48.7	41.6	104.7	54.5	34.4	30.1	22.2	48.3	26.7	116.2	35.9	55.7	30.5	112.3	32.8	53.4	38.2	27.2	38.1	5.2	126.1	29.4	25.0	57.3	47.1	55.7	42.3	42.7	34.6	36.6	27.9	32.9	7.7	33.8	21.8	74.0	33.5	30.5	29.6	26.2	29.7	31.1	67.7	20.2	28.0	15.7	28.3	56.6	46.3	59.2	50.5	65.0	22.5	42.3	61.4	35.2	48.6	19.2	60.9	79.2	16.8	41.4	26.8	20.1	28.0	13.0	26.2	21.2	59.4	115.2	34.7	64.5	120.0	22.0	36.8	76.1	41.4	50.3	45.4	33.0	37.4	25.7	23.4	36.8	106.2	60.1	24.9	42.0	26.0	42.7	92.6	30.2	71.3	23.0	41.1	33.4	28.3	27.1	26.5	27.9	20.3	23.3	31.2	85.1	22.3	48.5	38.4	30.9	49.2	109.4	111.6	117.5	159.2	106.0	119.4	116.3	112.8	116.2	116.2	112.3	126.1	0.5	153.8	154.3	0.3	0.4	0.3	0.7	0.3	0.6	0.4	0.5	0.5	0.0	0.0	96.6	0.0	0.0	0.1	0.2	0.2	0.0	0.2	2.8	0.3	0.7	17.8	0.0	0.0	0.1	0.2	0.1	18.5	0.5	0.4	65.6	0.2	0.4	0.3	0.3	0.0	0.1	0.0	0.0	0.6	0.0	4.3	0.0	20.9	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.2	0.3	117.3	0.3	0.0	0.2	0.4	1.0	0.5	1.0	0.1	0.3	9.1	0.5	0.1	0.5
RTF1	KIAA0252	ENSG00000137815	"RTF1 homolog, Paf1/RNA polymerase II complex component"	Q92541	15	41408408-41483563	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006714, CAB079946, CAB079947"	Supported		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB079946: , CAB079947: , HPA006714: AB_1079855"	"unprognostic (1.10e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.87e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.50e-2)"	17.8	23.2	24.7	18.8	26.3	45.1	22.4	26.8	42.7	24.3	19.2	21.6	19.2	25.1	19.5	21.4	17.1	20.3	24.6	27.1	24.0	19.0	19.9	19.4	28.2	21.0	21.3	29.4	16.6	36.9	11.4	24.5	20.9	23.4	22.4	26.4	16.7	22.8	49.4	25.9	19.8	26.3	20.0	23.8	20.8	29.8	23.9	28.8	29.5	34.8	25.0	23.1	17.5	24.6	32.0	20.6	66.5	54.2	37.0	43.4	31.2	41.8	46.8	56.0	46.5	40.4	19.8	30.2	33.0	43.9	24.9	55.3	38.9	34.8	47.6	46.2	36.1	63.5	45.2	30.4	25.8	57.2	35.5	31.4	34.3	30.0	30.1	41.6	45.8	54.0	49.2	34.0	46.5	24.2	55.1	35.1	35.9	39.6	28.0	59.0	51.8	28.9	36.5	67.5	34.0	44.9	37.6	47.4	19.0	35.9	38.9	54.5	37.9	54.6	34.4	54.8	46.5	38.9	65.0	49.6	39.4	53.5	34.1	5.4	3.1	6.9	3.4	2.1	3.1	6.9	3.3	2.9	2.2	5.3	4.0	3.2	8.5	6.2	2.7	5.5	4.3	1.1	24.7	26.3	26.8	42.7	27.1	24.0	21.0	21.3	20.9	20.0	23.9	24.6	118.0	128.2	80.1	23.8	109.0	145.0	98.7	120.4	102.4	213.5	152.6	129.7	94.3	111.5	89.7	123.2	93.8	168.3	117.1	129.6	164.4	103.0	333.7	103.9	162.6	116.4	87.8	85.0	40.3	110.5	119.1	103.5	71.9	126.2	91.2	127.9	129.5	193.2	95.5	148.0	43.6	145.4	109.9	86.7	94.4	348.5	145.1	83.0	108.5	15.9	116.1	106.2	128.8	16.6	23.5	127.0	105.1	159.9	104.1	141.9	112.6	186.4	70.7	188.2	85.5	115.4	146.9	198.3	59.9	83.4	163.0	219.3	113.0	126.1	133.2	99.2
SCOC	"HRIHFB2072, SCOCO, UNC-69"	ENSG00000153130	"Short coiled-coil protein"	Q9UIL1	4	140257286-140385728	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 320.8;Early spermatids: 537.1;Proximal tubular cells: 311.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061198, HPA070321"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		22000	"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA061198: AB_2684449, HPA070321: AB_2686252"	"unprognostic (2.27e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.37e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.82e-12)"	"unprognostic (2.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-2)"	44.8	66.8	81.8	27.7	84.5	14.7	69.4	87.4	114.6	42.6	72.0	43.9	45.4	48.0	79.5	54.1	44.7	39.7	103.6	85.1	109.1	101.6	74.3	35.9	29.7	91.3	96.8	42.6	51.3	94.1	43.2	48.3	103.1	59.9	49.8	74.5	49.2	47.1	40.8	29.9	37.1	50.9	91.4	27.9	53.7	33.8	95.2	29.3	67.4	59.3	32.8	38.9	19.4	105.6	53.9	38.1	92.6	49.9	80.6	109.3	67.4	85.5	78.0	64.6	71.8	24.4	81.0	22.0	75.5	83.9	60.6	22.6	57.3	113.6	95.7	79.1	40.4	33.5	18.8	59.7	70.1	70.2	40.5	72.5	155.9	59.0	63.1	124.1	87.1	63.8	53.0	60.0	116.3	36.5	94.7	42.5	30.2	47.6	57.1	54.0	39.1	32.1	197.1	52.9	68.4	70.4	57.0	84.5	97.0	81.7	63.4	41.9	68.0	104.4	60.5	86.9	83.1	94.4	193.4	64.9	118.2	32.2	102.3	47.8	16.5	23.0	27.5	23.0	35.1	36.8	32.3	27.3	21.4	30.3	46.8	36.4	9.7	36.9	23.1	26.7	33.2	37.0	81.8	84.5	87.4	114.6	85.1	109.1	91.3	96.8	103.1	91.4	95.2	105.6	63.2	48.1	47.2	15.3	34.4	61.1	69.7	74.1	78.6	135.0	84.9	96.0	140.3	62.9	51.8	126.9	22.9	139.9	31.3	63.4	320.8	99.2	537.1	67.5	52.4	54.4	37.8	34.7	33.8	112.8	82.2	58.3	66.8	58.4	36.8	32.0	51.4	65.0	47.6	171.6	37.1	42.7	114.0	23.0	27.9	91.2	60.0	34.5	138.7	17.8	36.7	205.6	22.6	20.6	42.9	92.9	37.0	66.2	30.8	91.7	46.8	311.1	54.9	71.0	46.0	40.8	64.5	60.7	56.1	83.8	56.7	88.9	36.3	39.6	46.1	56.0
SCPEP1	RISC	ENSG00000121064	"Serine carboxypeptidase 1"	Q9HB40	17	56978129-57006768	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 300.9"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 456.2;Club cells: 304.9;Respiratory ciliated cells: 397.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 319.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 389.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039102, HPA057200"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"HPA039102: AB_10673605, HPA057200: AB_2683365"	"unprognostic (5.83e-3)"	"unprognostic (7.43e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (1.00e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	64.1	121.5	25.7	32.6	26.4	75.8	91.0	27.3	42.9	69.8	34.5	46.9	31.4	37.5	73.1	54.8	48.5	71.2	60.1	27.2	30.9	88.6	32.0	95.1	48.7	30.1	29.5	53.6	17.0	300.9	28.7	20.8	30.6	61.6	33.7	8.1	90.0	102.9	15.8	46.3	40.3	60.9	28.7	44.8	54.2	14.3	28.4	14.6	135.1	32.5	60.6	71.1	51.1	33.6	48.3	20.9	49.4	41.4	389.3	85.6	26.0	23.3	119.6	41.9	77.8	13.7	33.3	63.3	126.4	55.9	65.8	44.0	22.0	105.4	46.8	82.0	36.1	19.8	28.2	8.7	89.1	39.1	190.1	103.7	45.0	52.0	43.0	37.5	72.3	24.3	5.1	257.9	59.1	20.3	19.9	100.4	20.4	15.2	39.3	24.2	53.8	41.4	9.3	143.7	13.8	33.8	56.3	45.6	33.3	57.1	19.1	104.1	34.1	118.3	29.9	68.8	26.5	250.5	187.2	35.9	88.1	28.5	34.4	2.1	228.5	319.0	11.8	137.1	8.0	56.0	8.2	8.3	105.7	55.1	11.3	12.3	34.8	23.7	141.0	18.0	10.2	118.7	25.7	26.4	27.3	42.9	27.2	30.9	30.1	29.5	30.6	28.7	28.4	33.6	48.8	44.8	61.8	25.1	52.7	23.7	208.6	456.2	37.5	12.7	52.4	110.7	32.5	10.0	304.9	95.6	16.7	9.9	20.5	2.0	19.6	22.2	1.0	51.5	24.5	27.1	24.4	21.2	37.2	6.8	19.4	115.4	4.6	13.6	8.2	4.3	62.8	15.7	160.5	10.1	24.9	5.0	126.1	135.0	33.7	3.4	64.3	110.2	24.9	20.6	142.2	18.9	25.7	21.1	20.7	4.8	1.6	68.1	39.0	74.1	62.4	29.7	397.8	17.0	52.6	28.1	63.2	4.4	12.3	38.1	19.9	11.1	18.8	67.1	8.0	122.6
SECISBP2L	KIAA0256	ENSG00000138593	"SECIS binding protein 2 like"	Q93073	15	48988476-49046447	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 119.4"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 248.6;Oligodendrocytes: 429.8;Syncytiotrophoblasts: 711.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039875	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA039875: AB_10673365"	"unprognostic (7.86e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.19e-3)"	"unprognostic (9.29e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (5.65e-8)"	"unprognostic (1.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.28e-1)"	18.8	16.1	36.4	11.9	72.7	22.6	18.6	61.1	57.1	18.6	5.8	13.5	9.6	18.4	21.9	17.0	18.4	14.6	15.4	39.5	43.2	25.0	18.7	37.2	13.7	69.2	58.2	19.5	15.0	76.3	9.2	29.9	61.8	20.8	11.6	32.4	45.0	17.5	12.1	11.0	11.4	14.9	58.8	15.1	19.1	13.9	54.7	14.9	23.9	18.3	13.4	12.9	11.8	119.4	9.5	10.4	20.7	18.0	28.6	21.9	12.9	31.3	25.8	25.1	31.6	11.2	8.2	6.6	15.1	24.0	26.5	8.0	26.2	8.2	30.0	40.7	7.0	18.4	14.1	8.4	15.5	10.0	20.0	17.5	9.7	22.1	12.3	27.0	25.3	16.2	11.4	16.0	29.9	4.2	11.8	9.6	7.5	5.9	9.0	11.1	23.2	25.4	32.8	19.5	3.7	14.7	21.5	36.5	29.5	34.7	11.2	11.4	31.7	23.3	11.3	23.6	15.1	13.5	25.0	11.5	17.9	14.8	30.8	10.8	5.3	16.3	8.9	5.1	8.2	12.8	7.9	6.2	3.8	14.4	10.7	8.6	9.9	8.7	6.9	8.8	6.3	4.5	36.4	72.7	61.1	57.1	39.5	43.2	69.2	58.2	61.8	58.8	54.7	119.4	41.6	115.4	248.6	60.7	47.8	14.8	15.1	24.3	18.2	34.7	26.0	21.7	43.1	18.6	55.2	33.1	27.1	105.2	33.3	27.3	15.6	28.1	15.0	94.8	49.2	39.4	9.6	15.8	105.9	18.6	37.8	37.8	34.1	153.2	33.5	32.3	29.6	25.2	26.5	57.2	74.0	14.9	28.5	20.8	18.3	11.1	33.5	29.8	46.2	53.4	30.9	39.7	37.0	82.4	429.8	37.8	15.7	36.5	48.8	31.3	20.9	37.9	86.4	27.2	6.6	47.0	35.2	22.2	31.1	18.8	13.5	711.3	35.6	21.1	11.7	41.5
SELENOV	SELV	ENSG00000186838	"Selenoprotein V"	P59797	19	39515113-39520686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 9.9"	"Cell type enhanced"	"Detected in single"		"Breast myoepithelial cells: 2.2"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059274	Uncertain					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 44: Endometrium - Transcription"			"HPA059274: AB_2683964"				"unprognostic (1.38e-3)"	"unprognostic (2.70e-2)"				"unprognostic (2.01e-1)"	"unprognostic (1.54e-1)"		"unprognostic (8.31e-2)"		"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.43e-4)"		0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.1	2.3	0.1	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.9	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.4	0.2	0.3	0.6	0.3	0.4	0.1	0.3	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERINC1	"KIAA1253, TDE1L, TDE2, TMS-2"	ENSG00000111897	"Serine incorporator 1"	Q9NRX5	6	122443351-122471807	"Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035738, HPA035739"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA035738: AB_10672990, HPA035739: AB_10669536"	"unprognostic (2.83e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.07e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.00e-2)"	213.6	242.8	220.4	93.2	248.8	148.2	157.8	237.5	334.0	151.4	178.5	104.6	99.4	146.6	108.1	94.9	104.4	128.0	163.7	248.3	257.3	194.1	241.3	160.5	96.8	258.9	243.3	164.4	100.4	243.3	71.7	195.1	282.9	139.6	100.1	225.5	97.1	143.3	152.6	79.0	114.3	141.7	268.4	123.6	96.5	65.6	241.3	89.7	203.1	194.8	79.5	121.7	84.8	306.8	40.5	49.1	121.7	111.8	450.2	245.1	64.5	208.4	259.8	111.6	171.6	57.8	106.9	27.1	159.7	236.5	127.9	78.7	72.6	90.2	166.1	87.1	86.0	76.9	79.0	105.9	201.3	77.5	146.3	256.7	173.0	139.0	190.8	256.4	98.1	69.9	77.4	149.3	233.8	46.8	35.1	51.4	39.7	63.5	61.9	42.5	60.0	66.5	240.3	70.1	63.6	114.5	92.3	101.2	146.8	107.4	70.0	107.1	201.3	133.7	57.9	110.8	109.9	112.4	134.4	35.9	176.8	62.1	159.5	158.3	43.0	92.6	44.7	53.2	48.1	27.7	45.9	43.3	35.9	23.7	53.2	46.9	108.7	51.7	62.0	28.0	54.2	56.0	220.4	248.8	237.5	334.0	248.3	257.3	258.9	243.3	282.9	268.4	241.3	306.8	167.8	150.6	99.2	44.4	73.9	66.2	81.1	55.7	61.5	114.4	71.7	57.1	156.2	87.2	58.9	77.3	70.9	53.8	80.9	88.8	9.8	63.0	3.2	54.9	103.3	130.0	84.5	81.5	92.5	48.7	57.7	131.4	39.8	106.8	124.0	58.1	127.8	132.1	73.1	138.0	145.7	41.8	36.7	158.2	86.4	10.0	126.8	107.4	94.3	65.6	58.1	97.2	58.7	48.2	134.0	78.4	43.6	131.3	80.0	86.1	80.1	44.0	56.1	70.6	59.2	105.1	110.6	25.7	17.0	39.0	74.9	119.7	100.7	99.8	32.7	97.1
SGK1	SGK	ENSG00000118515	"Serum/glucocorticoid regulated kinase 1"	O00141	6	134169246-134318112	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1007.1"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 1238.4;Proximal enterocytes: 789.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 43.4;eosinophil: 170.2;neutrophil: 91.6"	"Group enriched"	"Detected in all"	8	"granulocytes: 170.2;monocytes: 43.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 298.1;RPTEC TERT1: 469.5;SK-MEL-30: 319.7;TIME: 373.9;U-266/84: 358.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022085, CAB025148, HPA051251"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"CAB022085: , CAB025148: , HPA051251: AB_2681407"	"unprognostic (2.05e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.76e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.82e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.59e-2)"	147.5	121.5	35.8	47.4	57.3	68.9	83.2	40.0	51.4	61.1	96.9	68.4	51.4	37.0	9.5	108.4	36.5	170.0	35.8	41.2	42.7	105.2	99.3	81.8	33.6	64.5	44.9	125.8	177.1	1007.1	12.0	70.6	49.6	47.6	39.0	14.1	70.8	60.3	50.2	75.7	282.5	48.4	35.8	21.5	104.2	30.4	53.6	39.7	56.7	33.9	78.1	141.3	96.7	94.0	4.1	6.9	4.2	0.4	51.7	12.9	5.9	76.7	159.4	98.4	79.8	12.2	10.6	13.1	11.3	79.8	48.0	2.5	6.8	12.2	72.0	0.5	3.1	0.6	175.7	9.2	298.1	0.7	6.8	77.3	75.4	96.7	124.3	39.3	167.1	2.3	25.6	192.8	35.6	0.6	1.1	3.0	4.8	20.3	8.3	2.4	8.9	1.5	469.5	1.4	2.2	18.6	241.7	0.7	319.7	43.2	0.5	2.1	373.9	28.8	12.3	176.9	17.1	36.2	358.5	40.3	26.7	12.0	39.5	2.2	43.4	170.2	0.7	24.4	1.6	1.9	1.3	0.8	14.1	1.4	1.6	2.0	91.6	3.6	14.5	0.9	2.5	12.6	35.8	57.3	40.0	51.4	41.2	42.7	64.5	44.9	49.6	35.8	53.6	94.0	346.2	38.5	177.8	34.0	68.0	183.3	133.7	277.3	329.0	12.0	87.1	112.0	28.4	88.6	168.6	68.0	35.5	41.0	27.0	132.2	21.5	81.3	9.6	145.8	73.1	232.1	10.7	14.7	68.2	171.2	33.6	88.8	206.4	483.4	271.8	33.9	353.4	21.9	284.2	0.0	225.7	65.1	91.6	181.3	1238.4	7.7	15.2	492.5	268.6	58.1	29.6	4.6	2.1	270.9	377.7	36.2	123.9	15.8	92.4	51.0	789.1	124.3	61.5	29.3	13.1	43.5	102.9	38.1	10.2	348.1	116.2	579.8	46.9	48.9	36.3	123.8
SGMS1	"MGC17342, MOB, SMS1, TMEM23"	ENSG00000198964	"Sphingomyelin synthase 1"	Q86VZ5	10	50305586-50625163	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.1;Microglial cells: 229.5;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 422.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045191	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA045191: AB_10959605"	"unprognostic (1.13e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.34e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.95e-7)"	"unprognostic (8.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.05e-1)"	15.8	19.3	19.8	10.7	27.4	24.0	14.5	21.5	20.3	16.9	33.9	10.1	13.5	11.9	19.9	15.3	16.6	15.4	13.2	17.2	23.0	20.2	27.9	21.9	14.9	29.5	24.1	18.6	13.3	52.9	6.4	24.6	28.5	19.5	11.7	20.2	18.0	16.8	9.9	25.3	16.0	15.8	23.6	11.7	14.3	11.3	23.4	12.0	24.7	10.5	14.5	20.9	13.1	41.3	30.2	14.0	4.0	9.0	14.2	18.6	18.8	19.6	19.7	13.5	12.6	11.7	30.3	22.1	11.3	25.9	12.2	18.7	9.5	20.6	14.0	19.4	10.2	32.7	17.9	9.0	16.5	7.5	7.6	12.1	23.6	18.0	21.7	8.7	19.3	7.9	62.6	32.2	14.6	12.7	3.3	4.2	9.2	13.7	13.7	5.5	18.4	8.8	19.7	31.2	6.2	4.9	14.4	14.2	7.5	11.3	21.4	2.7	27.1	14.6	17.8	14.1	14.6	11.0	9.5	6.3	18.2	12.0	12.1	3.4	9.3	28.4	4.6	4.9	10.3	7.0	6.2	6.8	5.2	6.5	8.2	5.4	16.7	10.1	4.0	3.2	15.6	6.3	19.8	27.4	21.5	20.3	17.2	23.0	29.5	24.1	28.5	23.6	23.4	41.3	17.1	44.8	40.0	106.7	19.9	54.4	28.9	15.6	23.9	20.1	15.8	8.9	26.3	10.0	30.0	29.5	4.2	10.9	15.6	6.2	15.6	17.6	17.0	20.9	10.5	19.6	14.9	32.0	153.1	21.6	7.7	19.8	30.5	32.4	20.8	12.1	17.9	16.0	29.0	5.0	117.2	11.1	4.1	46.5	17.6	30.6	16.1	34.5	12.4	229.5	12.4	17.4	10.3	313.1	422.0	10.7	6.4	10.5	13.7	32.3	18.4	9.3	25.1	36.4	0.0	20.5	27.1	12.8	2.3	18.7	83.4	4.9	20.0	11.8	12.4	25.4
SLC17A5	"AST, ISSD, NSD, SD, SIALIN, SIASD, SLD"	ENSG00000119899	"Solute carrier family 17 member 5"	Q9NRA2	6	73593379-73653992	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"parathyroid gland: 310.5"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 99.9;ASC TERT1: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044479			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cytosol"		"HPA044479: "	"unprognostic (6.48e-3)"	"unprognostic (7.95e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-3)"	"unprognostic (4.44e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.09e-1)"	10.4	10.5	5.9	6.4	6.0	6.8	13.8	6.2	7.0	10.7	5.9	20.4	16.4	9.4	44.6	8.4	5.3	10.4	8.5	6.5	8.5	31.9	17.6	13.2	5.3	6.5	7.0	4.0	11.6	310.5	9.9	21.7	7.8	16.8	22.1	18.3	30.3	14.7	5.4	7.1	21.1	10.6	5.7	7.0	14.4	6.1	7.1	4.5	43.5	6.2	5.6	12.6	6.3	7.6	7.4	9.9	9.7	15.6	99.9	74.2	12.8	23.8	59.4	6.3	22.0	6.6	17.6	6.8	11.2	32.9	14.8	12.6	13.7	5.9	11.2	4.8	15.5	2.8	5.1	15.4	19.4	5.6	10.8	34.2	8.8	14.2	9.7	26.4	16.2	9.0	7.1	7.2	22.3	4.9	2.3	3.3	7.1	30.9	5.7	5.0	12.1	28.5	16.0	20.2	3.8	6.7	4.8	14.0	14.4	14.0	6.3	34.1	23.5	3.0	2.8	12.1	5.7	20.4	30.6	1.9	10.5	11.6	9.0	13.3	7.9	3.3	6.0	7.4	5.8	3.9	6.6	5.8	7.6	2.4	5.4	6.0	5.7	8.9	4.8	5.5	6.6	4.9	5.9	6.0	6.2	7.0	6.5	8.5	6.5	7.0	7.8	5.7	7.1	7.6	8.8	22.4	20.7	16.3	8.2	9.6	13.2	13.7	5.7	8.2	22.6	5.5	6.8	18.6	17.4	51.5	29.2	19.4	11.0	46.4	3.9	14.2	36.6	16.6	7.8	13.8	12.1	3.8	47.7	13.7	13.5	25.8	14.8	19.6	14.5	3.2	23.9	32.9	64.6	0.0	46.8	47.7	20.3	24.8	22.7	48.3	7.5	25.4	10.6	14.0	11.2	8.3	13.4	17.6	16.3	19.2	17.5	11.3	20.6	29.1	23.9	36.3	21.5	28.9	0.0	10.5	9.1	8.4	3.6	10.2	11.2	22.8	11.0	2.9	19.2	30.7
SLC31A2	"COPT2, CTR2, hCTR2"	ENSG00000136867	"Solute carrier family 31 member 2"	O15432	9	113150976-113164140	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 571.4;salivary gland: 409.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 96.4;Kupffer cells: 145.6;Macrophages: 101.3;monocytes: 84.1;Oligodendrocytes: 113.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	12	"classical monocyte: 226.0;intermediate monocyte: 331.9;myeloid DC: 134.6;neutrophil: 355.8;non-classical monocyte: 423.3"	"Group enriched"	"Detected in all"	47	"dendritic cells: 134.6;granulocytes: 355.8;monocytes: 423.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 54.4;hTCEpi: 85.0;hTERT-HME1: 57.7;LHCN-M2: 68.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014861	Approved		Approved	"Nuclear speckles,Plasma membrane,Intermediate filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Plasma membrane, Intermediate filaments"	"HPA014861: AB_1857098"	"unprognostic (2.26e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.89e-2)"	48.2	16.7	45.0	18.4	72.6	20.1	24.4	68.2	77.8	7.3	34.2	11.3	10.8	4.4	16.7	9.3	6.9	8.6	10.3	45.1	54.0	27.8	33.4	27.4	16.1	76.6	65.8	5.1	19.2	571.4	2.5	23.6	71.4	4.4	12.1	0.8	409.1	42.6	16.7	48.2	17.2	10.8	61.5	32.7	11.8	13.8	61.7	12.1	6.3	14.6	17.6	13.3	10.7	108.2	7.8	3.1	1.3	1.7	54.4	22.3	6.5	4.0	13.9	12.8	12.3	2.4	1.5	0.3	0.5	9.1	7.9	37.7	5.1	31.0	12.0	2.2	1.3	0.1	1.2	3.3	20.7	1.9	0.8	25.3	85.0	30.0	57.7	1.8	6.9	3.0	1.4	2.6	68.9	6.5	1.6	0.7	0.4	1.8	2.6	0.2	39.3	0.0	4.5	4.2	0.9	2.5	6.9	36.4	1.4	0.8	8.6	2.5	2.4	2.0	1.9	13.7	3.2	2.1	5.0	0.1	12.5	3.2	2.0	5.1	226.0	24.0	4.3	331.9	6.5	1.2	4.9	5.2	134.6	1.0	3.8	3.9	355.8	1.0	423.3	2.1	3.0	104.9	45.0	72.6	68.2	77.8	45.1	54.0	76.6	65.8	71.4	61.5	61.7	108.2	13.8	9.6	9.2	2.3	7.0	37.1	6.4	37.7	13.6	7.0	15.3	10.8	0.6	4.3	10.9	1.8	35.5	96.4	3.6	12.8	3.9	13.5	4.1	23.5	4.9	6.4	3.5	0.4	2.1	7.7	9.0	14.4	3.6	8.4	0.0	2.7	12.8	18.1	57.2	6.7	1.8	4.5	10.2	145.6	65.6	4.6	15.8	101.3	0.0	4.7	84.1	6.9	3.1	0.5	113.7	18.5	11.0	9.4	9.1	10.2	51.3	18.2	14.8	9.1	19.7	8.7	7.8	31.0	5.2	3.3	38.4	43.1	7.9	4.6	5.7	7.6
SLC36A1	"LYAAT-1, PAT1, TRAMD3"	ENSG00000123643	"Solute carrier family 36 member 1"	Q7Z2H8	5	151437046-151492379	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 76.3;parathyroid gland: 103.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.9;Early spermatids: 76.7;Excitatory neurons: 92.8;Inhibitory neurons: 62.1;Oligodendrocyte precursor cells: 48.7;Proximal enterocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	9	"cerebellum: 76.3"	"Group enriched"	"Detected in many"	4	"basophil: 21.7;classical monocyte: 8.7;neutrophil: 19.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.7;monocytes: 8.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035937	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035937: AB_10672995"	"unprognostic (5.49e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (6.30e-5)"	"unprognostic (1.86e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-1)"	6.3	4.9	2.0	7.9	2.8	29.5	4.0	76.3	8.4	3.6	0.0	14.8	44.2	4.0	4.4	5.4	3.3	10.4	3.1	3.1	0.0	4.7	2.8	5.6	6.1	4.6	3.2	3.2	6.2	103.2	3.7	5.5	5.3	12.5	22.5	1.9	4.8	6.2	7.8	4.9	39.3	6.6	0.0	8.5	4.4	13.4	0.6	18.4	3.1	5.9	5.3	6.0	4.2	4.1	5.4	9.2	4.7	3.2	11.6	8.5	25.4	15.4	8.6	10.4	11.7	21.2	7.8	12.4	8.9	18.5	11.1	13.0	15.1	9.5	10.2	3.4	13.1	3.8	14.7	7.1	14.9	9.3	20.3	6.2	10.8	8.8	5.8	2.9	9.4	6.7	9.0	10.5	8.9	5.9	2.7	4.6	4.7	6.8	8.6	0.0	11.4	4.9	2.7	8.0	4.2	8.0	9.6	11.4	5.6	9.5	8.7	13.4	9.5	13.8	7.7	22.8	8.7	5.0	7.6	7.9	8.8	16.0	9.4	21.7	8.7	3.6	1.5	3.8	1.1	2.0	1.4	2.5	3.0	2.1	1.1	1.0	19.6	0.4	4.1	0.6	1.6	1.3	2.0	2.8	76.3	8.4	3.1	0.0	4.6	3.2	5.3	0.0	0.6	4.1	2.1	0.0	1.7	10.4	2.3	1.5	1.4	1.1	1.2	1.0	4.1	1.3	3.0	4.3	1.3	1.8	2.1	0.6	1.9	52.9	0.0	1.8	76.7	1.1	3.6	1.4	0.0	32.4	92.8	2.0	8.1	3.6	10.2	1.3	1.3	18.0	3.6	2.0	13.9	1.7	62.1	5.4	0.0	22.7	3.0	29.5	5.0	10.6	1.8	11.2	6.2	0.8	1.0	48.7	30.4	1.8	22.2	11.7	2.3	1.9	48.4	4.6	0.6	1.1	0.0	1.7	2.4	0.5	2.0	4.5	1.3	0.3	2.4	0.8	9.8	1.8
SLC38A6	NAT-1	ENSG00000139974	"Solute carrier family 38 member 6"	Q8IZM9	14	60981114-61083733	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 178.2;Excitatory neurons: 98.8;Hofbauer cells: 100.3;Inhibitory neurons: 77.4;Late spermatids: 124.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018508	Approved		Approved	"Plasma membrane,Cell Junctions,Microtubules"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Cell Junctions"	"Plasma membrane, Microtubules"	"HPA018508: AB_2190518"	"unprognostic (7.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (9.47e-6)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-1)"	7.6	9.1	6.0	4.7	6.6	2.9	7.4	6.1	9.5	7.3	8.9	4.8	3.1	5.1	13.2	3.3	5.6	9.9	3.7	6.9	6.5	12.0	6.3	8.6	7.8	5.4	6.0	5.8	3.4	21.3	7.2	9.6	6.0	5.1	6.6	7.5	5.9	3.9	2.1	2.9	3.5	5.3	5.0	6.6	3.8	5.0	7.4	5.0	6.3	3.0	4.8	7.0	5.0	6.7	16.2	21.5	6.8	12.3	68.7	25.3	4.9	11.6	34.5	10.7	10.2	5.4	41.0	4.0	19.2	10.6	22.5	13.5	6.8	11.9	9.8	6.0	3.2	6.7	8.6	14.2	22.7	3.7	12.1	19.9	4.9	10.5	12.2	43.2	14.3	6.8	9.3	8.4	37.5	9.2	6.6	8.4	4.0	9.5	14.3	1.6	20.1	11.9	30.7	8.5	3.3	3.0	9.9	7.0	19.1	9.3	10.4	5.8	15.6	16.4	7.1	20.0	6.5	1.6	4.9	1.6	34.0	3.0	13.1	0.0	6.6	0.1	1.7	7.1	2.2	2.2	3.1	2.4	3.6	2.0	2.7	3.4	0.2	0.8	4.5	4.4	4.5	2.8	6.0	6.6	6.1	9.5	6.9	6.5	5.4	6.0	6.0	5.0	7.4	6.7	6.8	22.4	6.7	31.6	6.0	5.2	11.4	14.6	8.0	19.7	7.2	7.5	4.3	7.2	10.0	5.5	22.9	5.6	4.9	2.6	1.9	5.3	178.2	13.0	11.0	7.2	4.2	3.4	98.8	2.8	9.4	11.2	5.1	6.2	6.3	7.3	4.2	4.6	100.3	5.0	77.4	3.1	6.1	24.8	10.0	124.4	10.8	26.2	5.4	20.6	6.4	11.7	2.1	54.3	30.8	7.4	1.9	6.0	5.8	6.6	3.3	23.1	40.4	24.9	0.0	12.3	9.1	16.6	11.5	6.4	2.8	6.7	7.8	5.0	2.8	6.9
SLC7A8	"LAT2, LPI-PC1"	ENSG00000092068	"Solute carrier family 7 member 8"	Q9UHI5	14	23125295-23183674	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 331.1"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 74.1;Kupffer cells: 90.0;Proximal tubular cells: 144.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 9.3;eosinophil: 14.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 14.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 68.8;BEWO: 110.6;K-562: 136.9;NTERA-2: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046015, HPA051950, HPA060672"	Enhanced					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB046015: AB_2239464, HPA051950: AB_2681670, HPA060672: AB_2684340"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.97e-4)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.39e-3)"	"unprognostic (9.44e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.52e-4)"	27.6	15.2	1.2	7.0	7.1	1.6	27.7	5.5	7.6	31.3	42.8	12.5	36.3	43.6	4.8	37.5	45.9	18.6	7.9	3.4	6.5	119.3	6.9	15.4	4.5	3.4	3.1	67.5	19.9	331.1	15.8	16.0	5.8	39.2	13.7	13.9	23.8	35.5	49.4	31.6	24.2	20.9	0.0	18.5	63.4	21.2	6.7	4.9	23.7	15.4	9.0	29.9	37.5	1.4	1.6	0.0	52.9	0.1	68.8	8.5	110.6	6.0	26.3	0.3	2.0	60.4	3.6	0.4	0.8	13.9	5.4	11.7	8.5	3.5	0.3	0.0	5.2	0.6	0.3	0.0	25.5	0.2	35.8	54.1	33.2	0.9	0.9	11.6	5.2	5.4	136.9	0.3	1.5	1.2	0.3	0.8	64.0	12.9	47.4	0.1	0.9	12.5	0.7	21.4	8.2	0.3	0.2	12.0	32.3	60.1	42.8	0.6	0.5	2.3	1.8	0.7	0.0	0.3	15.9	0.2	6.9	0.0	0.4	9.3	0.1	14.0	0.0	0.1	1.1	0.1	0.9	0.1	0.0	0.0	0.9	3.3	0.4	0.0	0.1	0.0	0.5	2.3	1.2	7.1	5.5	7.6	3.4	6.5	3.4	3.1	5.8	0.0	6.7	1.4	0.5	16.0	15.0	2.3	1.8	3.1	28.8	6.4	29.0	26.4	31.6	15.2	5.7	0.0	9.0	16.5	0.0	18.7	0.5	8.3	5.9	1.9	2.2	13.6	74.1	2.1	33.0	0.0	24.8	2.4	4.4	15.5	53.5	18.4	5.1	27.3	66.4	1.3	59.2	26.9	53.5	33.7	4.1	90.0	3.3	3.1	9.6	15.3	19.6	15.9	0.5	39.3	0.0	4.0	2.6	3.0	6.5	7.9	1.6	26.4	27.3	144.8	1.0	4.4	0.0	2.8	4.7	1.1	1.3	25.3	3.0	41.3	2.9	3.4	18.5	32.3
SMARCA2	"BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2"	ENSG00000080503	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2"	P51531	9	1980290-2193624	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Hypotrichosis, Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 246.5;Inhibitory neurons: 263.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"HDLM-2: 1486.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029981, CAB037276"	Enhanced		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"		NA	NA		19000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB037276: AB_477083, HPA029981: AB_10602406"	"unprognostic (5.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.60e-3)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.26e-6)"	"unprognostic (3.09e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.50e-2)"	51.9	55.9	68.9	36.1	73.9	95.7	62.0	87.4	81.7	42.1	40.2	31.0	20.2	53.2	57.3	41.7	57.4	46.0	43.8	60.3	53.7	45.9	58.3	40.3	50.9	43.2	54.4	166.0	36.8	170.3	32.7	48.2	50.6	42.5	31.7	63.6	50.7	53.2	97.7	48.2	27.7	44.2	40.3	52.3	32.0	56.3	55.7	42.2	55.7	60.1	47.8	31.8	28.8	52.9	45.7	32.9	23.7	33.8	47.2	56.6	71.7	59.4	44.6	24.9	19.5	0.5	17.7	76.2	22.0	50.7	13.5	18.8	12.9	46.5	17.6	1486.7	20.2	208.3	88.2	16.2	18.7	88.3	118.1	37.6	17.5	24.9	46.4	44.9	40.3	35.4	7.3	255.1	43.0	19.1	22.2	72.3	23.4	26.4	12.6	97.6	30.5	69.4	57.6	40.9	15.3	14.0	36.2	8.3	14.9	34.1	16.3	55.8	49.1	40.6	19.8	25.8	27.3	22.9	31.8	33.6	43.5	32.5	11.4	26.1	5.2	15.8	10.8	7.2	10.4	12.3	10.5	11.2	6.4	9.4	13.1	10.3	14.6	9.9	10.3	12.5	12.6	5.0	68.9	73.9	87.4	81.7	60.3	53.7	43.2	54.4	50.6	40.3	55.7	52.9	83.9	73.7	70.6	246.5	57.2	58.6	18.3	55.0	82.6	57.6	103.7	74.3	95.2	31.5	54.1	106.7	37.5	99.3	102.8	32.0	31.3	30.6	38.0	44.1	61.6	69.0	37.2	41.2	216.2	22.4	24.5	65.7	19.4	45.2	48.0	27.9	36.8	62.0	31.5	35.3	263.2	31.2	48.8	54.9	34.7	22.6	76.7	57.5	49.8	142.4	45.2	53.4	43.3	120.6	100.8	18.7	15.1	86.9	71.4	13.9	26.9	18.5	88.3	37.4	13.1	58.7	40.3	42.9	14.6	66.2	52.7	88.7	74.8	56.1	28.2	12.7
SNX13	"KIAA0713, RGS-PX1"	ENSG00000071189	"Sorting nexin 13"	Q9Y5W8	7	17790761-17940501	"Predicted membrane proteins"	"Protein transport, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 274.3;Late spermatids: 211.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"				"unprognostic (7.26e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.02e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (5.98e-6)"	"unprognostic (8.12e-2)"	"unprognostic (6.96e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.46e-1)"	12.8	12.7	8.7	7.9	9.2	4.8	12.7	10.5	11.1	11.7	8.0	13.0	9.9	13.7	13.0	8.0	9.4	9.2	12.7	9.2	9.6	13.7	9.1	9.5	8.9	8.8	9.3	13.7	9.7	20.9	8.5	14.2	9.0	13.2	13.7	11.2	12.5	9.8	14.2	10.2	9.6	10.1	8.5	10.5	11.6	7.9	9.1	8.3	17.3	17.3	7.2	9.2	10.0	9.5	8.6	4.0	7.5	9.9	19.7	19.0	8.9	8.4	13.3	6.7	8.0	3.5	8.6	9.4	5.6	9.6	14.3	9.1	5.9	7.9	10.9	1.7	6.8	3.3	8.2	4.7	12.4	8.3	6.0	13.7	14.5	6.3	10.7	13.4	9.7	6.6	7.3	7.7	12.1	4.1	6.0	10.5	7.0	11.1	7.1	4.4	7.8	5.1	14.5	13.2	6.5	6.7	7.9	18.0	7.7	14.8	9.6	14.2	9.0	10.3	4.9	13.8	10.1	15.4	6.1	7.3	14.6	5.6	15.1	0.9	0.9	1.2	0.7	1.5	1.1	0.9	0.6	0.5	0.8	0.6	0.8	0.7	2.0	0.9	1.2	0.5	0.4	0.4	8.7	9.2	10.5	11.1	9.2	9.6	8.8	9.3	9.0	8.5	9.1	9.5	29.9	22.4	32.1	65.6	24.6	10.6	14.0	15.6	21.1	19.4	18.4	14.2	41.3	12.8	28.3	12.9	43.8	34.1	20.7	30.1	13.7	13.2	274.3	22.7	30.2	22.9	19.8	24.8	89.7	12.9	14.2	25.6	22.4	17.3	19.6	24.8	35.7	15.4	23.7	16.8	96.0	16.1	22.4	31.4	22.8	211.1	23.6	31.5	5.4	126.5	23.4	18.8	16.5	107.5	94.3	12.3	27.7	17.7	21.2	19.9	18.8	17.3	31.3	25.0	26.3	28.6	24.5	34.2	21.5	20.1	11.9	51.3	18.5	25.7	16.3	24.5
SNX6		ENSG00000129515	"Sorting nexin 6"	Q9UNH7	14	34561093-34630160	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049374	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"		"HPA049374: AB_2680734"	"unprognostic (1.89e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.36e-3)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.23e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	50.0	36.5	38.0	46.8	44.4	42.0	36.7	41.2	62.9	40.4	40.2	50.4	74.2	33.6	30.1	40.0	31.2	39.7	33.7	35.4	41.0	44.4	38.9	33.4	56.5	45.4	42.9	31.3	25.1	78.3	14.9	74.5	44.9	25.8	49.1	14.8	27.2	29.5	30.5	30.3	49.1	43.9	44.8	49.2	39.6	36.0	42.1	45.1	34.1	29.2	47.8	50.2	29.6	51.4	112.3	65.3	73.5	48.9	114.5	224.7	99.4	113.1	124.0	110.4	95.4	61.6	115.4	73.2	79.0	153.2	44.1	67.8	81.1	85.8	187.9	93.5	31.7	44.6	34.9	115.9	108.5	77.2	46.8	154.1	98.9	80.7	109.7	100.4	151.7	53.3	48.8	56.3	146.9	68.4	69.9	41.4	40.2	97.7	73.0	74.3	84.4	64.1	135.2	84.6	56.7	61.1	89.9	72.9	94.6	65.0	77.6	47.5	150.8	74.6	52.6	67.8	72.0	55.9	95.9	82.9	37.6	41.6	86.1	73.5	74.2	93.4	73.1	97.4	95.8	71.5	97.0	84.8	66.5	68.0	73.3	79.2	126.5	74.0	101.3	47.6	102.0	109.0	38.0	44.4	41.2	62.9	35.4	41.0	45.4	42.9	44.9	44.8	42.1	51.4	130.2	86.6	49.7	17.6	77.5	51.4	63.0	109.7	69.4	43.4	51.1	67.8	73.4	27.1	87.2	80.9	22.9	166.7	108.9	73.0	125.2	88.1	6.6	74.9	110.1	87.5	52.0	55.5	25.5	64.7	126.3	88.0	68.8	114.3	85.4	93.5	124.6	36.8	251.1	21.9	31.2	62.7	67.1	196.1	73.0	15.3	64.3	155.7	62.2	26.2	155.4	69.6	88.6	21.1	52.5	74.1	77.9	94.8	51.2	84.0	54.8	127.0	73.3	39.4	59.2	74.2	133.8	164.6	167.9	90.0	65.8	254.6	109.4	346.2	82.0	76.8
SPOCK3	testican-3	ENSG00000196104	"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3"	Q9BQ16	4	166733384-167234796	"Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 143.9;parathyroid gland: 175.0;prostate: 73.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 1010.6;Oligodendrocyte precursor cells: 399.1;Oligodendrocytes: 1851.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 1.8"	"Group enriched"	"Detected in many"	12	"dendritic cells: 1.8;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.2;hTERT-RPE1: 6.5;PC-3: 2.7;RH-30: 7.1;SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (3.54e-2)"	"unprognostic (8.69e-2)"		"unprognostic (2.90e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.09e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.94e-4)"	"unprognostic (8.92e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.64e-1)"	0.3	24.7	51.4	0.6	87.2	0.1	0.3	73.0	97.3	0.9	18.7	0.9	0.8	2.9	18.8	0.2	1.1	0.3	0.3	48.4	63.8	0.2	0.4	0.4	0.5	83.2	64.9	17.4	0.7	175.0	0.3	0.0	79.4	73.9	0.5	14.3	0.3	34.9	0.2	0.0	1.3	2.8	72.8	0.4	0.7	0.5	68.4	0.3	0.2	24.0	0.3	1.7	0.2	143.9	0.0	1.6	0.2	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.4	0.1	0.2	0.0	1.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	6.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	2.7	0.0	7.1	0.4	0.0	1.1	2.8	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.5	51.4	87.2	73.0	97.3	48.4	63.8	83.2	64.9	79.4	72.8	68.4	143.9	0.0	0.0	0.0	12.7	0.1	0.0	1.5	8.1	0.0	43.7	0.0	0.0	1.6	0.0	10.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	15.0	0.0	0.2	1.6	0.0	1.3	106.7	0.0	0.1	15.7	2.0	0.0	1.3	3.2	0.0	0.0	0.1	15.2	1010.6	0.0	6.1	0.0	0.0	2.9	0.9	0.5	0.0	98.4	0.2	1.3	0.0	399.1	1851.1	0.1	0.0	0.4	0.0	3.3	0.0	0.1	6.7	6.3	0.0	0.0	2.5	0.5	0.7	0.0	0.0	0.1	0.0	55.4	0.0	0.8
SSC4D	"S4D-SRCRB, SRCRB-S4D, SRCRB4D"	ENSG00000146700	"Scavenger receptor cysteine rich family member with 4 domains"	Q8WTU2	7	76389334-76409697	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.6;parathyroid gland: 7.0"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 11.0;Distal tubular cells: 3.9;Hepatocytes: 3.7;Spermatogonia: 3.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"EFO-21: 6.7;Hep G2: 9.6;SuSa: 10.7;U-2 OS: 25.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA062611	Uncertain				"Secreted - unknown location"	NA	NA		980000	"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 7: Non-specific - Mitochondria"			"HPA062611: AB_2684807"	"unprognostic (3.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (2.83e-6)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (3.52e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.18e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.73e-2)"	0.7	0.3	0.2	0.0	0.4	0.0	0.3	0.0	0.2	0.3	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	2.6	0.4	0.1	0.0	0.2	0.2	0.7	2.2	7.0	2.6	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.3	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	1.1	0.1	0.0	0.5	0.0	0.0	1.0	0.0	0.3	0.0	0.8	0.2	0.0	0.0	0.1	1.0	0.5	0.0	0.0	10.7	0.2	0.0	0.0	0.0	25.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.5	1.6	0.1	0.0	0.5	0.0	0.6	0.4	1.4	1.4	2.1	0.0	0.0	11.0	0.0	0.3	0.0	0.2	3.9	1.9	0.1	0.5	0.1	0.3	0.0	0.0	1.6	1.7	1.4	0.4	0.0	0.4	0.0	0.7	1.1	3.7	2.8	1.7	1.4	0.1	0.0	0.6	0.0	0.4	0.9	0.9	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.4	0.1	0.4	0.0	0.4	0.4	1.3	0.0	0.2	0.0	0.8	0.6	0.6	3.5	1.0	0.0	0.3	0.1	0.6	0.2	0.4
STT3A	"ITM1, MGC9042, STT3-A, TMC"	ENSG00000134910	"STT3 oligosaccharyltransferase complex catalytic subunit A"	P46977	11	125591712-125625215	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 391.8"	"Cell type enhanced"	"Detected in all"		"Plasma cells: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030735	Approved					NA	NA		23000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA030735: AB_10603342"	"unprognostic (8.25e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.82e-2)"	38.5	39.2	14.6	44.6	17.7	31.8	55.8	17.9	16.9	84.9	29.8	54.0	42.2	60.8	140.4	30.2	56.3	39.5	38.5	15.0	20.1	45.8	69.0	39.0	32.9	19.4	18.4	68.0	69.0	391.8	29.0	63.8	19.6	56.2	59.5	40.0	80.1	77.2	18.4	31.6	42.1	58.9	17.5	34.4	51.4	44.5	17.5	34.8	83.9	24.4	48.8	50.4	33.3	23.1	113.1	99.5	123.7	173.6	230.1	176.4	133.8	198.5	238.5	158.6	196.6	304.2	294.3	143.6	236.2	297.3	222.4	202.7	173.5	176.2	208.5	114.8	90.0	341.0	63.7	215.1	254.4	208.4	153.6	138.4	125.8	219.5	424.5	186.1	182.2	63.9	147.1	210.6	205.4	82.7	84.4	65.6	78.6	221.8	106.0	98.9	107.1	221.5	173.7	170.1	77.5	66.2	142.9	229.3	72.5	144.9	267.8	148.1	164.5	227.7	82.0	97.6	159.7	66.3	82.4	109.6	87.4	206.3	184.7	96.2	46.7	36.6	56.1	45.4	77.9	42.8	53.7	52.0	65.2	32.1	37.1	44.4	15.7	52.8	41.8	158.3	44.0	47.5	14.6	17.7	17.9	16.9	15.0	20.1	19.4	18.4	19.6	17.5	17.5	23.1	17.4	28.9	25.0	6.8	20.8	16.2	14.3	40.3	12.5	11.6	15.2	9.8	23.3	27.1	29.1	16.5	20.9	45.4	21.7	16.1	1.9	30.1	10.6	22.9	51.0	17.3	15.6	19.6	7.6	27.2	73.4	33.0	26.0	57.0	17.1	29.0	32.2	38.5	30.7	1.7	8.9	37.3	20.3	23.6	31.9	5.4	21.5	17.3	24.9	9.4	12.6	13.2	11.3	11.6	10.9	28.6	12.2	18.8	91.9	19.3	15.6	13.6	23.6	15.1	19.7	23.1	32.8	33.5	13.1	21.9	14.8	45.6	14.6	22.3	26.9	13.9
STXBP3	UNC-18C	ENSG00000116266	"Syntaxin binding protein 3"	O00186	1	108746674-108809523	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 206.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027225	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA027225: AB_1857627"	"unprognostic (3.14e-3)"	"unprognostic (4.33e-2)"	"unprognostic (7.18e-3)"	"unprognostic (4.88e-2)"	"unprognostic (6.54e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.55e-2)"	23.2	24.3	28.7	27.0	38.6	23.9	27.6	37.9	41.6	24.7	23.8	28.5	26.1	27.1	25.6	25.1	19.6	28.0	20.5	26.9	32.8	40.3	25.0	23.1	27.9	39.5	35.2	20.9	28.1	42.0	14.2	28.1	39.7	23.8	29.1	34.4	21.6	19.4	19.3	27.2	33.4	24.1	35.6	26.1	25.2	16.3	32.2	31.6	37.1	24.0	25.3	31.1	21.5	50.2	47.1	18.1	30.6	16.1	36.3	35.1	42.9	42.9	38.9	27.9	28.2	16.8	18.3	41.7	28.4	34.7	25.8	27.4	20.9	25.3	38.8	46.7	28.9	34.5	23.8	21.9	28.7	54.2	56.0	27.4	34.5	31.5	34.0	34.8	35.2	26.2	26.0	39.3	39.0	31.7	34.8	42.9	32.6	30.9	28.4	28.4	45.1	22.8	45.7	38.4	18.4	16.9	52.3	49.6	64.6	27.6	20.1	49.9	40.2	36.3	21.4	50.8	37.1	26.3	24.8	34.1	65.2	41.0	56.4	62.7	17.1	42.7	14.2	20.8	18.4	11.3	16.6	14.5	16.6	10.8	14.0	13.7	48.1	17.9	24.9	7.7	20.4	11.9	28.7	38.6	37.9	41.6	26.9	32.8	39.5	35.2	39.7	35.6	32.2	50.2	35.9	12.8	25.2	59.1	25.6	44.0	37.4	32.5	14.2	38.2	21.8	20.2	36.4	32.9	34.5	20.2	20.9	43.7	38.7	46.5	45.0	38.1	7.3	33.6	29.3	32.9	21.0	22.7	30.0	27.4	35.4	36.2	16.8	33.9	69.7	18.7	15.4	16.1	31.5	26.9	31.4	28.3	24.4	45.5	44.2	5.4	33.5	41.7	39.2	48.7	57.3	40.5	41.2	68.9	206.2	34.5	27.3	31.6	20.0	32.9	30.4	47.5	28.7	19.3	19.7	34.2	33.6	26.4	24.7	16.1	40.3	95.5	36.7	29.6	26.8	44.8
STXBP5	"LLGL3, tomosyn"	ENSG00000164506	"Syntaxin binding protein 5"	Q5T5C0	6	147204425-147390476	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 115.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 325.8;Excitatory neurons: 441.9;Inhibitory neurons: 300.1;Oligodendrocyte precursor cells: 206.1;Oligodendrocytes: 150.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 3.8;eosinophil: 9.2;neutrophil: 3.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 9.2"	"Cell line enhanced"	"Detected in many"		"HEL: 210.2;HMC-1: 219.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039991, HPA049727, CAB079016"	Enhanced	Supported	Enhanced	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB079016: , HPA039991: AB_10673368, HPA049727: AB_2680863"	"prognostic unfavorable (4.48e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.56e-4)"	"unprognostic (6.01e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.74e-7)"	"unprognostic (8.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.35e-3)"	7.0	9.1	7.2	9.5	12.7	34.3	7.8	24.2	13.2	9.5	0.0	14.2	8.0	8.3	7.7	13.7	5.9	9.5	5.9	9.5	6.5	3.6	3.9	6.6	7.8	0.6	0.5	5.5	15.5	115.8	7.7	6.3	0.5	11.4	16.3	20.1	5.5	14.5	7.7	15.4	11.2	10.9	0.0	8.3	8.0	22.2	0.6	9.4	6.3	8.1	9.6	8.5	9.9	8.5	10.8	9.4	4.9	16.5	23.4	48.8	5.4	24.5	36.1	17.8	19.9	8.0	7.0	7.8	5.6	48.8	30.5	12.7	14.1	21.5	21.6	17.1	11.0	210.2	27.2	9.0	26.8	72.7	219.6	35.6	15.0	35.6	72.0	42.1	23.2	12.2	57.8	9.6	35.4	15.7	11.6	18.8	4.0	8.9	21.4	1.7	25.4	3.0	9.7	18.4	10.6	7.6	18.9	13.3	8.2	8.7	3.9	28.0	26.9	25.4	9.2	12.6	22.5	7.9	0.1	9.1	14.0	26.2	18.5	3.8	0.3	9.2	0.9	0.4	0.9	0.3	0.5	1.1	0.4	0.9	0.8	1.3	3.1	0.4	0.5	0.3	0.2	0.3	7.2	12.7	24.2	13.2	9.5	6.5	0.6	0.5	0.5	0.0	0.6	8.5	12.1	16.0	8.8	325.8	5.7	3.6	2.6	1.9	3.4	38.8	6.7	7.7	14.1	11.5	6.7	16.5	31.3	5.2	9.5	18.7	0.0	4.8	39.0	10.1	10.5	10.8	41.1	10.1	441.9	12.9	4.6	10.1	14.3	20.5	44.2	5.1	8.9	4.5	4.7	33.7	300.1	30.3	0.0	7.8	3.1	42.8	7.8	7.8	10.6	97.4	8.5	5.4	6.2	206.1	150.4	11.7	21.4	7.2	5.8	10.4	29.3	1.9	2.2	29.0	13.1	12.7	5.6	13.1	11.5	11.0	6.7	3.8	9.3	5.4	19.3	3.6
SYCP2L	"C6orf177, dJ62D2.1, NO145"	ENSG00000153157	"Synaptonemal complex protein 2 like"	Q5T4T6	6	10886831-10979320	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"parathyroid gland: 68.7"	"Group enriched"	"Detected in many"	4	"Astrocytes: 21.5;dendritic cells: 9.5;Early spermatids: 17.1;Excitatory neurons: 28.5;granulocytes: 10.8;Inhibitory neurons: 23.1;Microglial cells: 13.1;Oligodendrocyte precursor cells: 14.1;Oligodendrocytes: 12.4;Spermatogonia: 8.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"basophil: 1.7;eosinophil: 3.4;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	17	"dendritic cells: 4.2;granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 13.4;HMC-1: 38.7;K-562: 10.7;NB-4: 15.3;SuSa: 8.1;THP-1: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA034679			Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA034679: AB_10669729"	"unprognostic (3.25e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.57e-3)"	"unprognostic (4.23e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-2)"	0.6	0.3	0.6	0.6	0.9	0.7	0.5	0.8	1.4	0.5	0.0	0.3	0.1	0.4	2.6	0.2	0.4	0.5	1.2	0.8	0.2	1.1	0.1	1.7	0.5	0.2	0.1	0.8	1.7	68.7	0.4	1.1	0.2	0.6	0.2	0.7	0.3	0.2	0.2	0.5	0.3	0.2	0.0	0.6	0.3	3.2	0.3	0.1	1.2	0.9	0.3	0.3	0.3	1.2	0.0	1.0	1.9	0.1	0.1	0.0	5.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.5	0.2	0.2	0.1	6.4	0.0	0.0	0.0	0.0	13.4	38.7	0.0	1.0	0.0	0.0	0.3	0.0	0.4	10.7	0.1	0.0	0.1	3.4	15.3	0.7	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.7	3.5	0.0	3.5	0.0	8.1	0.1	11.4	0.0	0.0	0.7	0.0	0.2	0.3	0.0	0.1	0.1	0.1	1.1	1.7	0.0	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.6	0.9	0.8	1.4	0.8	0.2	0.2	0.1	0.2	0.0	0.3	1.2	1.1	0.0	1.3	21.5	0.3	0.1	0.0	0.2	0.0	2.1	0.3	0.0	0.4	0.0	0.1	0.0	0.0	2.9	9.5	0.0	0.0	0.2	17.1	0.1	0.4	1.4	0.0	2.1	28.5	0.2	2.0	2.9	0.0	0.4	10.8	1.5	0.0	0.0	0.5	3.3	23.1	0.0	0.0	0.0	0.5	3.2	1.2	1.0	0.0	13.1	1.0	0.6	0.0	14.1	12.4	0.6	0.0	1.5	0.0	0.5	0.0	0.0	0.7	0.1	0.0	0.6	0.3	3.1	8.7	0.0	0.0	1.4	0.6	0.1	0.0	0.1
SYT12	SRG1	ENSG00000173227	"Synaptotagmin 12"	Q8IV01	11	67006778-67050863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 22.5;liver: 17.6;parathyroid gland: 63.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 8.8;Basal respiratory cells: 10.9;Excitatory neurons: 39.3;Inhibitory neurons: 21.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HeLa: 49.8;MCF7: 38.0;SiHa: 44.3;SK-BR-3: 20.9;T-47d: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011006, HPA074255"	Enhanced					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA011006: AB_2286996, HPA074255: "	"unprognostic (2.72e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (2.75e-1)"	"unprognostic (9.86e-4)"	"unprognostic (4.21e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.42e-2)"	"unprognostic (9.85e-2)"	0.6	6.9	9.4	0.2	10.9	0.0	4.6	22.5	19.0	0.2	1.7	0.0	0.7	0.1	5.1	0.4	3.8	0.6	0.7	9.9	7.6	0.3	17.6	0.0	0.1	10.3	9.5	0.1	0.3	63.8	5.6	0.8	10.9	1.6	0.0	0.4	1.6	0.8	0.3	0.8	0.3	0.0	4.8	0.0	0.3	1.4	7.9	0.0	0.4	0.0	0.1	1.2	0.2	10.9	0.0	2.0	0.3	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	8.1	1.5	3.4	1.3	0.3	1.5	0.2	4.5	0.0	0.0	0.4	0.0	49.8	0.1	0.0	0.0	0.1	0.5	0.3	0.1	0.0	4.6	0.0	0.0	0.1	0.1	0.0	38.0	0.0	0.1	0.9	0.2	1.7	0.0	0.0	0.0	0.6	0.0	0.3	0.0	44.3	20.9	0.1	0.1	19.3	0.2	0.0	0.0	7.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	10.9	22.5	19.0	9.9	7.6	10.3	9.5	10.9	4.8	7.9	10.9	0.2	0.0	0.0	8.8	0.1	1.3	3.8	10.9	0.0	2.2	6.9	6.6	1.2	1.5	3.1	1.8	0.0	0.4	0.1	0.5	0.0	2.9	0.5	0.8	0.3	0.4	0.0	0.0	39.3	0.0	1.5	1.1	0.0	0.5	0.0	0.3	0.0	5.8	0.1	0.0	21.6	0.0	0.0	0.0	1.2	0.2	0.0	0.1	0.0	4.7	0.0	0.1	0.0	3.0	2.3	0.4	0.0	0.4	0.1	1.2	0.2	0.1	1.6	1.2	0.0	1.2	1.6	0.8	1.2	0.0	1.1	1.9	0.5	0.0	0.4	1.3
TANC2	"DKFZP564D166, FLJ10215, FLJ11824, KIAA1148, KIAA1636, rols, ROLSA"	ENSG00000170921	"Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2"	Q9HCD6	17	63009556-63427699	"Disease related genes, Predicted intracellular proteins"			"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 30.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 597.7;Granulosa cells: 195.7;Inhibitory neurons: 394.9;Oligodendrocyte precursor cells: 641.4;Oligodendrocytes: 329.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 11.2;basal ganglia: 27.6;cerebral cortex: 22.3;hippocampal formation: 15.9;white matter: 17.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023274	Uncertain		Approved	Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA023274: AB_2199727"	"unprognostic (8.37e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.57e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.09e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.02e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.01e-1)"	5.8	6.4	11.2	2.9	27.6	12.0	5.6	0.0	22.3	6.8	0.0	4.2	2.0	5.1	8.3	6.1	4.2	5.4	5.1	15.9	2.8	6.3	2.2	12.5	1.5	1.6	0.0	4.4	4.2	30.5	10.4	4.1	4.3	6.1	2.0	6.4	7.3	5.3	2.2	11.1	2.5	7.0	1.3	2.5	3.8	18.4	1.1	3.4	3.7	2.5	1.7	8.3	7.0	17.5	28.2	25.9	15.8	2.7	7.9	19.0	30.5	17.6	17.3	17.0	21.0	1.5	8.0	0.0	5.3	30.3	21.6	3.8	25.6	51.6	38.2	10.9	11.8	41.0	38.9	1.5	6.9	11.2	0.0	29.3	29.5	19.9	56.9	18.8	5.5	10.4	5.2	0.0	24.6	21.4	7.4	1.8	1.8	4.9	16.8	5.7	31.7	2.1	15.1	38.4	26.5	29.2	9.8	18.3	7.2	27.3	8.4	2.9	28.0	41.3	21.4	2.7	21.7	0.0	0.0	0.0	15.2	2.9	15.1	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.3	0.4	0.0	0.3	0.1	0.2	0.3	0.9	0.0	0.4	0.0	0.0	11.2	27.6	0.0	22.3	15.9	2.8	1.6	0.0	4.3	1.3	1.1	17.5	13.2	16.0	59.4	79.0	2.3	25.1	13.0	25.3	6.8	63.1	11.6	8.5	3.9	10.0	19.2	27.6	16.7	8.0	9.4	3.4	1.9	10.9	17.5	15.4	12.6	12.3	4.2	3.8	597.7	14.0	35.0	8.5	7.7	19.7	0.0	195.7	24.3	1.3	7.3	8.4	394.9	3.3	20.3	9.7	10.9	10.4	5.6	16.7	10.6	151.8	11.2	3.9	14.4	641.4	329.8	29.4	2.8	3.4	2.9	10.6	0.3	1.7	10.2	7.1	19.7	62.9	6.9	23.0	20.4	10.8	15.9	16.4	9.9	8.8	2.2	11.8
TBXT	T	ENSG00000164458	"T-box transcription factor T"	O15178	6	166157656-166168700	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"parathyroid gland: 2.6;pituitary gland: 1.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	22	"testis cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HeLa: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003322	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA003322: AB_1080176"						"unprognostic (5.68e-2)"		"unprognostic (4.59e-2)"						"unprognostic (6.21e-3)"	"unprognostic (8.64e-3)"	"unprognostic (9.34e-3)"		0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	16.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCTN3	"C10orf61, DKFZP564D116, JBTS18, TECT3"	ENSG00000119977	"Tectonic family member 3"	Q6NUS6	10	95659823-95694143	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026987	Approved		Approved	Microtubules	"Intracellular and membrane"	NA	NA		4400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Microtubules		"HPA026987: AB_10600911"	"unprognostic (1.58e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.78e-2)"	"prognostic favorable (5.77e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.59e-1)"	21.3	25.3	8.6	15.7	9.0	5.1	25.2	9.1	11.3	26.3	24.0	22.1	17.6	24.8	65.0	17.0	35.4	22.7	18.4	8.8	9.8	32.5	26.8	19.4	14.3	9.7	9.5	30.6	27.1	69.9	22.8	26.9	9.5	25.6	25.6	22.2	25.4	27.7	9.5	20.5	15.4	26.8	9.2	17.3	19.1	19.4	9.6	14.0	70.6	11.5	18.0	23.9	18.6	9.2	34.0	54.1	44.1	89.3	93.6	74.6	25.7	45.3	94.8	46.9	55.3	35.4	57.3	31.3	40.1	60.4	49.8	46.7	43.9	54.5	56.5	33.6	36.4	10.9	21.6	49.2	46.9	37.4	22.8	65.2	49.2	46.6	72.4	88.0	80.7	27.7	21.0	40.3	63.4	32.5	23.4	27.9	12.1	49.7	38.1	25.3	33.9	38.3	67.8	23.3	11.5	24.5	37.7	18.5	52.6	40.8	71.0	35.1	37.9	35.6	24.9	23.9	49.5	18.9	37.9	20.7	57.5	47.1	19.0	6.8	14.2	4.9	25.8	21.9	32.0	28.3	23.1	25.2	45.2	19.4	24.2	20.0	1.6	26.8	24.3	23.6	22.2	21.3	8.6	9.0	9.1	11.3	8.8	9.8	9.7	9.5	9.5	9.2	9.6	9.2	14.8	19.2	16.2	16.6	29.3	14.4	23.7	33.8	31.3	24.0	18.2	15.0	8.5	27.1	20.3	31.3	37.5	50.3	18.8	20.2	7.9	27.2	18.6	25.5	25.7	20.4	13.8	11.6	17.3	20.3	44.2	27.3	11.7	18.3	8.2	29.8	21.4	16.8	28.5	25.2	17.7	12.5	26.4	14.1	59.1	14.1	20.8	18.7	16.0	16.9	14.8	36.7	15.5	20.6	13.7	14.1	12.7	25.2	35.9	19.8	16.2	16.1	27.5	44.4	13.1	23.9	19.8	39.8	34.1	15.3	11.5	31.5	23.0	34.2	23.7	14.6
TDRD9	"C14orf75, DKFZp434N0820, FLJ36164, NET54"	ENSG00000156414	"Tudor domain containing 9"	Q8NDG6	14	103928456-104052667	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"parathyroid gland: 30.6;testis: 40.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 43.2;Spermatocytes: 63.2;Spermatogonia: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"classical monocyte: 1.6"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 24.4;HeLa: 21.5;HMC-1: 94.2;RPTEC TERT1: 25.5;SK-MEL-30: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"				"unprognostic (3.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-4)"	"unprognostic (1.60e-2)"	"unprognostic (4.57e-3)"	"unprognostic (8.97e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (2.41e-2)"	0.4	0.5	0.9	0.6	0.8	1.7	0.5	1.3	0.9	0.4	1.2	0.3	0.1	0.4	0.4	0.2	0.9	0.9	0.6	0.8	0.8	2.1	0.3	1.0	0.5	1.7	1.0	0.2	0.5	30.6	1.0	0.5	2.0	0.3	0.2	3.5	0.3	0.5	0.1	0.1	0.3	0.5	1.1	3.0	0.8	40.7	1.1	0.3	5.4	0.5	0.5	0.4	0.2	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	21.5	0.0	0.0	0.0	94.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.0	8.7	0.0	0.0	0.6	13.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.8	1.3	0.9	0.8	0.8	1.7	1.0	2.0	1.1	1.1	1.3	0.9	6.4	2.0	2.3	0.0	0.0	0.1	0.1	0.0	4.3	1.0	0.4	12.4	0.0	0.7	0.0	4.2	0.0	0.5	0.0	1.9	0.6	13.1	43.2	1.5	0.9	0.0	1.3	9.1	0.0	0.0	0.7	0.0	3.7	0.0	0.3	0.4	0.1	1.9	6.7	4.6	0.0	2.0	1.8	0.0	7.3	0.9	1.5	0.0	2.8	2.9	0.6	0.0	1.0	4.6	0.5	0.0	2.2	0.3	0.5	0.0	2.5	0.2	2.3	6.6	0.9	0.8	63.2	38.6	0.0	0.0	0.0	0.3	11.7	0.0	0.1
TDRKH	TDRD2	ENSG00000182134	"Tudor and KH domain containing"	Q9Y2W6	1	151770107-151791416	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 30.1;testis: 22.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.9;Late spermatids: 60.4;Spermatocytes: 43.2;Spermatogonia: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016419, HPA019625"	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Centrosome	"HPA016419: AB_1857870, HPA019625: AB_1857871"	"unprognostic (2.27e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.14e-1)"	2.5	3.1	5.1	4.4	5.1	1.4	4.5	7.9	5.8	2.1	2.3	3.2	2.2	1.6	6.0	1.8	2.0	1.9	3.5	5.5	6.0	4.0	3.6	4.4	5.9	7.4	5.8	0.9	3.0	30.1	4.6	3.6	8.2	6.0	4.0	9.6	7.0	5.7	4.2	2.2	2.2	2.8	4.7	6.3	2.9	22.2	6.0	10.0	7.3	4.9	5.4	2.6	1.7	5.4	10.8	9.4	8.1	18.8	0.5	0.8	7.7	1.8	1.0	5.6	3.7	6.1	15.1	12.6	16.3	0.7	13.1	6.4	11.9	12.5	8.5	32.5	8.3	12.6	2.6	4.2	3.4	2.4	2.0	1.0	4.8	11.8	5.0	1.6	5.9	24.3	9.8	11.0	1.8	29.3	20.3	3.9	6.2	16.0	16.0	2.5	5.0	26.2	9.6	5.3	11.7	19.2	13.2	10.5	12.4	14.5	22.9	9.4	2.4	2.6	4.6	8.2	10.2	22.2	29.4	14.1	12.0	10.1	3.6	5.2	0.9	2.0	8.2	4.3	12.5	3.9	7.6	8.3	2.0	3.6	5.6	6.9	0.6	7.7	8.0	5.3	9.9	4.1	5.1	5.1	7.9	5.8	5.5	6.0	7.4	5.8	8.2	4.7	6.0	5.4	1.0	3.2	8.3	2.3	2.5	0.3	2.1	1.5	0.6	3.4	4.4	1.1	4.8	0.0	2.2	7.3	4.2	2.7	2.4	0.7	1.9	3.1	23.9	1.5	0.2	1.7	0.0	2.1	6.6	2.5	2.9	0.5	2.6	1.2	4.5	4.6	1.4	1.6	5.4	6.7	5.9	0.9	2.0	2.6	1.3	60.4	0.3	2.3	1.8	2.8	2.2	1.8	0.0	6.0	8.3	1.9	0.3	2.2	1.9	1.6	0.1	1.4	1.4	3.5	13.1	1.9	1.0	43.2	27.4	0.4	0.1	2.5	2.9	0.6	0.9	1.8
TIGD6	DKFZp761E2110	ENSG00000164296	"Tigger transposable element derived 6"	Q17RP2	5	149993118-150000654	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044599	Uncertain		Approved	"Nucleoplasm,Vesicles,Actin filaments"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Actin filaments"	"HPA044599: AB_10961286"	"unprognostic (1.06e-1)"	"unprognostic (3.25e-1)"	"prognostic favorable (5.35e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.30e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.85e-2)"	"prognostic favorable (5.88e-4)"	"unprognostic (1.94e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.18e-1)"	2.6	3.6	2.1	1.7	2.4	1.3	4.7	2.7	2.4	2.5	2.6	2.8	2.2	2.4	5.1	1.7	3.1	2.3	2.0	2.0	2.3	3.6	2.8	2.4	1.9	2.2	2.3	3.9	3.2	11.2	2.6	2.6	2.2	4.1	2.5	3.5	3.1	3.0	1.4	2.7	2.0	2.6	2.1	2.1	2.9	4.0	2.2	2.3	3.0	2.2	2.0	2.4	1.7	2.5	2.1	5.7	3.8	8.2	10.7	8.8	5.9	6.0	6.3	4.6	4.6	3.7	3.7	1.0	5.3	7.1	5.7	3.7	3.4	4.4	5.4	4.7	2.8	1.8	3.1	2.0	9.5	2.6	4.4	9.0	8.3	5.9	7.7	5.4	3.6	4.1	2.5	4.7	5.8	5.0	3.4	1.2	1.5	2.7	4.8	3.9	4.3	2.7	4.4	3.0	2.9	3.8	4.2	6.7	9.1	4.6	7.5	4.5	4.9	3.7	2.8	4.1	4.5	3.5	1.4	2.7	5.9	2.8	5.9	0.0	2.2	1.2	1.5	2.3	1.3	1.4	2.0	1.5	1.9	1.7	4.2	2.6	0.0	3.4	1.3	1.0	2.2	1.5	2.1	2.4	2.7	2.4	2.0	2.3	2.2	2.3	2.2	2.1	2.2	2.5	3.1	12.8	2.7	1.3	2.2	2.2	6.6	2.9	2.2	6.2	5.4	3.7	5.4	4.3	4.7	3.7	0.0	5.2	2.6	2.0	7.9	5.1	1.2	2.9	3.5	2.7	3.0	0.4	1.4	4.7	2.7	3.5	7.1	3.6	3.8	4.6	3.3	1.8	4.2	3.3	1.6	2.6	6.1	1.9	1.9	2.1	4.4	2.6	3.6	2.8	4.8	6.3	1.0	4.5	5.6	4.3	1.9	3.4	3.8	5.7	3.1	7.9	3.6	6.3	0.0	2.1	3.8	20.0	8.7	2.6	1.1	3.6	2.2	6.8	2.0	4.9
TINF2	TIN2	ENSG00000092330	"TERF1 interacting nuclear factor 2"	Q9BSI4	14	24239643-24242674	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 233.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059061, HPA069807"			Enhanced	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"		"HPA059061: AB_2683895, HPA069807: AB_2686203"	"prognostic favorable (4.96e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.04e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.78e-2)"	"unprognostic (7.44e-2)"	47.2	76.4	17.6	17.3	19.1	20.1	44.0	18.9	23.6	42.2	17.7	40.7	11.5	43.7	21.0	63.2	36.1	12.8	39.4	17.6	18.4	48.5	33.5	44.1	22.7	19.5	18.6	32.2	44.6	233.5	31.9	14.2	19.5	37.9	15.7	12.8	37.6	16.2	45.2	40.8	38.4	19.4	18.8	55.8	41.8	16.3	18.7	29.2	40.7	16.1	26.6	40.9	41.4	20.0	18.4	16.4	23.2	12.2	25.1	18.5	11.8	18.3	23.1	26.3	24.5	7.1	20.0	26.7	10.3	26.1	19.0	17.5	13.2	16.5	16.5	34.1	6.7	16.8	15.1	28.5	21.6	17.9	23.1	20.5	26.0	21.1	20.0	24.5	28.9	25.0	6.7	33.1	21.5	20.0	27.0	8.8	5.4	19.3	20.1	21.9	14.8	19.5	23.7	25.8	14.2	13.2	19.1	18.0	17.0	15.3	12.9	11.4	23.3	12.2	14.9	21.0	14.6	25.2	19.5	15.1	14.8	9.9	18.6	124.6	47.8	113.7	59.7	51.1	48.1	58.7	46.5	56.2	41.1	65.1	48.3	48.4	60.2	63.5	49.3	34.9	61.5	75.8	17.6	19.1	18.9	23.6	17.6	18.4	19.5	18.6	19.5	18.8	18.7	20.0	34.6	16.0	23.0	6.2	54.5	16.8	63.8	35.7	26.7	23.0	18.4	17.7	13.5	15.7	29.3	18.4	8.4	31.8	51.1	19.2	35.2	35.1	8.1	12.8	15.7	31.4	13.1	15.8	4.1	47.2	26.5	28.1	16.8	18.7	40.5	10.0	27.8	16.5	35.5	15.2	4.1	16.3	32.6	30.1	19.7	10.7	23.6	29.9	21.4	7.5	43.3	41.8	72.1	3.5	7.5	40.5	23.8	29.7	31.5	38.9	22.0	25.4	9.5	18.8	26.3	25.8	29.9	24.3	26.2	27.4	25.1	42.3	46.5	29.4	15.6	53.0
TMC3		ENSG00000188869	"Transmembrane channel like 3"	Q7Z5M5	15	81331088-81374213	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	30	"parathyroid gland: 83.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.7;Distal tubular cells: 1.9;Excitatory neurons: 1.0;Spermatocytes: 1.1"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040265, HPA040510"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA040265: AB_10795379, HPA040510: AB_10796123"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.20e-5)"	"unprognostic (2.32e-1)"	"unprognostic (1.97e-7)"	"unprognostic (1.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.96e-2)"	0.1	0.2	0.7	0.4	0.7	0.8	0.4	2.4	0.9	0.3	0.3	0.4	0.6	0.4	1.6	0.1	0.9	0.6	0.2	0.6	0.2	0.2	0.3	0.1	0.4	0.7	1.0	0.4	0.2	83.6	0.1	0.2	2.7	0.4	0.1	0.7	0.6	0.5	0.2	0.4	0.4	0.1	0.5	0.3	0.2	0.7	0.5	0.1	0.8	0.1	0.1	0.1	0.8	0.7	0.3	0.3	0.1	0.9	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.2	0.6	0.8	0.0	0.0	0.8	0.2	0.1	0.0	0.0	0.5	0.5	0.6	0.3	0.3	0.1	0.5	0.3	0.1	0.0	0.1	0.1	0.4	0.0	0.9	0.2	1.0	0.0	0.3	0.3	0.4	0.5	0.3	0.3	0.2	0.3	1.5	0.0	0.2	0.3	0.6	0.2	0.3	0.6	0.2	0.7	0.3	0.1	0.5	0.6	0.4	0.2	1.5	0.6	0.5	0.3	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.7	0.7	2.4	0.9	0.6	0.2	0.7	1.0	2.7	0.5	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.1	0.6	0.1	0.6	0.0	0.0	1.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMCO4	DKFZp686C23231	ENSG00000162542	"Transmembrane and coiled-coil domains 4"	Q5TGY1	1	19682240-19799945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA014601, HPA014620"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"HPA014601: AB_2204302, HPA014620: AB_2669051"	"unprognostic (3.31e-3)"	"unprognostic (8.94e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (3.71e-4)"	"unprognostic (6.99e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (9.21e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-2)"	"prognostic favorable (4.12e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.81e-2)"	"prognostic favorable (3.64e-4)"	7.9	8.9	1.4	5.3	2.4	4.7	9.5	1.3	1.4	8.7	6.5	7.9	17.3	9.8	21.0	8.4	10.3	6.4	4.8	1.6	1.7	9.2	5.4	6.1	6.9	1.9	2.2	7.2	10.8	34.6	3.6	3.1	1.7	13.2	6.1	0.3	17.0	10.6	2.3	5.7	9.6	5.6	1.7	9.5	11.7	1.7	2.0	3.7	11.5	2.4	5.0	9.4	7.9	1.5	9.3	5.6	0.0	0.3	7.5	5.2	6.2	6.8	20.9	13.1	7.3	4.6	42.5	16.2	9.9	19.7	5.8	6.9	1.7	6.8	2.7	13.8	1.7	6.1	6.6	2.3	6.1	0.0	8.1	5.4	7.6	4.4	2.5	4.8	6.3	0.3	1.2	10.7	5.8	7.9	0.0	3.6	0.6	12.6	7.9	3.1	17.5	10.0	11.2	7.2	0.0	0.7	9.0	12.3	13.9	0.9	10.6	10.4	4.0	10.0	4.6	7.2	4.7	1.2	0.6	4.6	11.4	13.8	6.5	0.1	3.8	2.1	4.7	6.7	4.7	4.2	5.0	5.0	7.4	4.9	3.7	3.2	0.3	4.2	4.1	0.2	3.9	3.6	1.4	2.4	1.3	1.4	1.6	1.7	1.9	2.2	1.7	1.7	2.0	1.5	5.8	12.8	11.0	8.8	9.9	2.8	9.6	6.3	4.6	0.2	17.0	15.4	8.0	2.8	12.0	11.0	0.0	9.3	6.0	12.3	9.8	13.2	0.3	10.6	8.1	5.2	6.0	6.5	2.4	16.9	18.6	7.7	15.8	16.5	3.8	7.7	5.3	5.1	9.1	0.0	5.0	15.9	12.2	7.1	3.3	0.5	6.2	6.7	10.6	11.2	9.5	3.0	5.2	3.0	0.4	11.0	7.5	5.7	6.9	11.4	4.5	7.9	18.8	0.5	0.0	6.1	7.7	0.3	2.1	7.9	2.6	7.3	8.2	5.7	14.2	7.9
TMED4	"HNLF, p24a3, p24alpha3"	ENSG00000158604	"Transmembrane p24 trafficking protein 4"	Q7Z7H5	7	44577894-44582287	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014650	Approved				"Intracellular and membrane"	NA	NA		24000	"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA014650: AB_1858066"	"unprognostic (7.34e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.46e-3)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (2.09e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.54e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.65e-2)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.21e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.11e-1)"	"unprognostic (6.61e-2)"	35.2	51.7	40.5	32.2	48.3	49.5	42.9	44.8	43.2	48.9	53.2	46.5	87.9	51.2	78.6	37.3	53.9	37.2	65.0	40.9	48.5	88.3	49.0	42.1	37.1	47.8	45.3	72.0	73.0	139.4	68.3	61.9	47.9	57.5	48.1	92.0	67.3	65.1	61.5	40.5	92.8	44.3	44.1	38.5	51.7	31.4	44.0	38.3	114.0	41.6	38.1	42.3	40.5	56.7	47.2	57.0	80.0	90.8	70.7	41.8	68.6	55.7	68.8	56.4	70.1	62.2	114.1	44.5	90.9	60.0	120.8	74.9	42.5	46.7	67.9	59.3	69.0	39.5	100.4	59.6	63.7	63.8	72.8	54.5	69.7	59.7	48.4	103.8	50.7	68.9	62.8	96.4	67.6	42.4	61.8	86.2	51.5	73.1	57.5	52.6	37.2	87.4	81.7	76.6	64.0	91.3	59.4	132.7	64.4	90.7	103.8	64.1	47.3	41.3	61.0	47.8	88.1	143.9	140.0	53.6	84.6	67.5	148.8	95.3	60.2	87.2	85.3	63.3	103.4	67.4	85.0	82.2	55.1	54.5	69.5	77.8	58.5	82.8	71.3	120.7	79.2	56.6	40.5	48.3	44.8	43.2	40.9	48.5	47.8	45.3	47.9	44.1	44.0	56.7	41.4	118.6	74.0	11.8	70.3	56.2	53.5	61.0	44.9	150.5	83.2	77.2	69.8	62.9	66.0	154.5	75.0	176.0	83.5	79.7	41.1	79.4	54.9	79.3	61.7	36.8	62.9	49.2	25.5	60.6	57.4	75.2	45.9	92.9	41.1	89.9	36.4	55.5	70.7	112.7	30.2	75.0	63.1	45.9	55.0	100.4	78.3	50.4	40.9	12.2	56.9	115.7	41.2	25.1	31.0	79.0	78.6	81.3	142.7	75.6	267.7	140.9	69.4	135.9	59.2	87.1	65.8	51.8	60.8	47.0	56.8	159.9	74.1	60.3	79.6	76.3
TMEM116	FLJ90167	ENSG00000198270	"Transmembrane protein 116"	Q8NCL8	12	111931282-112013185	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 59.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.8;Spermatocytes: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	4	"T-cells: 19.3"	"Cell line enhanced"	"Detected in many"		"RT4: 33.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040720	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Microtubules	Nucleoplasm	"HPA040720: AB_10795623"	"unprognostic (8.91e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.12e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.19e-3)"	3.8	8.8	7.0	2.2	7.8	1.2	11.4	9.2	8.4	6.0	27.5	4.2	11.1	2.7	7.1	4.2	4.9	6.8	26.3	6.4	6.5	30.8	12.3	8.5	4.5	7.2	7.5	5.2	4.2	59.7	6.5	2.9	7.2	3.9	3.7	7.0	13.3	5.9	6.6	11.1	6.3	2.1	6.9	3.4	10.2	27.1	7.5	5.4	6.3	5.8	6.8	7.4	3.2	8.5	6.2	6.4	8.9	9.7	8.3	6.6	6.0	5.1	7.5	6.1	6.6	4.6	5.1	6.9	2.9	3.5	7.6	5.9	4.8	5.1	5.4	17.1	4.1	4.4	5.4	5.1	13.2	1.6	0.7	7.8	8.5	7.7	13.5	6.7	2.2	13.2	8.7	5.0	6.5	9.4	2.3	14.2	10.6	14.5	3.9	7.0	3.8	12.2	18.9	33.1	8.1	5.6	5.3	4.4	8.3	11.7	16.0	22.9	1.6	5.8	1.8	5.1	2.2	6.5	12.1	6.6	7.9	5.5	8.0	1.1	2.6	4.5	8.1	4.5	6.8	2.9	18.5	15.6	2.9	3.6	9.6	10.8	0.4	2.4	3.5	4.2	19.3	4.0	7.0	7.8	9.2	8.4	6.4	6.5	7.2	7.5	7.2	6.9	7.5	8.5	4.0	3.2	18.5	17.3	6.2	5.5	6.2	8.8	7.4	11.2	14.0	12.8	21.7	7.2	10.1	29.5	16.7	18.6	10.2	5.7	23.5	4.2	67.8	7.0	4.3	3.5	0.0	3.4	28.3	4.0	5.9	5.9	7.7	3.7	5.7	7.0	2.2	5.4	5.1	10.1	25.6	4.6	24.4	4.1	4.5	33.5	9.3	3.9	7.2	7.5	3.6	13.4	11.3	13.0	33.3	2.7	3.2	4.9	5.5	4.2	20.9	10.3	18.6	17.3	6.6	6.5	6.6	123.5	37.4	6.2	5.4	40.1	17.4	7.0	6.0	7.6
TMEM167A	"FLJ30508, MGC23909, TMEM167"	ENSG00000174695	"Transmembrane protein 167A"	Q8TBQ9	5	83052846-83077863	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077278			Approved	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA077278: "	"unprognostic (5.38e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.78e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.06e-3)"	"unprognostic (7.74e-2)"	"unprognostic (9.94e-3)"	"unprognostic (3.99e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.29e-2)"	31.5	48.6	31.8	29.5	32.5	30.8	30.0	35.2	33.7	30.0	29.7	25.3	27.8	21.5	25.8	19.0	15.0	27.6	27.2	32.2	40.3	34.2	33.2	26.5	22.9	33.7	35.4	16.0	23.0	32.0	22.8	35.1	35.1	22.8	29.5	35.3	26.3	19.5	17.4	21.6	24.5	22.7	32.8	22.0	24.1	12.3	36.5	26.5	29.0	21.2	24.0	25.3	15.7	34.2	35.4	21.1	77.7	70.4	111.9	77.6	71.2	54.5	42.6	34.5	44.9	31.8	45.1	22.3	33.4	64.6	45.9	29.1	52.0	70.5	57.1	31.4	32.1	61.2	39.5	49.7	43.5	31.4	38.8	61.0	48.5	44.3	41.4	56.4	43.1	32.7	34.1	44.7	50.9	30.8	38.9	34.4	80.9	18.5	35.4	34.2	50.2	62.5	48.5	27.8	36.8	48.0	36.7	38.2	56.1	70.6	69.2	73.5	59.7	21.8	21.3	63.5	49.2	25.7	77.5	22.3	40.6	56.1	53.0	26.0	21.6	10.3	3.4	20.4	4.0	3.9	4.7	4.3	12.0	3.2	5.0	4.0	12.3	6.0	24.2	5.7	6.2	10.7	31.8	32.5	35.2	33.7	32.2	40.3	33.7	35.4	35.1	32.8	36.5	34.2	56.5	35.3	26.2	21.2	62.8	47.9	60.4	160.3	39.9	47.8	76.2	58.4	53.3	55.8	104.8	49.7	41.7	102.9	63.1	100.0	170.2	86.6	16.7	49.0	135.7	57.2	50.8	56.4	22.7	121.4	306.2	90.6	47.9	71.1	32.4	41.2	50.3	121.6	158.7	33.7	30.2	101.6	103.7	181.4	117.6	20.8	47.2	154.7	94.3	15.0	188.0	68.8	66.9	61.3	50.6	130.7	81.8	49.7	129.3	126.4	84.4	223.3	72.9	31.6	32.9	41.8	79.2	64.1	57.6	79.8	67.2	179.4	64.8	57.1	73.6	125.2
TMEM167B	"AD-020, C1orf119, FLJ90710"	ENSG00000215717	"Transmembrane protein 167B"	Q9NRX6	1	109090764-109096934	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"				"unprognostic (7.89e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.96e-2)"	"prognostic favorable (8.86e-4)"	"unprognostic (3.76e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.25e-1)"	31.7	35.5	29.9	24.2	30.3	53.7	33.1	30.0	34.4	32.4	29.6	27.7	23.2	30.9	31.6	24.0	25.4	25.6	35.9	30.1	30.5	33.3	33.0	28.4	26.2	29.1	30.2	29.7	25.7	45.1	15.9	33.8	29.6	36.9	29.8	31.3	30.3	27.9	21.3	28.9	23.7	30.6	31.3	28.3	32.4	23.4	30.9	25.1	41.7	25.9	27.7	27.2	16.3	33.0	36.1	6.5	23.4	32.3	47.8	47.0	20.9	54.2	49.7	30.0	27.8	13.7	13.4	24.0	30.1	55.9	17.8	17.4	15.1	24.1	43.0	37.4	11.4	22.4	8.7	18.8	53.6	43.6	36.6	38.8	64.7	27.9	46.7	40.8	26.5	30.8	28.5	33.9	33.0	22.2	33.0	28.1	17.7	31.0	33.1	20.5	37.1	19.0	38.6	22.5	16.6	17.0	26.2	38.0	53.0	20.8	23.7	32.0	25.2	30.6	30.8	67.0	26.6	34.0	20.6	23.7	51.7	44.7	65.0	38.1	20.7	35.4	13.3	23.8	19.1	14.4	17.6	17.0	19.1	13.5	17.8	17.8	45.4	17.5	30.8	11.7	17.9	19.9	29.9	30.3	30.0	34.4	30.1	30.5	29.1	30.2	29.6	31.3	30.9	33.0	29.6	32.1	31.4	10.7	30.1	30.5	29.4	25.7	16.5	30.1	28.2	17.9	34.0	22.8	28.6	18.4	12.5	42.1	38.7	20.0	19.6	26.7	19.1	16.2	25.2	30.7	20.9	25.9	11.5	30.1	44.3	32.3	23.0	27.1	32.3	21.7	27.8	21.7	39.1	25.2	12.5	25.2	24.4	36.8	42.8	17.0	28.9	38.8	26.6	6.5	56.3	36.0	24.7	12.5	16.4	29.3	19.7	25.2	16.8	39.8	25.9	29.6	19.7	30.1	0.0	21.7	26.8	28.9	28.2	26.0	35.7	63.1	32.9	20.4	19.1	51.5
TMEM184C	"FLJ10846, TMEM34"	ENSG00000164168	"Transmembrane protein 184C"	Q9NVA4	4	147617386-147672044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 131.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054013	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA054013: AB_2682343"	"unprognostic (5.45e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.31e-7)"	"unprognostic (4.68e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.31e-3)"	14.0	20.7	7.8	12.4	10.0	7.9	12.8	10.0	15.9	16.1	10.3	14.8	17.2	14.2	11.2	12.9	13.6	13.4	14.3	10.6	8.9	20.3	20.4	12.7	11.4	8.1	8.7	16.5	15.4	131.7	7.1	19.6	8.7	16.7	16.4	16.2	17.3	16.7	14.7	11.8	16.9	14.3	9.2	11.2	15.3	12.0	9.9	12.6	32.6	16.4	13.8	14.5	7.6	11.2	17.4	27.3	33.7	25.6	45.0	44.6	22.3	32.6	37.5	23.7	26.9	22.7	32.7	16.3	15.7	25.1	23.2	20.5	28.4	24.6	25.8	36.4	16.2	21.1	19.8	16.2	36.3	28.8	29.8	33.2	33.0	26.3	26.9	34.9	30.7	18.4	27.2	44.1	33.6	27.0	24.8	10.2	21.7	40.4	15.7	24.3	11.6	28.2	26.3	32.6	25.8	33.4	18.3	27.0	28.5	25.8	26.8	17.5	31.5	29.2	15.7	24.3	21.0	47.9	68.0	21.5	34.9	17.0	32.7	20.5	12.9	14.7	15.3	16.5	19.4	10.4	13.9	13.9	15.8	12.1	13.0	12.4	10.0	14.6	17.9	10.8	14.3	11.0	7.8	10.0	10.0	15.9	10.6	8.9	8.1	8.7	8.7	9.2	9.9	11.2	8.3	9.6	9.3	7.8	9.5	4.6	8.0	6.3	6.8	8.6	8.3	5.7	19.8	8.6	11.5	5.5	12.5	14.3	12.5	9.8	1.9	12.8	34.6	8.0	11.1	10.0	5.4	8.2	10.4	12.7	12.0	10.6	7.7	9.9	21.5	7.3	8.2	11.8	10.4	11.8	12.7	7.7	6.1	11.9	5.1	13.7	10.8	9.1	5.4	6.5	6.4	8.5	7.2	8.5	14.1	8.6	6.7	14.7	9.0	7.8	9.7	5.8	5.2	6.5	6.6	9.5	8.8	6.5	5.4	10.6	3.4	8.6	12.0	10.6	11.3	7.0
TMEM185B	"FAM11B, FLJ20979"	ENSG00000226479	"Transmembrane protein 185B"	Q9H7F4	2	120217479-120223400	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048295, HPA071744"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Endoplasmic reticulum"		"HPA048295: AB_2680345, HPA071744: AB_2686441"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.44e-4)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.55e-2)"	"prognostic unfavorable (5.71e-7)"	"unprognostic (3.09e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	11.8	7.9	7.6	7.6	8.8	5.7	9.8	8.3	7.4	7.4	7.7	8.5	6.1	10.4	5.2	9.9	9.6	6.5	11.9	7.3	7.8	9.3	6.8	8.7	6.9	8.7	8.6	5.5	9.0	25.9	6.3	7.3	8.5	9.3	5.9	4.5	9.9	7.0	10.8	7.9	8.0	9.1	8.5	7.2	8.1	13.1	8.3	7.4	10.2	7.8	7.8	9.4	8.1	9.4	29.5	11.2	9.0	18.8	20.2	24.9	16.7	23.1	21.1	19.3	16.5	34.8	27.7	0.0	16.7	20.9	22.1	18.1	8.8	17.2	24.2	13.5	15.4	13.5	9.7	7.3	22.7	0.0	26.3	20.7	24.9	20.8	24.7	18.1	15.7	14.7	13.1	14.9	17.3	23.2	13.9	19.6	13.0	13.1	23.7	9.7	0.0	9.1	17.9	22.0	13.5	12.8	19.1	27.5	18.2	10.2	9.5	21.4	20.2	10.2	22.7	20.9	8.6	10.1	15.5	12.8	12.4	15.2	27.9	0.1	0.6	0.9	0.9	0.9	1.0	0.3	0.7	0.5	0.6	0.4	0.7	0.7	1.5	1.4	0.7	0.5	0.8	0.3	7.6	8.8	8.3	7.4	7.3	7.8	8.7	8.6	8.5	8.5	8.3	9.4	12.2	16.0	2.6	4.9	9.4	8.4	36.0	7.3	14.8	2.7	8.2	5.7	8.6	5.7	4.3	7.3	6.2	9.4	4.7	4.6	1.9	18.0	12.6	4.1	5.7	11.1	1.2	3.4	2.0	12.3	29.3	12.1	12.2	7.4	7.0	5.4	7.5	4.5	15.4	1.7	1.8	4.5	2.0	7.2	4.7	6.1	4.7	8.4	7.2	3.7	5.4	7.5	5.2	5.5	6.1	13.4	6.7	2.2	6.9	16.2	5.0	3.9	6.0	3.8	0.0	17.1	8.8	18.5	9.3	10.4	4.4	14.5	7.9	4.1	4.6	14.2
TMEM245	"C9orf5, CG-2"	ENSG00000106771	"Transmembrane protein 245"	Q9H330	9	109015135-109119947	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023892	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA023892: AB_1845828"	"unprognostic (1.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (4.46e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-2)"	29.2	47.6	18.1	12.4	19.4	7.3	20.2	16.8	19.4	21.0	32.6	22.9	12.6	27.3	26.1	23.1	29.2	19.2	43.1	19.6	21.4	45.9	25.2	28.7	15.1	17.3	19.6	45.3	24.6	65.1	11.3	29.1	17.8	25.5	16.9	27.7	26.2	33.9	35.4	14.2	15.9	34.2	20.6	17.9	17.8	16.8	22.0	17.0	74.2	39.2	11.6	18.9	11.9	18.4	32.3	42.2	30.5	10.3	69.9	39.9	67.0	45.4	35.0	47.9	37.6	56.9	62.9	28.9	45.3	34.7	46.4	49.5	39.1	29.2	56.2	37.8	16.8	36.0	32.2	33.7	30.5	27.5	27.2	42.9	29.2	46.7	42.8	51.5	40.7	31.5	24.4	31.2	55.1	21.2	36.8	12.6	33.9	43.2	37.5	20.8	60.3	18.0	50.8	31.0	16.8	16.4	30.0	29.6	30.2	44.9	39.6	15.4	44.9	37.0	27.7	34.9	52.4	20.6	56.9	9.2	51.5	14.5	54.9	4.4	1.6	1.5	2.4	1.1	2.9	1.5	4.0	3.4	1.6	2.1	5.2	3.6	0.6	3.3	2.4	2.2	4.3	1.8	18.1	19.4	16.8	19.4	19.6	21.4	17.3	19.6	17.8	20.6	22.0	18.4	55.0	115.4	93.1	36.6	22.4	25.2	18.8	27.4	27.3	43.8	34.4	23.0	135.6	74.4	33.8	86.5	106.3	50.7	20.1	27.0	3.9	22.7	6.7	31.6	24.8	51.8	31.2	70.5	71.4	31.1	17.7	31.3	25.5	56.4	31.6	62.8	74.3	98.3	18.0	63.9	62.0	31.1	10.2	28.4	14.3	7.8	41.0	18.9	23.2	46.9	18.3	52.6	16.5	60.8	75.8	30.0	35.6	51.1	19.7	23.1	55.3	33.7	45.6	32.4	46.0	40.7	37.9	27.4	43.8	21.0	28.4	15.1	28.2	81.4	35.6	21.7
TMEM9B	C11orf15	ENSG00000175348	"TMEM9 domain family member B"	Q9NQ34	11	8947202-8965011	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037784	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA037784: AB_10671886"	"unprognostic (3.18e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.56e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.06e-1)"	"prognostic favorable (4.26e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.51e-3)"	"unprognostic (9.56e-2)"	34.2	40.0	67.6	33.8	70.5	78.0	47.9	70.1	80.8	37.0	62.3	63.6	54.6	22.2	59.0	62.4	31.4	39.5	53.3	65.1	69.3	60.2	39.8	50.7	40.5	70.6	69.5	24.1	41.4	63.9	38.5	45.2	71.5	34.2	67.0	42.3	51.4	26.0	47.4	45.5	54.8	22.2	70.8	41.7	59.3	27.5	72.0	35.6	75.0	42.9	43.3	47.3	35.9	75.2	63.0	42.4	23.7	46.0	117.1	65.9	41.1	78.4	69.3	45.2	46.3	32.4	96.7	39.1	40.3	81.6	53.2	81.9	22.3	57.5	47.3	72.7	45.0	26.2	36.8	31.0	66.3	53.2	79.5	61.1	94.6	27.9	56.0	61.7	54.5	26.4	21.0	58.0	87.2	43.9	16.6	33.9	7.4	90.1	49.5	18.8	30.4	31.6	67.7	72.4	26.4	22.5	44.8	92.3	40.6	29.7	55.7	35.1	59.4	55.0	24.9	93.7	48.6	24.1	44.7	27.8	69.0	35.0	47.5	178.7	104.5	151.8	98.5	134.7	101.7	103.2	94.3	109.8	112.6	89.3	77.7	109.0	50.5	93.3	150.2	80.7	136.8	159.8	67.6	70.5	70.1	80.8	65.1	69.3	70.6	69.5	71.5	70.8	72.0	75.2	61.5	41.7	52.0	17.9	65.7	65.0	65.5	155.5	58.6	61.0	67.5	35.9	28.6	70.1	104.1	95.6	20.9	104.8	69.6	124.0	70.5	84.5	16.4	29.2	28.0	49.3	31.2	111.6	21.9	80.7	112.9	48.0	34.7	43.8	88.1	21.1	55.0	30.5	109.3	43.7	23.2	78.8	213.6	79.0	109.8	13.4	38.2	70.1	60.5	15.9	58.1	82.6	77.2	24.1	33.8	70.9	103.9	28.6	53.6	59.2	114.7	45.7	53.2	49.2	19.7	41.6	26.2	56.4	58.2	83.7	87.4	160.8	66.8	40.3	82.8	80.6
TMX2	"PDIA12, TXNDC14"	ENSG00000213593	"Thioredoxin related transmembrane protein 2"	Q9Y320	11	57712593-57740973	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Lissencephaly, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040282, HPA063763"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"		"HPA040282: AB_10697715, HPA063763: AB_2685116"	"unprognostic (3.66e-3)"	"unprognostic (6.96e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.64e-4)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.26e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (5.88e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (3.37e-4)"	52.9	75.1	77.7	37.3	83.0	27.0	50.5	87.4	101.9	43.6	103.3	70.0	56.4	39.4	58.2	62.8	42.7	33.2	71.5	75.0	84.1	78.7	83.4	45.0	31.5	81.7	81.5	40.9	57.7	84.9	43.1	44.0	83.5	50.1	80.8	64.7	49.6	53.8	44.7	45.1	58.3	43.1	84.3	44.9	60.9	30.6	85.5	34.9	57.1	41.3	47.6	48.2	43.8	90.6	122.7	141.4	78.5	143.4	144.8	77.2	86.6	144.2	111.8	140.0	117.9	135.3	205.6	115.1	156.6	116.3	207.1	220.0	203.5	115.4	146.3	83.3	88.9	110.2	105.7	136.8	119.3	156.6	145.5	94.8	166.5	154.8	243.2	76.3	80.6	95.3	194.4	130.9	157.7	62.7	93.0	177.1	153.8	227.7	191.5	124.7	97.9	242.5	174.4	136.4	90.3	129.3	110.2	255.7	168.3	76.7	228.5	102.2	66.7	130.5	84.8	176.1	152.1	127.9	269.5	115.3	146.6	109.3	198.3	37.8	41.5	40.0	34.6	72.4	44.0	36.8	34.4	40.9	40.6	34.9	43.1	43.8	11.2	37.8	86.0	49.7	32.0	45.0	77.7	83.0	87.4	101.9	75.0	84.1	81.7	81.5	83.5	84.3	85.5	90.6	37.9	38.5	34.0	0.0	32.0	32.1	44.9	108.2	19.9	43.4	35.8	28.1	42.6	30.0	60.8	49.7	31.3	108.0	29.9	39.5	43.0	72.4	2.0	19.6	27.4	36.8	28.8	37.6	0.0	43.5	85.6	38.6	23.0	20.7	43.1	29.9	31.8	48.7	62.0	30.3	0.0	49.6	81.4	30.8	21.4	3.6	48.7	31.9	48.0	0.0	37.8	91.1	19.6	0.0	0.0	54.5	32.0	43.6	32.5	49.0	51.4	41.1	37.4	66.7	39.5	36.3	34.5	60.7	62.2	33.6	32.7	99.6	26.6	46.6	75.2	43.6
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 772.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA		30000000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favorable (4.71e-4)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	19.8	14.5	12.2	23.4	14.1	28.9	19.7	14.4	10.9	17.6	18.4	17.6	15.5	20.3	19.7	14.8	15.0	16.1	17.1	9.5	12.9	16.0	15.4	18.0	26.0	13.6	12.0	23.1	15.5	34.2	13.4	26.7	13.8	17.2	20.0	19.8	15.8	17.6	20.4	24.2	19.3	17.6	12.2	22.9	19.1	43.8	13.3	31.0	22.7	22.3	26.0	19.6	14.5	15.1	55.9	46.7	68.2	39.8	53.4	47.4	73.2	62.0	41.2	42.8	40.4	70.5	45.9	64.0	47.1	42.1	29.4	70.9	51.9	42.4	52.1	51.8	58.6	86.8	78.3	49.7	28.7	93.1	53.5	36.4	25.0	64.4	49.4	39.3	51.3	36.5	106.0	57.3	45.8	47.5	46.2	24.5	76.1	49.9	16.0	54.3	54.3	56.5	34.8	65.0	37.7	59.5	72.9	47.1	37.6	92.5	53.1	58.0	73.0	42.5	40.6	47.7	76.6	63.2	77.6	57.0	27.5	45.8	38.7	121.4	34.1	69.0	43.8	30.0	37.7	48.9	38.6	36.8	20.6	55.4	47.3	32.8	145.7	33.0	50.4	58.7	49.1	17.3	12.2	14.1	14.4	10.9	9.5	12.9	13.6	12.0	13.8	12.2	13.3	15.1	126.4	218.0	119.6	43.1	122.9	101.2	105.5	98.6	114.9	89.8	65.8	79.8	180.0	54.3	110.0	58.8	79.2	136.9	136.8	51.2	23.5	107.1	199.3	129.1	151.7	123.8	67.7	102.4	42.5	74.7	99.9	126.5	80.5	134.4	81.0	134.2	74.6	40.8	72.8	99.3	42.6	61.9	93.6	64.2	79.3	50.4	125.6	92.6	55.2	39.4	137.3	101.1	139.0	48.2	62.8	90.1	56.7	117.4	113.7	95.1	52.4	27.7	120.9	111.4	131.5	172.5	152.1	772.9	250.4	85.6	99.2	150.8	145.8	160.0	77.7	96.0
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 108.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 122.2;Oligodendrocytes: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 122.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	11.5	9.6	4.3	13.3	6.5	21.4	13.6	15.4	6.7	10.3	29.3	13.8	14.4	12.7	14.6	8.6	9.4	11.1	15.5	4.8	3.5	22.9	25.3	11.6	16.6	4.9	3.9	16.4	12.2	108.9	5.3	13.3	5.9	10.9	14.4	10.5	10.9	10.6	7.8	16.6	13.1	11.4	3.2	12.2	13.6	9.9	6.4	15.5	17.3	9.1	14.4	11.4	8.1	10.4	21.4	21.0	17.2	19.1	48.5	36.2	20.9	26.4	36.7	16.5	21.6	29.1	11.6	46.4	12.7	30.8	42.5	35.1	23.3	19.5	23.4	26.0	13.7	37.1	31.5	15.4	44.0	38.8	27.6	33.9	22.4	18.8	35.0	24.0	13.5	28.8	42.6	34.5	30.4	33.7	25.1	18.8	13.0	29.4	12.8	27.2	23.7	22.7	23.0	49.9	14.2	18.1	18.2	28.7	35.8	30.1	18.0	41.6	20.7	26.1	12.4	122.4	30.8	23.3	54.9	44.0	28.4	77.5	24.8	1.8	1.3	1.6	2.5	1.3	2.9	2.2	1.8	1.7	1.5	2.3	1.6	1.9	1.7	2.4	1.4	1.9	2.0	0.8	4.3	6.5	15.4	6.7	4.8	3.5	4.9	3.9	5.9	3.2	6.4	10.4	23.9	19.2	31.3	73.1	36.4	31.6	17.2	11.0	44.9	21.9	18.8	11.9	25.9	21.5	8.2	12.9	12.5	23.0	38.4	17.0	3.9	11.7	33.3	21.6	27.1	19.7	18.5	29.6	122.2	12.7	9.4	26.1	37.8	23.1	17.7	26.0	14.6	43.9	14.6	21.9	92.7	19.5	6.1	22.4	19.8	26.0	26.4	26.5	19.6	66.5	24.2	8.5	29.9	80.9	109.1	15.5	13.9	20.3	33.2	24.9	23.4	11.0	19.3	22.6	13.1	30.0	22.0	23.1	23.6	25.7	24.2	16.3	34.5	22.2	20.4	11.1
UBXN2B	p37	ENSG00000215114	"UBX domain protein 2B"	Q14CS0	8	58411359-58451501	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 42.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 42.8;monocytes: 12.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045278	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA045278: AB_10963578"	"unprognostic (1.98e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.22e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.42e-2)"	7.9	9.1	10.3	12.0	11.4	15.4	11.0	14.0	12.5	6.6	9.2	8.7	7.7	8.1	10.8	5.8	8.5	8.6	9.8	11.9	9.0	15.7	18.8	9.7	9.1	11.2	8.9	9.0	8.8	16.1	7.9	7.6	11.2	9.5	9.2	13.4	12.9	8.5	9.0	6.4	7.8	9.8	9.6	10.1	8.2	9.5	9.8	11.9	14.2	11.0	9.4	8.9	4.3	12.8	11.1	20.2	16.9	20.9	3.0	1.5	11.7	6.7	12.3	8.2	10.6	8.8	20.4	13.0	13.4	8.3	22.2	9.9	25.1	12.1	11.5	10.0	12.7	16.2	17.0	11.0	12.6	14.5	15.1	5.4	19.0	3.8	18.9	19.5	10.2	19.7	11.4	23.8	7.4	11.3	26.0	16.0	22.1	38.6	4.8	14.5	7.5	8.9	26.4	16.8	6.2	25.4	11.6	11.7	19.7	16.5	23.7	17.3	2.3	6.3	13.4	13.7	14.0	12.4	13.3	18.0	20.6	13.6	8.5	15.8	11.9	18.0	4.3	11.0	4.2	3.4	4.1	3.6	5.9	3.3	4.9	4.3	42.8	5.4	12.9	2.9	5.3	5.3	10.3	11.4	14.0	12.5	11.9	9.0	11.2	8.9	11.2	9.6	9.8	12.8	4.0	9.6	8.7	27.7	11.4	5.7	10.6	10.3	4.0	16.0	13.7	11.7	18.4	10.0	9.0	11.0	22.9	15.9	10.4	15.9	9.8	11.2	35.8	8.6	9.3	4.7	12.0	13.5	55.3	11.1	17.6	9.5	10.7	11.8	23.5	13.3	4.6	17.1	23.0	11.8	62.4	9.6	14.2	32.4	12.4	61.8	10.5	27.5	8.8	21.5	26.0	13.6	15.5	43.2	41.4	10.8	8.2	14.7	8.4	10.4	15.5	29.7	8.9	25.6	0.0	13.9	8.5	20.4	17.8	9.3	6.7	8.6	10.9	8.6	9.1	10.4
USP8	"HumORF8, KIAA0055, SPG59, UBPY"	ENSG00000138592	"Ubiquitin specific peptidase 8"	P40818	15	50424380-50514421	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050215	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA050215: AB_2681054"	"unprognostic (5.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.58e-1)"	20.3	18.8	11.5	21.1	11.0	27.6	19.6	14.4	13.3	20.5	18.1	21.5	26.7	19.1	10.4	20.7	18.5	16.4	15.1	9.1	14.6	27.0	28.1	19.5	19.0	14.1	13.1	19.9	17.4	45.1	10.6	20.3	12.5	17.0	20.8	22.2	19.8	17.2	17.6	14.2	24.4	18.4	11.5	18.7	22.5	32.0	13.6	20.9	25.4	22.7	24.3	20.0	12.6	13.2	30.6	35.8	23.7	41.1	32.3	44.3	31.0	45.7	43.9	35.7	40.4	19.5	17.7	28.8	35.0	43.5	46.6	57.8	28.8	28.3	39.9	27.2	19.3	52.9	31.9	27.3	35.9	34.3	34.4	32.4	36.2	26.0	55.8	37.0	36.3	23.3	28.4	36.8	32.9	45.9	26.6	12.0	28.5	32.6	17.1	24.1	39.1	45.8	29.5	61.3	29.1	23.8	42.5	55.9	57.4	48.9	35.8	36.9	45.0	41.1	24.1	122.7	52.7	28.5	69.8	32.4	30.6	65.6	40.1	114.6	27.7	50.1	21.4	26.1	22.1	37.3	22.9	23.3	22.7	34.3	24.0	21.2	47.9	22.1	35.0	20.5	20.0	16.0	11.5	11.0	14.4	13.3	9.1	14.6	14.1	13.1	12.5	11.5	13.6	13.2	63.5	96.1	130.8	36.2	101.8	28.9	40.7	47.3	35.9	54.5	41.7	40.0	69.8	51.5	72.7	47.8	68.8	59.0	92.7	79.5	25.4	53.7	153.7	91.5	79.7	53.8	53.3	36.8	41.0	51.3	45.4	55.8	58.1	65.6	86.7	48.5	51.0	56.6	45.4	33.7	44.3	68.7	36.7	73.2	38.2	28.4	53.7	77.6	40.9	46.9	85.3	45.5	72.1	34.7	46.1	57.3	58.2	61.7	87.1	51.0	88.9	49.9	114.9	74.2	46.0	108.2	56.2	140.5	54.8	39.6	41.5	105.2	72.6	77.1	64.8	55.3
VDR	"NR1I1, PPP1R163"	ENSG00000111424	"Vitamin D receptor"	P11473	12	47841537-47943048	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"parathyroid gland: 235.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 141.7;Proximal enterocytes: 88.7;Undifferentiated cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"classical monocyte: 3.5;eosinophil: 1.9;intermediate monocyte: 6.5;myeloid DC: 5.1;neutrophil: 6.5;non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.1;granulocytes: 6.5;monocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 55.5;HDLM-2: 80.0;U-937: 85.3"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.1"	"Region enhanced"	"Detected in some"		"spinal cord: 4.3"	"CAB004617, HPA047740, HPA072102"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Intermediate filaments, Cytosol"	"CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: "	"unprognostic (1.11e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.72e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (1.46e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.82e-2)"	3.6	13.7	0.2	13.3	0.2	8.2	11.3	0.2	0.4	5.0	0.9	40.4	56.0	1.6	0.4	13.6	1.8	8.5	1.2	0.2	0.7	21.0	1.1	7.7	5.3	0.7	0.4	0.5	2.1	235.9	11.1	2.9	0.6	1.9	35.3	0.2	6.1	1.8	2.8	22.1	55.0	3.8	0.1	2.6	7.4	1.0	1.4	1.5	2.2	0.6	7.2	10.4	7.6	0.3	15.0	2.6	0.1	0.1	12.0	16.4	0.2	17.7	8.6	15.0	12.9	10.6	12.1	3.5	17.4	13.6	10.7	27.1	0.5	55.5	6.4	80.0	4.0	6.3	3.1	0.9	8.1	12.2	20.3	23.6	30.5	16.4	26.0	22.3	1.2	1.3	1.8	3.9	7.0	9.2	0.3	6.0	0.2	34.8	19.1	0.3	0.0	9.9	13.3	13.5	6.2	0.2	14.7	42.6	5.9	0.1	47.6	6.7	1.0	28.8	7.3	8.2	10.2	2.2	0.1	3.0	8.6	85.3	7.7	0.1	3.5	1.9	0.0	6.5	0.1	0.5	0.3	0.0	5.1	0.0	0.1	0.0	6.5	0.2	6.7	0.4	0.7	1.5	0.2	0.2	0.2	0.4	0.2	0.7	0.7	0.4	0.6	0.1	1.4	0.3	0.4	12.8	20.1	0.3	1.4	36.1	9.0	8.5	24.5	0.5	21.2	13.7	1.7	0.0	9.2	7.3	0.0	0.2	0.9	141.7	7.9	3.5	0.2	11.9	0.5	1.3	21.7	0.0	0.4	10.9	0.1	5.3	14.3	4.7	7.0	0.2	0.0	0.3	3.4	0.0	0.3	32.8	2.0	7.3	43.4	0.0	0.0	21.2	8.8	1.0	10.4	0.2	0.0	0.5	0.1	22.4	43.3	0.4	10.9	8.3	88.7	32.0	9.0	0.2	0.0	1.1	2.2	0.7	0.3	23.4	40.6	0.3	2.8	0.0	72.4	11.6
VPS35L	"C16orf62, MGC16824"	ENSG00000103544	"VPS35 endosomal protein sorting factor like"	Q7Z3J2	16	19555240-19706793	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.4;Cytotrophoblasts: 29.4;Distal tubular cells: 29.4;Hofbauer cells: 44.9;Syncytiotrophoblasts: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042969, HPA053547"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA042969: AB_10794920, HPA053547: AB_2682183"	"unprognostic (7.15e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.57e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (1.31e-8)"	"unprognostic (1.82e-3)"	"unprognostic (8.92e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-2)"	19.3	22.7	23.3	15.9	33.5	13.2	17.1	21.8	24.9	21.2	11.7	19.2	13.7	20.1	22.4	16.8	19.2	17.5	17.8	20.7	23.5	22.2	14.4	16.2	14.6	23.3	24.4	23.3	16.5	35.6	20.4	20.2	24.6	15.9	19.4	16.1	12.4	18.9	22.2	13.8	15.3	25.1	20.5	17.2	13.3	31.5	28.0	16.1	22.7	25.2	16.6	18.3	15.6	40.3	22.3	37.5	35.7	28.4	44.2	60.1	5.8	32.5	52.3	33.9	38.9	6.4	37.0	27.1	67.4	51.7	0.2	6.2	27.5	16.7	36.5	1.6	15.7	16.4	32.6	0.6	57.4	25.9	31.6	43.9	24.4	31.7	21.5	48.2	54.4	13.2	22.3	6.2	55.7	15.7	23.0	7.2	24.8	3.9	5.1	19.6	11.7	7.1	38.6	5.2	21.8	22.1	43.7	1.5	18.6	27.2	12.9	22.2	61.0	17.4	16.2	25.7	3.7	23.8	45.2	10.6	33.6	21.1	27.5	26.5	35.3	16.5	18.9	42.0	23.5	14.7	18.0	18.8	42.6	23.5	21.0	18.6	4.2	37.6	37.7	11.5	21.6	28.5	23.3	33.5	21.8	24.9	20.7	23.5	23.3	24.4	24.6	20.5	28.0	40.3	32.4	6.4	16.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	9.5	9.1	0.0	0.0	8.1	16.5	0.0	29.4	5.0	0.0	29.4	20.4	0.0	8.2	15.8	15.5	0.0	0.0	0.0	17.0	19.5	8.1	0.0	11.1	3.8	18.1	0.0	0.0	44.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	10.5	0.0	0.0	1.2	0.0	0.0	21.9	2.9	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	40.2	3.4	21.0	0.0	0.0
VPS41	HVSP41	ENSG00000006715	"VPS41 subunit of HOPS complex"	P49754	7	38722974-38932394	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 118.2;Oligodendrocytes: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020080, HPA020299"	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA020080: AB_1858768, HPA020299: AB_1858769"	"unprognostic (9.20e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.40e-8)"	"unprognostic (1.62e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.28e-1)"	23.0	17.5	25.5	20.3	30.6	12.3	22.4	22.2	28.4	25.9	34.0	25.2	17.3	23.9	14.9	24.2	23.5	35.9	25.5	31.2	25.4	30.6	26.4	25.2	25.0	23.1	22.4	31.1	23.4	37.5	15.4	23.0	24.8	23.2	19.7	29.3	13.2	25.0	8.1	16.1	19.1	25.2	25.3	23.4	20.8	15.6	22.5	24.2	30.9	11.4	25.6	23.2	12.5	31.6	31.8	41.7	41.5	44.6	60.6	55.8	21.1	33.3	58.8	26.6	42.5	24.4	46.4	31.0	93.6	42.2	110.8	39.3	61.7	41.3	44.4	41.1	29.7	29.6	24.2	20.6	47.7	37.9	58.6	41.0	33.9	35.7	35.8	46.0	47.4	39.3	46.5	64.7	47.7	28.5	38.4	21.3	45.5	43.3	27.4	41.1	37.9	33.0	48.8	78.0	35.6	62.9	31.8	50.6	31.2	73.6	56.9	45.8	51.5	30.0	29.8	40.5	33.7	65.1	128.3	59.2	64.4	32.7	104.4	26.6	19.5	27.9	15.3	19.4	12.9	16.5	11.6	14.1	23.4	21.5	12.1	13.3	23.2	23.1	27.9	14.0	13.4	13.6	25.5	30.6	22.2	28.4	31.2	25.4	23.1	22.4	24.8	25.3	22.5	31.6	24.6	22.4	34.6	56.2	23.9	15.2	11.4	16.1	15.4	33.2	14.6	13.0	27.3	38.6	17.5	33.1	18.8	17.7	17.6	14.7	21.5	29.6	2.9	19.9	23.5	21.7	24.0	16.6	118.2	13.8	14.0	19.9	16.8	34.2	42.4	36.4	20.3	25.4	28.6	30.3	78.9	14.1	22.4	28.2	20.1	3.5	15.2	30.3	30.2	49.6	45.2	37.4	12.3	82.4	109.2	18.2	14.6	26.4	15.3	10.5	13.8	26.6	22.7	20.6	0.0	18.7	18.8	10.7	11.0	15.6	17.0	25.9	17.2	29.3	14.9	13.3
WDR11	"BRWD2, DR11, FLJ10506, HH14, KIAA1351, SRI1, WDR15"	ENSG00000120008	"WD repeat domain 11"	Q9BZH6	10	120851305-120909524	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038980	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Microtubules, Cytosol"		"HPA038980: AB_10675955"	"unprognostic (8.98e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.84e-1)"	"unprognostic (3.84e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.80e-3)"	"prognostic favorable (5.04e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.38e-2)"	15.2	12.3	5.9	16.9	5.7	6.6	15.3	6.7	5.1	15.4	10.8	15.2	14.2	15.3	10.8	14.8	17.7	15.0	7.8	6.0	7.1	24.4	20.2	15.2	18.6	10.1	6.5	16.0	13.6	38.6	5.3	16.8	10.9	15.6	16.6	15.1	14.4	14.2	3.5	9.7	14.9	16.9	10.3	18.5	16.1	11.5	6.6	17.9	22.5	6.5	20.2	15.7	8.6	14.7	28.5	25.1	24.8	43.4	35.4	42.2	18.0	26.0	52.4	28.3	34.9	14.7	29.1	19.9	13.1	37.5	22.5	26.5	29.1	35.8	35.4	26.5	24.2	20.8	19.9	15.3	33.6	29.6	23.6	36.7	28.5	26.2	42.2	51.7	53.1	14.0	16.9	23.3	30.1	12.1	18.7	12.9	12.8	24.8	16.1	7.7	43.3	17.4	33.7	21.8	12.2	21.8	22.6	24.9	68.8	43.3	18.4	18.7	40.0	18.6	11.6	2.8	25.1	12.9	8.6	24.3	26.4	24.8	9.9	27.4	8.5	3.8	4.5	11.2	3.6	8.5	3.0	4.1	9.7	4.6	3.1	3.3	0.6	5.9	25.3	2.3	4.3	5.2	5.9	5.7	6.7	5.1	6.0	7.1	10.1	6.5	10.9	10.3	6.6	14.7	23.7	6.4	16.4	77.7	42.3	12.0	13.5	15.5	10.8	42.8	16.6	13.6	8.3	27.1	20.1	25.8	98.0	19.3	30.5	24.3	11.7	18.3	3.8	31.7	33.1	24.4	27.1	16.6	57.0	10.5	12.1	21.8	29.6	32.7	9.5	34.2	33.9	33.9	32.2	25.2	54.2	24.5	12.2	43.2	16.5	4.4	43.5	34.9	3.6	30.9	42.4	21.0	20.6	112.1	84.7	25.3	23.4	38.7	25.6	17.9	34.8	19.9	30.1	85.3	19.7	28.9	17.9	25.8	16.3	15.6	14.2	15.2	18.9	41.7	20.6	19.3
WNT8B		ENSG00000075290	"Wnt family member 8B"	Q93098	10	100463009-100483744	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"parathyroid gland: 1.2"	"Cell type enhanced"	"Detected in single"		"Oligodendrocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.3;JURKAT: 3.1;RPMI-8226: 1.0;SCLC-21H: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA036570	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA036570: AB_10670113"	"unprognostic (6.92e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.16e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.24e-2)"	0.0	0.8	0.1	0.0	0.4	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.4	1.2	0.1	0.0	0.0	0.2	0.0	0.9	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.6	0.8	0.0	0.0	0.0	0.1	0.2	0.0	1.0	0.0	0.7	1.1	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WNT9B	"WNT14B, WNT15"	ENSG00000158955	"Wnt family member 9B"	O14905	17	46833201-46886730	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 14.0;seminal vesicle: 9.7"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Microglial cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SuSa: 7.4"	"Region enriched"	"Detected in single"	7	"thalamus: 5.8"	"Low region specificity"	"Detected in all"			"HPA058361, HPA059572"	Approved				"Secreted to extracellular matrix"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA058361: AB_2683691, HPA059572: AB_2684067"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.48e-3)"	"unprognostic (3.37e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.66e-2)"	"unprognostic (6.19e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.52e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.37e-1)"	0.3	0.3	0.6	0.0	1.0	0.1	0.3	0.3	0.8	0.1	0.0	0.0	1.7	0.2	1.2	0.1	0.1	0.1	0.5	0.4	0.6	3.2	0.7	0.2	0.1	0.7	1.3	0.0	0.1	14.0	0.0	0.6	0.3	0.1	0.0	0.1	0.0	9.7	0.1	2.4	0.9	0.2	0.5	1.0	0.0	0.1	2.3	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.6	1.0	0.3	0.8	0.4	0.6	0.7	1.3	0.3	0.5	2.3	0.5	0.1	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
YIPF6	"FinGER6, MGC21416"	ENSG00000181704	"Yip1 domain family member 6"	Q96EC8	X	68498562-68537282	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 278.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003720	Uncertain		Approved	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA003720: AB_1080626"	"unprognostic (5.07e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.85e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.32e-2)"	14.3	14.7	13.9	7.8	15.7	6.6	14.9	15.6	15.4	14.5	15.4	12.5	11.7	13.3	14.5	11.6	13.2	11.1	11.6	12.9	16.0	18.9	21.6	12.4	6.4	15.9	16.5	10.5	14.5	20.6	15.0	18.2	14.9	19.9	14.1	14.3	16.4	14.5	16.9	10.7	11.4	12.9	15.1	8.3	15.3	6.2	15.7	6.7	21.8	16.4	7.4	12.4	8.4	15.5	23.5	22.4	22.6	7.9	28.7	17.8	24.8	18.0	22.5	13.8	17.4	23.5	23.5	0.1	32.6	15.1	22.8	18.2	29.8	12.2	23.2	6.8	20.2	10.4	22.6	19.6	26.4	11.4	14.3	17.6	22.3	20.5	25.4	24.1	13.8	13.4	16.6	22.3	18.8	24.8	6.6	9.7	24.0	34.0	23.3	6.7	27.5	12.3	22.9	25.9	23.5	24.6	30.6	20.9	21.7	20.4	12.9	11.8	18.8	15.4	14.8	49.2	35.0	12.2	15.0	4.6	22.8	17.2	26.1	5.3	4.0	4.7	2.2	4.7	1.5	3.9	2.2	2.0	3.0	2.1	2.2	1.9	10.5	2.9	4.2	3.6	2.6	2.8	13.9	15.7	15.6	15.4	12.9	16.0	15.9	16.5	14.9	15.1	15.7	15.5	42.1	70.5	99.6	25.5	25.6	34.9	62.3	110.0	21.6	54.6	47.4	32.3	33.7	32.9	88.6	57.0	47.9	101.6	19.8	43.8	35.2	47.4	25.9	50.9	35.2	41.7	54.4	80.4	18.8	43.9	111.3	53.1	27.5	47.8	53.7	33.6	42.1	60.2	44.1	45.4	21.9	61.8	93.6	25.9	42.0	63.2	42.6	38.5	35.6	23.4	23.4	63.5	29.9	26.7	34.9	47.3	34.7	47.4	42.7	90.4	42.4	62.4	81.6	52.7	26.3	50.8	44.6	31.5	28.1	31.4	43.3	278.8	29.0	29.6	33.5	89.5
ZMAT4	FLJ13842	ENSG00000165061	"Zinc finger matrin-type 4"	Q9H898	8	40530590-40897833	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.5;retina: 4.4;thyroid gland: 16.3"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 220.9;Inhibitory neurons: 507.5"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	86	"NK-cell: 8.6"	"Lineage enriched"	"Detected in single"	86	"NK-cells: 8.6"	"Group enriched"	"Detected in some"	5	"AF22: 22.5;U-2197: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069813, HPA071585"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"		"HPA069813: AB_2686206, HPA071585: AB_2686423"	"unprognostic (1.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.07e-1)"		"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.46e-4)"	"unprognostic (5.44e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.79e-3)"	0.0	0.7	3.2	0.1	7.5	0.0	0.1	1.6	15.0	1.4	0.0	0.7	0.0	0.3	0.1	0.0	0.1	0.1	0.4	6.2	2.7	0.3	0.0	0.0	0.1	15.5	4.5	0.4	0.1	0.0	1.8	0.1	15.4	0.6	0.2	4.4	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.3	0.1	1.4	11.1	0.3	16.3	0.0	0.1	0.0	0.0	4.1	0.0	1.3	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.3	0.0	0.0	1.1	0.3	0.0	0.0	0.0	1.7	3.6	0.0	0.0	0.0	0.6	14.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.1	3.2	7.5	1.6	15.0	6.2	2.7	15.5	4.5	15.4	0.3	11.1	4.1	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.0	8.5	0.1	0.0	0.9	2.8	0.0	0.0	6.2	0.0	1.0	0.0	1.9	0.0	19.7	0.0	0.1	0.0	1.8	0.0	220.9	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	507.5	0.0	0.0	0.0	0.0	55.2	2.8	0.0	0.0	7.5	0.0	1.3	42.2	13.0	4.0	0.0	0.0	2.2	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.3	0.6	0.1	0.1
ZMYND11	BS69	ENSG00000015171	"Zinc finger MYND-type containing 11"	Q15326	10	134465-254637	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015816			Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA015816: AB_1845427"	"unprognostic (1.96e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (4.76e-7)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.42e-1)"	41.7	37.1	50.7	26.3	58.8	11.3	45.8	60.0	64.6	47.4	38.5	54.8	29.9	55.0	46.6	42.8	39.8	35.6	58.0	50.7	54.8	51.1	34.9	39.0	26.3	54.1	52.8	55.3	46.4	99.7	27.7	34.8	54.8	52.8	33.8	43.2	46.1	56.0	58.1	33.1	30.9	50.9	52.4	32.7	39.2	33.1	54.1	23.8	88.0	64.7	24.8	46.7	31.1	59.1	64.0	64.6	53.8	42.9	57.3	55.0	33.3	63.0	35.8	43.7	40.5	39.2	62.3	0.1	19.8	78.4	13.8	38.3	28.9	44.2	55.8	25.1	25.1	71.8	33.4	42.3	64.6	19.5	38.8	38.4	60.6	42.3	38.3	56.8	55.6	32.8	19.5	44.7	76.0	75.4	29.3	27.3	17.4	69.3	10.7	28.4	34.4	34.5	58.0	72.7	24.3	44.3	72.3	83.3	34.1	29.4	74.9	37.8	72.2	43.4	15.8	89.2	48.8	37.0	48.4	4.6	44.2	36.1	30.3	15.6	2.3	19.5	11.9	3.5	10.4	5.2	8.3	11.9	3.8	3.1	9.2	9.1	1.0	14.7	1.7	4.5	8.9	5.0	50.7	58.8	60.0	64.6	50.7	54.8	54.1	52.8	54.8	52.4	54.1	59.1	51.2	60.9	51.4	90.8	25.3	25.9	27.0	17.5	34.1	37.5	46.3	33.8	103.0	31.5	31.9	33.1	12.5	15.2	39.4	14.6	50.9	29.3	28.6	27.0	50.3	45.7	25.9	25.0	110.8	31.8	4.6	45.7	27.5	37.1	46.2	42.1	35.3	28.1	14.4	20.2	118.0	26.2	16.2	25.1	14.9	27.1	39.1	21.7	24.9	94.6	13.9	62.5	34.0	128.2	131.5	28.1	14.5	56.1	31.1	44.1	19.1	41.9	23.7	22.0	13.1	56.9	49.8	26.8	25.6	32.2	27.8	12.4	32.6	28.5	22.1	29.8
ZNF114	MGC17986	ENSG00000178150	"Zinc finger protein 114"	Q8NC26	19	48270081-48287608	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"thyroid gland: 5.9"	"Cell type enhanced"	"Detected in some"		"Spermatogonia: 4.4;Syncytiotrophoblasts: 15.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.2;Hep G2: 27.8;NTERA-2: 13.8;REH: 14.6"									"HPA025019, HPA029553"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA025019: AB_1859080, HPA029553: AB_10603005"	"unprognostic (1.82e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (2.67e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.63e-1)"	0.8	0.4	1.8	0.7	1.6	0.8	0.6	2.1	2.1	1.1	0.8	0.3	0.3	1.1	0.7	0.5	0.9	0.5	0.7	1.7	1.8	0.5	0.2	0.7	0.6	1.4	1.8	0.4	0.8	1.6	0.4	1.4	1.2	0.4	0.2	0.6	0.4	0.5	0.5	1.0	0.1	0.2	0.6	0.6	0.1	0.9	1.8	0.2	5.9	0.4	0.6	0.2	0.3	2.3	3.8	5.9	6.9	0.2	0.0	0.0	22.2	0.4	0.0	2.1	2.8	2.2	5.6	0.0	6.4	0.3	2.4	7.4	9.5	0.1	2.5	0.1	0.6	0.3	1.4	27.8	1.5	3.7	0.5	0.4	0.7	1.1	0.0	0.5	0.1	0.4	0.7	0.0	0.2	10.9	0.3	11.6	13.8	10.3	0.9	14.6	0.0	0.0	0.2	2.7	2.7	3.1	3.7	0.1	3.7	4.2	1.4	7.0	0.9	0.5	2.2	1.7	0.6	0.2	0.2	0.0	0.2	1.8	0.5	1.8	0.3	0.3	0.2	0.2	0.1	0.4	0.2	0.1	0.7	1.2	0.1	0.1	2.0	0.7	0.2	1.0	0.1	0.1	1.8	1.6	2.1	2.1	1.7	1.8	1.4	1.8	1.2	0.6	1.8	2.3	2.3	3.2	1.8	0.7	0.2	0.4	1.3	0.5	0.0	1.2	0.3	0.4	0.5	0.0	2.6	0.0	0.0	2.1	0.2	0.0	1.9	0.5	2.6	3.3	1.6	1.4	0.0	1.3	0.2	0.6	2.5	0.6	0.0	3.9	0.0	0.9	2.2	0.8	1.8	0.0	0.9	0.0	0.0	0.3	2.0	0.8	1.2	0.6	0.0	0.0	0.2	1.3	0.0	2.0	0.2	0.3	0.0	0.7	0.1	0.9	0.0	0.4	0.8	0.7	0.0	0.9	0.6	0.8	4.4	0.0	0.1	15.3	0.5	0.7	0.1	1.1
ZNF180	HHZ168	ENSG00000167384	"Zinc finger protein 180"	Q9UJW8	19	44474428-44500524	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028979, HPA028980"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA028979: AB_10600328, HPA028980: AB_10611524"	"unprognostic (2.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.38e-3)"	2.8	2.8	1.7	2.4	1.8	2.7	4.5	2.3	2.2	3.2	2.4	2.9	2.4	3.5	2.6	2.7	4.1	1.6	2.4	1.8	1.8	2.9	3.3	3.0	3.2	1.8	2.0	4.7	3.3	8.1	2.4	2.7	1.9	5.2	3.4	4.7	2.4	3.0	2.6	3.0	3.0	3.2	1.8	3.2	3.1	2.8	1.8	3.9	4.5	2.2	4.0	2.7	2.8	2.2	7.0	2.0	9.1	6.5	2.1	3.9	5.5	4.0	4.3	6.3	7.4	3.6	0.9	0.6	3.1	5.5	4.5	2.2	5.5	8.0	7.8	8.0	3.3	7.7	1.6	2.7	2.0	11.7	4.8	3.8	3.3	3.8	4.8	5.8	4.4	3.4	3.7	5.6	4.4	1.3	6.2	4.1	6.0	6.5	4.4	3.7	4.9	5.2	6.1	11.4	7.5	6.4	7.1	6.8	3.3	5.8	3.6	9.8	3.5	10.8	4.3	1.4	5.7	1.5	5.7	3.2	2.4	5.0	5.6	2.1	1.1	2.3	1.1	0.6	1.6	1.8	1.7	2.0	1.7	1.7	1.9	1.8	0.3	1.7	1.2	0.4	4.6	1.3	1.7	1.8	2.3	2.2	1.8	1.8	1.8	2.0	1.9	1.8	1.8	2.2	3.4	6.4	1.5	4.2	4.3	2.5	2.2	2.4	4.0	6.7	3.2	2.4	4.5	2.8	4.1	1.8	4.2	5.5	4.2	3.5	7.9	4.2	5.8	3.0	4.7	2.8	4.2	8.2	5.7	4.2	4.0	3.5	4.1	2.9	1.3	5.7	5.3	3.7	3.4	1.7	5.8	4.9	6.1	4.6	1.1	1.3	2.8	2.6	5.4	8.4	5.4	6.0	7.2	6.6	9.0	3.9	5.7	4.5	1.7	2.2	4.3	3.5	4.3	4.4	6.6	4.3	3.5	2.7	4.6	2.5	1.3	3.1	4.0	3.5	4.0	1.7
ZNF664	"DKFZp761B128, ZFOC1, ZNF176"	ENSG00000179195	"Zinc finger protein 664"	Q8N3J9	12	123971845-124015439	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 151.6;Late spermatids: 301.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047846			Approved	Nucleoplasm		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA047846: AB_2680179"	"unprognostic (4.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.90e-2)"	"unprognostic (8.12e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.85e-2)"	52.4	30.3	68.1	25.4	80.4	12.8	42.4	78.6	104.9	44.5	63.6	51.0	78.5	38.6	71.0	28.2	56.2	33.6	48.7	62.0	69.8	60.0	44.8	43.9	23.9	79.8	79.7	30.1	60.3	127.2	38.3	36.4	78.2	42.7	58.8	71.0	55.5	38.4	50.6	17.6	82.1	29.7	81.1	24.8	43.3	20.0	75.6	33.6	91.7	56.9	28.9	30.8	27.6	84.1	87.5	60.0	93.9	98.6	71.9	54.4	79.8	50.1	67.2	50.6	41.3	75.1	46.7	85.4	59.4	68.1	36.6	74.8	135.7	61.5	93.1	72.7	98.6	132.9	79.1	64.2	86.5	81.2	70.2	34.7	134.6	52.8	85.8	119.1	81.8	82.3	82.9	35.0	45.5	67.4	80.5	37.0	88.1	85.6	129.7	69.5	91.4	51.9	110.5	141.9	193.9	140.7	86.0	90.4	85.6	77.9	161.6	42.6	54.0	43.6	70.5	62.5	52.5	48.0	64.2	65.8	75.8	55.9	68.7	0.0	0.2	0.2	1.0	0.1	1.5	0.7	0.8	0.8	0.4	1.0	0.9	0.8	0.1	0.6	0.0	0.3	1.5	0.6	68.1	80.4	78.6	104.9	62.0	69.8	79.8	79.7	78.2	81.1	75.6	84.1	15.2	25.6	57.8	0.0	16.7	12.6	14.5	18.6	33.0	28.4	39.3	21.2	58.7	28.6	36.1	20.2	20.9	9.9	8.9	72.5	29.4	35.0	151.6	52.7	19.7	20.3	43.8	22.7	0.0	31.6	8.8	22.1	37.2	38.0	13.3	26.7	23.6	43.5	12.3	32.0	0.0	60.3	32.6	15.1	10.5	301.5	23.3	10.3	21.4	0.0	6.8	29.3	9.2	0.0	0.0	43.0	42.8	17.3	38.6	32.0	94.0	30.5	74.1	30.4	19.7	19.2	24.8	32.9	24.5	32.5	8.8	10.0	14.5	22.4	57.5	20.1
ZNF69	Cos5	ENSG00000198429	"Zinc finger protein 69"	Q9UC07	19	11887782-11914329	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 18.6;Late spermatids: 24.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 12.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 13.8"									HPA047845	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (1.08e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.97e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.83e-3)"	"unprognostic (4.12e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.93e-2)"	2.6	5.0	2.0	2.7	1.8	2.6	3.3	2.1	2.1	5.1	8.2	7.8	2.2	2.7	2.5	0.9	5.5	4.4	2.6	2.4	2.1	9.4	8.8	3.2	2.2	3.1	2.8	6.9	7.5	14.6	2.0	2.4	2.8	4.8	8.0	1.4	4.1	2.2	1.0	1.3	3.5	1.2	1.3	2.2	9.0	4.8	2.0	3.6	3.3	0.9	1.9	3.8	2.1	2.1	5.6	0.1	13.8	8.0	1.5	0.1	4.8	8.2	5.7	4.4	5.5	3.7	2.2	3.5	4.7	4.7	3.5	0.1	0.1	3.1	4.6	0.1	0.1	1.6	0.2	8.0	1.1	0.0	3.3	2.2	0.0	1.6	0.2	2.1	0.1	4.9	0.0	0.2	9.2	0.1	4.3	0.8	8.6	0.5	0.0	0.1	3.1	0.1	10.4	3.9	1.3	3.9	0.0	0.2	1.8	6.6	7.3	2.3	0.4	3.6	2.4	3.7	4.6	3.7	3.6	0.1	0.1	0.0	11.3	12.6	1.5	1.1	1.7	1.5	1.7	0.8	1.2	0.7	1.7	0.5	3.2	3.3	0.7	2.5	0.9	1.2	1.0	1.5	2.0	1.8	2.1	2.1	2.4	2.1	3.1	2.8	2.8	1.3	2.0	2.1	1.4	3.2	10.9	11.8	0.6	0.3	1.3	2.5	1.2	0.7	2.6	2.3	2.4	18.6	4.9	5.5	0.0	3.6	1.1	2.9	3.9	6.8	8.8	6.5	2.4	2.6	0.0	10.7	11.4	3.5	3.2	1.6	13.3	2.4	7.6	8.3	5.0	11.9	2.8	0.0	5.6	5.7	0.0	3.1	1.2	24.2	2.5	2.6	5.4	8.4	0.9	0.9	0.0	14.6	6.0	10.1	3.7	1.9	1.6	1.2	2.0	11.3	3.9	0.2	13.1	0.9	1.8	4.3	4.3	0.5	0.1	1.9	1.4	2.1	4.9	2.8
ZNF778	FLJ31875	ENSG00000170100	"Zinc finger protein 778"	Q96MU6	16	89217703-89237141	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 35.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA052057, HPA057151"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 6: T47d - Mammary gland"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear bodies"	Nucleoplasm	"HPA052057: AB_2681710, HPA057151: AB_2683352"	"unprognostic (3.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.53e-7)"	"unprognostic (2.51e-1)"	"unprognostic (2.85e-7)"	"unprognostic (3.22e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.63e-2)"	2.1	2.2	2.3	1.9	2.5	1.6	2.5	3.7	2.8	2.1	2.4	2.3	1.1	2.2	1.7	2.0	2.1	1.5	2.3	2.4	2.0	3.2	2.1	2.1	1.8	2.4	2.8	2.1	5.0	8.1	2.5	1.4	4.5	2.3	1.9	3.9	2.5	2.9	3.8	3.2	1.7	2.6	2.0	2.3	2.4	5.2	2.7	2.0	3.1	4.3	2.6	2.1	1.7	2.8	4.2	2.3	6.8	5.6	4.2	3.5	8.4	3.3	5.2	4.7	2.8	6.7	2.8	2.2	6.4	4.2	2.5	4.0	9.4	4.6	7.9	0.8	8.4	5.8	4.6	3.2	2.4	1.7	3.2	3.0	3.3	6.2	4.6	3.0	4.2	3.7	6.5	1.1	4.1	10.5	3.5	2.4	9.9	3.4	3.9	9.7	15.6	0.6	2.4	3.8	14.0	10.1	8.2	4.1	2.6	6.2	10.8	3.2	4.4	5.3	3.7	3.5	4.0	4.0	6.0	4.6	7.3	3.3	3.3	10.9	1.2	3.1	3.0	1.9	1.7	0.9	1.5	1.4	1.5	1.2	1.1	1.9	0.3	1.4	2.1	0.5	1.8	1.4	2.3	2.5	3.7	2.8	2.4	2.0	2.4	2.8	4.5	2.0	2.7	2.8	2.9	12.8	4.4	3.6	2.2	1.7	2.8	1.8	9.1	8.6	4.5	4.6	5.1	2.8	2.8	5.5	14.6	2.4	8.4	1.3	0.0	3.3	16.4	4.2	4.6	4.7	3.0	6.1	6.3	5.6	2.2	3.1	5.6	7.7	0.0	5.2	4.6	5.5	2.5	21.9	5.7	2.9	2.0	5.0	0.7	35.3	2.5	6.2	1.8	1.0	4.3	4.3	11.3	2.0	5.9	3.2	1.8	3.0	9.6	5.4	3.4	3.5	0.5	10.5	13.1	11.7	3.4	15.1	12.7	8.2	1.6	2.3	4.7	3.0	2.0	3.3
